id
stringlengths 7
10
| query
stringlengths 559
87.6k
| answer
stringlengths 16
1.58k
| text
stringlengths 288
87.3k
|
|---|---|---|---|
edtsum6524
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--The alcohol ethoxylates market is poised to grow by USD 1.29 billion during 2020-2024, progressing at a CAGR of about 4% during the forecast period. Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the Impact of Lockdown, and Customer Behaviour. Get FREE Sample Report in Minutes! The report on the alcohol ethoxylates market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for personal care products. The alcohol ethoxylates market analysis includes the application segment and geography landscape. This study identifies the rising demand for biosurfactants as one of the prime reasons driving the alcohol ethoxylates market growth during the next few years. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The alcohol ethoxylates market covers the following areas: Alcohol Ethoxylates Market Sizing Alcohol Ethoxylates Market Forecast Alcohol Ethoxylates Market Analysis Companies Mentioned Related Reports on Materials Include: Global Ethoxylates Market: The ethoxylates market size has the potential to grow by $ 2.13 bn during 2020-2024, and the markets growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes! Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Application Customer landscape Geographic Landscape Drivers, Challenges, and Trends Vendor Landscape Vendor Analysis Appendix Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Answer:
|
Global Alcohol Ethoxylates Market 2020-2024
|
LONDON--(BUSINESS WIRE)--The alcohol ethoxylates market is poised to grow by USD 1.29 billion during 2020-2024, progressing at a CAGR of about 4% during the forecast period. Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the Impact of Lockdown, and Customer Behaviour. Get FREE Sample Report in Minutes! The report on the alcohol ethoxylates market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for personal care products. The alcohol ethoxylates market analysis includes the application segment and geography landscape. This study identifies the rising demand for biosurfactants as one of the prime reasons driving the alcohol ethoxylates market growth during the next few years. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The alcohol ethoxylates market covers the following areas: Alcohol Ethoxylates Market Sizing Alcohol Ethoxylates Market Forecast Alcohol Ethoxylates Market Analysis Companies Mentioned Related Reports on Materials Include: Global Ethoxylates Market: The ethoxylates market size has the potential to grow by $ 2.13 bn during 2020-2024, and the markets growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes! Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Application Customer landscape Geographic Landscape Drivers, Challenges, and Trends Vendor Landscape Vendor Analysis Appendix Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
|
edtsum6527
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SALT LAKE CITY, April 1, 2021 /PRNewswire/ --Doxy.me's mission of telemedicine for all now includes dogs with dogsee.mea new telemedicine service where dogs can log in to a virtual clinic and meet with a team of dogtors. (PRNewsfoto/Doxy.me LLC) The simple, free, barkworthy telemedicine solution for dogs. Tweet this "It goes without saying that it has been a ruff year for dogs. Not only have they experienced an abundance of smothering by their stay-at-home owners over the last 12 months, but their time spent at the dog park has decreased considerably," said Brandon Welch, CEO and Founder of doxy.me. "We couldn't sit back and watch what was happening, so we adapted our industry-leading telemedicine software, doxy.me, for doctors to help enhance the well-being of our furry friends." Dogsee.me is now positioned as a leader in one of 2021's hottest telemedicine markets. Dogsee.me Fast Facts: Dogsee.me was designed with a dog-first user experience that is so simple, even the cat can do it. Dogsee.me offers a wide range of dogtors who specialize in everything from fur-care, sleep science, therapy, nutrition and more. Dogsee.me provides three unique features, including: Bone & Biscuit Prescribing, Playing Fetch and Smello-vision (the virtual sharing of olfactory cues). And the best part of all? Dogsee.me is completely free. To learn more about dogsee.me and find out what the company is really up to visit their website: https://dogsee.me/. About Doxy.meDoxy.me is the simple, free, and secure telemedicine solution. Founded in 2014 by Dr. Brandon Welch, doxy.me enables healthcare organizations to provide virtual care that's easily accessible to everyone, everywhere, on any device. According to KLAS research, doxy.me is the number one telemedicine solution healthcare organizations are relying on through the COVID-19 crisisThe platform currently hosts more than 750,000 healthcare providers who have collectively seen more than 90,000,000 patients in 2020 alone. Doxy.me is HIPAA complaint, works in-browser, and requires no additional downloads. To learn more, please visit doxy.me and follow us @doxy.me.MEDIA CONTACT: Dana FioravantiDoxy.me[emailprotected] (651) 302-3920SOURCE Doxy.me LLC Related Links www.doxy.me
Answer:
|
Doxy.me Launches Dogsee.me, The First Telemedicine Solution For Dogs Meet the team of dogsee.me dogtors, doxy.me's newest telemedicine service
|
SALT LAKE CITY, April 1, 2021 /PRNewswire/ --Doxy.me's mission of telemedicine for all now includes dogs with dogsee.mea new telemedicine service where dogs can log in to a virtual clinic and meet with a team of dogtors. (PRNewsfoto/Doxy.me LLC) The simple, free, barkworthy telemedicine solution for dogs. Tweet this "It goes without saying that it has been a ruff year for dogs. Not only have they experienced an abundance of smothering by their stay-at-home owners over the last 12 months, but their time spent at the dog park has decreased considerably," said Brandon Welch, CEO and Founder of doxy.me. "We couldn't sit back and watch what was happening, so we adapted our industry-leading telemedicine software, doxy.me, for doctors to help enhance the well-being of our furry friends." Dogsee.me is now positioned as a leader in one of 2021's hottest telemedicine markets. Dogsee.me Fast Facts: Dogsee.me was designed with a dog-first user experience that is so simple, even the cat can do it. Dogsee.me offers a wide range of dogtors who specialize in everything from fur-care, sleep science, therapy, nutrition and more. Dogsee.me provides three unique features, including: Bone & Biscuit Prescribing, Playing Fetch and Smello-vision (the virtual sharing of olfactory cues). And the best part of all? Dogsee.me is completely free. To learn more about dogsee.me and find out what the company is really up to visit their website: https://dogsee.me/. About Doxy.meDoxy.me is the simple, free, and secure telemedicine solution. Founded in 2014 by Dr. Brandon Welch, doxy.me enables healthcare organizations to provide virtual care that's easily accessible to everyone, everywhere, on any device. According to KLAS research, doxy.me is the number one telemedicine solution healthcare organizations are relying on through the COVID-19 crisisThe platform currently hosts more than 750,000 healthcare providers who have collectively seen more than 90,000,000 patients in 2020 alone. Doxy.me is HIPAA complaint, works in-browser, and requires no additional downloads. To learn more, please visit doxy.me and follow us @doxy.me.MEDIA CONTACT: Dana FioravantiDoxy.me[emailprotected] (651) 302-3920SOURCE Doxy.me LLC Related Links www.doxy.me
|
edtsum6532
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, March 10, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew York, NY 10036(212)682-3025(888) 593-4771[emailprotected] Sportsman's Warehouse Holdings, Inc. (NASDAQ: SPWH) WeissLaw LLPis investigating possible breaches of fiduciary duty and other violations of law by the board of directors ofSportsman's Warehouse Holdings, Inc. (NASDAQ: SPWH)in connection with the proposed acquisition of the company by a consortium led by Great American Outdoors Group, the parentcompany of Bass Pro Shops, Cabela's, White River Marine Group and a collection of nature-based resorts. Under the terms of the merger agreement, SPWH shareholders will receive $18.00 in cash for each SPWH share that they own. If you own SPWH shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/spwh/ Enable Midstream Partners LP (NYSE: ENBL) WeissLaw LLPis investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Enable Midstream Partners LP (NYSE: ENBL) in connection with the company's proposed combination with Energy Transfer LP ("ET"). Under the terms of agreement, ENBL unitholders will receive 0.8595 ET units for each ENBL unit that they own. If you own TPCOshares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/enbl/ NIC Inc. (NASDAQ: EGOV) WeissLaw LLPis investigating possible breaches of fiduciaryduty and other violations of law by the board of directors of NIC Inc. (NASDAQ: EGOV) in connection with the proposed acquisition of the company by TylerTechnologies Inc. Under the terms of the agreement, the company's shareholders will receive $34.00 in cash for each share of EGOV common stock that they hold. If you own EGOVshares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/egov/ GW Pharmaceuticals plc (NASDAQ: GWPH) WeissLaw LLPis investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GW Pharmaceuticals plc (NASDAQ: GWPH) in connection with the proposed acquisition of the company by Jazz Pharmaceuticals Public Limited Company ("Jazz"). Under the terms of the merger agreement, Jazz will acquire GWPH in a mixed cash-and-stock transaction for $220.00 per American Depositary Share ("ADS"), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares. If you own GWPHshares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/gwph/ SOURCE WeissLaw LLP Related Links http://weisslawllp.com
Answer:
|
SHAREHOLDER ALERT: WeissLaw LLP Reminds SPWH, ENBL, EGOV, and GWPH Shareholders About Its Ongoing Investigations
|
NEW YORK, March 10, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew York, NY 10036(212)682-3025(888) 593-4771[emailprotected] Sportsman's Warehouse Holdings, Inc. (NASDAQ: SPWH) WeissLaw LLPis investigating possible breaches of fiduciary duty and other violations of law by the board of directors ofSportsman's Warehouse Holdings, Inc. (NASDAQ: SPWH)in connection with the proposed acquisition of the company by a consortium led by Great American Outdoors Group, the parentcompany of Bass Pro Shops, Cabela's, White River Marine Group and a collection of nature-based resorts. Under the terms of the merger agreement, SPWH shareholders will receive $18.00 in cash for each SPWH share that they own. If you own SPWH shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/spwh/ Enable Midstream Partners LP (NYSE: ENBL) WeissLaw LLPis investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Enable Midstream Partners LP (NYSE: ENBL) in connection with the company's proposed combination with Energy Transfer LP ("ET"). Under the terms of agreement, ENBL unitholders will receive 0.8595 ET units for each ENBL unit that they own. If you own TPCOshares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/enbl/ NIC Inc. (NASDAQ: EGOV) WeissLaw LLPis investigating possible breaches of fiduciaryduty and other violations of law by the board of directors of NIC Inc. (NASDAQ: EGOV) in connection with the proposed acquisition of the company by TylerTechnologies Inc. Under the terms of the agreement, the company's shareholders will receive $34.00 in cash for each share of EGOV common stock that they hold. If you own EGOVshares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/egov/ GW Pharmaceuticals plc (NASDAQ: GWPH) WeissLaw LLPis investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GW Pharmaceuticals plc (NASDAQ: GWPH) in connection with the proposed acquisition of the company by Jazz Pharmaceuticals Public Limited Company ("Jazz"). Under the terms of the merger agreement, Jazz will acquire GWPH in a mixed cash-and-stock transaction for $220.00 per American Depositary Share ("ADS"), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares. If you own GWPHshares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/gwph/ SOURCE WeissLaw LLP Related Links http://weisslawllp.com
|
edtsum6541
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WASHINGTON, Aug. 11, 2020 /PRNewswire/ --The National Geographic Society today announced the election of Ellen Stofan, Joseph M. DeSimone and Rajiv Shah to its board of trustees. Stofan is the John and Adrienne Mars Director of the Smithsonian's National Air and Space Museum. DeSimone is the executive chairman and co-founder of Carbon, a leading 3D printing company, which uses molecular science and groundbreaking technology to advance the reduction of material waste in manufacturing. Shah serves as president of the Rockefeller Foundation, a global institution with a mission to promote the well-being of humanity around the world. Rajiv Shah. Photo credit: Samuel Stuart Hollenshead Joe DeSimone. Photo credit: Ian Momsen Ellen Stofan. Photo credit: Callie Broaddus "We could not be more delighted to add these three extraordinary leaders as trustees of the National Geographic Society," said Board Chair Jean M. Case. "Ellen, Joe and Rajiv represent cross-sector expertise, diverse perspectives and outstanding achievements in the realms of space, medicine, global development, finance, technology and innovation, and come to the Society at a unique point in our 132-year history. We believe it is more important than ever before to double down on our mission of using the power of science, exploration, education and storytelling to illuminate and protect the wonder of our world." With the addition of these three innovative leaders, the Board's diversity expands to 39 percent female and 22 percent people of color and further deepens its expertise in the areas of science, innovation, technology, media and education. This multicultural and multidisciplinary lens is a hallmark of the National Geographic Society during Case's tenure at the helm of the board and is a priority organization-wide, with the latest class of National Geographic Explorers the scientists, conservationists, educators and storytellers the Society funds the most diverse and multinational in the history of the organization. Thanks to National Geographic Partners the Society's joint venture partnership with The Walt Disney Company which combines the global National Geographic television channels with National Geographic's media and consumer-oriented assets more people than ever before are engaging with National Geographic content, including an unprecedented number of educators, parents and students.The Society's leadership is enhanced by the addition of new CEO Jill Tiefenthaler, who began her role as CEO on August 3."I'm looking forward to working alongside these three new trustees, as well as the rest of the board, to advance the Society's mission," said Tiefenthaler. "The Society has shown, just in the past few months, that our mission is more critical than ever. We have rapidly deployed engaging learn-at-home educational resources, a global COVID-19 emergency fund for journalistsand nine 2020-2021 Storytelling Fellowships. I'm grateful for the leadership and guidance that the board of trustees provides."More About Ellen StofanStofan is the first woman to hold her position at the National Air and Space Museum, which attracts millions of visitors each year, making it one of the world's most popular museums. She was previously NASA's chief scientist, where she helped guide the development of a long-range plan to get humans to Mars and provided input for the development of science policy in President Barack Obama's administration. Stofan is the recipient of the Presidential Early Career Award for Scientists and Engineers and the NASA Distinguished Service Medal. She has co-authored two books about space, both published by National Geographic. Stofan earned her bachelor's degree in geology at the College of William & Mary and her master's and doctoral degrees at Brown University, both in geological sciences.More About Joseph M. DeSimone DeSimone is the executive chairman and co-founder of Carbon, which is marrying the intricacies of molecular science with hardware and software technologies to advance the 3D printing industry. He is one of only 25 individuals who have been elected to all three branches of the U.S. National Academies: the National Academy of Medicine (2014), the National Academy of Sciences (2012) and the National Academy of Engineering (2005). He has received more than 50 major awards and recognitions, including the National Academy of Sciences Award for Convergent Science, the Heinz Award for Technology, the Economy and Employment, and the National Medal of Technology and Innovation, awarded by President Barack Obama. DeSimone is currently on leave from his roles at the University of North Carolina at Chapel Hill and North Carolina State University. He received his BS in Chemistry from Ursinus College, and his Ph.D. in Chemistry from Virginia Tech.More About Rajiv Shah Shah is president of the Rockefeller Foundation, a global institution with a mission to promote the well-being of humanity around the world. Previously, he was appointed USAID Administrator by President Barack Obama and unanimously confirmed by the U.S. Senate. During his tenure, he led the U.S. response to the Haiti earthquake and the West African Ebola pandemic and served on the National Security Council. Additionally, Shah has held roles at the Department of Agriculture, the Bill & Melinda Gates Foundation, co-founded private equity firm Latitude Capital and served as a Distinguished Fellow in Residence at Georgetown University. Shah is a graduate of the University of Michigan, the University of Pennsylvania School of Medicine, and the Wharton School of Business.Media Note:Headshots available here.About the National Geographic Society The National Geographic Society is a global nonprofit organization that uses the power of science, exploration, education and storytelling to illuminate and protect the wonder of our world. Since 1888, National Geographic has pushed the boundaries of exploration, investing in bold people and transformative ideas, providing more than 14,000 grants for work across all seven continents, reaching 3 million students each year through education offerings, and engaging audiences around the globe through signature experiences, stories and content. To learn more, visit www.nationalgeographic.orgor follow us on Instagram, Twitterand Facebook.Media Contact: Duncan Phillips, (202) 807-3258, [emailprotected]SOURCE National Geographic Society Related Links http://www.nationalgeographic.org
Answer:
|
National Geographic Society Names Three New Trustees: Ellen Stofan, Joseph M. DeSimone and Rajiv Shah New Appointments Further Strengthen the Society's Board Expertise in Science, Education, Innovation and Global Impact
|
WASHINGTON, Aug. 11, 2020 /PRNewswire/ --The National Geographic Society today announced the election of Ellen Stofan, Joseph M. DeSimone and Rajiv Shah to its board of trustees. Stofan is the John and Adrienne Mars Director of the Smithsonian's National Air and Space Museum. DeSimone is the executive chairman and co-founder of Carbon, a leading 3D printing company, which uses molecular science and groundbreaking technology to advance the reduction of material waste in manufacturing. Shah serves as president of the Rockefeller Foundation, a global institution with a mission to promote the well-being of humanity around the world. Rajiv Shah. Photo credit: Samuel Stuart Hollenshead Joe DeSimone. Photo credit: Ian Momsen Ellen Stofan. Photo credit: Callie Broaddus "We could not be more delighted to add these three extraordinary leaders as trustees of the National Geographic Society," said Board Chair Jean M. Case. "Ellen, Joe and Rajiv represent cross-sector expertise, diverse perspectives and outstanding achievements in the realms of space, medicine, global development, finance, technology and innovation, and come to the Society at a unique point in our 132-year history. We believe it is more important than ever before to double down on our mission of using the power of science, exploration, education and storytelling to illuminate and protect the wonder of our world." With the addition of these three innovative leaders, the Board's diversity expands to 39 percent female and 22 percent people of color and further deepens its expertise in the areas of science, innovation, technology, media and education. This multicultural and multidisciplinary lens is a hallmark of the National Geographic Society during Case's tenure at the helm of the board and is a priority organization-wide, with the latest class of National Geographic Explorers the scientists, conservationists, educators and storytellers the Society funds the most diverse and multinational in the history of the organization. Thanks to National Geographic Partners the Society's joint venture partnership with The Walt Disney Company which combines the global National Geographic television channels with National Geographic's media and consumer-oriented assets more people than ever before are engaging with National Geographic content, including an unprecedented number of educators, parents and students.The Society's leadership is enhanced by the addition of new CEO Jill Tiefenthaler, who began her role as CEO on August 3."I'm looking forward to working alongside these three new trustees, as well as the rest of the board, to advance the Society's mission," said Tiefenthaler. "The Society has shown, just in the past few months, that our mission is more critical than ever. We have rapidly deployed engaging learn-at-home educational resources, a global COVID-19 emergency fund for journalistsand nine 2020-2021 Storytelling Fellowships. I'm grateful for the leadership and guidance that the board of trustees provides."More About Ellen StofanStofan is the first woman to hold her position at the National Air and Space Museum, which attracts millions of visitors each year, making it one of the world's most popular museums. She was previously NASA's chief scientist, where she helped guide the development of a long-range plan to get humans to Mars and provided input for the development of science policy in President Barack Obama's administration. Stofan is the recipient of the Presidential Early Career Award for Scientists and Engineers and the NASA Distinguished Service Medal. She has co-authored two books about space, both published by National Geographic. Stofan earned her bachelor's degree in geology at the College of William & Mary and her master's and doctoral degrees at Brown University, both in geological sciences.More About Joseph M. DeSimone DeSimone is the executive chairman and co-founder of Carbon, which is marrying the intricacies of molecular science with hardware and software technologies to advance the 3D printing industry. He is one of only 25 individuals who have been elected to all three branches of the U.S. National Academies: the National Academy of Medicine (2014), the National Academy of Sciences (2012) and the National Academy of Engineering (2005). He has received more than 50 major awards and recognitions, including the National Academy of Sciences Award for Convergent Science, the Heinz Award for Technology, the Economy and Employment, and the National Medal of Technology and Innovation, awarded by President Barack Obama. DeSimone is currently on leave from his roles at the University of North Carolina at Chapel Hill and North Carolina State University. He received his BS in Chemistry from Ursinus College, and his Ph.D. in Chemistry from Virginia Tech.More About Rajiv Shah Shah is president of the Rockefeller Foundation, a global institution with a mission to promote the well-being of humanity around the world. Previously, he was appointed USAID Administrator by President Barack Obama and unanimously confirmed by the U.S. Senate. During his tenure, he led the U.S. response to the Haiti earthquake and the West African Ebola pandemic and served on the National Security Council. Additionally, Shah has held roles at the Department of Agriculture, the Bill & Melinda Gates Foundation, co-founded private equity firm Latitude Capital and served as a Distinguished Fellow in Residence at Georgetown University. Shah is a graduate of the University of Michigan, the University of Pennsylvania School of Medicine, and the Wharton School of Business.Media Note:Headshots available here.About the National Geographic Society The National Geographic Society is a global nonprofit organization that uses the power of science, exploration, education and storytelling to illuminate and protect the wonder of our world. Since 1888, National Geographic has pushed the boundaries of exploration, investing in bold people and transformative ideas, providing more than 14,000 grants for work across all seven continents, reaching 3 million students each year through education offerings, and engaging audiences around the globe through signature experiences, stories and content. To learn more, visit www.nationalgeographic.orgor follow us on Instagram, Twitterand Facebook.Media Contact: Duncan Phillips, (202) 807-3258, [emailprotected]SOURCE National Geographic Society Related Links http://www.nationalgeographic.org
|
edtsum6542
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DEERFIELD, Ill. & BURLINGTON, N.C.--(BUSINESS WIRE)--As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Labcorp to sell Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter in up to 6,000 Walgreens stores nationwide beginning in spring of this year. Walgreens is making significant strides to increase on-site testing capacity at more than 5,000 Walgreens pharmacy locations by April 1, with more than half of sites located in socially vulnerable areas. This kit will be Walgreens first over-the-counter COVID-19 testing option available for purchase in-store and is aimed to address stores that do not currently have testing available on-site. This builds upon Walgreens and Labcorps recent announcement of Pixel by Labcorp COVID-19 PCR Test Home Collection Kit availability on Walgreens Find Care, a digital health platform available on the Walgreens app and Walgreens.com. The addition of this over-the-counter collection kit in-store will help to ensure customers have access to testing solutions when and how they need it at-home, in-store or at one of Walgreens other conveniently located testing sites. Increasing access to COVID-19 testing continues to be a priority for Walgreens. Working with Labcorp, we can now offer testing solutions at a majority of Walgreens locations nationwide, said John Standley, president, Walgreens. This is another example of the power of innovative collaboration to drive greater access to care and products, and we look forward to continuing to work with Labcorp to provide health products and services to our communities. Labcorp is pleased to extend our strategic collaboration with Walgreens to now include over-the-counter sale of Pixel by Labcorp COVID-19 PCR Test Home Collection Kit, said Brian Caveney, M.D., chief medical officer and president, Labcorp Diagnostics. This is yet another convenient way for consumers to learn if they are infected with COVID-19, which can help communities continue the fight against this global pandemic. Customers will be able to purchase the Pixel by Labcorp COVID-19 PCR Test Home Collection Kit at the pharmacy counter without a prescription at up to 6,000 Walgreens stores nationwide. Once purchased, customers can self-administer the test collection using a short nasal swab and send their sample back to Labcorp via pre-paid FedEx Express Overnight. Once processed by Labcorp, test results are accessed by the customer via the Pixel by Labcorp website. If a COVID-19 test is positive, a Labcorp-verified healthcare staff member will contact individuals directly by phone or mail to discuss next steps. Pixel by Labcorp has contracted with a physician network to provide independent physician services for consultation. The Pixel by Labcorp COVID-19 PCR Test Home Collection Kit is not a substitute for visits to a healthcare professional and is for use by adults 18 and older. Labcorps COVID-19 PCR test has not been FDA cleared or approved and has been authorized by the FDA under an emergency use authorization only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Limited quantities available per store. About Walgreens Walgreens (www.walgreens.com) is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a global leader in retail and wholesale pharmacy. As Americas most loved pharmacy, health and beauty company, Walgreens purpose is to champion the health and well-being of every community in America. Operating more than 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving approximately 8 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with platforms bringing together physical and digital, supported by the latest technology to deliver high-quality products and services in local communities nationwide. About Labcorp Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With more than 70,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY2020. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. Cautionary Note Regarding Forward-Looking Statements. All statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, related to the ability to achieve target roll-out on schedule as well as those described in Item 1A (Risk Factors) of Walgreens Boots Alliance, Inc.s Form 10-K for its fiscal year ending August 31, 2020, and in other documents that Walgreens Boots Alliance, Inc. files or furnishes with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially. These forward-looking statements speak only as of the date they are made. Walgreens Boots Alliance, Inc. and Pixel Labcorp do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
Answer:
|
Walgreens to Make Pixel by Labcorp COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide Kit to be available for purchase at Walgreens without a prescription and will allow for greater access to testing, helping reduce the spread of COVID-19 and improve the health of communities
|
DEERFIELD, Ill. & BURLINGTON, N.C.--(BUSINESS WIRE)--As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Labcorp to sell Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter in up to 6,000 Walgreens stores nationwide beginning in spring of this year. Walgreens is making significant strides to increase on-site testing capacity at more than 5,000 Walgreens pharmacy locations by April 1, with more than half of sites located in socially vulnerable areas. This kit will be Walgreens first over-the-counter COVID-19 testing option available for purchase in-store and is aimed to address stores that do not currently have testing available on-site. This builds upon Walgreens and Labcorps recent announcement of Pixel by Labcorp COVID-19 PCR Test Home Collection Kit availability on Walgreens Find Care, a digital health platform available on the Walgreens app and Walgreens.com. The addition of this over-the-counter collection kit in-store will help to ensure customers have access to testing solutions when and how they need it at-home, in-store or at one of Walgreens other conveniently located testing sites. Increasing access to COVID-19 testing continues to be a priority for Walgreens. Working with Labcorp, we can now offer testing solutions at a majority of Walgreens locations nationwide, said John Standley, president, Walgreens. This is another example of the power of innovative collaboration to drive greater access to care and products, and we look forward to continuing to work with Labcorp to provide health products and services to our communities. Labcorp is pleased to extend our strategic collaboration with Walgreens to now include over-the-counter sale of Pixel by Labcorp COVID-19 PCR Test Home Collection Kit, said Brian Caveney, M.D., chief medical officer and president, Labcorp Diagnostics. This is yet another convenient way for consumers to learn if they are infected with COVID-19, which can help communities continue the fight against this global pandemic. Customers will be able to purchase the Pixel by Labcorp COVID-19 PCR Test Home Collection Kit at the pharmacy counter without a prescription at up to 6,000 Walgreens stores nationwide. Once purchased, customers can self-administer the test collection using a short nasal swab and send their sample back to Labcorp via pre-paid FedEx Express Overnight. Once processed by Labcorp, test results are accessed by the customer via the Pixel by Labcorp website. If a COVID-19 test is positive, a Labcorp-verified healthcare staff member will contact individuals directly by phone or mail to discuss next steps. Pixel by Labcorp has contracted with a physician network to provide independent physician services for consultation. The Pixel by Labcorp COVID-19 PCR Test Home Collection Kit is not a substitute for visits to a healthcare professional and is for use by adults 18 and older. Labcorps COVID-19 PCR test has not been FDA cleared or approved and has been authorized by the FDA under an emergency use authorization only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Limited quantities available per store. About Walgreens Walgreens (www.walgreens.com) is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a global leader in retail and wholesale pharmacy. As Americas most loved pharmacy, health and beauty company, Walgreens purpose is to champion the health and well-being of every community in America. Operating more than 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving approximately 8 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with platforms bringing together physical and digital, supported by the latest technology to deliver high-quality products and services in local communities nationwide. About Labcorp Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With more than 70,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY2020. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. Cautionary Note Regarding Forward-Looking Statements. All statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, related to the ability to achieve target roll-out on schedule as well as those described in Item 1A (Risk Factors) of Walgreens Boots Alliance, Inc.s Form 10-K for its fiscal year ending August 31, 2020, and in other documents that Walgreens Boots Alliance, Inc. files or furnishes with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially. These forward-looking statements speak only as of the date they are made. Walgreens Boots Alliance, Inc. and Pixel Labcorp do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
|
edtsum6544
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WASHINGTON, May 22, 2020 /PRNewswire/ -- NASA's Science Mission Directorate will hold a community town hall meeting via teleconference with Associate Administrator for Science Thomas Zurbuchen and his leadership team at 3 p.m. EDT Thursday, May 28, to discuss updates in NASA's science program and the current status of NASA activities. Members of the science community, academia, the media and the public are invited to participate by calling 888-989-9718. International participants should call 312-470-7045. Both numbers will use the passcode 8137047. Participants must provide their name at the prompt. A replay of the call will be available for one month at 203-369-3252. Charts for the meeting will be posted just prior to the start of the meeting and an audio recording will be available later that day at: https://science.nasa.gov To ask a question, participants can go to: https://arc.cnf.io/sessions/ykc8/#!/dashboard Users must provide their first and last name and organization, and can submit their own questions or vote up or down a list of questions submitted by others. The meeting leaders will try to answer as many of the submitted questions as possible. For more about NASA science, visit: https://science.nasa.gov SOURCE NASA Related Links http://www.nasa.gov
Answer:
|
NASA Science to Hold Virtual Community Town Hall Meeting
|
WASHINGTON, May 22, 2020 /PRNewswire/ -- NASA's Science Mission Directorate will hold a community town hall meeting via teleconference with Associate Administrator for Science Thomas Zurbuchen and his leadership team at 3 p.m. EDT Thursday, May 28, to discuss updates in NASA's science program and the current status of NASA activities. Members of the science community, academia, the media and the public are invited to participate by calling 888-989-9718. International participants should call 312-470-7045. Both numbers will use the passcode 8137047. Participants must provide their name at the prompt. A replay of the call will be available for one month at 203-369-3252. Charts for the meeting will be posted just prior to the start of the meeting and an audio recording will be available later that day at: https://science.nasa.gov To ask a question, participants can go to: https://arc.cnf.io/sessions/ykc8/#!/dashboard Users must provide their first and last name and organization, and can submit their own questions or vote up or down a list of questions submitted by others. The meeting leaders will try to answer as many of the submitted questions as possible. For more about NASA science, visit: https://science.nasa.gov SOURCE NASA Related Links http://www.nasa.gov
|
edtsum6550
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON, March 24, 2021 /PRNewswire/ --March 24, 2021 - After a 3-year hiatus, the crypto markets are back with a Big Bang Bitcoin is up nearly 500% in 12 months and even topped $58,000 in February. Ethereum has returned nearly 600% in that same time period. It's a bonanza for emerging blockchain innovators who are riding the crypto tailwinds to new areas of profit. Mentioned in today's commentary includes: Shopify Inc (NASDAQ: SHOP), Mastercard (NYSE: MA), IBM Corporation (NYSE: IBM), AMD (NASDAQ: AMD), Amazon (NASDAQ: AMZN). Seizing this unstoppable momentum, we have companies building blockchain and crypto tools such as Canada's Cloud Nine Web3 Technologies (CNI; CLGUF), andChina-based Canaan Inc. Their share prices have skyrocketed to the tune of 2,250% and 186%, respectively, over a 52-week period. Companies like Cloud Nine and Canaan Inc. are now taking the blockchain concept to an entirely new level. The Crypto Comeback Bitcoin defied pretty much every form of adversity in 2020. A key catalyst behind the massive price rise is that bitcoin has recorded a big influx of investors fromlarge-scale institutions such as pension funds, trusts, and even endowment funds. And thenumber of vendors accepting bitcoin as a form of payment is growing rapidly. PayPal now allowscustomers to buy, hold and sell bitcoin directly from their PayPal accounts Rival digital payment firmSquare reported in November that more of its Cash App users are buying the digital currency, and buying more on average than before. Possibly most importantly, Visa Inc. hasbeen warming to bitcoin. In October, the giant payment processorannounced a handful of bitcoin-related credit and debit cards with leading crypto exchange Coinbase. The Uber of Crypto Cloud Nine (CNI; CLGUF) made its name with the development of the cutting-edge Cloud Nine ESL Program for student mobility Now, it's pivoting to the crypto business in a big way It's just closed on a deal with Victory Square Technologies Inc. to acquire cryptocurrency and blockchain assets. A significant segment of the new company will operate under the Limitless brand name, with an exciting lineup of assets under the new banner, including: Desktop LimitlessCrypto Miner: A VPN-based patent pending user-based Bitcoin, Ethereum, and Altcoin miner for household use with a wait list of over 100,000 users for post-beta March 2021 launch. MicroBlock Miner, aka "Crypto in a box": A crypto miner that gives users a plug-and-play way to participate in proof-of-work mining protocols like Bitcoin, Ethereum, and other Altcoins. X2Crypto Wallet for Desktop & Mobile: A crypto credit card (VISA) paired with user friendly cryptocurrency banking services on desktop, mobile and hardware wallets. The Limitless Blockchain Platform has been branded the 'Uber of Crypto'--and for good reason. Through this acquisition,Cloud Nine (CNI; CLGUF) is rethinking the entire market. The first asset is the foundational software piece us a mobile application called Limitless VPN and it's free to download anywhere in the world. Where does the revenue come from? The VPN generates revenue from mining altcoins by leveraging the unused processing power from the Company and the User's servers. In Beta, the Limitless VPN Mining Network had an initial cost per user of $2. Upon hard launch to its 100,000 Waitlist, Cloud Nine expects to drive that user acquisition cost down to $0.15 per user and foresees up to $7.30 in profit per user / month. And by the end of 2021, Cloud Nine projects having over one million users across its platform. A Decentralized Financial Ecosystem Cloud Nine (CNI; CLGUF) believes that Bitcoin's increasing acceptance has set the stage for altcoins such as Ethereum and a new wave of financial experimentation. Coinciding with its acquisition of the Limitless VPN, they arebuilding out its user base even further with the MicroBlock 'Mine From Home', 'Crypto in a Box' Mining rigs; both of these assets really act as a funnel of sorts for its marquee asset, the 'X-2'an entire decentralized financial ecosystem. With the X-2, Cloud Ninehas a liquidity provider for banking services and crypto to crypto or crypto to fiat. The X-2 is the AirBnB of databases; a vast decentralized network through which they can distribute digital products with no centralized middleman, like AWS, Facebook or Twitter, which can (and do) shut down products at the snap of a finger. Tech Giants Are Diving Headfirst Into The Blockchain Realm Amazon (NASDAQ:AMZN)is another leader in the technology world. And it's not ignoring the blockchain boom, either. Amazon's managed blockchain platform is a game-changer. As a part of its AWS services, the relatively new platform will allow businesses to easily create and deploy their own blockchain solutions. Amazon's managed blockchain platform supports two major blockchain frameworks, the open-sourced Hyperledger Fabric platform, or the Ethereum blockchain platform. This gives users the opportunity to choose which platform works best for them. Users of Amazon's managed blockchain platform can leverage the power of this new tech in a number of different ways, from trading and asset transfers to retail and supply chain management. AMD (NASDAQ:AMD) is one of the world's leading GPU producers. And for those who aren't aware, GPUs are used to mine an array of cryptocurrencies including Ethereum. These processors are so desirable, in fact, that the demand for high-powered GPUs has eclipsed supply, creating a shortage in the market. Despite crypto miners hogging all the graphics cards, however, AMD has been very clear on its stance regarding this subject. Commenting on whether AMD's newest GPU, the RDNA 2, will limit crypto mining as its competitor, NVIDIA, has done, the company noted, "The short answer is no, we will not be blocking any workload, not just mining for that matter." IBM Corporation (NYSE:IBM) is a giant in the tech industry, with over 100 years of experience in technological innovation. IBM's long list of inventions throughout its history include; the automated teller machine (ATMs), the floppy disk, the hard drive, and much more. And it's not ignoring new trends, either. In fact, it has quickly emerged as one of the leaders in the growing blockchain space. IBM's blockchain platform, built on the open-source Hyperledger Fabric platform from the Linux Foundation is helping companies with a wide variety of blockchain solutions including tools for the finance sector, supply chain transparency, and letters of guarantee. IBM's blockchain platform even helps interested parties develop their own blockchain solutions through educational tools and personalized assistance. Mastercard (NYSE:MA) is a global innovator in payments processing that isn't ignoring the cryptocurrency and blockchain boom. In early 2021, Mastercard announced its plans to bring cryptocurrencies onto its network, stating "We are preparing right now for the future of crypto and payments, announcing that this year Mastercard will start supporting select cryptocurrencies directly on our network. This is a big change that will require a lot of work. We will be very thoughtful about which assets we support based on our principles for digital currencies, which focus on consumer protections and compliance." This move by Mastercard will help further bolster the robust payments network and allow customers to utilize the company's tried and true credit, debit, and prepaid cards to harness the power of cryptocurrency and blockchain technology in an entirely new way. Shopify Inc (NASDAQ:SHOP) is an absolute beast in the e-commerce world. In fact, because of its simple-to-use platform, it would be hard to have not stumbled onto a shop built with its technology. In addition to its revolutionary approach on e-commerce, Shopify is also delving into blockchain technology, making it a promising pick for investors, especially given that the sector is red hot right now. Its clients are even able to accept bitcoin and a variety of other cryptocurrencies as payments with a few clicks. Global lockdowns accelerated Shopify's already-tremendous growth. Since March 2020 alone, Shopify has seen its price rise from just $495 per share to a high of $1800 per share before settling down to its current price of $1400. The company has already shown its potential, but as it continues to grow, so will its innovative solutions for businesses, and by extension, it's share price. By. Pete Williams IMPORTANT NOTICE AND DISCLAIMER PAID ADVERTISEMENT. This article is a paid advertisement. GlobalInvestmentDaily.com and its owners, managers, employees, and assigns (collectively "the Publisher") is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher has been compensated by Cloud Nine Web Technologies Inc. ("Cloud Nine") to conduct investor awareness advertising and marketing. Cloud Nine paid the Publisher to produce and disseminate five similar articles and additional banner ads at a rate of sixty thousand US dollars per article. This compensation should be viewed as a major conflict with our ability to be unbiased. Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price may likely occur. This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company's SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and on interviews with company management, and does not (to the Publisher's knowledge, as confirmed by Cloud Nine) contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information. SHARE OWNERSHIP. The Publisher owns shares and/or stock options of the featured companies and therefore has an additional incentive to see the featured companies' stock perform well. The Publisher does not undertake any obligation to notify the market when it decides to buy or sell shares of the issuer in the market. The Publisher will be buying and selling shares of the featured company for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. FORWARD LOOKING STATEMENTS. This publication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. The Publisher notes that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the companies' actual results of operations. Factors that could cause actual results to differ include, but are not limited to, changing governmental laws and policies impacting the company's business including the regulation of cryptocurrency or affiliated blockchain technologies, the ability of the company to execute against its business plan, the degree of success with respect to bitcoin, various altcoins and cryptocurrency in general, the success of Cloud Nine's VPN, regulatory and / or exchange approval of any pending or future transactions, the size and growth of the market for the companies' products and services, the ability of management to execute its business plan, the continuity of management, the companies' ability to fund its capital requirements in the near term and long term, pricing pressures, etc. INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Publisher, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions. TERMS OF USE. By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here http://GlobalInvestmentDaily.com/Terms-of-Use. If you do not agree to the Terms of Use http://GlobalInvestmentDaily.com/Terms-of-Use, please contact GlobalInvestmentDaily.com to discontinue receiving future communications. INTELLECTUAL PROPERTY. GlobalInvestmentDaily.com is the Publisher's trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Publisher is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks. DISCLAIMER: GlobalInvestmentDaily.com is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with GlobalInvestmentDaily.com or any company mentioned herein. The commentary, views and opinions expressed in this release by GlobalInvestmentDaily.com are solely those of GlobalInvestmentDaily.com and are not shared by and do not reflect in any manner the views or opinions of FNM.FNM is not liable for any investment decisions by its readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release.FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements. Contact Information: Media Contact e-mail: [emailprotected] U.S. Phone: +1(954)345-0611 SOURCE GlobalInvestmentDaily.com
Answer:
|
A New Way To Play This Year's Crypto Boom - FN Media Group Presents GlobalInvestmentDaily.com Market Commentary
|
LONDON, March 24, 2021 /PRNewswire/ --March 24, 2021 - After a 3-year hiatus, the crypto markets are back with a Big Bang Bitcoin is up nearly 500% in 12 months and even topped $58,000 in February. Ethereum has returned nearly 600% in that same time period. It's a bonanza for emerging blockchain innovators who are riding the crypto tailwinds to new areas of profit. Mentioned in today's commentary includes: Shopify Inc (NASDAQ: SHOP), Mastercard (NYSE: MA), IBM Corporation (NYSE: IBM), AMD (NASDAQ: AMD), Amazon (NASDAQ: AMZN). Seizing this unstoppable momentum, we have companies building blockchain and crypto tools such as Canada's Cloud Nine Web3 Technologies (CNI; CLGUF), andChina-based Canaan Inc. Their share prices have skyrocketed to the tune of 2,250% and 186%, respectively, over a 52-week period. Companies like Cloud Nine and Canaan Inc. are now taking the blockchain concept to an entirely new level. The Crypto Comeback Bitcoin defied pretty much every form of adversity in 2020. A key catalyst behind the massive price rise is that bitcoin has recorded a big influx of investors fromlarge-scale institutions such as pension funds, trusts, and even endowment funds. And thenumber of vendors accepting bitcoin as a form of payment is growing rapidly. PayPal now allowscustomers to buy, hold and sell bitcoin directly from their PayPal accounts Rival digital payment firmSquare reported in November that more of its Cash App users are buying the digital currency, and buying more on average than before. Possibly most importantly, Visa Inc. hasbeen warming to bitcoin. In October, the giant payment processorannounced a handful of bitcoin-related credit and debit cards with leading crypto exchange Coinbase. The Uber of Crypto Cloud Nine (CNI; CLGUF) made its name with the development of the cutting-edge Cloud Nine ESL Program for student mobility Now, it's pivoting to the crypto business in a big way It's just closed on a deal with Victory Square Technologies Inc. to acquire cryptocurrency and blockchain assets. A significant segment of the new company will operate under the Limitless brand name, with an exciting lineup of assets under the new banner, including: Desktop LimitlessCrypto Miner: A VPN-based patent pending user-based Bitcoin, Ethereum, and Altcoin miner for household use with a wait list of over 100,000 users for post-beta March 2021 launch. MicroBlock Miner, aka "Crypto in a box": A crypto miner that gives users a plug-and-play way to participate in proof-of-work mining protocols like Bitcoin, Ethereum, and other Altcoins. X2Crypto Wallet for Desktop & Mobile: A crypto credit card (VISA) paired with user friendly cryptocurrency banking services on desktop, mobile and hardware wallets. The Limitless Blockchain Platform has been branded the 'Uber of Crypto'--and for good reason. Through this acquisition,Cloud Nine (CNI; CLGUF) is rethinking the entire market. The first asset is the foundational software piece us a mobile application called Limitless VPN and it's free to download anywhere in the world. Where does the revenue come from? The VPN generates revenue from mining altcoins by leveraging the unused processing power from the Company and the User's servers. In Beta, the Limitless VPN Mining Network had an initial cost per user of $2. Upon hard launch to its 100,000 Waitlist, Cloud Nine expects to drive that user acquisition cost down to $0.15 per user and foresees up to $7.30 in profit per user / month. And by the end of 2021, Cloud Nine projects having over one million users across its platform. A Decentralized Financial Ecosystem Cloud Nine (CNI; CLGUF) believes that Bitcoin's increasing acceptance has set the stage for altcoins such as Ethereum and a new wave of financial experimentation. Coinciding with its acquisition of the Limitless VPN, they arebuilding out its user base even further with the MicroBlock 'Mine From Home', 'Crypto in a Box' Mining rigs; both of these assets really act as a funnel of sorts for its marquee asset, the 'X-2'an entire decentralized financial ecosystem. With the X-2, Cloud Ninehas a liquidity provider for banking services and crypto to crypto or crypto to fiat. The X-2 is the AirBnB of databases; a vast decentralized network through which they can distribute digital products with no centralized middleman, like AWS, Facebook or Twitter, which can (and do) shut down products at the snap of a finger. Tech Giants Are Diving Headfirst Into The Blockchain Realm Amazon (NASDAQ:AMZN)is another leader in the technology world. And it's not ignoring the blockchain boom, either. Amazon's managed blockchain platform is a game-changer. As a part of its AWS services, the relatively new platform will allow businesses to easily create and deploy their own blockchain solutions. Amazon's managed blockchain platform supports two major blockchain frameworks, the open-sourced Hyperledger Fabric platform, or the Ethereum blockchain platform. This gives users the opportunity to choose which platform works best for them. Users of Amazon's managed blockchain platform can leverage the power of this new tech in a number of different ways, from trading and asset transfers to retail and supply chain management. AMD (NASDAQ:AMD) is one of the world's leading GPU producers. And for those who aren't aware, GPUs are used to mine an array of cryptocurrencies including Ethereum. These processors are so desirable, in fact, that the demand for high-powered GPUs has eclipsed supply, creating a shortage in the market. Despite crypto miners hogging all the graphics cards, however, AMD has been very clear on its stance regarding this subject. Commenting on whether AMD's newest GPU, the RDNA 2, will limit crypto mining as its competitor, NVIDIA, has done, the company noted, "The short answer is no, we will not be blocking any workload, not just mining for that matter." IBM Corporation (NYSE:IBM) is a giant in the tech industry, with over 100 years of experience in technological innovation. IBM's long list of inventions throughout its history include; the automated teller machine (ATMs), the floppy disk, the hard drive, and much more. And it's not ignoring new trends, either. In fact, it has quickly emerged as one of the leaders in the growing blockchain space. IBM's blockchain platform, built on the open-source Hyperledger Fabric platform from the Linux Foundation is helping companies with a wide variety of blockchain solutions including tools for the finance sector, supply chain transparency, and letters of guarantee. IBM's blockchain platform even helps interested parties develop their own blockchain solutions through educational tools and personalized assistance. Mastercard (NYSE:MA) is a global innovator in payments processing that isn't ignoring the cryptocurrency and blockchain boom. In early 2021, Mastercard announced its plans to bring cryptocurrencies onto its network, stating "We are preparing right now for the future of crypto and payments, announcing that this year Mastercard will start supporting select cryptocurrencies directly on our network. This is a big change that will require a lot of work. We will be very thoughtful about which assets we support based on our principles for digital currencies, which focus on consumer protections and compliance." This move by Mastercard will help further bolster the robust payments network and allow customers to utilize the company's tried and true credit, debit, and prepaid cards to harness the power of cryptocurrency and blockchain technology in an entirely new way. Shopify Inc (NASDAQ:SHOP) is an absolute beast in the e-commerce world. In fact, because of its simple-to-use platform, it would be hard to have not stumbled onto a shop built with its technology. In addition to its revolutionary approach on e-commerce, Shopify is also delving into blockchain technology, making it a promising pick for investors, especially given that the sector is red hot right now. Its clients are even able to accept bitcoin and a variety of other cryptocurrencies as payments with a few clicks. Global lockdowns accelerated Shopify's already-tremendous growth. Since March 2020 alone, Shopify has seen its price rise from just $495 per share to a high of $1800 per share before settling down to its current price of $1400. The company has already shown its potential, but as it continues to grow, so will its innovative solutions for businesses, and by extension, it's share price. By. Pete Williams IMPORTANT NOTICE AND DISCLAIMER PAID ADVERTISEMENT. This article is a paid advertisement. GlobalInvestmentDaily.com and its owners, managers, employees, and assigns (collectively "the Publisher") is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher has been compensated by Cloud Nine Web Technologies Inc. ("Cloud Nine") to conduct investor awareness advertising and marketing. Cloud Nine paid the Publisher to produce and disseminate five similar articles and additional banner ads at a rate of sixty thousand US dollars per article. This compensation should be viewed as a major conflict with our ability to be unbiased. Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price may likely occur. This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company's SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and on interviews with company management, and does not (to the Publisher's knowledge, as confirmed by Cloud Nine) contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information. SHARE OWNERSHIP. The Publisher owns shares and/or stock options of the featured companies and therefore has an additional incentive to see the featured companies' stock perform well. The Publisher does not undertake any obligation to notify the market when it decides to buy or sell shares of the issuer in the market. The Publisher will be buying and selling shares of the featured company for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. FORWARD LOOKING STATEMENTS. This publication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. The Publisher notes that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the companies' actual results of operations. Factors that could cause actual results to differ include, but are not limited to, changing governmental laws and policies impacting the company's business including the regulation of cryptocurrency or affiliated blockchain technologies, the ability of the company to execute against its business plan, the degree of success with respect to bitcoin, various altcoins and cryptocurrency in general, the success of Cloud Nine's VPN, regulatory and / or exchange approval of any pending or future transactions, the size and growth of the market for the companies' products and services, the ability of management to execute its business plan, the continuity of management, the companies' ability to fund its capital requirements in the near term and long term, pricing pressures, etc. INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Publisher, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions. TERMS OF USE. By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here http://GlobalInvestmentDaily.com/Terms-of-Use. If you do not agree to the Terms of Use http://GlobalInvestmentDaily.com/Terms-of-Use, please contact GlobalInvestmentDaily.com to discontinue receiving future communications. INTELLECTUAL PROPERTY. GlobalInvestmentDaily.com is the Publisher's trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Publisher is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks. DISCLAIMER: GlobalInvestmentDaily.com is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with GlobalInvestmentDaily.com or any company mentioned herein. The commentary, views and opinions expressed in this release by GlobalInvestmentDaily.com are solely those of GlobalInvestmentDaily.com and are not shared by and do not reflect in any manner the views or opinions of FNM.FNM is not liable for any investment decisions by its readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release.FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements. Contact Information: Media Contact e-mail: [emailprotected] U.S. Phone: +1(954)345-0611 SOURCE GlobalInvestmentDaily.com
|
edtsum6554
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals and specialty chemicals company, today announced it has entered into a definitive agreement to acquire Compass Minerals Amrica do Sul S.A., which includes the South American Plant Nutrition business of Compass Minerals after a planned carve-out of the existing water treatment and chemicals businesses for approximately R$2,207 million (~US$402 million, based on a Brazilian real-to-U.S. dollar exchange rate of R$5.4951/US$1.00). This amount includes the assumption of approximately R$600 million (~US$109 million) of net debt and is subject to customary post-closing adjustments. In addition, the transaction includes an earnout of up to approximately R$88 million (~US$16 million). The South American Plant Nutrition business is the leading specialty plant nutrition business in Brazil and offers a broad range of solutions for plant nutrition and stimulation, soil treatment, seed treatment and plant health, covering all key Brazilian crops. Its product portfolio includes enhanced efficiency fertilizers and controlled-release fertilizers, soil and foliar micronutrients, secondary nutrients, biostimulants, and adjuvants. The business has an existing presence in 25 out of 26 Brazilian states and serves more than 32,000 farms directly and indirectly, with direct-to-farm sales accounting for approximately 50% of total sales. This transaction, together with our recent acquisition of Fertilqua in Brazil and our existing specialty plant nutrition business there, will position ICL as the leading specialty plant nutrition company in Brazil, one of the worlds fastest growing agriculture markets. This important next step delivers on our stated strategy of achieving leadership positions in high-growth specialty plant nutrition markets, such as Brazil, and also accelerates our progress toward long-term global leadership for our Innovative Ag Solutions division, said Raviv Zoller, president and CEO of ICL. Also, this will significantly expand ICLs product portfolio and profitability, while providing further seasonal balance between the Northern and Southern hemispheres. In addition, this acquisition is expected to generate significant commercial and operational synergy opportunities through the combined strengths of ICL, Fertilqua and the market leading South American Plant Nutrition business of Compass Minerals and will also allow us to deliver the critical mass we have been seeking in Brazil. We look forward to welcoming the South American Plant Nutrition team and having them join our existing team in Brazil, concluded Zoller. Upon completion of the acquisition, ICL expects it will be able to offer the broadest and most advanced portfolio of plant nutrition products covering the entire agricultural value chain. Its expanded customer base will span from B2B providers such as plant nutrition manufacturers and bulk blenders to B2C partners such as ag-input retailers, co-operatives and large farms. The combined businesses will leverage a well-established asset base, with a total of eight production sites and a sizable salesforce providing full commercial coverage for all agricultural regions in Brazil. While the South American Plant Nutrition business is not part of our forward-looking strategy, we continue to believe the future is bright for these productive assets, said Kevin S. Crutchfield, president and CEO of Compass Minerals. We are therefore pleased to see this business, and more importantly the strong team of professionals who operate it, find such a strategic home with ICL. The acquisition is expected to close by the third quarter of 2021, subject to the completion of the carve-out of Compass Minerals South American water treatment and chemicals businesses and the fulfilment of customary closing conditions, including regulatory approvals. About Compass Minerals Amrica do Sul S.A. Founded in 1965 as Produqumica, the company is the leading specialty plant nutrition player in Brazil and offers a broad range of solutions for plant nutrition and stimulation, seed treatment, and plant health across all key Brazilian crops, including soybeans, corn, coffee, sugarcane, cotton, fruits, and vegetables. The company's product portfolio includes enhanced efficiency fertilizers and controlled-release fertilizers, soil and foliar micronutrients, secondary nutrients (calcium, magnesium and sulfur), biostimulants, and adjuvants, as well as animal nutrition and plant nutrition ingredients for B2B customers. The company has a presence in 25 out of 26 Brazilian states and serves more than 2,000 farms directly and more than 30,000 farms indirectly, by also serving more than 250 ag-input retailers and co-operatives. Headquartered in So Paulo, the company employs more than 1,000 people and operates six production sites and one research and development center. Full year 2020 net revenue was approximately R$1,442 million (~US$284 million), with EBITDA of approximately R$235 million (~US$46 million), excluding the water treatment and chemicals businesses(1). These results demonstrate strong top-line growth and reflect a compounded annual growth rate of approximately 10%, since the business was acquired by Compass Mineral in 2015 and 2016. About ICL ICL Group Ltd. is a leading global specialty minerals and chemicals company that creates impactful solutions for humanity's sustainability challenges in global food, agriculture, and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its passionate team of talented employees, and its strong focus on R&D and technological innovation to drive growth across its end markets. ICL shares are dually listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs over 11,000 people worldwide, and its 2020 revenues totaled approximately $5.0 billion. About Compass Minerals Compass Minerals (NYSE: CMP) is a leading provider of essential minerals focused on safely delivering where and when it matters to help solve natures challenges for customers and communities. Its salt products help keep roadways safe during winter weather and are used in numerous other consumer, industrial and agricultural applications. Its plant nutrition business manufactures an innovative and diverse portfolio of products that improve the quality and yield of crops, while supporting sustainable agriculture. Additionally, its specialty chemical business serves the water treatment industry and other industrial processes. The company operates 21 production and packaging facilities with more than 3,000 personnel throughout the U.S., Canada, Brazil and the U.K. Visit compassminerals.com for more information about the company and its products. For more information, visit ICL's website at www.icl-group.com. To access ICL's interactive Corporate Social Responsibility report, please click here. You can also learn more about ICL on Facebook, LinkedIn and Instagram. (1) Amounts reflect average Brazilian Real to U.S. Dollar exchange rate for 2020. Forward Looking Statements This announcement contains statements that constitute forwardlooking statements, many of which can be identified by the use of forwardlooking words such as anticipate, believe, could, expect, should, plan, intend, estimate and potential, among others. Forward-looking statements appear in a number of places in this press release and include, but are not limited to, statements regarding the companys intent, belief or current expectations. Forward-looking statements are based on managements beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to: the companys ability to satisfy the closing conditions for the transaction on a timely basis or at all; the anticipated effect of the transaction on the crop nutrition business; ICL's strategic focus in Brazil; and estimated accretion, sales, synergy capture and other related metrics; as well as, ICL's expectations and assumptions concerning the time necessary to satisfy the conditions to the closing of the transaction, including the regulatory approvals in connection therewith and synergy capture. Although ICL believes the expectations and assumptions on which such forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because ICL can give no assurance they will prove to be correct. The anticipated timeline for completion of the transaction may change for a number of reasons, including the inability to secure necessary regulatory approvals in the time assumed or the need for additional time to satisfy the conditions to the completion of the transaction. Other factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, estimates, forecasts and statements as to management's expectations with respect to, among other things, business and financial prospects, financial multiples and accretion estimates, future trends, plans, strategies, positioning, objectives and expectations, failure to complete the transaction as contemplated and the ability to successfully integrate the new business into the existing business in an effective manner, general economic, market and business conditions, weather conditions, crop prices, the supply and demand and price levels for our major products and products associated with the plant nutrition business, governmental and regulatory requirements and actions by governmental authorities, including changes in government policy, changes in environmental, tax and other laws or regulations and the interpretation thereof. As a result of the foregoing, readers should not place undue reliance on the forward-looking statements contained in this press release concerning the timing of the transaction, or other more specific risks and uncertainties facing ICL, such as those set forth in the Risk Factors section of its Annual Report on Form 20-F filed on March 2, 2021, as such risk factors may be updated from time to time in its Current Reports on Form 6-K and other filings ICL makes with the U.S. Securities and Exchange Commission from time to time. Forward-looking statements refer only to the date they are made, and the company does not undertake any obligation to update them in light of new information or future developments or to publicly release any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.
Answer:
|
ICL to Acquire South American Plant Nutrition Business from Compass Minerals Acquisition positions ICL as Brazils leading specialty plant nutrition company
|
TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals and specialty chemicals company, today announced it has entered into a definitive agreement to acquire Compass Minerals Amrica do Sul S.A., which includes the South American Plant Nutrition business of Compass Minerals after a planned carve-out of the existing water treatment and chemicals businesses for approximately R$2,207 million (~US$402 million, based on a Brazilian real-to-U.S. dollar exchange rate of R$5.4951/US$1.00). This amount includes the assumption of approximately R$600 million (~US$109 million) of net debt and is subject to customary post-closing adjustments. In addition, the transaction includes an earnout of up to approximately R$88 million (~US$16 million). The South American Plant Nutrition business is the leading specialty plant nutrition business in Brazil and offers a broad range of solutions for plant nutrition and stimulation, soil treatment, seed treatment and plant health, covering all key Brazilian crops. Its product portfolio includes enhanced efficiency fertilizers and controlled-release fertilizers, soil and foliar micronutrients, secondary nutrients, biostimulants, and adjuvants. The business has an existing presence in 25 out of 26 Brazilian states and serves more than 32,000 farms directly and indirectly, with direct-to-farm sales accounting for approximately 50% of total sales. This transaction, together with our recent acquisition of Fertilqua in Brazil and our existing specialty plant nutrition business there, will position ICL as the leading specialty plant nutrition company in Brazil, one of the worlds fastest growing agriculture markets. This important next step delivers on our stated strategy of achieving leadership positions in high-growth specialty plant nutrition markets, such as Brazil, and also accelerates our progress toward long-term global leadership for our Innovative Ag Solutions division, said Raviv Zoller, president and CEO of ICL. Also, this will significantly expand ICLs product portfolio and profitability, while providing further seasonal balance between the Northern and Southern hemispheres. In addition, this acquisition is expected to generate significant commercial and operational synergy opportunities through the combined strengths of ICL, Fertilqua and the market leading South American Plant Nutrition business of Compass Minerals and will also allow us to deliver the critical mass we have been seeking in Brazil. We look forward to welcoming the South American Plant Nutrition team and having them join our existing team in Brazil, concluded Zoller. Upon completion of the acquisition, ICL expects it will be able to offer the broadest and most advanced portfolio of plant nutrition products covering the entire agricultural value chain. Its expanded customer base will span from B2B providers such as plant nutrition manufacturers and bulk blenders to B2C partners such as ag-input retailers, co-operatives and large farms. The combined businesses will leverage a well-established asset base, with a total of eight production sites and a sizable salesforce providing full commercial coverage for all agricultural regions in Brazil. While the South American Plant Nutrition business is not part of our forward-looking strategy, we continue to believe the future is bright for these productive assets, said Kevin S. Crutchfield, president and CEO of Compass Minerals. We are therefore pleased to see this business, and more importantly the strong team of professionals who operate it, find such a strategic home with ICL. The acquisition is expected to close by the third quarter of 2021, subject to the completion of the carve-out of Compass Minerals South American water treatment and chemicals businesses and the fulfilment of customary closing conditions, including regulatory approvals. About Compass Minerals Amrica do Sul S.A. Founded in 1965 as Produqumica, the company is the leading specialty plant nutrition player in Brazil and offers a broad range of solutions for plant nutrition and stimulation, seed treatment, and plant health across all key Brazilian crops, including soybeans, corn, coffee, sugarcane, cotton, fruits, and vegetables. The company's product portfolio includes enhanced efficiency fertilizers and controlled-release fertilizers, soil and foliar micronutrients, secondary nutrients (calcium, magnesium and sulfur), biostimulants, and adjuvants, as well as animal nutrition and plant nutrition ingredients for B2B customers. The company has a presence in 25 out of 26 Brazilian states and serves more than 2,000 farms directly and more than 30,000 farms indirectly, by also serving more than 250 ag-input retailers and co-operatives. Headquartered in So Paulo, the company employs more than 1,000 people and operates six production sites and one research and development center. Full year 2020 net revenue was approximately R$1,442 million (~US$284 million), with EBITDA of approximately R$235 million (~US$46 million), excluding the water treatment and chemicals businesses(1). These results demonstrate strong top-line growth and reflect a compounded annual growth rate of approximately 10%, since the business was acquired by Compass Mineral in 2015 and 2016. About ICL ICL Group Ltd. is a leading global specialty minerals and chemicals company that creates impactful solutions for humanity's sustainability challenges in global food, agriculture, and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its passionate team of talented employees, and its strong focus on R&D and technological innovation to drive growth across its end markets. ICL shares are dually listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs over 11,000 people worldwide, and its 2020 revenues totaled approximately $5.0 billion. About Compass Minerals Compass Minerals (NYSE: CMP) is a leading provider of essential minerals focused on safely delivering where and when it matters to help solve natures challenges for customers and communities. Its salt products help keep roadways safe during winter weather and are used in numerous other consumer, industrial and agricultural applications. Its plant nutrition business manufactures an innovative and diverse portfolio of products that improve the quality and yield of crops, while supporting sustainable agriculture. Additionally, its specialty chemical business serves the water treatment industry and other industrial processes. The company operates 21 production and packaging facilities with more than 3,000 personnel throughout the U.S., Canada, Brazil and the U.K. Visit compassminerals.com for more information about the company and its products. For more information, visit ICL's website at www.icl-group.com. To access ICL's interactive Corporate Social Responsibility report, please click here. You can also learn more about ICL on Facebook, LinkedIn and Instagram. (1) Amounts reflect average Brazilian Real to U.S. Dollar exchange rate for 2020. Forward Looking Statements This announcement contains statements that constitute forwardlooking statements, many of which can be identified by the use of forwardlooking words such as anticipate, believe, could, expect, should, plan, intend, estimate and potential, among others. Forward-looking statements appear in a number of places in this press release and include, but are not limited to, statements regarding the companys intent, belief or current expectations. Forward-looking statements are based on managements beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to: the companys ability to satisfy the closing conditions for the transaction on a timely basis or at all; the anticipated effect of the transaction on the crop nutrition business; ICL's strategic focus in Brazil; and estimated accretion, sales, synergy capture and other related metrics; as well as, ICL's expectations and assumptions concerning the time necessary to satisfy the conditions to the closing of the transaction, including the regulatory approvals in connection therewith and synergy capture. Although ICL believes the expectations and assumptions on which such forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because ICL can give no assurance they will prove to be correct. The anticipated timeline for completion of the transaction may change for a number of reasons, including the inability to secure necessary regulatory approvals in the time assumed or the need for additional time to satisfy the conditions to the completion of the transaction. Other factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, estimates, forecasts and statements as to management's expectations with respect to, among other things, business and financial prospects, financial multiples and accretion estimates, future trends, plans, strategies, positioning, objectives and expectations, failure to complete the transaction as contemplated and the ability to successfully integrate the new business into the existing business in an effective manner, general economic, market and business conditions, weather conditions, crop prices, the supply and demand and price levels for our major products and products associated with the plant nutrition business, governmental and regulatory requirements and actions by governmental authorities, including changes in government policy, changes in environmental, tax and other laws or regulations and the interpretation thereof. As a result of the foregoing, readers should not place undue reliance on the forward-looking statements contained in this press release concerning the timing of the transaction, or other more specific risks and uncertainties facing ICL, such as those set forth in the Risk Factors section of its Annual Report on Form 20-F filed on March 2, 2021, as such risk factors may be updated from time to time in its Current Reports on Form 6-K and other filings ICL makes with the U.S. Securities and Exchange Commission from time to time. Forward-looking statements refer only to the date they are made, and the company does not undertake any obligation to update them in light of new information or future developments or to publicly release any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.
|
edtsum6559
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BLOOMINGTON, Minn., Aug. 11, 2020 /PRNewswire/ -- Caravel Autism Health has opened the doors to a new autism therapy center in Bloomington, MN for children who are on the autism spectrum and their families. Located at 6300 West Old Shakopee Road, the new Bloomington center is staffed by autism health specialists who provide diagnostic evaluations and evidence-based treatment. Caravel Autism Health's team includes clinical professionals who are specially trained in evaluating children who may be on the autism spectrum. The team also has expertise in creating and leading individualized Applied Behavior Analysis ("ABA") treatment plans that help children with autism develop skills, create connections, and gain confidence. One in 54 children in the U.S. has autism, according to the Centers for Disease Control and Prevention. In Minnesota, one in 44 children has autism. According to Caravel Autism Health CEO Mike Miller, "We saw very strong demand from Minnesota families who wanted better access to specialists who can provide both diagnosis and treatment. We wanted to step up and close that gap." Caravel Autism Health opened its first Minnesota autism therapy center in Rochester in October 2019 and has quickly added seven other new centers across the state since then. "Families with questions about whether their children were on the autism spectrum were encountering significant wait times for seeing specialists," explained Jackie Vick, Vice President of Minnesota Clinical Operations for Caravel Autism Health. "These delays are significant because timing is critical. The earlier we can begin providing intensive ABA therapy for children with autism, the greater the gains can be in learning, communication, and social skills. We knew these families needed us to open our doors, so we couldn't let the pandemic stop us," said Vick. Caravel Autism Health has implemented strict COVID-19 protocols and practices, guided by the CDC and its own internal safety committee. Caravel Autism Health will host a ribbon-cutting event in September. To learn more, visit www.caravelautism.com or call the Client Intake Team at 507-322-7752. About Caravel Autism HealthFounded in 2009, Caravel Autism Health is devoted to helping families navigate the challenges of childhood autism. Caravel's team of autism health experts specializes in the evaluation, diagnosis and treatment of children on the autism spectrum. Caravel's research-based programs help children with autism reshape their development and embrace new ways of interacting with the world. SOURCE Caravel Autism Health Related Links https://www.caravelautism.com
Answer:
|
Caravel Autism Health Opens 8th New Center in Minnesota
|
BLOOMINGTON, Minn., Aug. 11, 2020 /PRNewswire/ -- Caravel Autism Health has opened the doors to a new autism therapy center in Bloomington, MN for children who are on the autism spectrum and their families. Located at 6300 West Old Shakopee Road, the new Bloomington center is staffed by autism health specialists who provide diagnostic evaluations and evidence-based treatment. Caravel Autism Health's team includes clinical professionals who are specially trained in evaluating children who may be on the autism spectrum. The team also has expertise in creating and leading individualized Applied Behavior Analysis ("ABA") treatment plans that help children with autism develop skills, create connections, and gain confidence. One in 54 children in the U.S. has autism, according to the Centers for Disease Control and Prevention. In Minnesota, one in 44 children has autism. According to Caravel Autism Health CEO Mike Miller, "We saw very strong demand from Minnesota families who wanted better access to specialists who can provide both diagnosis and treatment. We wanted to step up and close that gap." Caravel Autism Health opened its first Minnesota autism therapy center in Rochester in October 2019 and has quickly added seven other new centers across the state since then. "Families with questions about whether their children were on the autism spectrum were encountering significant wait times for seeing specialists," explained Jackie Vick, Vice President of Minnesota Clinical Operations for Caravel Autism Health. "These delays are significant because timing is critical. The earlier we can begin providing intensive ABA therapy for children with autism, the greater the gains can be in learning, communication, and social skills. We knew these families needed us to open our doors, so we couldn't let the pandemic stop us," said Vick. Caravel Autism Health has implemented strict COVID-19 protocols and practices, guided by the CDC and its own internal safety committee. Caravel Autism Health will host a ribbon-cutting event in September. To learn more, visit www.caravelautism.com or call the Client Intake Team at 507-322-7752. About Caravel Autism HealthFounded in 2009, Caravel Autism Health is devoted to helping families navigate the challenges of childhood autism. Caravel's team of autism health experts specializes in the evaluation, diagnosis and treatment of children on the autism spectrum. Caravel's research-based programs help children with autism reshape their development and embrace new ways of interacting with the world. SOURCE Caravel Autism Health Related Links https://www.caravelautism.com
|
edtsum6564
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: HOWELL, N.J., March 9, 2021 /PRNewswire/ --Cardknox, the leading developer-friendly payment solution provider, today announced its new Split Capture tool that's been designed to enhance business operations for e-commerce merchants who process payments through Cardknox. With the help of this valuable feature, online businesses that ship out orders in increments can capture the amount of each separate shipment as it goes out. As a standard practice, many e-commerce merchants process an authorization-only transaction at the time of sale in order to place a hold on the cardholder's funds. Then, once the order has shipped out, the merchant will capture the prior authorization-only transaction in order to transfer the funds out of the cardholder's account. While this payment processing method is ideal when the order consists of just one shipment, it is not as suitable for orders that are fulfilled in multiple increments. To address this common pain point for wholesalers and other online retailers, Cardknox has launched its new Split Capture tool. Cardknox clients who use the Cardknox Merchant Portal web application to process payments now have the option to enable Split Capture in order to run multiple captures for a single transaction. By doing so, merchants are able to place a hold on the total transaction amount at the time of sale and then initiate funding as each shipment goes out. As a result, they'll enjoy more control over their payment processing flow, and they'll be able to maintain more organized records in which payments adequately reflect shipments. In addition to rolling out Split Capture within the Cardknox Merchant Portal, Cardknox has added Split Capture to its API so that independent software vendors and developers can set up clients with Split Capture via a Cardknox gateway integration. "We're excited to add Split Capture to our extensive lineup of e-commerce features," says Mark Paley, VP of Sales at Cardknox. "Cardknox strives to develop payment solutions that cater to the unique needs of merchants, and for e-commerce businesses in particular, we know that having a streamlined order fulfillment and invoicing process is of tremendous value." To learn more about Cardknox's e-commerce solutions preferred by merchants and ISVs alike, visit www.cardknox.com/ecommerce-payments. About Cardknox Cardknox is an omnichannel payment gateway that can be seamlessly integrated with POS systems, ERP software, e-commerce, and mobile platforms. Offering flexible payment solutions and innovative technology to qualify transactions for the lowest interchange rates, Cardknox serves thousands of partners and customers across every major industry throughout the U.S., the U.K., and Canada. For more information, visit www.cardknox.com. Media Contact: Chaya Poltorak Director of Marketing and Product[emailprotected] (844) 227-3566 SOURCE Cardknox
Answer:
|
Cardknox's Online Payment Processing Solutions Now Supports Split Capture Payments for E-Commerce The Split Capture feature enables e-commerce businesses to capture multiple payments for a single authorization-only transaction.
|
HOWELL, N.J., March 9, 2021 /PRNewswire/ --Cardknox, the leading developer-friendly payment solution provider, today announced its new Split Capture tool that's been designed to enhance business operations for e-commerce merchants who process payments through Cardknox. With the help of this valuable feature, online businesses that ship out orders in increments can capture the amount of each separate shipment as it goes out. As a standard practice, many e-commerce merchants process an authorization-only transaction at the time of sale in order to place a hold on the cardholder's funds. Then, once the order has shipped out, the merchant will capture the prior authorization-only transaction in order to transfer the funds out of the cardholder's account. While this payment processing method is ideal when the order consists of just one shipment, it is not as suitable for orders that are fulfilled in multiple increments. To address this common pain point for wholesalers and other online retailers, Cardknox has launched its new Split Capture tool. Cardknox clients who use the Cardknox Merchant Portal web application to process payments now have the option to enable Split Capture in order to run multiple captures for a single transaction. By doing so, merchants are able to place a hold on the total transaction amount at the time of sale and then initiate funding as each shipment goes out. As a result, they'll enjoy more control over their payment processing flow, and they'll be able to maintain more organized records in which payments adequately reflect shipments. In addition to rolling out Split Capture within the Cardknox Merchant Portal, Cardknox has added Split Capture to its API so that independent software vendors and developers can set up clients with Split Capture via a Cardknox gateway integration. "We're excited to add Split Capture to our extensive lineup of e-commerce features," says Mark Paley, VP of Sales at Cardknox. "Cardknox strives to develop payment solutions that cater to the unique needs of merchants, and for e-commerce businesses in particular, we know that having a streamlined order fulfillment and invoicing process is of tremendous value." To learn more about Cardknox's e-commerce solutions preferred by merchants and ISVs alike, visit www.cardknox.com/ecommerce-payments. About Cardknox Cardknox is an omnichannel payment gateway that can be seamlessly integrated with POS systems, ERP software, e-commerce, and mobile platforms. Offering flexible payment solutions and innovative technology to qualify transactions for the lowest interchange rates, Cardknox serves thousands of partners and customers across every major industry throughout the U.S., the U.K., and Canada. For more information, visit www.cardknox.com. Media Contact: Chaya Poltorak Director of Marketing and Product[emailprotected] (844) 227-3566 SOURCE Cardknox
|
edtsum6566
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, Feb. 1, 2021 /PRNewswire/ --Hunch Snacks, a natural snacks start-up, is ready to break off a piece of the confectionary category with a better for you snack indulgence for today's consumer. Introducing a fresh take on an iconic treat, Hunch launched a line of Organic Dark Chocolate Bites in four flavors: Peanut Butter, Almond, Hazelnut and Chocolate. Each crispy, creamy bite is certified organic, non-GMO, kosher, gluten-free and is free from artificial colors and flavors. Introducing a fresh take on an iconic treat, Hunch launched a line of Organic Dark Chocolate Bites in four flavors. "As consumers, we've come to taste the difference between high-quality, better for you snacks and what we fondly munched on as kids," said Yael Hazum, CMO at Hunch. "Chocolate lovers now know there is absolutely no need to compromise since the most delicious snacks are made from the best ingredients. We are thrilled to bring the first organic and gluten-free dark chocolate wafers to market for consumers who seek yummy goodness in every bite." Whether as a snack just for you, or to share with friends and family, these high-quality bites are made from ingredients you can feel good about enjoying. Hunch Organic Dark Chocolate Bites are naturally delicious and each light, crispy wafer is covered in an irresistible silky, dark chocolate made with 60% cocoa solids. Packaged in beautiful, brightly colored 3.5oz resealable pouches, they are perfect for any snack pantry. Shoppers are far more discerning when it comes to what they eat during the current pandemic, but are still enthusiastically embracing sweets and treats, turning to comforting foods that bring joy and pleasure, according to a June 2020 Packaged Facts research report.Hunch Organic Dark Chocolate Bites are available nationally at natural and conventional grocery retailers or on Amazon.com. We have a hunch you'll love them all!About Hunch SnacksNatural snack start-up Hunch Snacks is deliciously elevating snack perfection with every bite-sized treat. Hunch launched with four flavors of Hunch Organic Chocolate Bites: Peanut Butter, Almond, Hazelnut and Chocolate. Hunch snacks are made with only the highest quality ingredients, including organic nut butters and smooth chocolate made with 60% cocoa solids. Each crispy, creamy wafer bite is certified organic, non-GMO, kosher, gluten-free and is always free from artificial colors and flavors. We have a hunch you'll love them! For more information visit www.hunchsnacks.com. SOURCE Hunch Snacks
Answer:
|
We Have a Hunch You'll Love This! ORGANIC DARK CHOCOLATE BITES ARE SNACKING PERFECTION
|
NEW YORK, Feb. 1, 2021 /PRNewswire/ --Hunch Snacks, a natural snacks start-up, is ready to break off a piece of the confectionary category with a better for you snack indulgence for today's consumer. Introducing a fresh take on an iconic treat, Hunch launched a line of Organic Dark Chocolate Bites in four flavors: Peanut Butter, Almond, Hazelnut and Chocolate. Each crispy, creamy bite is certified organic, non-GMO, kosher, gluten-free and is free from artificial colors and flavors. Introducing a fresh take on an iconic treat, Hunch launched a line of Organic Dark Chocolate Bites in four flavors. "As consumers, we've come to taste the difference between high-quality, better for you snacks and what we fondly munched on as kids," said Yael Hazum, CMO at Hunch. "Chocolate lovers now know there is absolutely no need to compromise since the most delicious snacks are made from the best ingredients. We are thrilled to bring the first organic and gluten-free dark chocolate wafers to market for consumers who seek yummy goodness in every bite." Whether as a snack just for you, or to share with friends and family, these high-quality bites are made from ingredients you can feel good about enjoying. Hunch Organic Dark Chocolate Bites are naturally delicious and each light, crispy wafer is covered in an irresistible silky, dark chocolate made with 60% cocoa solids. Packaged in beautiful, brightly colored 3.5oz resealable pouches, they are perfect for any snack pantry. Shoppers are far more discerning when it comes to what they eat during the current pandemic, but are still enthusiastically embracing sweets and treats, turning to comforting foods that bring joy and pleasure, according to a June 2020 Packaged Facts research report.Hunch Organic Dark Chocolate Bites are available nationally at natural and conventional grocery retailers or on Amazon.com. We have a hunch you'll love them all!About Hunch SnacksNatural snack start-up Hunch Snacks is deliciously elevating snack perfection with every bite-sized treat. Hunch launched with four flavors of Hunch Organic Chocolate Bites: Peanut Butter, Almond, Hazelnut and Chocolate. Hunch snacks are made with only the highest quality ingredients, including organic nut butters and smooth chocolate made with 60% cocoa solids. Each crispy, creamy wafer bite is certified organic, non-GMO, kosher, gluten-free and is always free from artificial colors and flavors. We have a hunch you'll love them! For more information visit www.hunchsnacks.com. SOURCE Hunch Snacks
|
edtsum6567
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WASHINGTON, Oct. 29, 2020 /PRNewswire/ -- The Association for Digital Asset Markets (ADAM) announced the appointment of Michelle Bond as its new Chief Executive Officer. Bond is widely respected in the financial services industry, and she plans to broaden and deepen ADAM's role as the industry leader in developing best practices to boost market integrity and foster fair and orderly conduct in the digital asset marketplace. "ADAM is focused on bridging the gap between firms in digital asset markets and regulators. We look forward to Michelle leveraging her expertise to guide us through a rapidly changing landscape, grow our membership, and launch exciting new strategic initiatives that help our members stay ahead of breaking developments in digital asset regulation." Mike Novogratz, CEO of Galaxy Digital Serving in both the public and private sectors, Bond brings with her a wealth of strategic, regulatory, and legal experience. Most recently, Bond has served as the global head of policy and regulatory affairs at two fintech companies, where she developed and executed global regulatory strategy for digital assets, blockchain, global payments, and fintech. Bond has engaged directly with global regulators, legislators, and industry associations, in addition to overseeing teams of attorneys and regulatory affairs professionals. Bond also worked at Bloomberg LP as head of global regulatory affairs, and she is an expert in securities, derivatives, banking, and fintech regulation. Before joining the private sector, Bond served as senior counsel at the U.S. Securities and Exchange Commission and worked on implementation of the Dodd-Frank Act, with a specific focus on securities and derivatives regulations, the Volcker Rule, and banking and fintech issues. Bond was also a subject matter expert on the U.S. Senate Committee on Banking, Housing, and Urban Affairs for the Dodd-Frank Act and its technical corrections bill, as well as the Jumpstart Our Business Startups Act (JOBS Act). In her capacity as Banking Committee counsel, Bond wrote legislation that was enacted into law and oversaw the federal financial regulatory agencies. Bond launched her legal career at the Financial Industry Regulatory Authority (FINRA) before practicing law at Hogan Lovells and WilmerHale. "Michelle's significant experience at the highest levels of government and private industry will ensure that ADAM is well positioned as the leading voice with regulators and policymakers. Our Code of Conduct was the first step in bringing high-quality industry leaders together to shape the future of the digital asset marketplace, and Michelle brings a comprehensive skill set to ADAM that will serve our organization extremely well." Brad Vopni, Head of Digital Assets at Hudson River Trading "As the digital asset market continues to evolve, it will become increasingly important for high-integrity market participants to contribute to shaping policy solutions and industry best practices.Michelle has a strong background in the financial services industry across both public and private sectors.She is well-suited to bring participants together across the digital asset ecosystem to work through important issues for our industry, and to serve as a leading voice with regulators and policymakers." Michael Moro, CEO of Genesis "Digital asset markets are a critical component of financial services moving forward, and their future hinges on market integrity and effective policy. ADAM's unique Code of Conduct ensures that our members are committed to high standards for integrity, fairness, efficiency, and compliance and it also serves as an excellent predicate for our members to participate in the regulatory policy processes. I look forward to leading this organization at such an exciting time for the industry, as well as focusing on cutting-edge policy issues with our members." Michelle Bond, CEO of ADAM Bond is asumma cum laudegraduate of Baruch College and The Catholic University of America's Columbus School of Law, graduating first in her class at law school. Bond is licensed to practice law in both New York and DC and has been covered byFortune'sMost Powerful Women, as well as featured inBusiness Insider, POLITICO, The Hill, CoinDesk, and other leading publications. About the Association for Digital Asset Markets (ADAM) ADAM is a private, membership-based association of firms operating in the digital asset marketplace. ADAM works with leading financial firms, entrepreneurs, and regulators to develop industry best practices to facilitate safe, secure, and efficient digital asset markets. ADAM members include market participants such as trading platforms, custodians, investors, asset managers, traders, liquidity providers, and brokers that operate in the digital asset ecosystem. In collaboration with leading financial firms, entrepreneurs, industry and legal experts, academics, and regulators,ADAM created a Code of Conductto promote integrity, fairness, and efficiency in digital asset markets. The ADAM Code is intended to inform market participants on best practices and to complement, not replace, existing regulation as part of a long-term effort to define and promote ethical conduct by all digital asset market participants. ADAM Members include Anchorage, BitGo, BitOoda, BlockFi, BTIG, CMT Digital, Cumberland, Galaxy Digital, Genesis Global Trading, GSR, Hudson River Trading, Parataxis Capital, Paxos, Sarson Funds, Symbiont, and XBTO. Contact:Rosemarie Calabro Tully[emailprotected]| 202-641-6209 Permalink SOURCE Association for Digital Asset Markets (ADAM)
Answer:
|
Michelle Bond Appointed CEO of the Association for Digital Asset Markets (ADAM) Bond Brings Executive Leadership Experience in the Public and Private Sectors to Focus on Boosting Digital Asset Market Integrity
|
WASHINGTON, Oct. 29, 2020 /PRNewswire/ -- The Association for Digital Asset Markets (ADAM) announced the appointment of Michelle Bond as its new Chief Executive Officer. Bond is widely respected in the financial services industry, and she plans to broaden and deepen ADAM's role as the industry leader in developing best practices to boost market integrity and foster fair and orderly conduct in the digital asset marketplace. "ADAM is focused on bridging the gap between firms in digital asset markets and regulators. We look forward to Michelle leveraging her expertise to guide us through a rapidly changing landscape, grow our membership, and launch exciting new strategic initiatives that help our members stay ahead of breaking developments in digital asset regulation." Mike Novogratz, CEO of Galaxy Digital Serving in both the public and private sectors, Bond brings with her a wealth of strategic, regulatory, and legal experience. Most recently, Bond has served as the global head of policy and regulatory affairs at two fintech companies, where she developed and executed global regulatory strategy for digital assets, blockchain, global payments, and fintech. Bond has engaged directly with global regulators, legislators, and industry associations, in addition to overseeing teams of attorneys and regulatory affairs professionals. Bond also worked at Bloomberg LP as head of global regulatory affairs, and she is an expert in securities, derivatives, banking, and fintech regulation. Before joining the private sector, Bond served as senior counsel at the U.S. Securities and Exchange Commission and worked on implementation of the Dodd-Frank Act, with a specific focus on securities and derivatives regulations, the Volcker Rule, and banking and fintech issues. Bond was also a subject matter expert on the U.S. Senate Committee on Banking, Housing, and Urban Affairs for the Dodd-Frank Act and its technical corrections bill, as well as the Jumpstart Our Business Startups Act (JOBS Act). In her capacity as Banking Committee counsel, Bond wrote legislation that was enacted into law and oversaw the federal financial regulatory agencies. Bond launched her legal career at the Financial Industry Regulatory Authority (FINRA) before practicing law at Hogan Lovells and WilmerHale. "Michelle's significant experience at the highest levels of government and private industry will ensure that ADAM is well positioned as the leading voice with regulators and policymakers. Our Code of Conduct was the first step in bringing high-quality industry leaders together to shape the future of the digital asset marketplace, and Michelle brings a comprehensive skill set to ADAM that will serve our organization extremely well." Brad Vopni, Head of Digital Assets at Hudson River Trading "As the digital asset market continues to evolve, it will become increasingly important for high-integrity market participants to contribute to shaping policy solutions and industry best practices.Michelle has a strong background in the financial services industry across both public and private sectors.She is well-suited to bring participants together across the digital asset ecosystem to work through important issues for our industry, and to serve as a leading voice with regulators and policymakers." Michael Moro, CEO of Genesis "Digital asset markets are a critical component of financial services moving forward, and their future hinges on market integrity and effective policy. ADAM's unique Code of Conduct ensures that our members are committed to high standards for integrity, fairness, efficiency, and compliance and it also serves as an excellent predicate for our members to participate in the regulatory policy processes. I look forward to leading this organization at such an exciting time for the industry, as well as focusing on cutting-edge policy issues with our members." Michelle Bond, CEO of ADAM Bond is asumma cum laudegraduate of Baruch College and The Catholic University of America's Columbus School of Law, graduating first in her class at law school. Bond is licensed to practice law in both New York and DC and has been covered byFortune'sMost Powerful Women, as well as featured inBusiness Insider, POLITICO, The Hill, CoinDesk, and other leading publications. About the Association for Digital Asset Markets (ADAM) ADAM is a private, membership-based association of firms operating in the digital asset marketplace. ADAM works with leading financial firms, entrepreneurs, and regulators to develop industry best practices to facilitate safe, secure, and efficient digital asset markets. ADAM members include market participants such as trading platforms, custodians, investors, asset managers, traders, liquidity providers, and brokers that operate in the digital asset ecosystem. In collaboration with leading financial firms, entrepreneurs, industry and legal experts, academics, and regulators,ADAM created a Code of Conductto promote integrity, fairness, and efficiency in digital asset markets. The ADAM Code is intended to inform market participants on best practices and to complement, not replace, existing regulation as part of a long-term effort to define and promote ethical conduct by all digital asset market participants. ADAM Members include Anchorage, BitGo, BitOoda, BlockFi, BTIG, CMT Digital, Cumberland, Galaxy Digital, Genesis Global Trading, GSR, Hudson River Trading, Parataxis Capital, Paxos, Sarson Funds, Symbiont, and XBTO. Contact:Rosemarie Calabro Tully[emailprotected]| 202-641-6209 Permalink SOURCE Association for Digital Asset Markets (ADAM)
|
edtsum6573
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--The single-photon emission computed tomography (SPECT) market is poised to grow by USD 620.21 million during 2020-2024, progressing at a CAGR of over 6% during the forecast period. Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour. Get FREE Sample Report in Minutes! The report on the single-photon emission computed tomography (SPECT) market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the growing adoption of the SPECT/CT hybrid imaging system. The single-photon emission computed tomography (SPECT) market analysis includes the product, application, and geography landscape. This study identifies the increased use of nuclear medicine for detecting diseases at an early stage as one of the prime reasons driving the single-photon emission computed tomography (SPECT) market growth during the next few years. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The single-photon emission computed tomography (SPECT) market covers the following areas: Single-Photon Emission Computed Tomography (SPECT) Market Sizing Single-Photon Emission Computed Tomography (SPECT) Market Forecast Single-Photon Emission Computed Tomography (SPECT) Market Analysis Companies Mentioned Related Reports on Health Care Include: Global Optical Coherence Tomography for Ophthalmology Market - Global optical coherence tomography for ophthalmology market is segmented by product (conventional OCT systems, and hand-held and integrated OCT systems), end-users (hospitals and clinics, ASCs, and physicians' offices), and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report Global Dental Cone Beam Computed Tomography Market - Global dental cone beam computed tomography market is segmented by end-user (hospitals and dental clinics and laboratories), application (dental implants, endodontic and periodontics, orthodontic, and dental surgeries), and geography (North America, Europe, Asia, and ROW). Click Here to Get an Exclusive Free Sample Report Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Product Market Segmentation by Application Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Answer:
|
Global Single-Photon Emission Computed Tomography (SPECT) Market to Grow by Over $620 Million at 6% CAGR During 2020-2024 | Technavio
|
LONDON--(BUSINESS WIRE)--The single-photon emission computed tomography (SPECT) market is poised to grow by USD 620.21 million during 2020-2024, progressing at a CAGR of over 6% during the forecast period. Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour. Get FREE Sample Report in Minutes! The report on the single-photon emission computed tomography (SPECT) market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the growing adoption of the SPECT/CT hybrid imaging system. The single-photon emission computed tomography (SPECT) market analysis includes the product, application, and geography landscape. This study identifies the increased use of nuclear medicine for detecting diseases at an early stage as one of the prime reasons driving the single-photon emission computed tomography (SPECT) market growth during the next few years. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The single-photon emission computed tomography (SPECT) market covers the following areas: Single-Photon Emission Computed Tomography (SPECT) Market Sizing Single-Photon Emission Computed Tomography (SPECT) Market Forecast Single-Photon Emission Computed Tomography (SPECT) Market Analysis Companies Mentioned Related Reports on Health Care Include: Global Optical Coherence Tomography for Ophthalmology Market - Global optical coherence tomography for ophthalmology market is segmented by product (conventional OCT systems, and hand-held and integrated OCT systems), end-users (hospitals and clinics, ASCs, and physicians' offices), and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report Global Dental Cone Beam Computed Tomography Market - Global dental cone beam computed tomography market is segmented by end-user (hospitals and dental clinics and laboratories), application (dental implants, endodontic and periodontics, orthodontic, and dental surgeries), and geography (North America, Europe, Asia, and ROW). Click Here to Get an Exclusive Free Sample Report Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Product Market Segmentation by Application Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
|
edtsum6576
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--SL Green Realty Corp. (NYSE:SLG), Manhattans largest office landlord, announced the topping off of 185 Broadway, a 34-story, mixed-use building in Lower Manhattan. The milestone moment for the ground-up development comes on schedule and under budget, despite the challenges presented by the COVID-19 pandemic. Once completed, the property will be the areas first development to be built under the Affordable New York Housing Program, providing affordable housing and creating 600 jobs. Located directly across from the Fulton Transit Center, the 260,000-square-foot building will consist of 17,000 square feet of flagship retail space at the base across the basement, ground, and 2nd floors, 26,000 square feet of commercial space across floors 3 - 5, and 217,000 square feet of residential space. The column-free ground floor retail sits directly on Broadway and features 22-foot high ceilings. The Dey Street building frontage contains two separate entrance lobbies for the residential and commercial spaces. SL Green has a long history of investing in Lower Manhattan and 185 Broadway enables us to bring essential affordable housing to the neighborhood through the Affordable New York Program, said Edward V. Piccinich, Chief Operating Officer, SL Green. During this difficult economic time for the City, SL Green is proud to advance the construction at 185 Broadway, One Madison Avenue and One Vanderbilt Avenue, generating thousands of jobs for New Yorkers and investing in the future of this great city. FX Collaborative designed the 209-unit rental property, of which 30 percent of the units will be affordable (63 units), with a mixture of studio, one-bedroom, two-bedroom and three-bedroom units. The buildings interiors were designed by INC Architecture & Design, including three floors of amenities. Anticipated amenity features include co-working space, a state-of-the-art fitness center, club lounge, board room and abundant outdoor spaces. Pavarini McGovern is overseeing the construction of the development. The development was made possible in part through the use of unutilized air rights purchased by SL Green from the Metropolitan Transportation Authority (MTA), providing discretionary funding to the MTA. In addition to 185 Broadway, SL Green has successfully completed the ground-up development of nearby residential buildings, 180 Broadway and 33 Beekman, and recently broke ground on a build-to-suit project in the neighborhood for Pace University. About SL Green SL Green Realty Corp., an S&P 500 company and Manhattan's largest office landlord, is a fully integrated real estate investment trust, or REIT, that is focused primarily on acquiring, managing and maximizing value of Manhattan commercial properties. As of June 30, 2020, SL Green held interests in 96 buildings totaling 41.0 million square feet. This included ownership interests in 28.7 million square feet of Manhattan buildings and 11.2 million square feet securing debt and preferred equity investments. Forward Looking Statement This press release includes certain statements that may be deemed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are intended to be covered by the safe harbor provisions thereof. All statements, other than statements of historical facts, included in this press release that address activities, events or developments that we expect, believe or anticipate will or may occur in the future, are forward-looking statements. Forward-looking statements are not guarantees of future performance and we caution you not to place undue reliance on such statements. Forward-looking statements are generally identifiable by the use of the words may, will, should, expect, anticipate, estimate, believe, intend, project, continue, or the negative of these words, or other similar words or terms. Forward-looking statements contained in this press release are subject to a number of risks and uncertainties, many of which are beyond our control, that may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by forward-looking statements made by us. Factors and risks to our business that could cause actual results to differ from those contained in the forward-looking statements are described in our filings with the Securities and Exchange Commission. These risks and uncertainties include, but are not limited to, potential risks and uncertainties relating to the novel coronavirus (COVID-19). SLG-DEV Source: SL Green Realty Corp.
Answer:
|
SL Green Celebrated Topping Off of 185 Broadway, the First Project to be Built in Lower Manhattan Under the Affordable New York Program The 34-story mixed-use building includes retail, commercial and residential spaces adjacent to the Fulton Transit Center
|
NEW YORK--(BUSINESS WIRE)--SL Green Realty Corp. (NYSE:SLG), Manhattans largest office landlord, announced the topping off of 185 Broadway, a 34-story, mixed-use building in Lower Manhattan. The milestone moment for the ground-up development comes on schedule and under budget, despite the challenges presented by the COVID-19 pandemic. Once completed, the property will be the areas first development to be built under the Affordable New York Housing Program, providing affordable housing and creating 600 jobs. Located directly across from the Fulton Transit Center, the 260,000-square-foot building will consist of 17,000 square feet of flagship retail space at the base across the basement, ground, and 2nd floors, 26,000 square feet of commercial space across floors 3 - 5, and 217,000 square feet of residential space. The column-free ground floor retail sits directly on Broadway and features 22-foot high ceilings. The Dey Street building frontage contains two separate entrance lobbies for the residential and commercial spaces. SL Green has a long history of investing in Lower Manhattan and 185 Broadway enables us to bring essential affordable housing to the neighborhood through the Affordable New York Program, said Edward V. Piccinich, Chief Operating Officer, SL Green. During this difficult economic time for the City, SL Green is proud to advance the construction at 185 Broadway, One Madison Avenue and One Vanderbilt Avenue, generating thousands of jobs for New Yorkers and investing in the future of this great city. FX Collaborative designed the 209-unit rental property, of which 30 percent of the units will be affordable (63 units), with a mixture of studio, one-bedroom, two-bedroom and three-bedroom units. The buildings interiors were designed by INC Architecture & Design, including three floors of amenities. Anticipated amenity features include co-working space, a state-of-the-art fitness center, club lounge, board room and abundant outdoor spaces. Pavarini McGovern is overseeing the construction of the development. The development was made possible in part through the use of unutilized air rights purchased by SL Green from the Metropolitan Transportation Authority (MTA), providing discretionary funding to the MTA. In addition to 185 Broadway, SL Green has successfully completed the ground-up development of nearby residential buildings, 180 Broadway and 33 Beekman, and recently broke ground on a build-to-suit project in the neighborhood for Pace University. About SL Green SL Green Realty Corp., an S&P 500 company and Manhattan's largest office landlord, is a fully integrated real estate investment trust, or REIT, that is focused primarily on acquiring, managing and maximizing value of Manhattan commercial properties. As of June 30, 2020, SL Green held interests in 96 buildings totaling 41.0 million square feet. This included ownership interests in 28.7 million square feet of Manhattan buildings and 11.2 million square feet securing debt and preferred equity investments. Forward Looking Statement This press release includes certain statements that may be deemed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are intended to be covered by the safe harbor provisions thereof. All statements, other than statements of historical facts, included in this press release that address activities, events or developments that we expect, believe or anticipate will or may occur in the future, are forward-looking statements. Forward-looking statements are not guarantees of future performance and we caution you not to place undue reliance on such statements. Forward-looking statements are generally identifiable by the use of the words may, will, should, expect, anticipate, estimate, believe, intend, project, continue, or the negative of these words, or other similar words or terms. Forward-looking statements contained in this press release are subject to a number of risks and uncertainties, many of which are beyond our control, that may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by forward-looking statements made by us. Factors and risks to our business that could cause actual results to differ from those contained in the forward-looking statements are described in our filings with the Securities and Exchange Commission. These risks and uncertainties include, but are not limited to, potential risks and uncertainties relating to the novel coronavirus (COVID-19). SLG-DEV Source: SL Green Realty Corp.
|
edtsum6578
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SANTA MONICA, Calif., March 24, 2021 /PRNewswire/ --Quantgene, Inc. and CureMatch, Inc. have announced a strategic partnership to combine genomic, cloud and AI technologies and improve precision treatments and long-term outcomes for patients diagnosed with cancer. Quantgene Liquid uses blood samples of cancer patients to help provide a systemic understanding of the mutational profiles of a tumor, also known as a "Liquid Biopsy". Liquid Biopsies allow physicians to understand the mutational status of tumors without being limited to just a biopsy from a specific part of the tumor. By profiling cell-free DNA fragments in the blood, Quantgene Liquid allows better insights into both primary and metastatic tumors. Quantgene Liquid's technology is a highly accurate and precise cancer mutation detection system. Quantgene, Inc. and CureMatch, Inc. are partnering to improve precisiontreatments and outcomes for patients diagnosed with cancer. Tweet this The CureMatch Decision Support System provides actionable intelligenceto oncologists. CureMatch supports the doctor with therapy options matched specifically to a patient's unique molecular tumor profile. The clinical decision support system leverages proprietary algorithms, as well as curated clinical and scientific knowledge, and provides a matching score to help doctors identify combination and monotherapies for optimal cancer treatment. By combining both technologies, patients and oncologists can now get access to a turnkey solution that requires just a simple blood draw to match them to appropriate cancer therapies. Cancer patients can get results in as little as 3 weeks from a blood draw, to a Quantgene test result1 to a CureMatch report that informs their precision treatment. In addition to ensuring a successful combination of these two products, the companies will collaborate more closely on advancing Genomics and AI-guided oncology solutions. Jo Bhakdi, founder and CEO of Quantgene said of the partnership: "Deep Genomics and AI can be a game-changer for cancer patients. New combination treatments can significantly improve outcomes. But sadly until now, the majority of patients didn't have access to the genomics and AI technologies required to get there. Together with CureMatch, we can make precision treatment insights available to everyone through a simple blood draw."Navid Alipour, CEO of CureMatch added, "We are honored and excited to integrate with Quantene's innovations. Their ability to unlock the human genome and further inform our decision support system for oncology, complements the CureMatch precision medicine solution and supports our mission of helping to extend and save lives."To Learn more, please visit Quantgene.comand CureMatch.com.About QuantgeneQuantgene, a Los Angeles, CA and Berlin, Germany based biotech startup, is building the future of medicine by combining Deep Genomics, Cloud and AI to deliver the next level of precision preventative medicine. With $20MM in capital raised, Quantgene has achieved cash flow positivity and rapid growth in record time. Its genomics platforms and business model innovations continue to redefine the possibilities for precision medicine and set new industry standards. By delivering the world's most advanced genomics, cloud and AI technologies, Quantgene is moving closer to its goal: To extend the healthy human lifespan by 10 years within the next 10 years. Quantgene.comAbout CureMatchCureMatch, a San Diego, CA company, is a leader in precision medicine digital solutions. Created to empower oncologists with world-class research, the CureMatch Decision Support System supports the doctor with therapeutic options that are personalized for individual patients based on the molecular profile of their tumor. www.CureMatch.com Note: Liquid Biopsy is a Laboratory Developed Tests that has not undergone FDA premarket review. SOURCE Quantgene Related Links quantgene.com
Answer:
|
Quantgene and CureMatch Announce Strategic Partnership To Help Cancer Patients Find the Best Precision Treatment
|
SANTA MONICA, Calif., March 24, 2021 /PRNewswire/ --Quantgene, Inc. and CureMatch, Inc. have announced a strategic partnership to combine genomic, cloud and AI technologies and improve precision treatments and long-term outcomes for patients diagnosed with cancer. Quantgene Liquid uses blood samples of cancer patients to help provide a systemic understanding of the mutational profiles of a tumor, also known as a "Liquid Biopsy". Liquid Biopsies allow physicians to understand the mutational status of tumors without being limited to just a biopsy from a specific part of the tumor. By profiling cell-free DNA fragments in the blood, Quantgene Liquid allows better insights into both primary and metastatic tumors. Quantgene Liquid's technology is a highly accurate and precise cancer mutation detection system. Quantgene, Inc. and CureMatch, Inc. are partnering to improve precisiontreatments and outcomes for patients diagnosed with cancer. Tweet this The CureMatch Decision Support System provides actionable intelligenceto oncologists. CureMatch supports the doctor with therapy options matched specifically to a patient's unique molecular tumor profile. The clinical decision support system leverages proprietary algorithms, as well as curated clinical and scientific knowledge, and provides a matching score to help doctors identify combination and monotherapies for optimal cancer treatment. By combining both technologies, patients and oncologists can now get access to a turnkey solution that requires just a simple blood draw to match them to appropriate cancer therapies. Cancer patients can get results in as little as 3 weeks from a blood draw, to a Quantgene test result1 to a CureMatch report that informs their precision treatment. In addition to ensuring a successful combination of these two products, the companies will collaborate more closely on advancing Genomics and AI-guided oncology solutions. Jo Bhakdi, founder and CEO of Quantgene said of the partnership: "Deep Genomics and AI can be a game-changer for cancer patients. New combination treatments can significantly improve outcomes. But sadly until now, the majority of patients didn't have access to the genomics and AI technologies required to get there. Together with CureMatch, we can make precision treatment insights available to everyone through a simple blood draw."Navid Alipour, CEO of CureMatch added, "We are honored and excited to integrate with Quantene's innovations. Their ability to unlock the human genome and further inform our decision support system for oncology, complements the CureMatch precision medicine solution and supports our mission of helping to extend and save lives."To Learn more, please visit Quantgene.comand CureMatch.com.About QuantgeneQuantgene, a Los Angeles, CA and Berlin, Germany based biotech startup, is building the future of medicine by combining Deep Genomics, Cloud and AI to deliver the next level of precision preventative medicine. With $20MM in capital raised, Quantgene has achieved cash flow positivity and rapid growth in record time. Its genomics platforms and business model innovations continue to redefine the possibilities for precision medicine and set new industry standards. By delivering the world's most advanced genomics, cloud and AI technologies, Quantgene is moving closer to its goal: To extend the healthy human lifespan by 10 years within the next 10 years. Quantgene.comAbout CureMatchCureMatch, a San Diego, CA company, is a leader in precision medicine digital solutions. Created to empower oncologists with world-class research, the CureMatch Decision Support System supports the doctor with therapeutic options that are personalized for individual patients based on the molecular profile of their tumor. www.CureMatch.com Note: Liquid Biopsy is a Laboratory Developed Tests that has not undergone FDA premarket review. SOURCE Quantgene Related Links quantgene.com
|
edtsum6581
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PLEASANTON, Calif., Aug. 19, 2020 /PRNewswire/ -- Home purchases represented 46 percent of all closed loans in July, up from 42 percent in June according to the latest Origination Insight Reportfrom Ellie Mae, the leading cloud-based loan origination platform provider for the mortgage industry. Refinances still represented the majority of closed loans in the month at 54 percent, down from 58 percent the month prior. The 30-year rate on all loans continued to drop to 3.24 percent, down from 3.40 percent in June. The 30-year note rate on conventional loans fell to 3.26 percent in July, down from 3.42 percent in June. Similarly, the 30-year rate on FHA loans fell to 3.26 percent in July, down from 3.41 percent in June. The 30-year rate on VA loans dropped to 3.02 percent in July, down from 3.20 percent in June. Other statistics of note in July included: The time to close all loans held at 47 days for the second month. Time to close for purchase loans decreased to 44 days, down from 46 the month prior, while time to close refinances increased to 50 days, up from 48 days the month prior. FICO scores increased month-over-month for refinances across Conventional, FHA and VA loans. Closing rates increased to 77.1 percent in July, up from 73.4 percent in June. "Interest rates have continued to decrease, down to 3.24 percent in July. If we look at this month versus the same time in 2019, interest rates are down close to a full percentage point, giving new homebuyers the opportunity to stretch their dollar as they purchase and existing homebuyers the ability to reduce monthly costs," said Jonathan Corr, President and CEO of Ellie Mae. "We're also seeing an increase in closing rates for Ellie Mae lenders highlighting the value of mortgage technology as they contend with significant volume, remote workforces and homebuyers looking to complete the process completely online." The Origination Insight Report mines data from a robust sampling of approximately 80 percent of all mortgage applications that were initiated on the Encompassall-in-one mortgage management solution. Ellie Mae believes the Origination Insight Report is a strong proxy of the underwriting standards employed by lenders across the country. In addition to the Origination Insight Report, Ellie Mae also distributes data from its monthly Ellie Mae Millennial Trackeron the first Wednesday of each month. The Ellie Mae Millennial Tracker focuses on mortgage applications submitted by borrowers born between the years 1980 and 1999. Ellie Mae also offers Ellie Mae Insights, the only analytics solution in the market that provides peer benchmarking comparison analysis in near real time. Ellie Mae Insights analyzes key metrics such as efficiency levels, operational costs, rates and market penetration, demographic data and pull through rates to help lenders of all sizes to make informed decisions. MONTHLY ORIGINATION OVERVIEW FOR JULY 2020 July 2020* June 2020* 6 MonthsAgo (Jan. 2020*) 1 Year Ago (July 2019*) Closed Loans Purpose Refinance 54% 58% 50% 38% Purchase 46% 42% 50% 62% Type FHA 11% 10% 16% 17% Conventional 79% 80% 71% 69% VA 6% 7% 8% 10% Days to Close All 47 47 48 42 Refinance 50 48 48 40 Purchase 44 46 48 43 Percentage of ARM and Fixed Loan Volume ARM % 3.0% 3.5% 5.3% 5.7% 30-Year Rate Average 3.24% 3.40% 3.96% 4.18% *All references to months should be read as month ended. PROFILES OF CLOSED LOANS FOR JULY 2020 Closed First-Lien Loans(All Types) FICO Score (FICO) 750 Loan-to-Value (LTV) 75 Debt-to-Income (DTI) 23/35 More information and analysis of closed and denied loans by loan purpose and investor are available in the full report at http://www.elliemae.com/about-us/news-reports/ellie-mae-reports/. To get a meaningful view of lender pull-through, Ellie Mae reviewed a sampling of loan applications initiated 90 days prioror the April 2020 applicationsto calculate an overall closing rate of 77.1 percent in July 2020 (see full report). About the Ellie Mae Origination Insight Report The Origination Insight Report focuses on loans that closed in a specific month and compares their characteristics to similar loans. The closing rate is calculated on a 90-day cycle rather than on a monthly basis because most loan applications typically take one-and-a-half to two months from application to closing. Loans that do not close could still be active applications or applications withdrawn by consumers or denied for incompleteness or non-qualification. The Origination Insight Report details aggregated, de-identified data pulled from Ellie Mae's Encompass origination platform. News organizations have the right to reuse this data, provided that Ellie Mae, Inc. is credited as the source. About Ellie Mae Ellie Mae is the leading cloud-based loan origination platform provider for the mortgage industry. Ellie Mae's technologysolutions enable lenders to originate more loans, lower origination costs, and reduce the time to close, all while ensuring the highest levels of compliance, quality, and efficiency. Visit EllieMae.comor call (877) 355-4362to learn more. 2020 Ellie Mae, Inc. Ellie Mae, Encompass, AllRegs, Mavent, Velocify, Capsilon, the Ellie Mae logo and other trademarks or service marks of Ellie Mae, Inc. appearing herein are the property of Ellie Mae, Inc. or its subsidiaries. All rights reserved. Other company and product names may be trademarks or copyrights of their respective owners. SOURCE Ellie Mae Related Links https://www.elliemae.com/
Answer:
|
July Ellie Mae Origination Insight Report Data Shows Homebuyer Purchase Activity On The Rise; Interest Rates Continue To Fall
|
PLEASANTON, Calif., Aug. 19, 2020 /PRNewswire/ -- Home purchases represented 46 percent of all closed loans in July, up from 42 percent in June according to the latest Origination Insight Reportfrom Ellie Mae, the leading cloud-based loan origination platform provider for the mortgage industry. Refinances still represented the majority of closed loans in the month at 54 percent, down from 58 percent the month prior. The 30-year rate on all loans continued to drop to 3.24 percent, down from 3.40 percent in June. The 30-year note rate on conventional loans fell to 3.26 percent in July, down from 3.42 percent in June. Similarly, the 30-year rate on FHA loans fell to 3.26 percent in July, down from 3.41 percent in June. The 30-year rate on VA loans dropped to 3.02 percent in July, down from 3.20 percent in June. Other statistics of note in July included: The time to close all loans held at 47 days for the second month. Time to close for purchase loans decreased to 44 days, down from 46 the month prior, while time to close refinances increased to 50 days, up from 48 days the month prior. FICO scores increased month-over-month for refinances across Conventional, FHA and VA loans. Closing rates increased to 77.1 percent in July, up from 73.4 percent in June. "Interest rates have continued to decrease, down to 3.24 percent in July. If we look at this month versus the same time in 2019, interest rates are down close to a full percentage point, giving new homebuyers the opportunity to stretch their dollar as they purchase and existing homebuyers the ability to reduce monthly costs," said Jonathan Corr, President and CEO of Ellie Mae. "We're also seeing an increase in closing rates for Ellie Mae lenders highlighting the value of mortgage technology as they contend with significant volume, remote workforces and homebuyers looking to complete the process completely online." The Origination Insight Report mines data from a robust sampling of approximately 80 percent of all mortgage applications that were initiated on the Encompassall-in-one mortgage management solution. Ellie Mae believes the Origination Insight Report is a strong proxy of the underwriting standards employed by lenders across the country. In addition to the Origination Insight Report, Ellie Mae also distributes data from its monthly Ellie Mae Millennial Trackeron the first Wednesday of each month. The Ellie Mae Millennial Tracker focuses on mortgage applications submitted by borrowers born between the years 1980 and 1999. Ellie Mae also offers Ellie Mae Insights, the only analytics solution in the market that provides peer benchmarking comparison analysis in near real time. Ellie Mae Insights analyzes key metrics such as efficiency levels, operational costs, rates and market penetration, demographic data and pull through rates to help lenders of all sizes to make informed decisions. MONTHLY ORIGINATION OVERVIEW FOR JULY 2020 July 2020* June 2020* 6 MonthsAgo (Jan. 2020*) 1 Year Ago (July 2019*) Closed Loans Purpose Refinance 54% 58% 50% 38% Purchase 46% 42% 50% 62% Type FHA 11% 10% 16% 17% Conventional 79% 80% 71% 69% VA 6% 7% 8% 10% Days to Close All 47 47 48 42 Refinance 50 48 48 40 Purchase 44 46 48 43 Percentage of ARM and Fixed Loan Volume ARM % 3.0% 3.5% 5.3% 5.7% 30-Year Rate Average 3.24% 3.40% 3.96% 4.18% *All references to months should be read as month ended. PROFILES OF CLOSED LOANS FOR JULY 2020 Closed First-Lien Loans(All Types) FICO Score (FICO) 750 Loan-to-Value (LTV) 75 Debt-to-Income (DTI) 23/35 More information and analysis of closed and denied loans by loan purpose and investor are available in the full report at http://www.elliemae.com/about-us/news-reports/ellie-mae-reports/. To get a meaningful view of lender pull-through, Ellie Mae reviewed a sampling of loan applications initiated 90 days prioror the April 2020 applicationsto calculate an overall closing rate of 77.1 percent in July 2020 (see full report). About the Ellie Mae Origination Insight Report The Origination Insight Report focuses on loans that closed in a specific month and compares their characteristics to similar loans. The closing rate is calculated on a 90-day cycle rather than on a monthly basis because most loan applications typically take one-and-a-half to two months from application to closing. Loans that do not close could still be active applications or applications withdrawn by consumers or denied for incompleteness or non-qualification. The Origination Insight Report details aggregated, de-identified data pulled from Ellie Mae's Encompass origination platform. News organizations have the right to reuse this data, provided that Ellie Mae, Inc. is credited as the source. About Ellie Mae Ellie Mae is the leading cloud-based loan origination platform provider for the mortgage industry. Ellie Mae's technologysolutions enable lenders to originate more loans, lower origination costs, and reduce the time to close, all while ensuring the highest levels of compliance, quality, and efficiency. Visit EllieMae.comor call (877) 355-4362to learn more. 2020 Ellie Mae, Inc. Ellie Mae, Encompass, AllRegs, Mavent, Velocify, Capsilon, the Ellie Mae logo and other trademarks or service marks of Ellie Mae, Inc. appearing herein are the property of Ellie Mae, Inc. or its subsidiaries. All rights reserved. Other company and product names may be trademarks or copyrights of their respective owners. SOURCE Ellie Mae Related Links https://www.elliemae.com/
|
edtsum6582
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MISSION, Kan., Feb. 8, 2021 /PRNewswire/ -- (Family Features) Committing to a daily wellness routine may include many components from eating healthy and exercising to meditating and achieving quality sleep. For some, the most difficult of these goals is changing eating habits to consume more nutritious foods. Photo courtesy of Marukan Apple Cider Vinegar However, rethinking the way you eat (and drink) doesn't have to mean a colossal shift in your diet. According to Healthline, clean eating and the addition of a small amount of apple cider vinegar to your daily routine can help support healthy digestion, weight range maintenance, healthy glucose levels and a functioning immune system. In fact, some experts recommend consuming 1 ounce of apple cider vinegar each day as a shot or part of a recipe. Consider an apple cider vinegar option from Marukan, which has brewed premium vinegars for 370 years, to create dishes from breakfast to dinner. Start your day by enjoying this Blueberry Apple Cider Vinegar Smoothie that takes just 5 minutes to make so it doesn't throw off your morning routine. A quick, nutritious and easy weeknight dinner is what many families strive for, and you can accomplish that feat with Apple Cider Vinegar Beef and Broccoli. Cooked broccoli florets and beef strips are combined with an apple cider vinegar and ponzu soy dressing-based sauce and served over cooked rice for a 20-minute meal your loved ones can savor together while simultaneously enhancing your nutrition.These recipes can help you participate in the Marukan Apple Cider Vinegar 24-Day Challenge, which encourages entrants to consume 1 ounce of apple cider vinegar each day and share the benefits they experience while creating daily wellness habits on their journeys to healthier routines. Find more information about participating in the challenge along with nutritious recipes at MarukanACV.com. Blueberry Apple Cider Vinegar Smoothie Total time: 5 minutes Servings: 21 cup spinach 1/2 cup water 2 tablespoons Marukan Organic Apple Cider & Rice Vinegar Drink Blend 1 tablespoon almond butter 1/2 cup bananas, frozen 1/2 cup blueberries, frozen 1 tablespoon chia seeds 1/4 teaspoon cinnamon, ground 1/4 teaspoon ginger, minced 1/2 cup almond milk yogurt, plain fresh blueberries, for garnishIn blender, blend spinach, water, organic apple cider, almond butter, frozen bananas, frozen blueberries, chia seeds, cinnamon, ginger and yogurt until smooth. Pour into two glasses and garnish with fresh blueberries. Apple Cider Vinegar Beef and Broccoli Total time: 20 minutes Servings: 41 tablespoon vegetable oil 1 pound broccoli florets 1 pound beef strips 1 tablespoon garlic, minced 1/2 cup Marukan Ponzu Premium Soy Dressing with Sudachi Citrus 1/2 cup low-sodium beef broth 1 tablespoon sesame oil 2 tablespoons brown sugar 1/4 cup honey 3 tablespoons Marukan Organic Apple Cider Vinegar 1 tablespoon cornstarch cooked ricesliced green onions, for garnishcilantro, for garnishsesame seeds, for garnishIn skillet over medium heat, heat vegetable oil. Cook broccoli 3 minutes until slightly softened; set aside. Add beef to pan and cook 3 minutes until browned. Add garlic and cook 30 seconds until fragrant. In bowl, mix ponzu soy dressing, beef broth, sesame oil, brown sugar, honey, apple cider vinegar and cornstarch. Add sauce mixture to beef in skillet and cook 10 minutes until sauce mixture cooks down. Toss in broccoli and cook 2 minutes. Serve over rice and garnish with green onions, cilantro and sesame seeds. Michael French [emailprotected]1-888-824-3337 editors.familyfeatures.comAbout Family Features Editorial SyndicateA leading source for high-quality food, lifestyle and home and garden content, Family Features provides readers with topically and seasonally relevant tips, takeaways, information, recipes, videos, infographics and more. Find additional articles and information at Culinary.net and eLivingToday.com. SOURCE Family Features Editorial Syndicate Related Links http://www.familyfeatures.com
Answer:
|
Eat and Drink Your Way to Daily Wellness
|
MISSION, Kan., Feb. 8, 2021 /PRNewswire/ -- (Family Features) Committing to a daily wellness routine may include many components from eating healthy and exercising to meditating and achieving quality sleep. For some, the most difficult of these goals is changing eating habits to consume more nutritious foods. Photo courtesy of Marukan Apple Cider Vinegar However, rethinking the way you eat (and drink) doesn't have to mean a colossal shift in your diet. According to Healthline, clean eating and the addition of a small amount of apple cider vinegar to your daily routine can help support healthy digestion, weight range maintenance, healthy glucose levels and a functioning immune system. In fact, some experts recommend consuming 1 ounce of apple cider vinegar each day as a shot or part of a recipe. Consider an apple cider vinegar option from Marukan, which has brewed premium vinegars for 370 years, to create dishes from breakfast to dinner. Start your day by enjoying this Blueberry Apple Cider Vinegar Smoothie that takes just 5 minutes to make so it doesn't throw off your morning routine. A quick, nutritious and easy weeknight dinner is what many families strive for, and you can accomplish that feat with Apple Cider Vinegar Beef and Broccoli. Cooked broccoli florets and beef strips are combined with an apple cider vinegar and ponzu soy dressing-based sauce and served over cooked rice for a 20-minute meal your loved ones can savor together while simultaneously enhancing your nutrition.These recipes can help you participate in the Marukan Apple Cider Vinegar 24-Day Challenge, which encourages entrants to consume 1 ounce of apple cider vinegar each day and share the benefits they experience while creating daily wellness habits on their journeys to healthier routines. Find more information about participating in the challenge along with nutritious recipes at MarukanACV.com. Blueberry Apple Cider Vinegar Smoothie Total time: 5 minutes Servings: 21 cup spinach 1/2 cup water 2 tablespoons Marukan Organic Apple Cider & Rice Vinegar Drink Blend 1 tablespoon almond butter 1/2 cup bananas, frozen 1/2 cup blueberries, frozen 1 tablespoon chia seeds 1/4 teaspoon cinnamon, ground 1/4 teaspoon ginger, minced 1/2 cup almond milk yogurt, plain fresh blueberries, for garnishIn blender, blend spinach, water, organic apple cider, almond butter, frozen bananas, frozen blueberries, chia seeds, cinnamon, ginger and yogurt until smooth. Pour into two glasses and garnish with fresh blueberries. Apple Cider Vinegar Beef and Broccoli Total time: 20 minutes Servings: 41 tablespoon vegetable oil 1 pound broccoli florets 1 pound beef strips 1 tablespoon garlic, minced 1/2 cup Marukan Ponzu Premium Soy Dressing with Sudachi Citrus 1/2 cup low-sodium beef broth 1 tablespoon sesame oil 2 tablespoons brown sugar 1/4 cup honey 3 tablespoons Marukan Organic Apple Cider Vinegar 1 tablespoon cornstarch cooked ricesliced green onions, for garnishcilantro, for garnishsesame seeds, for garnishIn skillet over medium heat, heat vegetable oil. Cook broccoli 3 minutes until slightly softened; set aside. Add beef to pan and cook 3 minutes until browned. Add garlic and cook 30 seconds until fragrant. In bowl, mix ponzu soy dressing, beef broth, sesame oil, brown sugar, honey, apple cider vinegar and cornstarch. Add sauce mixture to beef in skillet and cook 10 minutes until sauce mixture cooks down. Toss in broccoli and cook 2 minutes. Serve over rice and garnish with green onions, cilantro and sesame seeds. Michael French [emailprotected]1-888-824-3337 editors.familyfeatures.comAbout Family Features Editorial SyndicateA leading source for high-quality food, lifestyle and home and garden content, Family Features provides readers with topically and seasonally relevant tips, takeaways, information, recipes, videos, infographics and more. Find additional articles and information at Culinary.net and eLivingToday.com. SOURCE Family Features Editorial Syndicate Related Links http://www.familyfeatures.com
|
edtsum6583
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SCOTTSDALE, Ariz.--(BUSINESS WIRE)--LeadMD, a leading performance marketing consultancy, is eagerly embracing the new year and looking back on some of its most notable achievements from 2020. The company spent much of the past year focusing on helping clients, partners, and marketers overcome the challenges presented by COVID-19 and capitalizing on opportunities for innovation. The organization did this while simultaneously posting another record growth year themselves. LeadMD enjoyed a 30 percent compound annual growth rate year-over-year and expanded its team by 20 percent, which is truly remarkable during a year plagued by a global pandemic as well as economic and social instability. The agency was also recognized as one of Chief Marketers top 200 marketing agencies of 2021, while adding new capabilities, partner accreditations and marquee clients. In most years, we focus on leading the industry and aiming for uncommon growth for ourselves and our clients, but 2020 took on a different mission, said Justin Gray, founder and chief executive officer of LeadMD. Given the magnitude of tragedy, loss and unpredictability in every area of life this past year, we prioritized what matters most helping other humans. Im especially proud of how our team banded together to extend a hand, lending our considerable resources to other businesses in need. We also didnt resort to furloughs or layoffs. In fact, we never have in our decade long history, and for a consultancy, thats truly rare. Instead, we encouraged our tribes natural service mentality, and through that value above all approach, we were able to help a lot of businesses and, in turn, a lot of people. When COVID-19 first began to spread, LeadMD acted fast to create and launch the Arizona Local Impact Fund alongside Invest Southwest and the StartupAZ Foundation. LeadMD donated $60,000 to help small businesses struggling in the immediate wake of the pandemic and have since supported four Arizona-based organizations through the fund. Then, in an effort to understand the B2B industrys most pressing needs, LeadMD conducted a Marketing in Crisis & Buyer Insights Survey. Not only did LeadMD follow this up with a report to shed light on the state of B2B marketing in the spring of 2020, but LeadMD put these insights to good use, offering free workshops and practical recommendations to other businesses finding their footing in the midst of the chaos. Also during the year, LeadMDs consulting department earned an American Business Stevie Award for Customer Success and the company as a whole landed on AZ Centrals list of the Top Companies to Work for in Arizona for 2020. In December, LeadMD was honored to be named in the first ever editorial list of the Top Brand Engagement & Activation Agencies in the U.S. by Chief Marketer. Last April, LeadMD was recognized as an Americas Digital Experience Solution Partner of the Year for Marketo Engage. LeadMD also earned sales accreditations for Adobe Experience Manager, Adobe Campaign and Adobe Analytics. As a Platinum-level partner, LeadMD is in the highest tier of Adobes Solution Partner Program, setting them apart from others in the industry. Partners are a critical part of our growth and customer success strategy here at Adobe, said Tony Sanders, Senior Director, Americas Partner Sales at Adobe. LeadMD worked in lockstep with our team to navigate the changes that 2020 brought, ensuring our joint clients digital transformation success. We look forward to our continued collaboration in 2021. As further testament of its leadership in the industry and proven results, LeadMD welcomed multiple noteworthy clients on board, including Invoca, ROHM, Sterling Bancorp, Nextiva, Seismic, InVision and CME Group, to name a few. LeadMD is looking forward to a new year full of further leadership, collaboration, service and growth. About LeadMD LeadMD is the number one performance marketing consultancy in the U.S. Launched in 2009, LeadMD empowers marketers to drive revenue and customer success. The company focuses on people, processes, and technology that create predictable and sustainable revenue for high growth and enterprise brands. LeadMD has helped thousands of brands improve and deliver value through strategy and proven tactics that work. For more information, visit www.leadmd.com or email at [email protected]. LeadMD and the LeadMD logo are trademarks of LeadMD, Inc. All other trademarks are the property of their respective owners. Helpful links: Facebook: www.facebook.com/leadmd Twitter: www.twitter.com/myleadmd LinkedIn: https://www.linkedin.com/company/leadmd
Answer:
|
LeadMD Shares Silver Linings of 2020; Welcomes 2021 with Anticipation The consultancy spent the past year serving others, growing and earning industry recognition
|
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--LeadMD, a leading performance marketing consultancy, is eagerly embracing the new year and looking back on some of its most notable achievements from 2020. The company spent much of the past year focusing on helping clients, partners, and marketers overcome the challenges presented by COVID-19 and capitalizing on opportunities for innovation. The organization did this while simultaneously posting another record growth year themselves. LeadMD enjoyed a 30 percent compound annual growth rate year-over-year and expanded its team by 20 percent, which is truly remarkable during a year plagued by a global pandemic as well as economic and social instability. The agency was also recognized as one of Chief Marketers top 200 marketing agencies of 2021, while adding new capabilities, partner accreditations and marquee clients. In most years, we focus on leading the industry and aiming for uncommon growth for ourselves and our clients, but 2020 took on a different mission, said Justin Gray, founder and chief executive officer of LeadMD. Given the magnitude of tragedy, loss and unpredictability in every area of life this past year, we prioritized what matters most helping other humans. Im especially proud of how our team banded together to extend a hand, lending our considerable resources to other businesses in need. We also didnt resort to furloughs or layoffs. In fact, we never have in our decade long history, and for a consultancy, thats truly rare. Instead, we encouraged our tribes natural service mentality, and through that value above all approach, we were able to help a lot of businesses and, in turn, a lot of people. When COVID-19 first began to spread, LeadMD acted fast to create and launch the Arizona Local Impact Fund alongside Invest Southwest and the StartupAZ Foundation. LeadMD donated $60,000 to help small businesses struggling in the immediate wake of the pandemic and have since supported four Arizona-based organizations through the fund. Then, in an effort to understand the B2B industrys most pressing needs, LeadMD conducted a Marketing in Crisis & Buyer Insights Survey. Not only did LeadMD follow this up with a report to shed light on the state of B2B marketing in the spring of 2020, but LeadMD put these insights to good use, offering free workshops and practical recommendations to other businesses finding their footing in the midst of the chaos. Also during the year, LeadMDs consulting department earned an American Business Stevie Award for Customer Success and the company as a whole landed on AZ Centrals list of the Top Companies to Work for in Arizona for 2020. In December, LeadMD was honored to be named in the first ever editorial list of the Top Brand Engagement & Activation Agencies in the U.S. by Chief Marketer. Last April, LeadMD was recognized as an Americas Digital Experience Solution Partner of the Year for Marketo Engage. LeadMD also earned sales accreditations for Adobe Experience Manager, Adobe Campaign and Adobe Analytics. As a Platinum-level partner, LeadMD is in the highest tier of Adobes Solution Partner Program, setting them apart from others in the industry. Partners are a critical part of our growth and customer success strategy here at Adobe, said Tony Sanders, Senior Director, Americas Partner Sales at Adobe. LeadMD worked in lockstep with our team to navigate the changes that 2020 brought, ensuring our joint clients digital transformation success. We look forward to our continued collaboration in 2021. As further testament of its leadership in the industry and proven results, LeadMD welcomed multiple noteworthy clients on board, including Invoca, ROHM, Sterling Bancorp, Nextiva, Seismic, InVision and CME Group, to name a few. LeadMD is looking forward to a new year full of further leadership, collaboration, service and growth. About LeadMD LeadMD is the number one performance marketing consultancy in the U.S. Launched in 2009, LeadMD empowers marketers to drive revenue and customer success. The company focuses on people, processes, and technology that create predictable and sustainable revenue for high growth and enterprise brands. LeadMD has helped thousands of brands improve and deliver value through strategy and proven tactics that work. For more information, visit www.leadmd.com or email at [email protected]. LeadMD and the LeadMD logo are trademarks of LeadMD, Inc. All other trademarks are the property of their respective owners. Helpful links: Facebook: www.facebook.com/leadmd Twitter: www.twitter.com/myleadmd LinkedIn: https://www.linkedin.com/company/leadmd
|
edtsum6584
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES, Nov. 24, 2020 /PRNewswire/ --The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired HP Inc. ("HP" or the "Company") (NYSE: HPQ) common stock between November 6, 2015 and June 21, 2016, inclusive (the "Class Period"). HP investors have until January 4, 2021 to file a lead plaintiff motion. If you are a shareholder who suffered a loss, click here to participate. On June 21, 2016, after the market closed, HP revealed that it would reduce its Supplies channel inventory by $450 million, resulting in a corresponding reduction of $450 million in Supplies revenue over the remainder of 2016. On this news, HP's stock price fell $0.72, or 5.4%, to close at $12.61 per share on June 22, 2016. The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose: (1) that HP's channel inventory management and sales practices resulted in the sale of supplies to customers that did not need or want the product in order to artificially increase revenues and profits; (2) that HP's channel inventory management and sales practices resulted in the sale of supplies to customers outside of designated regions at unsustainable discounts in order to artificially increase revenues and profits; (3) that HP's channel inventory management and sales practices resulted in the sale of supplies at steep discounts to customers to encourage those customers to sell the supplies further down the supply channel, out of HP's inventory management metrics; and (4) that, as a result of the foregoing, defendants' statements about the Company's business condition and prospects were materially false and misleading when made. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased HP securities during the Class Period, you may move the Court no later than January 4, 2021 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you purchased HP securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [emailprotected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. SOURCE The Law Offices of Frank R. Cruz, Los Angeles Related Links http://www.frankcruzlaw.com
Answer:
|
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of HP Inc. (HPQ) Investors
|
LOS ANGELES, Nov. 24, 2020 /PRNewswire/ --The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired HP Inc. ("HP" or the "Company") (NYSE: HPQ) common stock between November 6, 2015 and June 21, 2016, inclusive (the "Class Period"). HP investors have until January 4, 2021 to file a lead plaintiff motion. If you are a shareholder who suffered a loss, click here to participate. On June 21, 2016, after the market closed, HP revealed that it would reduce its Supplies channel inventory by $450 million, resulting in a corresponding reduction of $450 million in Supplies revenue over the remainder of 2016. On this news, HP's stock price fell $0.72, or 5.4%, to close at $12.61 per share on June 22, 2016. The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose: (1) that HP's channel inventory management and sales practices resulted in the sale of supplies to customers that did not need or want the product in order to artificially increase revenues and profits; (2) that HP's channel inventory management and sales practices resulted in the sale of supplies to customers outside of designated regions at unsustainable discounts in order to artificially increase revenues and profits; (3) that HP's channel inventory management and sales practices resulted in the sale of supplies at steep discounts to customers to encourage those customers to sell the supplies further down the supply channel, out of HP's inventory management metrics; and (4) that, as a result of the foregoing, defendants' statements about the Company's business condition and prospects were materially false and misleading when made. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased HP securities during the Class Period, you may move the Court no later than January 4, 2021 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you purchased HP securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [emailprotected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. SOURCE The Law Offices of Frank R. Cruz, Los Angeles Related Links http://www.frankcruzlaw.com
|
edtsum6586
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (AdaptHealth or the Company), a leading provider of home medical equipment, supplies and related services in the United States, announced today that Luke McGee, Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 at 10:00 am EST. The virtual conference will be held from January 11-14, 2021. A live webcast and replay will be accessible through the Investors section of AdaptHealths website (www.adapthealth.com). Please visit AdaptHealths website approximately 5-10 minutes prior to the presentation to register and download any necessary audio software. About AdaptHealth Corp. AdaptHealth Corp. is a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States. AdaptHealth provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home, adapt to life and thrive. Product and services offerings include (i) sleep therapy equipment, supplies and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea, (ii) medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps), (iii) home medical equipment (HME) to patients discharged from acute care and other facilities, (iv) oxygen and related chronic therapy services in the home, and (v) other HME medical devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid and commercial insurance payors. As of September 30, 2020, AdaptHealth services over approximately 1.8 million patients annually in all 50 states through its network of 269 locations in 41 states.
Answer:
|
AdaptHealth Corp. to Present at 39th Annual J.P. Morgan Healthcare Conference
|
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (AdaptHealth or the Company), a leading provider of home medical equipment, supplies and related services in the United States, announced today that Luke McGee, Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 at 10:00 am EST. The virtual conference will be held from January 11-14, 2021. A live webcast and replay will be accessible through the Investors section of AdaptHealths website (www.adapthealth.com). Please visit AdaptHealths website approximately 5-10 minutes prior to the presentation to register and download any necessary audio software. About AdaptHealth Corp. AdaptHealth Corp. is a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States. AdaptHealth provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home, adapt to life and thrive. Product and services offerings include (i) sleep therapy equipment, supplies and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea, (ii) medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps), (iii) home medical equipment (HME) to patients discharged from acute care and other facilities, (iv) oxygen and related chronic therapy services in the home, and (v) other HME medical devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid and commercial insurance payors. As of September 30, 2020, AdaptHealth services over approximately 1.8 million patients annually in all 50 states through its network of 269 locations in 41 states.
|
edtsum6588
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: HANGZHOU, China, April 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services in China, today announced that Hangzhou Economic and Information Bureau ("HEIB") and Central Office of ChinesePeasantsandWorkersDemocraticParty[1] ("CPWDP") conveyed to the Company their appreciation and thanks for the Company's contribution in combating the novel coronavirus outbreak ("COVID-19"). In the thank-you letter from HEIB, the Company was recognized as one of seven municipal-level temporary reserve organizations of prevention and control materials. The Company was praised for actively exerting initiative to ensure the market supply and effectively alleviating the imbalance between supply and demand of epidemic prevention materials such as masks in the market. CPWDP thanked Mr. Wei Hu, the Chief Operating Officer of Jo-Jo Drugstores, for his contribution of monitoring and responding to the outbreak of COVID-19. Under Mr. Hu's guidance, the Company established the "24-hour Coronavirus Emergency Team" to ensure the implementation of the coronavirus prevention and control work. As of March 31, 2020, the Company has provided communities with over 3 million masks, 200,000 bottles of disinfectant, 1.5 million pairs of gloves, 150,000 bottles of alcohol, 100,000 various temperature measuring instruments and 500,000 boxes of other anti-epidemic materials and medicines. In addition, the Company made cash donations to the needed communities in the amount of RMB 200,000. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are excited to receive thank-you letters from HEIB and CPWDP. Looking forward, we will continue to work hard to make greater contributions to Hangzhou, allocate medical supplies to stabilize the market, and fulfil our visionto make the world healthier." [1]ChinesePeasantsandWorkersDemocraticParty. One of the democratic parties on the patriotic united front led by the Communist Party of China("CPC"), the CPWDP is mainly composed of intellectuals from health and medical circles. Since founded in Shanghai on September 1, 1930, CPWDP has played an important part in the state political life, economic construction and health and medical undertakings. About China Jo-Jo Drugstores, Inc. China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores" or the "Company"), is a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services inChina. Jo-Jo Drugstores currently operates an online pharmacy and retail drugstores with licensed doctors on site for consultation, examination and treatment of common ailments at scheduled hours. It is also a wholesale distributor of products similar to those carried in its pharmacies. In addition, Jo-Jo Drugstores cultivates herbs used for traditional Chinese medicine. For more information about the Company, please visit http://jiuzhou360.com.The Company routinely posts important information on its website. Forward-Looking Statements This press release contains information about the Company's view of its future expectations, plans and prospects that constitute forward-looking statements.Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property.The Company's encourages you to review other factors that may affect its future results in the Company's annual reports and in its other filings with the Securities and Exchange Commission. For more information, please contact: Company Contact: Frank ZhaoChief Financial Officer+86-571-88077108[emailprotected] Steve LiuInvestor Relations Director[emailprotected] Investor Relations Contact: Tina XiaoAscent Investor Relations LLC+1-917-609-0333[emailprotected] SOURCE China Jo-Jo Drugstores, Inc. Related Links http://jiuzhou360.com
Answer:
|
China Jo-Jo Drugstores Received Thank-You Letters from Hangzhou Economic and Information Bureau and Central Office of Chinese Peasants and Workers Democratic Party
|
HANGZHOU, China, April 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services in China, today announced that Hangzhou Economic and Information Bureau ("HEIB") and Central Office of ChinesePeasantsandWorkersDemocraticParty[1] ("CPWDP") conveyed to the Company their appreciation and thanks for the Company's contribution in combating the novel coronavirus outbreak ("COVID-19"). In the thank-you letter from HEIB, the Company was recognized as one of seven municipal-level temporary reserve organizations of prevention and control materials. The Company was praised for actively exerting initiative to ensure the market supply and effectively alleviating the imbalance between supply and demand of epidemic prevention materials such as masks in the market. CPWDP thanked Mr. Wei Hu, the Chief Operating Officer of Jo-Jo Drugstores, for his contribution of monitoring and responding to the outbreak of COVID-19. Under Mr. Hu's guidance, the Company established the "24-hour Coronavirus Emergency Team" to ensure the implementation of the coronavirus prevention and control work. As of March 31, 2020, the Company has provided communities with over 3 million masks, 200,000 bottles of disinfectant, 1.5 million pairs of gloves, 150,000 bottles of alcohol, 100,000 various temperature measuring instruments and 500,000 boxes of other anti-epidemic materials and medicines. In addition, the Company made cash donations to the needed communities in the amount of RMB 200,000. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are excited to receive thank-you letters from HEIB and CPWDP. Looking forward, we will continue to work hard to make greater contributions to Hangzhou, allocate medical supplies to stabilize the market, and fulfil our visionto make the world healthier." [1]ChinesePeasantsandWorkersDemocraticParty. One of the democratic parties on the patriotic united front led by the Communist Party of China("CPC"), the CPWDP is mainly composed of intellectuals from health and medical circles. Since founded in Shanghai on September 1, 1930, CPWDP has played an important part in the state political life, economic construction and health and medical undertakings. About China Jo-Jo Drugstores, Inc. China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores" or the "Company"), is a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services inChina. Jo-Jo Drugstores currently operates an online pharmacy and retail drugstores with licensed doctors on site for consultation, examination and treatment of common ailments at scheduled hours. It is also a wholesale distributor of products similar to those carried in its pharmacies. In addition, Jo-Jo Drugstores cultivates herbs used for traditional Chinese medicine. For more information about the Company, please visit http://jiuzhou360.com.The Company routinely posts important information on its website. Forward-Looking Statements This press release contains information about the Company's view of its future expectations, plans and prospects that constitute forward-looking statements.Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property.The Company's encourages you to review other factors that may affect its future results in the Company's annual reports and in its other filings with the Securities and Exchange Commission. For more information, please contact: Company Contact: Frank ZhaoChief Financial Officer+86-571-88077108[emailprotected] Steve LiuInvestor Relations Director[emailprotected] Investor Relations Contact: Tina XiaoAscent Investor Relations LLC+1-917-609-0333[emailprotected] SOURCE China Jo-Jo Drugstores, Inc. Related Links http://jiuzhou360.com
|
edtsum6591
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MENLO PARK, Calif.--(BUSINESS WIRE)--RapidAI, the leader in advanced cerebrovascular imaging, today announced it has partnered with the World Stroke Organization (WSO) and Sociedad Iberoamericana de Enfermedad Cerebrovascular (SIECV) to become the exclusive neuroimaging partner for their new Stroke Center Certification Program in Latin America. Within the cross-continent initiative, RapidAI will provide a combination of its comprehensive AI-powered Rapid stroke imaging platform and its unique Rapid U stroke training and certification program to hospitals across Latin America. The new Stroke Center Certification Program in Latin America was created by WSO President-Elect Dr. Sheila Martins to increase the quality and safety of stroke treatment in Latin American and improve patient outcomes. Per the WSO, the certification of stroke centers is critical to ensure that hospitals implement and monitor all priority strategies that change the natural history of stroke, reducing mortality and disability. It is a great opportunity for continuous improvement of services and qualification of comprehensive care in the region. The program aims to certify more than 100 advanced and essential stroke centers across Latin America, in the next year. This is the most exciting time in history to be working in stroke care, because we have the tools, the program, and now the exclusive partnerships to bring world-class stroke education and technology to stroke centers throughout Latin America, said Dr. Sheila Martins, President-elect of the WSO, founder of the Brazilian Stroke Network, Neurology Professor of Universidade Federal do Rio Grande do Sul and Chief of Neurology and Neurosurgery Service at Hospital Moinhos de Vento. We are incredibly grateful to have RapidAI on board as our advanced medical imaging partner. Their clinically proven technology and training has been instrumental in expanding and improving stroke care internationally. Further, their understanding of the region will contribute to the programs success and growth. Already in over 60 countries, Rapid is the most widely used advanced cerebrovascular imaging platform for patient care, research and clinical trials across the globe. RapidAI is committed to improving stroke care on a global level, and we are delighted that this exclusive partnership with the WSO and SIECV enables us to bring AI-powered stroke imaging to more hospitals and more patients across Latin America, said Dr. Greg Albers, Professor of Neurology at Stanford University, Director of the Stanford Stroke Center and cofounder of RapidAI. Ever since our research helped significantly expand stroke care guidelines in 2018, the worldwide need for Rapid imaging has continued to accelerate. We look forward to contributing to this programs success and using it as a blueprint to facilitate similar WSO initiatives around the world. To learn more about the WSO and SIECV Stroke Center Certification Program in Latin America, visit www.globalstrokealliance.com To learn more about RapidAI, as well as the Rapid platform, visit www.RapidAI.com About RapidAI RapidAI is the worldwide leader in advanced cerebrovascular imaging and workflow. Based on intelligence gained over 2 million scans from more than 1,800 hospitals in over 60 countries, the Rapid platform uses artificial intelligence to create high quality, advanced images from non-contrast CT, CT angiography, CT perfusion, CBCT angiography and MRI diffusion and perfusion scans. The Rapid imaging platform includes Rapid ICH, Rapid ASPECTS, Rapid CTA, Rapid LVO, Rapid CTP, Rapid for Angio and Rapid MRI. RapidAI also offers Rapid Aneurysm, a comprehensive aneurysm management platform. RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients using clinically proven, data-driven technology. With its validated, trusted products developed by medical experts, clinicians worldwide are improving patient care and outcomes every day. For more information, visit www.RapidAI.com.
Answer:
|
RapidAI Named Exclusive Advanced Neuroimaging Partner for the WSO and SIECV Stroke Center Certification Program in Latin America RapidAI Partners with the World Stroke Organization and Sociedad Iberoamericana de Enfermedad Cerebrovascular to Expand the Availability of AI-Powered Stroke Imaging Throughout Latin America
|
MENLO PARK, Calif.--(BUSINESS WIRE)--RapidAI, the leader in advanced cerebrovascular imaging, today announced it has partnered with the World Stroke Organization (WSO) and Sociedad Iberoamericana de Enfermedad Cerebrovascular (SIECV) to become the exclusive neuroimaging partner for their new Stroke Center Certification Program in Latin America. Within the cross-continent initiative, RapidAI will provide a combination of its comprehensive AI-powered Rapid stroke imaging platform and its unique Rapid U stroke training and certification program to hospitals across Latin America. The new Stroke Center Certification Program in Latin America was created by WSO President-Elect Dr. Sheila Martins to increase the quality and safety of stroke treatment in Latin American and improve patient outcomes. Per the WSO, the certification of stroke centers is critical to ensure that hospitals implement and monitor all priority strategies that change the natural history of stroke, reducing mortality and disability. It is a great opportunity for continuous improvement of services and qualification of comprehensive care in the region. The program aims to certify more than 100 advanced and essential stroke centers across Latin America, in the next year. This is the most exciting time in history to be working in stroke care, because we have the tools, the program, and now the exclusive partnerships to bring world-class stroke education and technology to stroke centers throughout Latin America, said Dr. Sheila Martins, President-elect of the WSO, founder of the Brazilian Stroke Network, Neurology Professor of Universidade Federal do Rio Grande do Sul and Chief of Neurology and Neurosurgery Service at Hospital Moinhos de Vento. We are incredibly grateful to have RapidAI on board as our advanced medical imaging partner. Their clinically proven technology and training has been instrumental in expanding and improving stroke care internationally. Further, their understanding of the region will contribute to the programs success and growth. Already in over 60 countries, Rapid is the most widely used advanced cerebrovascular imaging platform for patient care, research and clinical trials across the globe. RapidAI is committed to improving stroke care on a global level, and we are delighted that this exclusive partnership with the WSO and SIECV enables us to bring AI-powered stroke imaging to more hospitals and more patients across Latin America, said Dr. Greg Albers, Professor of Neurology at Stanford University, Director of the Stanford Stroke Center and cofounder of RapidAI. Ever since our research helped significantly expand stroke care guidelines in 2018, the worldwide need for Rapid imaging has continued to accelerate. We look forward to contributing to this programs success and using it as a blueprint to facilitate similar WSO initiatives around the world. To learn more about the WSO and SIECV Stroke Center Certification Program in Latin America, visit www.globalstrokealliance.com To learn more about RapidAI, as well as the Rapid platform, visit www.RapidAI.com About RapidAI RapidAI is the worldwide leader in advanced cerebrovascular imaging and workflow. Based on intelligence gained over 2 million scans from more than 1,800 hospitals in over 60 countries, the Rapid platform uses artificial intelligence to create high quality, advanced images from non-contrast CT, CT angiography, CT perfusion, CBCT angiography and MRI diffusion and perfusion scans. The Rapid imaging platform includes Rapid ICH, Rapid ASPECTS, Rapid CTA, Rapid LVO, Rapid CTP, Rapid for Angio and Rapid MRI. RapidAI also offers Rapid Aneurysm, a comprehensive aneurysm management platform. RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients using clinically proven, data-driven technology. With its validated, trusted products developed by medical experts, clinicians worldwide are improving patient care and outcomes every day. For more information, visit www.RapidAI.com.
|
edtsum6592
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, May 21, 2020 /PRNewswire/ -- The "APAC Biologics CMO Directory" report has been added to ResearchAndMarkets.com's offering. Ten years ago, it was hard for Chinese biopharmaceutical service companies to meet the requirements of a Western client. Today, there is a proliferation of companies such as WuXi Biologics, MabPlex, JHL Biotech and more. Furthermore, recently in Asia: Eirgenix received approval from Japan's PMDA, opportuning it to sell to the Japanese market. Korea's Celltrion has budgeted $514 million over five years to build China's biggest biologics facility at a capacity of 120,000 litres, manufacturing Celltrion's own biologics and performing contract work for Chinese biotechs. New mammalian production lines established by AGC biologics to produce monoclonal antibodies (MAbs) and fusion proteins Contract biomanufacturing in Asia is poised for growth. If you're keen on understanding the Asian CMO landscape, check out this latest release - a 150-page directory, Asia-Pacific Biologic CMO Directory, gives you a comprehensive analysis of the CMOs in Asia.The report provides detailed research and analysis of the Manufacturing Capacity, Facility Design, Product Lines, Regulatory Certifications, Team-Distribution, Financial Performance, Technologies Housed, and Facility Expansion Plans of 50+ CMOs in the Asian region from countries such as China, Taiwan, Korea, Japan, India, Singapore and more.Access in-depth research and analysis of Contract Manufacturing (CMOs) providers for the Biologics industry in Asia. The 150 page report covers key biologics Contract Manufacturing companies from Asian markets such as China, Korea, Japan, Southeast Asia, and India are covered, featuring extensive information: years of operation, types of bioreactors used, manufacturing capacity, types of products, financial performance, current clients, and future expansion plans.Key Topics Covered: Section 1 Preface Report Scope & Data Coverage Research Methodology Section 2: Company-Wise Data & Analysis Company Overview Manufacturing Sites Facility Design Plant Capacity Batch Size GMP Certification Products Manufactured Manufacturing Services Projects Partnerships & Collaborations Capacity Planning & Future Expansion Interview Industry News & Updates Swot Analysis References Section 3: Region-Wise Data & Analysis of CMO's Products manufactured: vaccines - cell therapy - recombinant proteins & mabs - others Technologies housed & manufacturing services Production lines GMP certification Facility size, design and capacity planning Team size & distribution PESTEL analysis Companies Mentioned Amaran Biotechnology Boehringer Ingelheim Cmab Biopharma Cellular Biomedicine Group Cp Goujian Pharma Eirgenix Innovent Biologics Jade Biomedical Jhl Biotech Joinn Biologics Lonza China Mycenax Biotech Obio Technology Orient Pharma Sinobioway Taron Solutions United Biopharma Wuxi Apptec Clonz Biotech Intas Pharmaceuticals Kemwell Biopharma Stelis Biosource Syngene Zumotor Biologics Mesoblast Pfizer Centreone Luina Bio Biocon Esco Aster Inno Biologics Lonza Ag Singapore Cellworx Anterogen Binex Celltrion Eubiologics Kolon Life Sciences Masthercell Samsung Biologics SK Corp Agc Biologics Ajinomoto Bio- Pharma Bushu Pharmaceuticals Hitachi Chemical Id Pharma Medinet Pharmabio Takara Bio Toyobo For more information about this report visit https://www.researchandmarkets.com/r/khctqm About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer:
|
Contract Manufacturing (CMO) in the Asian Biologics Industry: 2020 Directory Covering 50+ Biologics CMOs with 100+ Production Lines
|
DUBLIN, May 21, 2020 /PRNewswire/ -- The "APAC Biologics CMO Directory" report has been added to ResearchAndMarkets.com's offering. Ten years ago, it was hard for Chinese biopharmaceutical service companies to meet the requirements of a Western client. Today, there is a proliferation of companies such as WuXi Biologics, MabPlex, JHL Biotech and more. Furthermore, recently in Asia: Eirgenix received approval from Japan's PMDA, opportuning it to sell to the Japanese market. Korea's Celltrion has budgeted $514 million over five years to build China's biggest biologics facility at a capacity of 120,000 litres, manufacturing Celltrion's own biologics and performing contract work for Chinese biotechs. New mammalian production lines established by AGC biologics to produce monoclonal antibodies (MAbs) and fusion proteins Contract biomanufacturing in Asia is poised for growth. If you're keen on understanding the Asian CMO landscape, check out this latest release - a 150-page directory, Asia-Pacific Biologic CMO Directory, gives you a comprehensive analysis of the CMOs in Asia.The report provides detailed research and analysis of the Manufacturing Capacity, Facility Design, Product Lines, Regulatory Certifications, Team-Distribution, Financial Performance, Technologies Housed, and Facility Expansion Plans of 50+ CMOs in the Asian region from countries such as China, Taiwan, Korea, Japan, India, Singapore and more.Access in-depth research and analysis of Contract Manufacturing (CMOs) providers for the Biologics industry in Asia. The 150 page report covers key biologics Contract Manufacturing companies from Asian markets such as China, Korea, Japan, Southeast Asia, and India are covered, featuring extensive information: years of operation, types of bioreactors used, manufacturing capacity, types of products, financial performance, current clients, and future expansion plans.Key Topics Covered: Section 1 Preface Report Scope & Data Coverage Research Methodology Section 2: Company-Wise Data & Analysis Company Overview Manufacturing Sites Facility Design Plant Capacity Batch Size GMP Certification Products Manufactured Manufacturing Services Projects Partnerships & Collaborations Capacity Planning & Future Expansion Interview Industry News & Updates Swot Analysis References Section 3: Region-Wise Data & Analysis of CMO's Products manufactured: vaccines - cell therapy - recombinant proteins & mabs - others Technologies housed & manufacturing services Production lines GMP certification Facility size, design and capacity planning Team size & distribution PESTEL analysis Companies Mentioned Amaran Biotechnology Boehringer Ingelheim Cmab Biopharma Cellular Biomedicine Group Cp Goujian Pharma Eirgenix Innovent Biologics Jade Biomedical Jhl Biotech Joinn Biologics Lonza China Mycenax Biotech Obio Technology Orient Pharma Sinobioway Taron Solutions United Biopharma Wuxi Apptec Clonz Biotech Intas Pharmaceuticals Kemwell Biopharma Stelis Biosource Syngene Zumotor Biologics Mesoblast Pfizer Centreone Luina Bio Biocon Esco Aster Inno Biologics Lonza Ag Singapore Cellworx Anterogen Binex Celltrion Eubiologics Kolon Life Sciences Masthercell Samsung Biologics SK Corp Agc Biologics Ajinomoto Bio- Pharma Bushu Pharmaceuticals Hitachi Chemical Id Pharma Medinet Pharmabio Takara Bio Toyobo For more information about this report visit https://www.researchandmarkets.com/r/khctqm About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
|
edtsum6595
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: GUANGZHOU, China, Dec. 22, 2020 /PRNewswire/ -- China Sports Culture Expo and China Sports Tourism Expo (CSCTE) 2020, co-organized by International Data Group (IDG Asia),will be held online on December 21st-23rd. Under the theme of Healthy China, Powered by Sports, CSCTE 2020 has set up over ten exhibition areas, forums and many supporting events. To be held in the forms such as "cloud display", "cloud forum", "cloud event" and "cloud matchmaking", CSCTE 2020 is providing a multi-dimensional online display platform, an online forum-based platform and a business matchmaking service platform. Through the virtual exhibition halls, the "cloud display" focuses on displaying the charm of local sports culture and sports tourism, sports technology and comprehensive health, innovative sports products, sports brands, as well as large-scale stadiums. The sports culture exhibition zone exhibits and displays intangible sports culture heritage projects such as the martial arts and the chess event Go. The "cloud forum" integrates the advantageous resources of sports parties, interprets the central and local governments' policies on sports, and brings together industry elites, experts and scholars to discuss new trends in the development of sports culture and sports tourism, and to interpret the path of sports reform and innovative development. To meet the diverse public needs for sports culture and sports tourism, the "cloud event" mainly includes the online promotion of the outstanding Chinese sports culture projects and the excellent Chinese sports tourism projects, the online exhibition of the traditional Chinese sports, contract signing for China Sports Culture Development Fund, and online display and exchanges regarding sports calligraphy and paintings, film and TV, and photography, etc. The "cloud matchmaking" offers online trading channels and platforms; provides online promotion, supply and procurement matchmaking, online negotiations, etc.; offers online transactions and contract signing; and facilitates the integrated development of sports culture and sports tourism industry. Information about CSCTE 2020 is available at the official CSCTE website http://www.cectexpo.com/ and the WeChat official account. CSCTE adopts innovative methods to grow into a smart and digital event, which dovetails with the digital development of the sports industry, and also provides practitioners of relevant industries in CSCTE 2020 with new ideas and excellent model for "Internet Plus sports". China Sports Culture Expo is the only expo hosted by the General Administration of Sport of China. China Sports Tourism Expo was honored as key exhibition designated by the Ministry of Commerce. As a high standard global event concerning sports culture, sports tourism, and sports industry, China Sports Culture Expo is hosted by the General Administration of Sport of China and the Chinese Olympic Committee; China Sports Tourism Expo is hosted by the All-China Sports Federation, Chinese Olympic Committee, and China Tourism Association. The CSCTE is to be organized by Guangzhou Municipal People's Government, Sports Culture Development Center of the General Administration of Sport of China, International Data Group, and Aiqi Sports. SOURCE IDG Asia
Answer:
|
China Sports Culture Expo and China Sports Tourism Expo (CSCTE) 2020 To Be Beld Online On 21st-23rd, December
|
GUANGZHOU, China, Dec. 22, 2020 /PRNewswire/ -- China Sports Culture Expo and China Sports Tourism Expo (CSCTE) 2020, co-organized by International Data Group (IDG Asia),will be held online on December 21st-23rd. Under the theme of Healthy China, Powered by Sports, CSCTE 2020 has set up over ten exhibition areas, forums and many supporting events. To be held in the forms such as "cloud display", "cloud forum", "cloud event" and "cloud matchmaking", CSCTE 2020 is providing a multi-dimensional online display platform, an online forum-based platform and a business matchmaking service platform. Through the virtual exhibition halls, the "cloud display" focuses on displaying the charm of local sports culture and sports tourism, sports technology and comprehensive health, innovative sports products, sports brands, as well as large-scale stadiums. The sports culture exhibition zone exhibits and displays intangible sports culture heritage projects such as the martial arts and the chess event Go. The "cloud forum" integrates the advantageous resources of sports parties, interprets the central and local governments' policies on sports, and brings together industry elites, experts and scholars to discuss new trends in the development of sports culture and sports tourism, and to interpret the path of sports reform and innovative development. To meet the diverse public needs for sports culture and sports tourism, the "cloud event" mainly includes the online promotion of the outstanding Chinese sports culture projects and the excellent Chinese sports tourism projects, the online exhibition of the traditional Chinese sports, contract signing for China Sports Culture Development Fund, and online display and exchanges regarding sports calligraphy and paintings, film and TV, and photography, etc. The "cloud matchmaking" offers online trading channels and platforms; provides online promotion, supply and procurement matchmaking, online negotiations, etc.; offers online transactions and contract signing; and facilitates the integrated development of sports culture and sports tourism industry. Information about CSCTE 2020 is available at the official CSCTE website http://www.cectexpo.com/ and the WeChat official account. CSCTE adopts innovative methods to grow into a smart and digital event, which dovetails with the digital development of the sports industry, and also provides practitioners of relevant industries in CSCTE 2020 with new ideas and excellent model for "Internet Plus sports". China Sports Culture Expo is the only expo hosted by the General Administration of Sport of China. China Sports Tourism Expo was honored as key exhibition designated by the Ministry of Commerce. As a high standard global event concerning sports culture, sports tourism, and sports industry, China Sports Culture Expo is hosted by the General Administration of Sport of China and the Chinese Olympic Committee; China Sports Tourism Expo is hosted by the All-China Sports Federation, Chinese Olympic Committee, and China Tourism Association. The CSCTE is to be organized by Guangzhou Municipal People's Government, Sports Culture Development Center of the General Administration of Sport of China, International Data Group, and Aiqi Sports. SOURCE IDG Asia
|
edtsum6603
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PORT OF PALM BEACH, Fla., March 12, 2021 /PRNewswire/ --RGF Environmental Group, Inc., a leader in environmental design and manufacturing, announces the successful installation of RGF's patented air treatment solutions across the Jacksonville Transportation Authority's (JTA) real estate portfolio. The 29 buildings represent over 203,000 square feet protected by RGF air treatment solutions with a proven efficacy of greater than 99% for neutralizing the SARS-CoV-2 virus within indoor spaces. Third-party study results of RGFs REME HALO with PHI-Cell technology. RGF technology inactivated greater than 99.9% of SARS-CoV-2 on surfaces. RGF technology inactivated 99.5% of the aerosolized form of SARS-CoV-2. "RGF is working with building owners across the United States to provide safe environments for employees," said Tony Julian, Vice President of Commercial Products, RGF Environmental Group, Inc. "Multi-modal transportation hubs, such as the Jacksonville Regional Transportation Center, are critical links to get Americans safety to and from their places of work." "The Jacksonville Transportation Authority is committed to the safety of our customers and employees during this public health emergency and beyond," said JTA Chief Executive Officer Nathaniel P. Ford Sr. "The installation of RGF's equipment in our indoor spaces is an example of our commitment to providing a safe and welcoming environment for everyone to experience." "Within a service and maintenance contract with JTA, Weather Engineers, Inc. provided engineering and installation services for RGF's air treatment solutions," notes Dan Griffin, president of Weather Engineers, Inc. "The Indoor Air Quality enhancement project includes the new Jacksonville Regional Transportation Center at LaVilla which serves as the JTA's main bus transfer facility, regional mobility hub and the JTA's administrative offices." For the project, the JTA chose RGF's award-winning REME HALO, Package PHI Units, Mini Split PHI, BLU QR and PTAC PHI units.RGF equipment is installed in every HVAC unit and in every building that JTA occupies. When integrated into HVAC units, the RGF equipment inactivates SARS-CoV-2 by more than 99.9% as demonstrated in a third-party study.The independent third-party study focused on the inactivation of SARS-CoV-2 using RGF's proprietary REME HALO product with PHI-Cell technology. The study demonstrated efficacy rates greater than 99.9% against the SARS-CoV-2 virus, commonly known as the coronavirus 2019 or COVID-19. The testing, performed at the Innovative Bioanalysis Laboratories in Cypress, Calif., looked at neutralizing the virus within the occupied space in the air and on surfaces. Results of the study can be viewed here: Test Environment Requirements: Large Real-World Chamber, SARS-CoV-2 Virus (not surrogate), Testing of Surfaces & Aerosolized Form Test Results: 99.9% of Virus Inactivated on Surfaces; 99.5% Aerosolized Virus Reduction For more information or to schedule an interview, please contact Stan Wagner at [emailprotected]or 303-618-5080. DISCLAIMER: The summary and any comments herein are based on the results from an independent laboratory study performed under controlled conditions and are not in any way medical claims. The product(s) and technologies described are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease, virus or illness.About RGF Environmental Group, Inc.RGFEnvironmental Group, Inc. manufactures over 500 environmental products and has a 36+ yearhistory of providing the world with the safest air, water and food without the use of chemicals. RGF is an ISO 9001:2015 certified research and innovation company, holding numerous patents for wastewater treatment systems, air purifying devices, and food sanitation systems. Situated in the heart of the Port of Palm Beach Enterprise Zone, RGF Headquarters span 9 acres, with 130,000 square feet of manufacturing, warehouse and office facilities. RGF's Lakeland, FL facility adds over 40,000 square feet for back-up production and lamp production. RGF continues to upgrade its facilities, creating an increased vertical approach to manufacturing, further allowing the company to provide the highest quality and best-engineered products on the market. For more information, visitRGF.com.About Weather Engineers, Inc.Weather Engineers, Inc. was established in 1963. Since that time, we have become the leader in the North Florida marketplace in providing products and services to condition the indoor environment for homes, commercial buildings and industrial facilities. We have developed and maintained this market leadership by constantly seeking technological innovations to better serve our customers. We have been and will continue to be market leaders in providing our customers with high efficiency solutions to increase reliability and reduce operating costs. Another example of our commitment to technological innovation and leadership is our Envirovac business unit which provides indoor air quality services including duct cleaning, sanitizations, air purification and repairs. For more information visit weatherengineers.com and envirovac.orgAbout the Jacksonville Transportation Authority (JTA)The Jacksonville Transportation Authority (JTA) is an independent state agency serving Duval County, with multi-modal responsibilities. The JTA designs and constructs bridges and highways and provides varied mass transit services. These include express and regular bus service, monorail, the St. Johns River Ferry, paratransit and other mobility and on-demand services. The JTA serves the largest city in the continental U.S. in terms of landmass. An integrated transportation network is a critical element in any community to properly manage growth, provide mobility and offer a good quality of life. Learn more atwww.jtafla.com.SOURCE RGF Environmental Group, Inc.
Answer:
|
RGF Environmental Group and Weather Engineers Provide Jacksonville Transportation Authority (JTA) Facilities with Air Treatment Solutions 200 air purification units installed in 29 JTA properties, including the new Jacksonville Regional Transportation Center, to protect riders and employees
|
PORT OF PALM BEACH, Fla., March 12, 2021 /PRNewswire/ --RGF Environmental Group, Inc., a leader in environmental design and manufacturing, announces the successful installation of RGF's patented air treatment solutions across the Jacksonville Transportation Authority's (JTA) real estate portfolio. The 29 buildings represent over 203,000 square feet protected by RGF air treatment solutions with a proven efficacy of greater than 99% for neutralizing the SARS-CoV-2 virus within indoor spaces. Third-party study results of RGFs REME HALO with PHI-Cell technology. RGF technology inactivated greater than 99.9% of SARS-CoV-2 on surfaces. RGF technology inactivated 99.5% of the aerosolized form of SARS-CoV-2. "RGF is working with building owners across the United States to provide safe environments for employees," said Tony Julian, Vice President of Commercial Products, RGF Environmental Group, Inc. "Multi-modal transportation hubs, such as the Jacksonville Regional Transportation Center, are critical links to get Americans safety to and from their places of work." "The Jacksonville Transportation Authority is committed to the safety of our customers and employees during this public health emergency and beyond," said JTA Chief Executive Officer Nathaniel P. Ford Sr. "The installation of RGF's equipment in our indoor spaces is an example of our commitment to providing a safe and welcoming environment for everyone to experience." "Within a service and maintenance contract with JTA, Weather Engineers, Inc. provided engineering and installation services for RGF's air treatment solutions," notes Dan Griffin, president of Weather Engineers, Inc. "The Indoor Air Quality enhancement project includes the new Jacksonville Regional Transportation Center at LaVilla which serves as the JTA's main bus transfer facility, regional mobility hub and the JTA's administrative offices." For the project, the JTA chose RGF's award-winning REME HALO, Package PHI Units, Mini Split PHI, BLU QR and PTAC PHI units.RGF equipment is installed in every HVAC unit and in every building that JTA occupies. When integrated into HVAC units, the RGF equipment inactivates SARS-CoV-2 by more than 99.9% as demonstrated in a third-party study.The independent third-party study focused on the inactivation of SARS-CoV-2 using RGF's proprietary REME HALO product with PHI-Cell technology. The study demonstrated efficacy rates greater than 99.9% against the SARS-CoV-2 virus, commonly known as the coronavirus 2019 or COVID-19. The testing, performed at the Innovative Bioanalysis Laboratories in Cypress, Calif., looked at neutralizing the virus within the occupied space in the air and on surfaces. Results of the study can be viewed here: Test Environment Requirements: Large Real-World Chamber, SARS-CoV-2 Virus (not surrogate), Testing of Surfaces & Aerosolized Form Test Results: 99.9% of Virus Inactivated on Surfaces; 99.5% Aerosolized Virus Reduction For more information or to schedule an interview, please contact Stan Wagner at [emailprotected]or 303-618-5080. DISCLAIMER: The summary and any comments herein are based on the results from an independent laboratory study performed under controlled conditions and are not in any way medical claims. The product(s) and technologies described are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease, virus or illness.About RGF Environmental Group, Inc.RGFEnvironmental Group, Inc. manufactures over 500 environmental products and has a 36+ yearhistory of providing the world with the safest air, water and food without the use of chemicals. RGF is an ISO 9001:2015 certified research and innovation company, holding numerous patents for wastewater treatment systems, air purifying devices, and food sanitation systems. Situated in the heart of the Port of Palm Beach Enterprise Zone, RGF Headquarters span 9 acres, with 130,000 square feet of manufacturing, warehouse and office facilities. RGF's Lakeland, FL facility adds over 40,000 square feet for back-up production and lamp production. RGF continues to upgrade its facilities, creating an increased vertical approach to manufacturing, further allowing the company to provide the highest quality and best-engineered products on the market. For more information, visitRGF.com.About Weather Engineers, Inc.Weather Engineers, Inc. was established in 1963. Since that time, we have become the leader in the North Florida marketplace in providing products and services to condition the indoor environment for homes, commercial buildings and industrial facilities. We have developed and maintained this market leadership by constantly seeking technological innovations to better serve our customers. We have been and will continue to be market leaders in providing our customers with high efficiency solutions to increase reliability and reduce operating costs. Another example of our commitment to technological innovation and leadership is our Envirovac business unit which provides indoor air quality services including duct cleaning, sanitizations, air purification and repairs. For more information visit weatherengineers.com and envirovac.orgAbout the Jacksonville Transportation Authority (JTA)The Jacksonville Transportation Authority (JTA) is an independent state agency serving Duval County, with multi-modal responsibilities. The JTA designs and constructs bridges and highways and provides varied mass transit services. These include express and regular bus service, monorail, the St. Johns River Ferry, paratransit and other mobility and on-demand services. The JTA serves the largest city in the continental U.S. in terms of landmass. An integrated transportation network is a critical element in any community to properly manage growth, provide mobility and offer a good quality of life. Learn more atwww.jtafla.com.SOURCE RGF Environmental Group, Inc.
|
edtsum6604
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NAPERVILLE, Ill., June 11, 2020 /PRNewswire/ --Dealer Inspire (DI), a Cars.com Inc. (NYSE: CARS) company that provides disruptive technology and digital marketing solutions to the automotive industry, announced today a new OEM agreement with American Honda Motor Co. DI has been selected as a website and technology platform provider for Honda's 997 U.S.-based dealerships. The company is already an approved digital advertising provider for Honda and works with approximately 220 Honda dealers across the country. "We are excited to expand our relationship with Honda dealers and offer a fully connected and customizable website platform that seamlessly integrates with our digital advertising program and technology solutions for utmost efficiency," said Joe Chura, CEO and co-founder of Dealer Inspire. "We believe we can help Honda dealers meet the needs of today's digital shoppers and better compete in the rapidly shifting automotive market." A seven-time AWA Pinnacle Platform Winner, Dealer Inspire'sadvanced website platformis the core of its connected ecosystem of solutions that make automotive retail faster, easier, and smarter from search to signature. Built on a customizable platform and designed with user behavior data, DI websites are set apart by advanced technologies that drive modern consumers toward purchase decisions. DI customers receive additional benefits as part of Cars.com Inc., which includes Cars.com, Dealer Inspire and DealerRater. The company leverages integrated technologies across brands to drive Cars.com's 25 million in-market monthly car shoppers to dealers' digital and physical storefronts. Honda dealers who partner with DI also gain access to: Advanced Website Platform: DI's website platform is flexible, fast, and built to convert. It adapts to each individual shopper with personalization and geofencing technology, and features Lightning Inventory to instantly guide them to the right vehicle for their needs. Seamlessly integrated to the rest of DI's products, the website platform is the customizable core of any dealer's business. 24/7 Omnichannel Messaging: Conversations is the advanced messaging platform built to connect today's car shoppers with dealerships wherever, whenever, and however they want to shop. Featuring live video and SMS texting capabilities to keep shoppers connected offline, Conversations is deeply integrated with the dealer's website in unprecedented ways, replacing static lead forms by instantly answering questions and making connections. Connected Marketing: DI also offers a full suite of connected digital marketing services to drive new customers to the platform, including Fuel In-Market Video, Search Engine Marketing, Email Marketing, Social Advertising and Creative Services. By deploying the company's fully connected strategy, dealers can guide customers through each touchpoint in the car shopping journey. Proprietary Reporting Platform: Every DI website also comes with PRIZM, an advanced reporting platform at no additional cost, giving dealers ROI summaries, metric deep dives, group-level reporting, and proactive alerts for website analytics, marketing and product performance, and even open support requests all from one beautiful dashboard. Superior Customer Support: Dealer Inspire supports a best-in-class dealer-to-employee ratio to ensure industry-leading service, achieving an average dealer satisfaction score of 9.5 out of 10. A dedicated team of performance managers partner with dealers to continually increase results through marketing strategy, execution, and transparent reporting. For more information about DI's offerings for Honda and other dealers, please visit www.dealerinspire.com/honda. Honda dealers interested in partnering with DI can call (877) 899-8346 or email [emailprotected]. Dealer Inspire Dealer Surveys, Based on 2,800 dealer respondents. Avg. quality satisfaction 9.58; Avg. NPS: 9.55, January-August 2019 ABOUT DEALER INSPIREFounded in 2011, Dealer Inspire (DI), a Cars.com Inc. (NYSE: CARS) company is an award-winning website, technology, and digital marketing provider for progressive dealer partners across the United States and Canada. The company builds technology that helps future-proof dealerships for changing consumer behaviors and makes the car buying process faster and easier. With a team that has more than doubled in growth each year to serve 25 global brands, DI maintains its reputation for customer support with a standard of 15-minute response and 24-hour solution times. SOURCE Dealer Inspire Related Links https://www.dealerinspire.com
Answer:
|
Honda Selects Dealer Inspire as a Preferred Website and Technology Platform Provider for its Nearly 1,000 US Dealerships Dealer Inspire will provide Honda dealers one end-to-end digital platform with seamless marketing, website and messaging technologies built-in.
|
NAPERVILLE, Ill., June 11, 2020 /PRNewswire/ --Dealer Inspire (DI), a Cars.com Inc. (NYSE: CARS) company that provides disruptive technology and digital marketing solutions to the automotive industry, announced today a new OEM agreement with American Honda Motor Co. DI has been selected as a website and technology platform provider for Honda's 997 U.S.-based dealerships. The company is already an approved digital advertising provider for Honda and works with approximately 220 Honda dealers across the country. "We are excited to expand our relationship with Honda dealers and offer a fully connected and customizable website platform that seamlessly integrates with our digital advertising program and technology solutions for utmost efficiency," said Joe Chura, CEO and co-founder of Dealer Inspire. "We believe we can help Honda dealers meet the needs of today's digital shoppers and better compete in the rapidly shifting automotive market." A seven-time AWA Pinnacle Platform Winner, Dealer Inspire'sadvanced website platformis the core of its connected ecosystem of solutions that make automotive retail faster, easier, and smarter from search to signature. Built on a customizable platform and designed with user behavior data, DI websites are set apart by advanced technologies that drive modern consumers toward purchase decisions. DI customers receive additional benefits as part of Cars.com Inc., which includes Cars.com, Dealer Inspire and DealerRater. The company leverages integrated technologies across brands to drive Cars.com's 25 million in-market monthly car shoppers to dealers' digital and physical storefronts. Honda dealers who partner with DI also gain access to: Advanced Website Platform: DI's website platform is flexible, fast, and built to convert. It adapts to each individual shopper with personalization and geofencing technology, and features Lightning Inventory to instantly guide them to the right vehicle for their needs. Seamlessly integrated to the rest of DI's products, the website platform is the customizable core of any dealer's business. 24/7 Omnichannel Messaging: Conversations is the advanced messaging platform built to connect today's car shoppers with dealerships wherever, whenever, and however they want to shop. Featuring live video and SMS texting capabilities to keep shoppers connected offline, Conversations is deeply integrated with the dealer's website in unprecedented ways, replacing static lead forms by instantly answering questions and making connections. Connected Marketing: DI also offers a full suite of connected digital marketing services to drive new customers to the platform, including Fuel In-Market Video, Search Engine Marketing, Email Marketing, Social Advertising and Creative Services. By deploying the company's fully connected strategy, dealers can guide customers through each touchpoint in the car shopping journey. Proprietary Reporting Platform: Every DI website also comes with PRIZM, an advanced reporting platform at no additional cost, giving dealers ROI summaries, metric deep dives, group-level reporting, and proactive alerts for website analytics, marketing and product performance, and even open support requests all from one beautiful dashboard. Superior Customer Support: Dealer Inspire supports a best-in-class dealer-to-employee ratio to ensure industry-leading service, achieving an average dealer satisfaction score of 9.5 out of 10. A dedicated team of performance managers partner with dealers to continually increase results through marketing strategy, execution, and transparent reporting. For more information about DI's offerings for Honda and other dealers, please visit www.dealerinspire.com/honda. Honda dealers interested in partnering with DI can call (877) 899-8346 or email [emailprotected]. Dealer Inspire Dealer Surveys, Based on 2,800 dealer respondents. Avg. quality satisfaction 9.58; Avg. NPS: 9.55, January-August 2019 ABOUT DEALER INSPIREFounded in 2011, Dealer Inspire (DI), a Cars.com Inc. (NYSE: CARS) company is an award-winning website, technology, and digital marketing provider for progressive dealer partners across the United States and Canada. The company builds technology that helps future-proof dealerships for changing consumer behaviors and makes the car buying process faster and easier. With a team that has more than doubled in growth each year to serve 25 global brands, DI maintains its reputation for customer support with a standard of 15-minute response and 24-hour solution times. SOURCE Dealer Inspire Related Links https://www.dealerinspire.com
|
edtsum6616
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON, April 14, 2021 /PRNewswire/ -- TIGA, the games industry trade association, is pleased to announce the re-accreditation of the following games courses at Sheffield Hallam University: BSc (Hons) Computer Science for GamesRe-accreditation awarded MComp (Hons) Computer Science for GamesRe-accreditation - awarded The BSc (Hons) Computer Science for Gameshas a strong programming focus with plenty of opportunities to develop the skills students will require for technical careers in the games industry, including working on indie or AAA titles. The MComp (Hons) Computer Science for Gamescourse shares the first two years and much of the third with the BSc, but provides an additional year to develop the depth and breadth of students' industry skills. The opportunity to focus on shader programming and multiprocessor architectures would equip students well for working in core technology roles or on product teams. The recorded destinations of students graduating from both courses showed significant proportions gaining employment and a high level of graduates using their game technology skills in future employment. BSc (Hons) Computer Science for Games Destinations Percentage employed after 15 months: 85% (Graduate Outcomes survey data from HESA 2017-18) Percentage employed in games: 21%(University data for 2017-2018 ignoring unknown students) Percentage employed using their game technology skills: 88% (University data for 2017-2018 ignoring unknown students) MComp (Hons) Computer Science for Games Student Destinations Percentage employed after 15 months: 80%(from Graduate Outcomes survey data from HESA 2017-18) Percentage employed in games: 29%(University data for 2017-2018 ignoring unknown students) Percentage employed using their game technology skills: 94% (University data for 2017-2018 ignoring unknown students) The TIGA Accreditation Team was impressed by the following examples of best practice: The accredited courses demonstrate a well thought out course structure with technical C++ programming skills embedded throughout the programmes. This technical emphasis prepares graduates well for employment in programming roles in the games industry and has been well integrated into the new Project Based Learning (PBL) course structure. Students have one group project every year of the course where they work with artists and designers. Interdisciplinary team-working skills are central to game development and there is significant value in giving students regular opportunities to develop and practice these skills. Students on these courses enjoy access to market-leading PlayStation development facilities, including over 50 PlayStation development kits,and three specialised labs with high-spec, dual monitor PCs with industry-standard software. The Steel Minions game studio is an excellent example of engagement with industry practice, providing industry-relevant "workplace simulation" opportunities to the students on these accredited courses. The studio has accrued an authentic body of published console work shipping 4 PlayStation titles since 2012. The peer mentoring scheme for programming support represented particularly good practice, providing students with skills-focus employment while supporting fellow students on the course. Overall, the TIGA Accreditation Team was impressed by a well-structured submission, coherent course structures and the opportunities that PBL presents. Accreditation TeamThe Accreditation Team from TIGA who reviewed the courses comprised:Dr Richard Wilson, OBE CEO TIGADr Jacob Habgood, TIGA Educational Advisor (Sumo Digital Group)Karl Hilton, Studio's Director Lockwood PublishingMike Healey, Head of Programming Rebellion Dr Richard Wilson OBE, TIGA CEO, said:"Sheffield Hallam's TIGA accredited games courses are effectively preparing their students for employment. Stand out achievements include: workplace simulations via the Steel Minions game studio; inter-disciplinary team working; and 70 per cent of students on the BSc (Hons) Computer Science games course secure placements in the software industry annually.Congratulations to the staff and students of Sheffield Hallum University on on achieving re-accreditation of your courses." Dr Jacob Habgood, TIGA Educational Advisor said:"Sheffield Hallam's games courses have provided Sumo with a steady stream of graduate talent over many years. Many alumni now hold senior positions within the games industry, and some have played instrumental roles in BAFTA award-winning products. Hallam's game programming degrees continue to offer engineering-focussed content which stresses the underpinning technical skills required to thrive in the games industry as a programmer." Mark Featherstone, senior lecturer, Sheffield Hallam University, said:"The team are really pleased to see both courses accredited once more, working with TIGA has really helped us create industry relevant and up to date game coding courses and it's so satisfying to see our graduates heading into the games industry armed with the skills and knowledge they need to succeed." Get in touch: Tel: 0845 468 2330 Email: [emailprotected] Web: www.tiga.org Twitter: www.twitter.com/tigamovement Facebook: www.facebook.com/TIGAMovement LinkedIn: http://www.linkedin.com/company/tiga SOURCE TIGA c/o Osbourne Clarke
Answer:
|
Sheffield Hallam University Achieves TIGA Accreditation
|
LONDON, April 14, 2021 /PRNewswire/ -- TIGA, the games industry trade association, is pleased to announce the re-accreditation of the following games courses at Sheffield Hallam University: BSc (Hons) Computer Science for GamesRe-accreditation awarded MComp (Hons) Computer Science for GamesRe-accreditation - awarded The BSc (Hons) Computer Science for Gameshas a strong programming focus with plenty of opportunities to develop the skills students will require for technical careers in the games industry, including working on indie or AAA titles. The MComp (Hons) Computer Science for Gamescourse shares the first two years and much of the third with the BSc, but provides an additional year to develop the depth and breadth of students' industry skills. The opportunity to focus on shader programming and multiprocessor architectures would equip students well for working in core technology roles or on product teams. The recorded destinations of students graduating from both courses showed significant proportions gaining employment and a high level of graduates using their game technology skills in future employment. BSc (Hons) Computer Science for Games Destinations Percentage employed after 15 months: 85% (Graduate Outcomes survey data from HESA 2017-18) Percentage employed in games: 21%(University data for 2017-2018 ignoring unknown students) Percentage employed using their game technology skills: 88% (University data for 2017-2018 ignoring unknown students) MComp (Hons) Computer Science for Games Student Destinations Percentage employed after 15 months: 80%(from Graduate Outcomes survey data from HESA 2017-18) Percentage employed in games: 29%(University data for 2017-2018 ignoring unknown students) Percentage employed using their game technology skills: 94% (University data for 2017-2018 ignoring unknown students) The TIGA Accreditation Team was impressed by the following examples of best practice: The accredited courses demonstrate a well thought out course structure with technical C++ programming skills embedded throughout the programmes. This technical emphasis prepares graduates well for employment in programming roles in the games industry and has been well integrated into the new Project Based Learning (PBL) course structure. Students have one group project every year of the course where they work with artists and designers. Interdisciplinary team-working skills are central to game development and there is significant value in giving students regular opportunities to develop and practice these skills. Students on these courses enjoy access to market-leading PlayStation development facilities, including over 50 PlayStation development kits,and three specialised labs with high-spec, dual monitor PCs with industry-standard software. The Steel Minions game studio is an excellent example of engagement with industry practice, providing industry-relevant "workplace simulation" opportunities to the students on these accredited courses. The studio has accrued an authentic body of published console work shipping 4 PlayStation titles since 2012. The peer mentoring scheme for programming support represented particularly good practice, providing students with skills-focus employment while supporting fellow students on the course. Overall, the TIGA Accreditation Team was impressed by a well-structured submission, coherent course structures and the opportunities that PBL presents. Accreditation TeamThe Accreditation Team from TIGA who reviewed the courses comprised:Dr Richard Wilson, OBE CEO TIGADr Jacob Habgood, TIGA Educational Advisor (Sumo Digital Group)Karl Hilton, Studio's Director Lockwood PublishingMike Healey, Head of Programming Rebellion Dr Richard Wilson OBE, TIGA CEO, said:"Sheffield Hallam's TIGA accredited games courses are effectively preparing their students for employment. Stand out achievements include: workplace simulations via the Steel Minions game studio; inter-disciplinary team working; and 70 per cent of students on the BSc (Hons) Computer Science games course secure placements in the software industry annually.Congratulations to the staff and students of Sheffield Hallum University on on achieving re-accreditation of your courses." Dr Jacob Habgood, TIGA Educational Advisor said:"Sheffield Hallam's games courses have provided Sumo with a steady stream of graduate talent over many years. Many alumni now hold senior positions within the games industry, and some have played instrumental roles in BAFTA award-winning products. Hallam's game programming degrees continue to offer engineering-focussed content which stresses the underpinning technical skills required to thrive in the games industry as a programmer." Mark Featherstone, senior lecturer, Sheffield Hallam University, said:"The team are really pleased to see both courses accredited once more, working with TIGA has really helped us create industry relevant and up to date game coding courses and it's so satisfying to see our graduates heading into the games industry armed with the skills and knowledge they need to succeed." Get in touch: Tel: 0845 468 2330 Email: [emailprotected] Web: www.tiga.org Twitter: www.twitter.com/tigamovement Facebook: www.facebook.com/TIGAMovement LinkedIn: http://www.linkedin.com/company/tiga SOURCE TIGA c/o Osbourne Clarke
|
edtsum6624
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that National Government Services, Inc. (NGS), one of seven Medicare Administrative Contractors (MACs), became the third MAC to establish a physician fee schedule for procedure code 0356T for the administration of drug-eluting intracanalicular inserts, including DEXTENZA (dexamethasone ophthalmic insert) 0.4mg, effective July 1, 2020. The professional fee for CPT code 0356T is now eligible to be paid per the established local fee schedule, which can be found on the NGS website. We are pleased with the continued momentum we are seeing by MACs publishing physician fee schedules for procedure code 0356T, commented Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix. Combined, the three MACs with published fee schedules consisting of NGS, First Coast and Novitas Solutions cover approximately 50% of all Medicare beneficiaries. This continues to be a positive development and one that could impact adoption, not only for DEXTENZA, but also for the other product candidates in our pipeline utilizing the same route of administration. NGS covers Medicare patients in ten states, consisting of Illinois, Minnesota, Wisconsin, New York, Massachusetts, Connecticut, New Hampshire, Maine, Rhode Island, and Vermont. About DEXTENZA DEXTENZA is FDA approved for the treatment of ocular inflammation and pain following ophthalmic surgery. DEXTENZA is a corticosteroid intracanalicular insert placed in the punctum, a natural opening in the inner portion of the eyelid, and into the canaliculus and is designed to deliver dexamethasone to the ocular surface for up to 30 days without preservatives. DEXTENZA resorbs and exits the nasolacrimal system without the need for removal. The safety of DEXTENZA was assessed in three Phase 3 clinical trials and a Phase 2 clinical trial. Overall, 567 subjects were exposed to DEXTENZA. The most common ocular adverse reactions in subjects treated with DEXTENZA were: anterior chamber inflammation including iritis and iridocyclitis (10%), increased intraocular pressure (6%), reduced visual acuity (2%), cystoid macular edema (1%), corneal edema (1%), eye pain (1%), and conjunctival hyperemia (1%). The most common non-ocular adverse event was headache (1%). Please see Important Safety Information and full Prescribing Information at www.DEXTENZA.com. About Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology. Ocular Therapeutixs first commercial drug product, DEXTENZA, is FDA-approved for the treatment of ocular inflammation and pain following ophthalmic surgery. Ocular Therapeutix recently completed a Phase 3 clinical trial evaluating DEXTENZA for the treatment of ocular itching associated with allergic conjunctivitis. The Companys earlier stage development assets currently in Phase 1 trials include OTX-TIC (travoprost intracameral implant) for the reduction of intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension, OTX-CSI (cyclosporine intracanalicular insert) for the treatment of the signs and symptoms of dry eye disease and OTX-TKI (axitinib intravitreal implant) for the treatment of retinal diseases. Also, Ocular Therapeutix is currently developing OTX-DED (dexamethasone intracanalicular insert) for the treatment of episodic dry eye and, in collaboration with Regeneron, OTX-AFS (aflibercept suprachoroidal injection) for an extended-delivery formulation of aflibercept for the treatment of retinal diseases, and Ocular Therapeutix's first product, ReSure Sealant, is FDA-approved to seal corneal incisions following cataract surgery. Forward Looking Statements Any statements in this press release about future expectations, plans, and prospects for the Company, including the commercialization of DEXTENZA, ReSure Sealant, or any of the Companys product candidates; the commercial launch of, and effectiveness of reimbursement codes for, DEXTENZA; the development and regulatory status of the Companys product candidates, such as the Companys development of and prospects for approvability of DEXTENZA for additional indications including allergic conjunctivitis, OTX-DED for the treatment of episodic dry eye disease, OTX-CSI for the treatment of dry eye disease, OTX-TIC for the treatment of primary open-angle glaucoma and ocular hypertension, OTX-TKI for the treatment of retinal diseases including wet AMD, and OTX-AFS as an extended-delivery formulation of the VEGF trap aflibercept for the treatment of retinal diseases including wet AMD; the ongoing development of the Companys extended-delivery hydrogel depot technology; the size of potential markets for our product candidates; the potential utility of any of the Companys product candidates; the potential benefits and future operation of the collaboration with Regeneron Pharmaceuticals, including any potential future payments thereunder; projected net product revenue and other financial metrics of DEXTENZA; the expected impact of the COVID-19 pandemic on the Company and its operations; the sufficiency of the Companys cash resources and other statements containing the words "anticipate," "believe," "estimate," "expect," "intend", "goal," "may", "might," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Such forward-looking statements involve substantial risks and uncertainties that could cause the Companys clinical development programs, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the timing and costs involved in commercializing DEXTENZA, ReSure Sealant or any product candidate that receives regulatory approval, including the conduct of post-approval studies, the ability to retain regulatory approval of DEXTENZA, ReSure Sealant or any product candidate that receives regulatory approval, the ability to maintain reimbursement codes for DEXTENZA, the initiation, timing and conduct of clinical trials, availability of data from clinical trials and expectations for regulatory submissions and approvals, the Companys scientific approach and general development progress, the availability or commercial potential of the Companys product candidates, the Companys ability to generate its projected net product revenue on the timeline expected, if at all, the sufficiency of cash resources, the Companys existing indebtedness, the ability of the Companys creditors to accelerate the maturity of such indebtedness upon the occurrence of certain events of default, the outcome of the Companys ongoing legal proceedings, the severity and duration of the COVID-19 pandemic including its effect on the Companys and relevant regulatory authorities operations, the need for additional financing or other actions and other factors discussed in the Risk Factors section contained in the Companys quarterly and annual reports on file with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Companys views as of the date of this press release. The Company anticipates that subsequent events and developments will cause the Companys views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so except as required by law. These forward-looking statements should not be relied upon as representing the Companys views as of any date subsequent to the date of this press release.
Answer:
|
Ocular Therapeutix Announces Third Medicare Administrative Contractor to Establish New Published Physician Fee Schedule for Administration of Intracanalicular Inserts Physicians in National Government Services, Inc. (NGS) jurisdictions may now seek professional payment for insertion of DEXTENZA using CPT code 0356T
|
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that National Government Services, Inc. (NGS), one of seven Medicare Administrative Contractors (MACs), became the third MAC to establish a physician fee schedule for procedure code 0356T for the administration of drug-eluting intracanalicular inserts, including DEXTENZA (dexamethasone ophthalmic insert) 0.4mg, effective July 1, 2020. The professional fee for CPT code 0356T is now eligible to be paid per the established local fee schedule, which can be found on the NGS website. We are pleased with the continued momentum we are seeing by MACs publishing physician fee schedules for procedure code 0356T, commented Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix. Combined, the three MACs with published fee schedules consisting of NGS, First Coast and Novitas Solutions cover approximately 50% of all Medicare beneficiaries. This continues to be a positive development and one that could impact adoption, not only for DEXTENZA, but also for the other product candidates in our pipeline utilizing the same route of administration. NGS covers Medicare patients in ten states, consisting of Illinois, Minnesota, Wisconsin, New York, Massachusetts, Connecticut, New Hampshire, Maine, Rhode Island, and Vermont. About DEXTENZA DEXTENZA is FDA approved for the treatment of ocular inflammation and pain following ophthalmic surgery. DEXTENZA is a corticosteroid intracanalicular insert placed in the punctum, a natural opening in the inner portion of the eyelid, and into the canaliculus and is designed to deliver dexamethasone to the ocular surface for up to 30 days without preservatives. DEXTENZA resorbs and exits the nasolacrimal system without the need for removal. The safety of DEXTENZA was assessed in three Phase 3 clinical trials and a Phase 2 clinical trial. Overall, 567 subjects were exposed to DEXTENZA. The most common ocular adverse reactions in subjects treated with DEXTENZA were: anterior chamber inflammation including iritis and iridocyclitis (10%), increased intraocular pressure (6%), reduced visual acuity (2%), cystoid macular edema (1%), corneal edema (1%), eye pain (1%), and conjunctival hyperemia (1%). The most common non-ocular adverse event was headache (1%). Please see Important Safety Information and full Prescribing Information at www.DEXTENZA.com. About Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology. Ocular Therapeutixs first commercial drug product, DEXTENZA, is FDA-approved for the treatment of ocular inflammation and pain following ophthalmic surgery. Ocular Therapeutix recently completed a Phase 3 clinical trial evaluating DEXTENZA for the treatment of ocular itching associated with allergic conjunctivitis. The Companys earlier stage development assets currently in Phase 1 trials include OTX-TIC (travoprost intracameral implant) for the reduction of intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension, OTX-CSI (cyclosporine intracanalicular insert) for the treatment of the signs and symptoms of dry eye disease and OTX-TKI (axitinib intravitreal implant) for the treatment of retinal diseases. Also, Ocular Therapeutix is currently developing OTX-DED (dexamethasone intracanalicular insert) for the treatment of episodic dry eye and, in collaboration with Regeneron, OTX-AFS (aflibercept suprachoroidal injection) for an extended-delivery formulation of aflibercept for the treatment of retinal diseases, and Ocular Therapeutix's first product, ReSure Sealant, is FDA-approved to seal corneal incisions following cataract surgery. Forward Looking Statements Any statements in this press release about future expectations, plans, and prospects for the Company, including the commercialization of DEXTENZA, ReSure Sealant, or any of the Companys product candidates; the commercial launch of, and effectiveness of reimbursement codes for, DEXTENZA; the development and regulatory status of the Companys product candidates, such as the Companys development of and prospects for approvability of DEXTENZA for additional indications including allergic conjunctivitis, OTX-DED for the treatment of episodic dry eye disease, OTX-CSI for the treatment of dry eye disease, OTX-TIC for the treatment of primary open-angle glaucoma and ocular hypertension, OTX-TKI for the treatment of retinal diseases including wet AMD, and OTX-AFS as an extended-delivery formulation of the VEGF trap aflibercept for the treatment of retinal diseases including wet AMD; the ongoing development of the Companys extended-delivery hydrogel depot technology; the size of potential markets for our product candidates; the potential utility of any of the Companys product candidates; the potential benefits and future operation of the collaboration with Regeneron Pharmaceuticals, including any potential future payments thereunder; projected net product revenue and other financial metrics of DEXTENZA; the expected impact of the COVID-19 pandemic on the Company and its operations; the sufficiency of the Companys cash resources and other statements containing the words "anticipate," "believe," "estimate," "expect," "intend", "goal," "may", "might," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Such forward-looking statements involve substantial risks and uncertainties that could cause the Companys clinical development programs, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the timing and costs involved in commercializing DEXTENZA, ReSure Sealant or any product candidate that receives regulatory approval, including the conduct of post-approval studies, the ability to retain regulatory approval of DEXTENZA, ReSure Sealant or any product candidate that receives regulatory approval, the ability to maintain reimbursement codes for DEXTENZA, the initiation, timing and conduct of clinical trials, availability of data from clinical trials and expectations for regulatory submissions and approvals, the Companys scientific approach and general development progress, the availability or commercial potential of the Companys product candidates, the Companys ability to generate its projected net product revenue on the timeline expected, if at all, the sufficiency of cash resources, the Companys existing indebtedness, the ability of the Companys creditors to accelerate the maturity of such indebtedness upon the occurrence of certain events of default, the outcome of the Companys ongoing legal proceedings, the severity and duration of the COVID-19 pandemic including its effect on the Companys and relevant regulatory authorities operations, the need for additional financing or other actions and other factors discussed in the Risk Factors section contained in the Companys quarterly and annual reports on file with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Companys views as of the date of this press release. The Company anticipates that subsequent events and developments will cause the Companys views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so except as required by law. These forward-looking statements should not be relied upon as representing the Companys views as of any date subsequent to the date of this press release.
|
edtsum6625
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DALLAS, Aug. 28, 2020 /PRNewswire/ -- Comerica Bank's Michigan Economic Activity Index declined in June to a level of 86.6. June's reading is a new historical low for the index. The index averaged 117.7 points for all of 2019, 0.9 points below the index average for 2018. May's index reading was 90.3. Our state economic activity indexes for June showed some further deterioration in state economies. This is partially a result of smoothing techniques that we use to process the data. We expect Michigan and other states to show positive overall numbers in July and August reflecting states' relaxation of their social mitigation policies. Even as we see stronger Q3 data for the U.S. and most states, we caution against assuming that this is a V-shaped economic recovery. After relaxing some social mitigation policies in late spring, many states experienced an uptick in COVID-19 cases by mid-summer requiring them to tighten policies again. Now with the school year starting, we remain cautious about the potential for increased COVID-19 cases this fall. Also, the demand destruction from the spring shutdowns is still reverberating through the economy. We expect most states, including Michigan, to face a lingering high unemployment rate well into next year, and that will be a drag on overall economic activity. In June, four of the nine sub-indexes for Michigan were positive. They were housing starts, house prices, light vehicle production and hotel occupancy. The five negative sub-indexes were nonfarm employment, unemployment insurance claims (inverted), industrial electricity demand, total state trade and state sales tax revenues. Despite the huge amount of economic churn that we are seeing, housing markets and auto sales have been stronger than expected, helped by low interest rates. However, shaky consumer confidence is a risk to both consumer sectors. The Michigan Economic Activity Index consists of nine variables, as follows: nonfarm payroll employment, continuing claims for unemployment insurance, housing starts, house price index, industrial electricity sales, auto assemblies, total trade, hotel occupancy and sales tax revenue. All data are seasonally adjusted. Nominal values have been converted to constant dollar values. Index levels are expressed in terms of three-month moving averages. Comerica Incorporated (NYSE: CMA) is a financial services company headquartered in Dallas, Texas, and strategically aligned by three business segments: The Commercial Bank, The Retail Bank, and Wealth Management. Comerica focuses on relationships, and helping people and businesses be successful. In addition to Texas, Comerica Bank locations can be found in Arizona, California, Florida and Michigan, with select businesses operating in several other states, as well as in Canada and Mexico. Comerica reported total assets of $84 billion at June 30, 2020. To subscribe to our publications or for questions, contact us at [emailprotected].Archives are available at http://www.comerica.com/insights. Follow us on Twitter: @Comerica_Econ. SOURCE Comerica Bank
Answer:
|
Comerica Bank's Michigan Index Bottoming
|
DALLAS, Aug. 28, 2020 /PRNewswire/ -- Comerica Bank's Michigan Economic Activity Index declined in June to a level of 86.6. June's reading is a new historical low for the index. The index averaged 117.7 points for all of 2019, 0.9 points below the index average for 2018. May's index reading was 90.3. Our state economic activity indexes for June showed some further deterioration in state economies. This is partially a result of smoothing techniques that we use to process the data. We expect Michigan and other states to show positive overall numbers in July and August reflecting states' relaxation of their social mitigation policies. Even as we see stronger Q3 data for the U.S. and most states, we caution against assuming that this is a V-shaped economic recovery. After relaxing some social mitigation policies in late spring, many states experienced an uptick in COVID-19 cases by mid-summer requiring them to tighten policies again. Now with the school year starting, we remain cautious about the potential for increased COVID-19 cases this fall. Also, the demand destruction from the spring shutdowns is still reverberating through the economy. We expect most states, including Michigan, to face a lingering high unemployment rate well into next year, and that will be a drag on overall economic activity. In June, four of the nine sub-indexes for Michigan were positive. They were housing starts, house prices, light vehicle production and hotel occupancy. The five negative sub-indexes were nonfarm employment, unemployment insurance claims (inverted), industrial electricity demand, total state trade and state sales tax revenues. Despite the huge amount of economic churn that we are seeing, housing markets and auto sales have been stronger than expected, helped by low interest rates. However, shaky consumer confidence is a risk to both consumer sectors. The Michigan Economic Activity Index consists of nine variables, as follows: nonfarm payroll employment, continuing claims for unemployment insurance, housing starts, house price index, industrial electricity sales, auto assemblies, total trade, hotel occupancy and sales tax revenue. All data are seasonally adjusted. Nominal values have been converted to constant dollar values. Index levels are expressed in terms of three-month moving averages. Comerica Incorporated (NYSE: CMA) is a financial services company headquartered in Dallas, Texas, and strategically aligned by three business segments: The Commercial Bank, The Retail Bank, and Wealth Management. Comerica focuses on relationships, and helping people and businesses be successful. In addition to Texas, Comerica Bank locations can be found in Arizona, California, Florida and Michigan, with select businesses operating in several other states, as well as in Canada and Mexico. Comerica reported total assets of $84 billion at June 30, 2020. To subscribe to our publications or for questions, contact us at [emailprotected].Archives are available at http://www.comerica.com/insights. Follow us on Twitter: @Comerica_Econ. SOURCE Comerica Bank
|
edtsum6627
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN FRANCISCO, Oct. 27, 2020 /PRNewswire/ -- Airbnb, Inc. announced today that it intends to list its common stock on Nasdaq. This press release is being made pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as amended (the "Securities Act") and shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act. SOURCE Airbnb, Inc. Related Links https://www.airbnb.com/
Answer:
|
Airbnb, Inc. intends to list its common stock on Nasdaq
|
SAN FRANCISCO, Oct. 27, 2020 /PRNewswire/ -- Airbnb, Inc. announced today that it intends to list its common stock on Nasdaq. This press release is being made pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as amended (the "Securities Act") and shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act. SOURCE Airbnb, Inc. Related Links https://www.airbnb.com/
|
edtsum6636
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TOPEKA, Kan.--(BUSINESS WIRE)--Information Network of Kansas (INK), NIC Kansas, the Kansas Secretary of State and the Kansas Departments of Agriculture, Commerce, Labor and Revenue have developed business starter kits for aspiring entrepreneurs. The kits can be found on the Kansas Business One Stop (KBOS) website. Starting a business in Kansas has never been easier, said Secretary of State Scott Schwab. We are thrilled with the addition of the starter kits to the Kansas Business One Stop. This collaborative government effort will help provide entrepreneurs with essential resources that help simplify the process of starting a business. The KBOS website features starter kits for some of the most commonly formed businesses in Kansas: "We are thrilled to have more resources for the entrepreneurs in our state, said Nolan Jones, NIC Kansas General Manager. This addition to the Kansas Business One Stop website will help many begin their business journeys without the stress of searching for the forms and items they need. The starter kits come less than a year since the Kansas Business One Stop site was launched. During that time, the group has also released a business wizard, which helps prospective business owners navigate the state requirements for opening and operating a business. For more information, check out the business starter kit video or visit ksbiz.kansas.gov. ABOUT THE INFORMATION NETWORK OF KANSAS INC. (INK) The Information Network of Kansas, Inc. (INK) is a public-private partnership responsible for the development of the official website for the state of Kansas, Kansas.gov as well as many other services provided to the citizens, businesses and agencies of the State of Kansas. ABOUT NIC KANSAS Headquartered in Topeka, Kan., NIC Kansas is a division of NIC Inc., and a proud partner of the State of Kansas and INK. NIC Kansas is committed to making government services accessible to all through innovative digital solutions. ABOUT NIC NIC (Nasdaq: EGOV) is a leading digital government solutions and payments company, serving more than 7,000 federal, state and local government agencies across the nation. With headquarters in Olathe, Kansas, and offices in 28 states, NIC partners with government to deliver user-friendly digital services that make it easier and more efficient to interact with government providing valuable conveniences like applying for unemployment insurance, submitting business filings, renewing licenses, accessing information and making secure payments without visiting a government office. In the COVID-19 era and beyond, NIC helps government agencies rapidly deliver new digital solutions to provide essential services to citizens and businesses alike. Having served the public sector for nearly 30 years, NIC continues to evolve with its federal, state and local government partners to deliver innovative and cost-effective digital government to constituents. Learn more at www.egov.com.
Answer:
|
Information Network of Kansas, NIC Kansas, Kansas State Agencies Launch Starter Kits for Aspiring Entrepreneurs Resources tailored to business type to help Kansas citizens start a business
|
TOPEKA, Kan.--(BUSINESS WIRE)--Information Network of Kansas (INK), NIC Kansas, the Kansas Secretary of State and the Kansas Departments of Agriculture, Commerce, Labor and Revenue have developed business starter kits for aspiring entrepreneurs. The kits can be found on the Kansas Business One Stop (KBOS) website. Starting a business in Kansas has never been easier, said Secretary of State Scott Schwab. We are thrilled with the addition of the starter kits to the Kansas Business One Stop. This collaborative government effort will help provide entrepreneurs with essential resources that help simplify the process of starting a business. The KBOS website features starter kits for some of the most commonly formed businesses in Kansas: "We are thrilled to have more resources for the entrepreneurs in our state, said Nolan Jones, NIC Kansas General Manager. This addition to the Kansas Business One Stop website will help many begin their business journeys without the stress of searching for the forms and items they need. The starter kits come less than a year since the Kansas Business One Stop site was launched. During that time, the group has also released a business wizard, which helps prospective business owners navigate the state requirements for opening and operating a business. For more information, check out the business starter kit video or visit ksbiz.kansas.gov. ABOUT THE INFORMATION NETWORK OF KANSAS INC. (INK) The Information Network of Kansas, Inc. (INK) is a public-private partnership responsible for the development of the official website for the state of Kansas, Kansas.gov as well as many other services provided to the citizens, businesses and agencies of the State of Kansas. ABOUT NIC KANSAS Headquartered in Topeka, Kan., NIC Kansas is a division of NIC Inc., and a proud partner of the State of Kansas and INK. NIC Kansas is committed to making government services accessible to all through innovative digital solutions. ABOUT NIC NIC (Nasdaq: EGOV) is a leading digital government solutions and payments company, serving more than 7,000 federal, state and local government agencies across the nation. With headquarters in Olathe, Kansas, and offices in 28 states, NIC partners with government to deliver user-friendly digital services that make it easier and more efficient to interact with government providing valuable conveniences like applying for unemployment insurance, submitting business filings, renewing licenses, accessing information and making secure payments without visiting a government office. In the COVID-19 era and beyond, NIC helps government agencies rapidly deliver new digital solutions to provide essential services to citizens and businesses alike. Having served the public sector for nearly 30 years, NIC continues to evolve with its federal, state and local government partners to deliver innovative and cost-effective digital government to constituents. Learn more at www.egov.com.
|
edtsum6637
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ALHAMBRA, Calif., March 2, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced the appointment of Jeremy R. Jackson, M.D., to the newly created role of Chief of Staff, effective March 10, 2021. In his role as Chief of Staff, Dr. Jackson will work closely with the executive team and play a key role in special projects for ApolloMed's technology platform, business development, strategy and operations. Dr. Jackson brings 10 years of healthcare industry experience in management consulting and as a practicing physician to ApolloMed. He previously served as a Project Leader in the Boston Consulting Group's healthcare practice and, from 2011 to 2018, was a resident physician in the Department of General Surgery at Brigham and Women's Hospital (Harvard Medical School) where he led the postoperative care teams serving patients across a broad spectrum of surgical disease. Dr. Jackson was also a Chief Resident in Quality and Patient Safety for the Department of Surgery at the Boston Veterans Affairs Hospital from 2017 to 2018 and a research fellow in the Department of Pediatric Surgery at the Children's Hospital Los Angeles from 2014 to 2016. Dr. Jackson received his Doctor of Medicine from the University of Michigan Medical School and Bachelor of Arts in Biological Sciences, Magna Cum Laude, from the University of Southern California. Kenneth Sim, M.D., Executive Chairman and Co-Chief Executive Officer of ApolloMed, stated, "We are thrilled to welcome Jeremy to the ApolloMed leadership team at this exciting time in the Company's history. Jeremy's prior experience as a practicing physician and as a strategy consultant to various companies within the healthcare space made him the ideal person to take on the Chief of Staff role. He is familiar with the challenges facing today's healthcare providers and will play a key role in ensuring the Company is prioritizing and working on our initiatives effectively, which is particularly important given our aggressive growth strategy." Dr. Jackson added, "I am pleased to be joining ApolloMed, one of the leading providers of integrated value-based care management and delivery in the country. I believe the Company has developed a unique physician-centric model that, combined with the proprietary technologies built and implemented over the past couple of years, make it truly stand out from its peers. I look forward to making my contributions to ApolloMed's efforts as we continue to focus on cost effectively ensuring positive health outcomes and experiences for our patients." About Apollo Medical Holdings, Inc.ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary population health management and healthcare delivery platform, ApolloMed operates an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner. Headquartered in Alhambra, California, ApolloMed's subsidiaries include management services organizations ("MSOs"), affiliated independent practice associations ("IPAs") and a Next Generation Accountable Care Organization ("NGACO"). Network Medical Management, Inc. and Apollo Medical Management, Inc. are the administrative and managerial services companies for the affiliated physician owned professional corporations that contract with independent physicians to deliver medical services in-office and virtually under the Allied Pacific of California IPA, Alpha Care Medical Group, Inc. and Accountable Health Care IPA brands. These affiliates are supported by ApolloMed Hospitalists, a Medical Corporation. Our NGACO operates under the APA ACO, Inc. brand and participates in the Centers for Medicare & Medicaid Services program that allows provider groups to assume higher levels of financial risk and potentially achieve a higher reward from participation in the program's attribution-based risk sharing model. For more information, please visit www.apollomed.net. Forward Looking StatementsThis press release contains forward-looking statementswithin the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements about the Company's continued growth, operational focus and strategic growth plans.Forward-looking statements reflect current views with respect to future events and financial performance and therefore cannot be guaranteed.Such statements are basedonthe current expectations and certain assumptions of the Company's management, and some or all of such expectations and assumptions may not materialize or may vary significantly from actual results.Actual results may also vary materially from forward-looking statements due to risks, uncertainties and other factors, known and unknown, including the risk factors described from time to time in the Company's reports to the SEC, including, without limitation the risk factors discussed in theCompany'sAnnual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC and any subsequent quarterly reports on Form 10-Q. FOR MORE INFORMATION, PLEASE CONTACT:Investor Relations(626) 943-6491[emailprotected] Carolyne Sohn, The Equity Group(415) 568-2255[emailprotected] SOURCE Apollo Medical Holdings, Inc. Related Links http://apollomed.net
Answer:
|
Apollo Medical Holdings, Inc. Appoints Jeremy R. Jackson, M.D., as Chief of Staff
|
ALHAMBRA, Calif., March 2, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced the appointment of Jeremy R. Jackson, M.D., to the newly created role of Chief of Staff, effective March 10, 2021. In his role as Chief of Staff, Dr. Jackson will work closely with the executive team and play a key role in special projects for ApolloMed's technology platform, business development, strategy and operations. Dr. Jackson brings 10 years of healthcare industry experience in management consulting and as a practicing physician to ApolloMed. He previously served as a Project Leader in the Boston Consulting Group's healthcare practice and, from 2011 to 2018, was a resident physician in the Department of General Surgery at Brigham and Women's Hospital (Harvard Medical School) where he led the postoperative care teams serving patients across a broad spectrum of surgical disease. Dr. Jackson was also a Chief Resident in Quality and Patient Safety for the Department of Surgery at the Boston Veterans Affairs Hospital from 2017 to 2018 and a research fellow in the Department of Pediatric Surgery at the Children's Hospital Los Angeles from 2014 to 2016. Dr. Jackson received his Doctor of Medicine from the University of Michigan Medical School and Bachelor of Arts in Biological Sciences, Magna Cum Laude, from the University of Southern California. Kenneth Sim, M.D., Executive Chairman and Co-Chief Executive Officer of ApolloMed, stated, "We are thrilled to welcome Jeremy to the ApolloMed leadership team at this exciting time in the Company's history. Jeremy's prior experience as a practicing physician and as a strategy consultant to various companies within the healthcare space made him the ideal person to take on the Chief of Staff role. He is familiar with the challenges facing today's healthcare providers and will play a key role in ensuring the Company is prioritizing and working on our initiatives effectively, which is particularly important given our aggressive growth strategy." Dr. Jackson added, "I am pleased to be joining ApolloMed, one of the leading providers of integrated value-based care management and delivery in the country. I believe the Company has developed a unique physician-centric model that, combined with the proprietary technologies built and implemented over the past couple of years, make it truly stand out from its peers. I look forward to making my contributions to ApolloMed's efforts as we continue to focus on cost effectively ensuring positive health outcomes and experiences for our patients." About Apollo Medical Holdings, Inc.ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary population health management and healthcare delivery platform, ApolloMed operates an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner. Headquartered in Alhambra, California, ApolloMed's subsidiaries include management services organizations ("MSOs"), affiliated independent practice associations ("IPAs") and a Next Generation Accountable Care Organization ("NGACO"). Network Medical Management, Inc. and Apollo Medical Management, Inc. are the administrative and managerial services companies for the affiliated physician owned professional corporations that contract with independent physicians to deliver medical services in-office and virtually under the Allied Pacific of California IPA, Alpha Care Medical Group, Inc. and Accountable Health Care IPA brands. These affiliates are supported by ApolloMed Hospitalists, a Medical Corporation. Our NGACO operates under the APA ACO, Inc. brand and participates in the Centers for Medicare & Medicaid Services program that allows provider groups to assume higher levels of financial risk and potentially achieve a higher reward from participation in the program's attribution-based risk sharing model. For more information, please visit www.apollomed.net. Forward Looking StatementsThis press release contains forward-looking statementswithin the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements about the Company's continued growth, operational focus and strategic growth plans.Forward-looking statements reflect current views with respect to future events and financial performance and therefore cannot be guaranteed.Such statements are basedonthe current expectations and certain assumptions of the Company's management, and some or all of such expectations and assumptions may not materialize or may vary significantly from actual results.Actual results may also vary materially from forward-looking statements due to risks, uncertainties and other factors, known and unknown, including the risk factors described from time to time in the Company's reports to the SEC, including, without limitation the risk factors discussed in theCompany'sAnnual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC and any subsequent quarterly reports on Form 10-Q. FOR MORE INFORMATION, PLEASE CONTACT:Investor Relations(626) 943-6491[emailprotected] Carolyne Sohn, The Equity Group(415) 568-2255[emailprotected] SOURCE Apollo Medical Holdings, Inc. Related Links http://apollomed.net
|
edtsum6640
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: Blend of scientific, industry, investment and entrepreneurial expertise complements FACIT's leading role in growing Ontario's life sciences commercialization TORONTO, Jan. 26, 2021 /PRNewswire/ -The Board of Directors of FACIT, a commercialization venture firm for Ontario cancer innovations, is pleased to report on the addition of Mr. Ken Newport, in the role of Director. Mr. Newport is a passionate executive and advocate of Ontario's life science sector, having decades of leadership experience in both public and private ventures. A chartered accountant by training, Mr. Newport founded and was President of CroMedical Global Inc., a contract research organization he helped grow to 600 employees and later merged with PRA International Inc. He has also founded several other biotech start-ups including global Biomedical Capital Corporation, Zelos Therapeutics, and Prime Trials Inc., and has served on several boards including Jenerex, Nordion, MedGenesis, Aeterna Zentaris, OICR, OHRI and BioCanRx. FACIT also congratulates Board member Dr. Shana Kelley on her appointment to the Order of Ontario. Dr. Kelley was recognized for her contributions to advancing drug discovery and diagnostics, including her leading entrepreneurial role in FACIT start-up Cellular Analytics. FACIT's Board, with its deep experience and strategic insights, is critical to helping FACIT achieve its mandate of commercializing Ontario's most promising cancer innovations to the benefit of the local economy and patients. In addition to Dr. Kelley and Mr. Newport, FACIT's Board consists of Mr. John Morrison, Mr. Har Grover and Mr. Ken Lawless. Bios of individual Board members can be found on FACIT's website. Mr. Kevin Empey is stepping down from the Board to focus on his work within the Board of FACIT's strategic partner, the Ontario Institute for Cancer Research (OICR). "On behalf of FACIT, I am pleased to welcome Mr. Newport to the Board, and congratulate Dr. Kelley on her prestigious achievement," said Mr. Morrison, Chair of FACIT. "The Board's entrepreneurial and industry expertise is invaluable during this time of heightened interest in translating the health system benefits of homegrown intellectual property. We thank Mr. Empey for his insight and guidance in supporting FACIT's mission to realize the full potential of Ontario's valuable cancer-related IP." About FACITFACIT is an award-winning commercialization venture firm that builds companies with entrepreneurs to accelerate oncology innovation, with a portfolio that has attracted more than $1 billion in investment to Ontario. Blending industry experience, capital and the unsurpassed clinician-scientist network of its strategic partner the Ontario Institute for Cancer Research (OICR), FACIT capitalizes on the province's investment in research and healthcare to the benefit of the local economy and patients worldwide. FACIT's commercialization portfolio includes Turnstone Biologics, Fusion Pharmaceuticals, Triphase Accelerator and other biotechnology organizations. Cancer Breakthroughs. Realized. facit.ca. SOURCE FACIT Inc. Related Links http://facit.ca/
Answer:
|
FACIT welcomes life sciences executive Ken Newport to its Board; Director Shana Kelley appointed to the Order of Ontario
|
Blend of scientific, industry, investment and entrepreneurial expertise complements FACIT's leading role in growing Ontario's life sciences commercialization TORONTO, Jan. 26, 2021 /PRNewswire/ -The Board of Directors of FACIT, a commercialization venture firm for Ontario cancer innovations, is pleased to report on the addition of Mr. Ken Newport, in the role of Director. Mr. Newport is a passionate executive and advocate of Ontario's life science sector, having decades of leadership experience in both public and private ventures. A chartered accountant by training, Mr. Newport founded and was President of CroMedical Global Inc., a contract research organization he helped grow to 600 employees and later merged with PRA International Inc. He has also founded several other biotech start-ups including global Biomedical Capital Corporation, Zelos Therapeutics, and Prime Trials Inc., and has served on several boards including Jenerex, Nordion, MedGenesis, Aeterna Zentaris, OICR, OHRI and BioCanRx. FACIT also congratulates Board member Dr. Shana Kelley on her appointment to the Order of Ontario. Dr. Kelley was recognized for her contributions to advancing drug discovery and diagnostics, including her leading entrepreneurial role in FACIT start-up Cellular Analytics. FACIT's Board, with its deep experience and strategic insights, is critical to helping FACIT achieve its mandate of commercializing Ontario's most promising cancer innovations to the benefit of the local economy and patients. In addition to Dr. Kelley and Mr. Newport, FACIT's Board consists of Mr. John Morrison, Mr. Har Grover and Mr. Ken Lawless. Bios of individual Board members can be found on FACIT's website. Mr. Kevin Empey is stepping down from the Board to focus on his work within the Board of FACIT's strategic partner, the Ontario Institute for Cancer Research (OICR). "On behalf of FACIT, I am pleased to welcome Mr. Newport to the Board, and congratulate Dr. Kelley on her prestigious achievement," said Mr. Morrison, Chair of FACIT. "The Board's entrepreneurial and industry expertise is invaluable during this time of heightened interest in translating the health system benefits of homegrown intellectual property. We thank Mr. Empey for his insight and guidance in supporting FACIT's mission to realize the full potential of Ontario's valuable cancer-related IP." About FACITFACIT is an award-winning commercialization venture firm that builds companies with entrepreneurs to accelerate oncology innovation, with a portfolio that has attracted more than $1 billion in investment to Ontario. Blending industry experience, capital and the unsurpassed clinician-scientist network of its strategic partner the Ontario Institute for Cancer Research (OICR), FACIT capitalizes on the province's investment in research and healthcare to the benefit of the local economy and patients worldwide. FACIT's commercialization portfolio includes Turnstone Biologics, Fusion Pharmaceuticals, Triphase Accelerator and other biotechnology organizations. Cancer Breakthroughs. Realized. facit.ca. SOURCE FACIT Inc. Related Links http://facit.ca/
|
edtsum6647
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SUGAR LAND, Texas, March 11, 2021 /PRNewswire/ -- HCSS, a leading provider of innovative solutions that help heavy civil businesses streamline their operations, introduces myField, a mobile employee engagement and time tracking solution for heavy construction operations. The easy-to-use mobile solution allows workers to stay on top of their work while in the field or at the job site. Continue Reading myField Mobile App for Heavy Construction "HCSS believes in getting tools in the hands of those who need them, whether in the field, officeor at the job site," said Rateb Almasri, Manager of Growth, HCSS. "myField empowers workers to document their own hours across various jobs, record safety observations, monitor meter readings and send maintenance requests, improving efficiency and productivity." HCSS myField is designed for operators, laborers, flaggers, truck drivers, craftsmen, and office personnel. Instead of verbally communicating with the foreman, myField allows crew members to directly clock in or submit their time and information about what they worked on that day. Once submitted, the foreman receives a copy and can review events and times per employee. The solution can also be used for: Time Management - Individual time tracking of employees with the ability to log lunches, breaks, and capture signatures. Equipment Inspections - Perform quick safety inspections on mobile devices. Cost Code Work - Employees note what they worked on and cost code their work. Documentation - Quickly capture daily information from easy-to-answer questions. Safety Observations - Record unsafe conditions with photos, description, and severity. View My Hours - Employees can view the hours they logged and compare them to what has been approved including pay classes and overtime. GPS Location - All clock in/out locations are stamped with longitude and latitude. Maintenance Requests - Submit equipment issues to the shop for immediate review and action. HCSS myField integrates with the HCSS solutions suite of job management, safety, equipment, and dispatching software.ABOUT HCSSSince 1986, HCSS has been developing software to help construction companies streamline their operations. Today, we are recognized as a pioneer and trusted leader in estimating, operations, and fleet software, serving thousands of construction companies across the nation. Visit www.hcss.comto learn more.For More Information, Contact:Becky BoydMediaFirst PROffice: 770.642.2080 x 214Cell: 404.421.8497Email: [emailprotected]Related Imagesmyfield-screen-shot.jpg myField Screen Shot myField Mobile App for Heavy Construction Related LinksHCSS Heavy Civil Construction Software myField SOURCE HCSS
Answer:
|
HCSS Introduces myField Mobile Time Tracking and Engagement App Faster Time to Reckon Hours, Work, Pay
|
SUGAR LAND, Texas, March 11, 2021 /PRNewswire/ -- HCSS, a leading provider of innovative solutions that help heavy civil businesses streamline their operations, introduces myField, a mobile employee engagement and time tracking solution for heavy construction operations. The easy-to-use mobile solution allows workers to stay on top of their work while in the field or at the job site. Continue Reading myField Mobile App for Heavy Construction "HCSS believes in getting tools in the hands of those who need them, whether in the field, officeor at the job site," said Rateb Almasri, Manager of Growth, HCSS. "myField empowers workers to document their own hours across various jobs, record safety observations, monitor meter readings and send maintenance requests, improving efficiency and productivity." HCSS myField is designed for operators, laborers, flaggers, truck drivers, craftsmen, and office personnel. Instead of verbally communicating with the foreman, myField allows crew members to directly clock in or submit their time and information about what they worked on that day. Once submitted, the foreman receives a copy and can review events and times per employee. The solution can also be used for: Time Management - Individual time tracking of employees with the ability to log lunches, breaks, and capture signatures. Equipment Inspections - Perform quick safety inspections on mobile devices. Cost Code Work - Employees note what they worked on and cost code their work. Documentation - Quickly capture daily information from easy-to-answer questions. Safety Observations - Record unsafe conditions with photos, description, and severity. View My Hours - Employees can view the hours they logged and compare them to what has been approved including pay classes and overtime. GPS Location - All clock in/out locations are stamped with longitude and latitude. Maintenance Requests - Submit equipment issues to the shop for immediate review and action. HCSS myField integrates with the HCSS solutions suite of job management, safety, equipment, and dispatching software.ABOUT HCSSSince 1986, HCSS has been developing software to help construction companies streamline their operations. Today, we are recognized as a pioneer and trusted leader in estimating, operations, and fleet software, serving thousands of construction companies across the nation. Visit www.hcss.comto learn more.For More Information, Contact:Becky BoydMediaFirst PROffice: 770.642.2080 x 214Cell: 404.421.8497Email: [emailprotected]Related Imagesmyfield-screen-shot.jpg myField Screen Shot myField Mobile App for Heavy Construction Related LinksHCSS Heavy Civil Construction Software myField SOURCE HCSS
|
edtsum6652
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree TAKE-TWO INTERACTIVE SOFTWARE INC (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 21 December 2020 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A NO 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: Common Stock (US8740541094) Interests Short Positions Number % Number % (1) Relevant securities owned and/or controlled: 4,038,899 3.51 % (2) Cash-settled derivatives: (3) Stock-settled derivatives (including options) and agreements to purchase/sell: Total 4,038,899 * 3.51 % * Massachusetts Financial Services Company does not have discretion regarding voting decisions in respect of 41,905 shares that are included in the total above. All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit Common Stock (US8740541094) Sale 129 201.3350 USD (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none None (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure 22 December 2020 Contact name Nikki Cagan Telephone number +442074297243 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
Answer:
|
Form 8.3 - TAKE-TWO INTERACTIVE SOFTWARE INC
|
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree TAKE-TWO INTERACTIVE SOFTWARE INC (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 21 December 2020 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A NO 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: Common Stock (US8740541094) Interests Short Positions Number % Number % (1) Relevant securities owned and/or controlled: 4,038,899 3.51 % (2) Cash-settled derivatives: (3) Stock-settled derivatives (including options) and agreements to purchase/sell: Total 4,038,899 * 3.51 % * Massachusetts Financial Services Company does not have discretion regarding voting decisions in respect of 41,905 shares that are included in the total above. All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit Common Stock (US8740541094) Sale 129 201.3350 USD (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none None (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure 22 December 2020 Contact name Nikki Cagan Telephone number +442074297243 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
|
edtsum6659
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOUISVILLE,Colo., Dec. 9, 2020 /PRNewswire/ --Pivot3, the leading provider of intelligent hyperconverged infrastructure (HCI) solutions for mission-critical video, today announced the addition of HCI appliances to the Pivot3 HCI portfolio purpose-built for running and utilizing intelligent video analytics at scale. In conjunction with these new solutions, Pivot3 has also developed a reference architecture for deploying industry leading video content analytics platform BriefCamon Pivot3 infrastructure. The new Pivot3 solutions and reference architecture are designed to ensure that organizations can extract the full value of insights from their mission-critical video by making it secure, retrievable and actionable. Video analytics software and infrastructure constitute an important and quickly expanding market segment. However, sizing, configuring, and deploying video analytics at scale can be challenging, often resulting in under or over-sizing and not realizing the full value of the solution and the potential ROI. Analytics technology is rapidly evolving, so organizations need flexible infrastructure to keep pace and accommodate different deployment models. Pivot3 is the industry's first and only HCI provider to integrate and leverage NVIDIA T4 GPUs and the NVIDIA Metropolis platformfor video analytics use cases. Pivot3's new analytics appliances provide optimized NVIDIA GPU-dense configurations, designed to support leading video analytics functions including line crossing, license plate recognition, object and event filtering, appearance similarity, real-time and smart alerts, multi-camera search, and video search and VIDEO SYNOPSIS capabilities. Pivot3 infrastructure deployments result in 50% lower TCO for video management and analytics through reduced hardware footprint and resource consolidation, reduced risk due to eliminating critical analytics downtime and granular pay-as-you-grow scaling. "Customers are turning to video analytics to help get more out of the massive amount of video they are capturing," said Ben Bolles, vice president of product, Pivot3. "Video analytics is crucial to security operations and is incredibly compute-intensive; Pivot3 excels at mission-critical video with the only HCI platform designed for intelligent video applications." Pivot3 has tested and benchmarked BriefCam's video analytics in Pivot's Solutions Test Lab and has developed a comprehensive set of deployment and configuration best practices. Pivot3's validated reference architecture for the BriefCam Video Content Analytics platform optimizes the business and technical considerations associated with deploying next-generation video analytics in mid-to-large-scale mission-critical environments. The reference architecture is based on a combination of next generation analytics, video management and enterprise grade IT infrastructure powered by NVIDIA GPUs, with all the simplicity, economics and ease of scaling that security teams need. "The growing demand for actionable data in mission-critical environments is a significant driver toward providing customers with a tested, resilient and scalable solution to deploy comprehensive video analytics," said Yogev Wallach, Senior Product Manager, BriefCam. "Pivot3's intelligent HCI platform supports the specific performance parameters and workload requirements of our innovative and extensible video analytics platform. This optimizes the sizing and deployment process for our system integrators and accelerates the time to ROI for our customers." About Pivot3Pivot3 is the leading provider of intelligent hyperconverged infrastructure solutions for video surveillance, video analytics, VDI and mixed workloads. Pivot3's solutions provide security, resilience and management simplicity at scale for customers' mission-critical environments. With thousands of customers in 64 countries, and deployments in education, hospitality, transportation, government, defense, healthcare, gaming, financial services and retail, Pivot3 allows IT to manage complexity at scale through intelligence and automation. Visit pivot3.com to learn more. About BriefCamBriefCam is the industry's leading provider of deep learning solutions for rapid video review and search, vehicle and license plate recognition, real-time alerting, quantitative video insights, and more. By transforming raw video into actionable intelligence, BriefCam dramatically shortens the time-to-target for security threats while increasing safety and optimizing operations. SOURCE Pivot3, Inc. Related Links www.pivot3.com
Answer:
|
Pivot3 Simplifies Design, Deployment and Scaling of Intelligent Video Analytics New solutions integrating BriefCam and NVIDIA Metropolis deliver industry firsts for growing market needs
|
LOUISVILLE,Colo., Dec. 9, 2020 /PRNewswire/ --Pivot3, the leading provider of intelligent hyperconverged infrastructure (HCI) solutions for mission-critical video, today announced the addition of HCI appliances to the Pivot3 HCI portfolio purpose-built for running and utilizing intelligent video analytics at scale. In conjunction with these new solutions, Pivot3 has also developed a reference architecture for deploying industry leading video content analytics platform BriefCamon Pivot3 infrastructure. The new Pivot3 solutions and reference architecture are designed to ensure that organizations can extract the full value of insights from their mission-critical video by making it secure, retrievable and actionable. Video analytics software and infrastructure constitute an important and quickly expanding market segment. However, sizing, configuring, and deploying video analytics at scale can be challenging, often resulting in under or over-sizing and not realizing the full value of the solution and the potential ROI. Analytics technology is rapidly evolving, so organizations need flexible infrastructure to keep pace and accommodate different deployment models. Pivot3 is the industry's first and only HCI provider to integrate and leverage NVIDIA T4 GPUs and the NVIDIA Metropolis platformfor video analytics use cases. Pivot3's new analytics appliances provide optimized NVIDIA GPU-dense configurations, designed to support leading video analytics functions including line crossing, license plate recognition, object and event filtering, appearance similarity, real-time and smart alerts, multi-camera search, and video search and VIDEO SYNOPSIS capabilities. Pivot3 infrastructure deployments result in 50% lower TCO for video management and analytics through reduced hardware footprint and resource consolidation, reduced risk due to eliminating critical analytics downtime and granular pay-as-you-grow scaling. "Customers are turning to video analytics to help get more out of the massive amount of video they are capturing," said Ben Bolles, vice president of product, Pivot3. "Video analytics is crucial to security operations and is incredibly compute-intensive; Pivot3 excels at mission-critical video with the only HCI platform designed for intelligent video applications." Pivot3 has tested and benchmarked BriefCam's video analytics in Pivot's Solutions Test Lab and has developed a comprehensive set of deployment and configuration best practices. Pivot3's validated reference architecture for the BriefCam Video Content Analytics platform optimizes the business and technical considerations associated with deploying next-generation video analytics in mid-to-large-scale mission-critical environments. The reference architecture is based on a combination of next generation analytics, video management and enterprise grade IT infrastructure powered by NVIDIA GPUs, with all the simplicity, economics and ease of scaling that security teams need. "The growing demand for actionable data in mission-critical environments is a significant driver toward providing customers with a tested, resilient and scalable solution to deploy comprehensive video analytics," said Yogev Wallach, Senior Product Manager, BriefCam. "Pivot3's intelligent HCI platform supports the specific performance parameters and workload requirements of our innovative and extensible video analytics platform. This optimizes the sizing and deployment process for our system integrators and accelerates the time to ROI for our customers." About Pivot3Pivot3 is the leading provider of intelligent hyperconverged infrastructure solutions for video surveillance, video analytics, VDI and mixed workloads. Pivot3's solutions provide security, resilience and management simplicity at scale for customers' mission-critical environments. With thousands of customers in 64 countries, and deployments in education, hospitality, transportation, government, defense, healthcare, gaming, financial services and retail, Pivot3 allows IT to manage complexity at scale through intelligence and automation. Visit pivot3.com to learn more. About BriefCamBriefCam is the industry's leading provider of deep learning solutions for rapid video review and search, vehicle and license plate recognition, real-time alerting, quantitative video insights, and more. By transforming raw video into actionable intelligence, BriefCam dramatically shortens the time-to-target for security threats while increasing safety and optimizing operations. SOURCE Pivot3, Inc. Related Links www.pivot3.com
|
edtsum6661
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Getka Group, a Tulsa-based midstream hydrocarbon operator with extensive pipeline and terminal asset experience in the U.S. and Canada, has appointed Odgers Berndtson U.S.'s Chief Operating Officer, Kennon Kincaid, to its Board of Advisors. A first mover in zero-impact energy transitions, Getka Group is working to modernize hydrocarbon infrastructure by minimizing carbon output. Headquartered in Tulsa, Oklahoma, Getka employs a blend of alternative energy sources (mainly solar and wind energy) to build, update, and maintain traditional hydrocarbon transportation and delivery mechanisms. The company is committed to using the latest technology to operate carbon-zero construction equipment and road fleets, and is also working closely with local governments in both Oklahoma and Europe on a number of environmentally minded job-creation initiatives. "We are thrilled that Kennon will be joining Getka's board of advisors," said Dariusz Cichocki, CEO and President of Getka. "As someone with an extensive diplomatic background who understands how to build teams and lead growth and diversification strategies, he will bring a wealth of global experience and knowledge to our group. Kennon's expertise and ingenuity will be an incredible asset to our team as we look to transform the oil industry." Working with their strategic partner Unimot, a Polish Energy company, Getka is committed to providing competitively priced American oil to countries in Eastern Europe, expanding their supply options while improving their economic independence and stability. Kennon's expertise will contribute to Getka's ability to navigate domestic and international government channels and facilitate similar overseas energy transactions. As the COO of Odgers Berndtson U.S., Kennon oversees the firm's U.S. operations and is the Co-Head of its U.S. brand extensions: Berwick Partners and Odgers Interim. Prior to joining Odgers, Kennon spent more than a decade as a U.S. diplomat before joining Rocket Lab, a cutting-edge aerospace company and launch service provider, where he established and then led the international business development, security operations, and international government relations functions. "I'm delighted to be part of Getka's advisory team," said Kennon. "The company is taking a leadership role in the transformation and modernization of hydrocarbon infrastructure, working to clean up the environment while simultaneously optimizing the delivery of North American hydrocarbons abroad to drive economic growth. I am honored to work with Getka to create and implement the best practices of the future for the energy sector." About Odgers Berndtson For more than 50 years, Odgers Berndtson has delivered executive search, leadership assessment, and development strategies to the world's biggest and best organizations. Odgers Berndtson's 250+ partners cover more than 50 sectors and operate out of more than sixty offices in 29 countries. The U.S. branch of the firm launched in 2011 and is one of the fastest growing search firms in the Americas. Odgers Berndtson currently has U.S. offices in Atlanta, Austin, Boston, Chicago, Dallas, Denver, Houston, Los Angeles, Miami, Minneapolis, New York, Philadelphia, San Francisco, and Washington DC. About the Getka Group Based in Tulsa, Oklahoma, Getka is a globally focused developer of pipelines, terminals, and energy infrastructure. The company is committed to being a first mover in altering how the midstream space operates and impacts the world around us, developing a series of midstream operations whose significantly lowered carbon output makes for a more efficient future. Getka's local assets and global understanding allow the Group to bridge the gaps in today's changing energy marketplace. From the heart of North America's crude oil hub in Cushing, Oklahoma, to the ports of the Gulf Coast, Europe, and Asia, Getka is a leader in mid-stream energy solutions. CONTACT Anne Board, 646-612-7208 [emailprotected] SOURCE Odgers Berndtson Related Links http://www.odgersberndtson.com
Answer:
|
Odgers Berndtson COO, Kennon Kincaid, Joins Getka's Board of Advisors
|
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Getka Group, a Tulsa-based midstream hydrocarbon operator with extensive pipeline and terminal asset experience in the U.S. and Canada, has appointed Odgers Berndtson U.S.'s Chief Operating Officer, Kennon Kincaid, to its Board of Advisors. A first mover in zero-impact energy transitions, Getka Group is working to modernize hydrocarbon infrastructure by minimizing carbon output. Headquartered in Tulsa, Oklahoma, Getka employs a blend of alternative energy sources (mainly solar and wind energy) to build, update, and maintain traditional hydrocarbon transportation and delivery mechanisms. The company is committed to using the latest technology to operate carbon-zero construction equipment and road fleets, and is also working closely with local governments in both Oklahoma and Europe on a number of environmentally minded job-creation initiatives. "We are thrilled that Kennon will be joining Getka's board of advisors," said Dariusz Cichocki, CEO and President of Getka. "As someone with an extensive diplomatic background who understands how to build teams and lead growth and diversification strategies, he will bring a wealth of global experience and knowledge to our group. Kennon's expertise and ingenuity will be an incredible asset to our team as we look to transform the oil industry." Working with their strategic partner Unimot, a Polish Energy company, Getka is committed to providing competitively priced American oil to countries in Eastern Europe, expanding their supply options while improving their economic independence and stability. Kennon's expertise will contribute to Getka's ability to navigate domestic and international government channels and facilitate similar overseas energy transactions. As the COO of Odgers Berndtson U.S., Kennon oversees the firm's U.S. operations and is the Co-Head of its U.S. brand extensions: Berwick Partners and Odgers Interim. Prior to joining Odgers, Kennon spent more than a decade as a U.S. diplomat before joining Rocket Lab, a cutting-edge aerospace company and launch service provider, where he established and then led the international business development, security operations, and international government relations functions. "I'm delighted to be part of Getka's advisory team," said Kennon. "The company is taking a leadership role in the transformation and modernization of hydrocarbon infrastructure, working to clean up the environment while simultaneously optimizing the delivery of North American hydrocarbons abroad to drive economic growth. I am honored to work with Getka to create and implement the best practices of the future for the energy sector." About Odgers Berndtson For more than 50 years, Odgers Berndtson has delivered executive search, leadership assessment, and development strategies to the world's biggest and best organizations. Odgers Berndtson's 250+ partners cover more than 50 sectors and operate out of more than sixty offices in 29 countries. The U.S. branch of the firm launched in 2011 and is one of the fastest growing search firms in the Americas. Odgers Berndtson currently has U.S. offices in Atlanta, Austin, Boston, Chicago, Dallas, Denver, Houston, Los Angeles, Miami, Minneapolis, New York, Philadelphia, San Francisco, and Washington DC. About the Getka Group Based in Tulsa, Oklahoma, Getka is a globally focused developer of pipelines, terminals, and energy infrastructure. The company is committed to being a first mover in altering how the midstream space operates and impacts the world around us, developing a series of midstream operations whose significantly lowered carbon output makes for a more efficient future. Getka's local assets and global understanding allow the Group to bridge the gaps in today's changing energy marketplace. From the heart of North America's crude oil hub in Cushing, Oklahoma, to the ports of the Gulf Coast, Europe, and Asia, Getka is a leader in mid-stream energy solutions. CONTACT Anne Board, 646-612-7208 [emailprotected] SOURCE Odgers Berndtson Related Links http://www.odgersberndtson.com
|
edtsum6677
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, Aug. 10, 2020 /PRNewswire/ --IAC (NASDAQ: IAC) today announced its accumulation of a 12% interest in global hospitality and entertainment company MGM Resorts International (NYSE: MGM) for an aggregate of approximately $1 billion. "With the separation of Match Group from IAC, and 'new' IAC emerging with $3.9 billion of cash, no debt, and its opportunistic zeal intact, we are energized and excited to make this investment in MGM. What initially attracted us to MGM, besides its leadership in leisure, hospitality and gaming, was an area that currently comprises a tiny portion of its revenue online gaming,"said Barry Diller, Chairman and Senior Executive of IAC. "IAC's foundational concept of seeking opportunities to build interactive businesses is our base rationale there is a digital first opportunity within MGM Resorts' already impressive offline businesses, and with our experience we hope we can strongly contribute to the growth of online gaming." "MGM Resorts presents a unique opportunity for IAC to own a meaningful piece of a preeminent brand in a large category with immense potential to move online," said Joey Levin, CEO of IAC. "We will be a minority investor and a long-term strategic partner, and would welcome the opportunity to contribute to MGM's success in any way that MGM's Board would look favorably on our involvement." IAC published a letter to shareholders today, outlining the rationale for its investment in MGM Resorts in more detail. The letter in its entirety is below. August 10, 2020 Dear Shareholders, Over the last few months we've accumulated a 12% interest in MGM Resorts International ("MGM") for an aggregate of approximately $1 billion. Investors reading that prior sentence may be surprised by some, or quite possibly all, of its components. First, we accumulated a large minority position in a public company, which is not our usual methodology. Second, the securities we purchased are common equity securities, the exact same securities that any investor with exactly $19 could buy and sell any day in the market. Third, we bought securities in a business that has relatively little to do with the Internet today. Fourth, we invested a portion of our cash in a new direction for IAC. The answer to all four of those concerns is that we believe MGM presented a "once in a decade" opportunity for IAC to own a meaningful piece of a preeminent brand in a large category with great potential to move online. IAC has always been opportunistic with its capital, and if ever there was a time, this moment is unique. We believe we can generate compelling returns for our shareholders and hope our expertise will be additive to MGM's opportunities, but even if we never advance our involvement from here, the value was too compelling to ignore. Having taken this step, we have a very long-term view of this investment and will be open to all the opportunities it presents along the way. MGM is a leader in gaming, hospitality, and leisure with a storied brand and an enviable market position. The current pandemic brought revenue (though not expenses) to a temporary halt, and required MGM to repurpose cash it had wisely stockpiled for share repurchases to instead defend the solvency of the company. The good news is, we believe MGM has enough cash and access to capital to make it to the other side competitively stronger. When the world returns to normal, MGM will be just as capable post-pandemic as it was pre-pandemic in servicing visitors in over 35% of the Las Vegas Strip's available rooms, plus eight regional properties across the US, two in Macau, and hopefully in Japan. The 34 million members of MGM's loyalty program still have their M-life Rewards, and we're confident that many are eager to return to the properties they love. And when Las Vegas fully re-opens even if it must wait until a vaccine for that to occur we expect it to roar back: a new NFL team, a new stadium, a drivable destination, and months of pent-up demand could drive a powerful resurgence. But that's not what originally drove us to MGM, nor in large part drove our final decision to invest. We have a history and much experience in online commerce. So we began our analysis with a focus on a small piece of MGM, a portion of its revenue so small that it rounds down to zero: its online gaming revenue. We've followed the online gaming space for a while, looking for an opportunity to enter, but we were generally unsatisfied with the landscape we saw. The regulations in this $450 billion global industry, with less than 10% U.S. online penetration, have required a physical presence and geographic boundaries in each state to operate the product consumers demanded anathema to the borderless environment in which we've operated our businesses. To operate true sports betting and digital gaming, a provider is currently required to partner with a local casino operator. And while we believe that regulatory environments generally catch up with consumer demand, it's taken quite a while in this category, so we found one of the leading players operating in 7 going on 11 states by the end of 2020: MGM, which pairs a strong physical presence and brand with talented online operators in a fast-growing joint venture in online gaming. Similar to Disney's advantages over pure-play streaming companies with an iconic brand and multiple avenues to monetize the same intellectual property between streaming, theatrical releases, merchandise, and theme parks, we believe MGM also is an aspirational brand, which could be delivered with daily accessibility and offer gaming consumers (including the 34 million M-life Rewards members) a wider range of services, both physical and digital, than any competitor. And MGM, with its highly capable joint venture partner GVC, has only just barely begun to deliver these products. Our history in driving off-line to on-line conversion gives us confidence in the path and, like other industries we've seen transform, a conviction that it will be assisted by natural tailwinds. Industry Relevance Year of Acquisition/Investment US Online Market in Year of Acquisition/Investment US Online Market in 2020 Dating Match Group 1999 0 Subscribers 10M+ Subscribers Ticketing Ticketmaster 2001 $1 Billion $13 Billion Travel Expedia 2002 $9 Billion $1.1 Trillion Homeservices ANGI Homeservices 2004 2 Million Service Requests 29 Million Service Requests Gambling MGM 2020 $6 Billion Turns out, MGM also has a $2.5 billion EBITDAR (a gaming industry metric designed to reflect profitability before taxes, capital expenses, and real estate expensesand simplify comparisons between those operators that own real estate and those that do not) operationdomestically that comes alongside the opportunity in digital sports betting and table games, at a normalized free cash flow yield over 10%. This combination doesn't exist in any growing internet opportunity. As we looked further into MGM, we recognized a familiar sum-of-the-parts story with publicly-traded subsidiaries. MGM's implied "stub" the domestic business without the real estate trades at an implied value of nearly zero. That's not unlike IAC's "stub" which is perennially valued at zero (or less). When we saw the collection of well-run businesses (check), a sturdy balance sheet (check), and the undervalued "stub" after accounting for cash and publicly-traded securities (check), we realized that the MGM situation is remarkably similar to that of IAC. Implied MGM Domestic Value ($ in billions, except per share data) MGM Share Price $19 Shares Outstanding(1) 493 Market Capitalization $9.4 (-) MGP stake(2) (4.9) (-) MGM China stake(2) (2.6) (+) Domestic Net Debt(3) 1.4 (-) Value of equity investments(4) (1.7) Implied Enterprise Value - MGM Domestic $1.5 We will be a minority investor in MGM, but given the size of our financial commitment, we'd welcome the opportunity to contribute to MGM's success in any number of areas. We think MGM could be one of the largest direct marketers on the internet as online gaming grows, and online direct marketing is an area we know well. We also see transformative opportunities beyond gaming for theatrical onsite activities, including in the regional casinos, and we'd bring our relationships and ideas to make that happen, as well as the potential for expansion into new worlds of media and wagering with innovative and exclusive content. And having served nearly 15 million paying subscribers throughout IAC's businesses last year and an order of magnitude more customers who don't yet pay to subscribe to our products but use free or "freemium" versions of our services we'd love to help MGM optimize its "funnel" of M-life loyalty customers and attract new digital-first audiences. The good news is, from the outside looking in, it seems clear to us that MGM's leadership sees these same opportunities, and we will cheer them on as partners. Over the next decade, free cash flow at MGM could be in excess of its current valuation, and we believe the business will have ample opportunities to invest that capital. If nothing else, of course, our ownership will steadily accrete up if MGM continues to use that free cash flow to shrink its capital base. Regardless of how MGM chooses to put its cash flow to work, the power of that cash flow doesn't appear to be getting much value in the market, and we believe that those financial dynamics on top of all the other positives make this investment and its potential return every bit as worthy as other opportunities we may have to deploy our capital. Although we would never "bet the company," we know that this is a large bet for IAC. We have long been driven to look opportunistically for chances to build great interactive businesses and compound capital for our shareholders, and MGM has a rare but clear opportunity to deliver on that promise. And while we can't say where our investment goes from here, we do believe this is the first step in what will hopefully be a very long and productive relationship. We begin in total alignment with MGM shareholders, management, and the board and we intend to assist and support them in all their ambitions. Sincerely, Barry Diller & Joey Levin 1Shares outstanding per Q2 2020 10-Q2Reflects MGM's 56% ownership of MGM China at $1.24 per share and 57% ownership of MGM Growth Properties at $28.22 per share as of 8/7/203Net debt for MGM Domestic as of Q2 2020 10-Q excludes debt of subsidiaries (MGM China and MGM Growth Properties); includes $163 million secured note receivable from sale of Circus Circus on 12/20/19 and redeemable non-controlling interest of $59 million for non-controlling parties in MGM National Harbor redeemable beginning 12/31/194Equity investments represents ownership in CityCenter based on research average of $1.5 billion; includes other equity affiliates at $226 million book value and excludes MGP equity investment in MGP BREIT Venture of $806 million as it is held at MGP subsidiary and counted in MGP's equity market capitalization IAC disclosed its share acquisition on Schedule 13D filed today with the Securities and Exchange Commission. IAC is actively engaged with gaming regulators in the jurisdictions in which MGM Resorts operates to obtain necessary licenses. About IACIAC (NASDAQ: IAC) builds companies. We are guided by curiosity, a questioning of the status quo, and a desire to invent or acquire new products and brands. From the single seed that started as IAC over two decades ago have emerged 10 public companies and generations of exceptional leaders. We will always evolve, but our basic principles of financially-disciplined opportunism will never change. IAC today operates Vimeo, Dotdash and Care.com, among many others, and has majority ownership of ANGI Homeservices, which includes HomeAdvisor, Angie's List and Handy. The Company is headquartered in New York City and has business operations and satellite offices worldwide. Cautionary Statement Regarding Forward-Looking Information Certain statements and information in this communication may be deemed to be "forward-looking statements" within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to IAC's and MGM's anticipated financial performance, objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that IAC and MGM intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as "believe," "hope," "may," "anticipate," "should," "intend," "plan," "will," "expect," "estimate," "project," "positioned," "strategy" and similar expressions, and are based on assumptions and assessments made by IAC's and MGM's management in light of their experience and their perception of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. IAC and MGM undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance. Whether actual results will conform to expectations and predictions is subject to known and unknown risks and uncertainties, including: risks and uncertainties discussed in reports that IAC and MGM have filed with the SEC and other circumstances beyond IAC's and MGM's control. You should not place undue reliance on these forward-looking statements. For more details on factors that could affect these expectations, please see IAC's and MGM's filings with the SEC. Contact Us IAC Investor RelationsMark Schneider(212) 314-7400 IAC Corporate CommunicationsValerie Combs(212) 314-7361 SOURCE IAC
Answer:
|
IAC Invests in MGM Resorts International
|
NEW YORK, Aug. 10, 2020 /PRNewswire/ --IAC (NASDAQ: IAC) today announced its accumulation of a 12% interest in global hospitality and entertainment company MGM Resorts International (NYSE: MGM) for an aggregate of approximately $1 billion. "With the separation of Match Group from IAC, and 'new' IAC emerging with $3.9 billion of cash, no debt, and its opportunistic zeal intact, we are energized and excited to make this investment in MGM. What initially attracted us to MGM, besides its leadership in leisure, hospitality and gaming, was an area that currently comprises a tiny portion of its revenue online gaming,"said Barry Diller, Chairman and Senior Executive of IAC. "IAC's foundational concept of seeking opportunities to build interactive businesses is our base rationale there is a digital first opportunity within MGM Resorts' already impressive offline businesses, and with our experience we hope we can strongly contribute to the growth of online gaming." "MGM Resorts presents a unique opportunity for IAC to own a meaningful piece of a preeminent brand in a large category with immense potential to move online," said Joey Levin, CEO of IAC. "We will be a minority investor and a long-term strategic partner, and would welcome the opportunity to contribute to MGM's success in any way that MGM's Board would look favorably on our involvement." IAC published a letter to shareholders today, outlining the rationale for its investment in MGM Resorts in more detail. The letter in its entirety is below. August 10, 2020 Dear Shareholders, Over the last few months we've accumulated a 12% interest in MGM Resorts International ("MGM") for an aggregate of approximately $1 billion. Investors reading that prior sentence may be surprised by some, or quite possibly all, of its components. First, we accumulated a large minority position in a public company, which is not our usual methodology. Second, the securities we purchased are common equity securities, the exact same securities that any investor with exactly $19 could buy and sell any day in the market. Third, we bought securities in a business that has relatively little to do with the Internet today. Fourth, we invested a portion of our cash in a new direction for IAC. The answer to all four of those concerns is that we believe MGM presented a "once in a decade" opportunity for IAC to own a meaningful piece of a preeminent brand in a large category with great potential to move online. IAC has always been opportunistic with its capital, and if ever there was a time, this moment is unique. We believe we can generate compelling returns for our shareholders and hope our expertise will be additive to MGM's opportunities, but even if we never advance our involvement from here, the value was too compelling to ignore. Having taken this step, we have a very long-term view of this investment and will be open to all the opportunities it presents along the way. MGM is a leader in gaming, hospitality, and leisure with a storied brand and an enviable market position. The current pandemic brought revenue (though not expenses) to a temporary halt, and required MGM to repurpose cash it had wisely stockpiled for share repurchases to instead defend the solvency of the company. The good news is, we believe MGM has enough cash and access to capital to make it to the other side competitively stronger. When the world returns to normal, MGM will be just as capable post-pandemic as it was pre-pandemic in servicing visitors in over 35% of the Las Vegas Strip's available rooms, plus eight regional properties across the US, two in Macau, and hopefully in Japan. The 34 million members of MGM's loyalty program still have their M-life Rewards, and we're confident that many are eager to return to the properties they love. And when Las Vegas fully re-opens even if it must wait until a vaccine for that to occur we expect it to roar back: a new NFL team, a new stadium, a drivable destination, and months of pent-up demand could drive a powerful resurgence. But that's not what originally drove us to MGM, nor in large part drove our final decision to invest. We have a history and much experience in online commerce. So we began our analysis with a focus on a small piece of MGM, a portion of its revenue so small that it rounds down to zero: its online gaming revenue. We've followed the online gaming space for a while, looking for an opportunity to enter, but we were generally unsatisfied with the landscape we saw. The regulations in this $450 billion global industry, with less than 10% U.S. online penetration, have required a physical presence and geographic boundaries in each state to operate the product consumers demanded anathema to the borderless environment in which we've operated our businesses. To operate true sports betting and digital gaming, a provider is currently required to partner with a local casino operator. And while we believe that regulatory environments generally catch up with consumer demand, it's taken quite a while in this category, so we found one of the leading players operating in 7 going on 11 states by the end of 2020: MGM, which pairs a strong physical presence and brand with talented online operators in a fast-growing joint venture in online gaming. Similar to Disney's advantages over pure-play streaming companies with an iconic brand and multiple avenues to monetize the same intellectual property between streaming, theatrical releases, merchandise, and theme parks, we believe MGM also is an aspirational brand, which could be delivered with daily accessibility and offer gaming consumers (including the 34 million M-life Rewards members) a wider range of services, both physical and digital, than any competitor. And MGM, with its highly capable joint venture partner GVC, has only just barely begun to deliver these products. Our history in driving off-line to on-line conversion gives us confidence in the path and, like other industries we've seen transform, a conviction that it will be assisted by natural tailwinds. Industry Relevance Year of Acquisition/Investment US Online Market in Year of Acquisition/Investment US Online Market in 2020 Dating Match Group 1999 0 Subscribers 10M+ Subscribers Ticketing Ticketmaster 2001 $1 Billion $13 Billion Travel Expedia 2002 $9 Billion $1.1 Trillion Homeservices ANGI Homeservices 2004 2 Million Service Requests 29 Million Service Requests Gambling MGM 2020 $6 Billion Turns out, MGM also has a $2.5 billion EBITDAR (a gaming industry metric designed to reflect profitability before taxes, capital expenses, and real estate expensesand simplify comparisons between those operators that own real estate and those that do not) operationdomestically that comes alongside the opportunity in digital sports betting and table games, at a normalized free cash flow yield over 10%. This combination doesn't exist in any growing internet opportunity. As we looked further into MGM, we recognized a familiar sum-of-the-parts story with publicly-traded subsidiaries. MGM's implied "stub" the domestic business without the real estate trades at an implied value of nearly zero. That's not unlike IAC's "stub" which is perennially valued at zero (or less). When we saw the collection of well-run businesses (check), a sturdy balance sheet (check), and the undervalued "stub" after accounting for cash and publicly-traded securities (check), we realized that the MGM situation is remarkably similar to that of IAC. Implied MGM Domestic Value ($ in billions, except per share data) MGM Share Price $19 Shares Outstanding(1) 493 Market Capitalization $9.4 (-) MGP stake(2) (4.9) (-) MGM China stake(2) (2.6) (+) Domestic Net Debt(3) 1.4 (-) Value of equity investments(4) (1.7) Implied Enterprise Value - MGM Domestic $1.5 We will be a minority investor in MGM, but given the size of our financial commitment, we'd welcome the opportunity to contribute to MGM's success in any number of areas. We think MGM could be one of the largest direct marketers on the internet as online gaming grows, and online direct marketing is an area we know well. We also see transformative opportunities beyond gaming for theatrical onsite activities, including in the regional casinos, and we'd bring our relationships and ideas to make that happen, as well as the potential for expansion into new worlds of media and wagering with innovative and exclusive content. And having served nearly 15 million paying subscribers throughout IAC's businesses last year and an order of magnitude more customers who don't yet pay to subscribe to our products but use free or "freemium" versions of our services we'd love to help MGM optimize its "funnel" of M-life loyalty customers and attract new digital-first audiences. The good news is, from the outside looking in, it seems clear to us that MGM's leadership sees these same opportunities, and we will cheer them on as partners. Over the next decade, free cash flow at MGM could be in excess of its current valuation, and we believe the business will have ample opportunities to invest that capital. If nothing else, of course, our ownership will steadily accrete up if MGM continues to use that free cash flow to shrink its capital base. Regardless of how MGM chooses to put its cash flow to work, the power of that cash flow doesn't appear to be getting much value in the market, and we believe that those financial dynamics on top of all the other positives make this investment and its potential return every bit as worthy as other opportunities we may have to deploy our capital. Although we would never "bet the company," we know that this is a large bet for IAC. We have long been driven to look opportunistically for chances to build great interactive businesses and compound capital for our shareholders, and MGM has a rare but clear opportunity to deliver on that promise. And while we can't say where our investment goes from here, we do believe this is the first step in what will hopefully be a very long and productive relationship. We begin in total alignment with MGM shareholders, management, and the board and we intend to assist and support them in all their ambitions. Sincerely, Barry Diller & Joey Levin 1Shares outstanding per Q2 2020 10-Q2Reflects MGM's 56% ownership of MGM China at $1.24 per share and 57% ownership of MGM Growth Properties at $28.22 per share as of 8/7/203Net debt for MGM Domestic as of Q2 2020 10-Q excludes debt of subsidiaries (MGM China and MGM Growth Properties); includes $163 million secured note receivable from sale of Circus Circus on 12/20/19 and redeemable non-controlling interest of $59 million for non-controlling parties in MGM National Harbor redeemable beginning 12/31/194Equity investments represents ownership in CityCenter based on research average of $1.5 billion; includes other equity affiliates at $226 million book value and excludes MGP equity investment in MGP BREIT Venture of $806 million as it is held at MGP subsidiary and counted in MGP's equity market capitalization IAC disclosed its share acquisition on Schedule 13D filed today with the Securities and Exchange Commission. IAC is actively engaged with gaming regulators in the jurisdictions in which MGM Resorts operates to obtain necessary licenses. About IACIAC (NASDAQ: IAC) builds companies. We are guided by curiosity, a questioning of the status quo, and a desire to invent or acquire new products and brands. From the single seed that started as IAC over two decades ago have emerged 10 public companies and generations of exceptional leaders. We will always evolve, but our basic principles of financially-disciplined opportunism will never change. IAC today operates Vimeo, Dotdash and Care.com, among many others, and has majority ownership of ANGI Homeservices, which includes HomeAdvisor, Angie's List and Handy. The Company is headquartered in New York City and has business operations and satellite offices worldwide. Cautionary Statement Regarding Forward-Looking Information Certain statements and information in this communication may be deemed to be "forward-looking statements" within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to IAC's and MGM's anticipated financial performance, objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that IAC and MGM intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as "believe," "hope," "may," "anticipate," "should," "intend," "plan," "will," "expect," "estimate," "project," "positioned," "strategy" and similar expressions, and are based on assumptions and assessments made by IAC's and MGM's management in light of their experience and their perception of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. IAC and MGM undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance. Whether actual results will conform to expectations and predictions is subject to known and unknown risks and uncertainties, including: risks and uncertainties discussed in reports that IAC and MGM have filed with the SEC and other circumstances beyond IAC's and MGM's control. You should not place undue reliance on these forward-looking statements. For more details on factors that could affect these expectations, please see IAC's and MGM's filings with the SEC. Contact Us IAC Investor RelationsMark Schneider(212) 314-7400 IAC Corporate CommunicationsValerie Combs(212) 314-7361 SOURCE IAC
|
edtsum6686
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SANTA CRUZ, Calif., April 22, 2020 /PRNewswire/ --Santa Cruz County Bank(OTC Pink: SCZC),with assetsover $1billion, is a top rated community bank headquartered inSanta Cruz County. Today the Bankannounced record unaudited net income for the first quarter ended March 31, 2020 of $4.4 million. This represents an increase of 48% compared to the first quarter 2019. For the quarter, basic earnings per share decreased $0.07, or 6% to $1.14, compared to the first quarter in 2019. The decline is reflective of the increased number of shares outstanding as the result of the Bank's merger with Lighthouse Bank in the fourth quarter of 2019. Pretax income for the quarter ended March 31, 2020 was $6.2 million, an increase of $2.0 million, 48%, compared to $4.2 million for the quarter ended March 31, 2019. President and CEO David V. Heald commented, "On behalf of the Board of Directors and Management team, I commend our entire staff for our first quarter performance and care for our customers and community. As an essential business, our team has gone above and beyond in delivering critical services to our community at the greatest time of need in the history of our Bank and undoubtedly, our careers. The quarter ended with two significant occurrences, our systems integration with Lighthouse Bank and concurrently being hit with the COVID 19 pandemic, which has dramatically altered the way we do business. To respond to the significant impact of this crisis on our community, we developed a Paycheck Protection Program loan application portal on our website, far ahead of the curve. Our dedicated team has worked long hours, nights and weekends to ensure Paycheck Protection Program funding supports small businesses and helps them keep employees on the payroll. Through these efforts, a total of approximately 29,218 jobs were saved, which speaks volumes about dedication and commitment to serving our community, whether in good times or during a crisis." Selected financial information is presented in the following table: Three-Months Ended, 03.31.20 12.31.19 03.31.19 Balance Sheet Total assets $1,069,462,569 $1,070,983,369 $668,097,706 Gross loans 752,562,735 758,076,034 484,895,169 Allowance for loan losses 10,349,444 10,296,230 9,842,656 Non interest-bearing deposits 356,715,560 345,604,709 250,817,502 Total deposits 899,126,540 904,348,022 581,733,803 Shareholders' equity 154,891,396 151,098,368 83,425,030 Net Income $4,381,461 $3,015,857 $2,964,909 Ratios Net interest margin 4.51% 4.38% 4.92% Tier 1 leverage ratio 12.26% 11.85% 10.74% Return on average assets 1.67% 1.12% 1.80% Return on average equity 11.42% 8.35% 17.07% Return on tangible equity 14.23% 9.99% 17.28% Efficiency ratio 47.55% 62.67% 51.72% Share and Per Share Data Basic earnings per common share $1.14 $0.85 $1.21 Diluted earnings per common share $1.13 $0.85 $1.20 Book value per common share $40.22 $39.25 $29.14 Tangible book value per share $32.15 $31.13 $28.38 Total common shares outstanding 3,851,041 3.849,841 2,452,294 First Quarter Financial Highlights: Net interest margin of 4.51% First quarter return on average assets and equity of 1.67% and 11.42%, respectively Well capitalized with a total risk based capital ratio of 16.65% Continued exceptional credit quality with no loans on non-accrual 55% growth in deposits, $317.4 million increase over the first quarter of 2019 Basic earnings per share decreased to $1.14 from $1.21 compared to the first quarter of 2019 and increased by $0.29 per share over the fourth quarter 2019, when the merger closed Book value per share after dividends increased by $11.08 or 38%, to $40.22 since the first quarter of 2019 Loans, Asset Quality & Deposits Total assets declined by $1.5 million to $1.069 billion in the first quarter but increased significantly by $401.4 million over the last twelve months. The Bank's asset quality remained exceptional. For the first quarter, gross loans were down $5.5 million (in part due to loan sales), but year over year increased $267.7 million, 55% to $752.6 million. Allowance for loan losses of $10.3 million at March 31, 2020 represents a 5% increase over the same period last year. Deposits declined by 1%, $5.2 million since December 31, 2019 and increased significantly by $317 million or 55% comparing the first quarter of 2020 to the same period in 2019. Non-Interest Income / Expense and Net Interest Margin A component of the Bank's core business is the origination and sale of loans generated by its top producing SBA Department which results in gains that are included in non-interest income. For the first quarter of 2020, the non-interest income total was $1.02 million which included $188 thousand of gains on loans sold. The variance from first quarter 2019 is due primarily to volume resulting from the merger. The variance from fourth quarter 2019 is attributable to the aforementioned gain on sale of loans. Non-interest expense for the three-month period ended March 31, 2020, increased 28% or $1.3 million compared to prior quarter and increased 27% or $1.2 million compared to the same period last year. The more recent variance is due primarily to the reversal of expense accrued in prior periods that was unused and then reversed during quarter four 2019. The year over year increase resulted from the combined non-interest expense of both banks. Net interest income of $11 million for the quarter ended March 31, 2020 was basically equivalent to prior quarter but exceeded the first quarter of 2019 by $3.3 million or 42%. The year over year increase again is due to the larger volume of the combined earning assets of both banks resulting from the merger. Shareholders' Equity Total shareholders' equity was $154.9 million at March 31, 2020, an $83.4 million, 117% increase over March 31, 2019. The majority of the increase was due to the issuance of common stock related to the merger and the value added to our shareholders due to continued strong earnings. Approximately $29 million of intangible value arising from the merger is included in the $83.4 million increase. This increase was reduced by the payout of quarterly cash dividends. Common stock cash dividends totaled $839 thousand in 2019 and $289 thousand or $0.075 per share for the quarter ended March 31, 2020. For the three month period ended March 31, 2020, the Bank's return on average equity was 11.42% (return on tangible equity 14.23%) and return on average assets was 1.67%. The book value per share of Santa Cruz County Bank's common stock at March 31, 2020 was $40.22, up from $29.14 for the same period in 2019. ANNUAL MEETING NOTICE The Bank's Annual Meeting of Shareholders has been set for August 18, 2020. Shareholders will be notified of the meeting time and format (virtual, in person or hybrid) for attendance through a proxy mailing scheduled for mid-July. ABOUTSANTA CRUZ COUNTYBANK Santa Cruz County Bank was founded in 2004. It is a top-rated, locally-owned and operated, full-service community bank headquartered inSanta Cruz, California. The bank has seven branchesAptos,Capitola,Cupertino,Santa Cruz(2),Scotts ValleyandWatsonvilleall of which are Green Business Certified in accordance with the Bank's commitment to the environment. Santa Cruz County Bank is distinguished from "big banks" by its relationship-based service, problem-solving focus, and direct access to decision makers. The bank is a leading SBA lender inSanta Cruz Countyand Silicon Valley, and a top USDA lender in the state of California.As a full-service bank, Santa Cruz County Bank offers competitive deposit and lending solutions for businesses and individuals; including business loans, lines of credit, commercial real estate financing, construction lending, agricultural loans, SBA and USDA government guaranteed loans, credit cards, merchant services, remote deposit capture, mobile and online banking, bill payment, and treasury management. True to its community roots, Santa Cruz County Bank has supported regional well-being by actively participating in and donating to local not-for-profit organizations. Santa Cruz County Bank stock is publicly traded on the OTC marketplace under the symbol SCZC. Stock purchase orders may be placed online, through a brokerage firm, or through Market Makers listed in the Investor Relations section of the bank's website. For more information about Santa Cruz County Bank, visitwww.sccountybank.com. NATIONAL, STATE, AND LOCAL RATINGS AND AWARDS S&P Global Top 100 Community Banks: Santa Cruz County Bank ranked 4thin the nation out of more than 4,200 banks with assets under$3 billionbased upon 2019 performance. The Bank has ranked in the Top 100 Community Banks by S&P Global for four consecutive years.Financial Management Consulting (FMC) Group: Santa Cruz County Bank has ranked in FMC's top ten banks inCaliforniafor the past five years.The Findley Reports, Inc.: The Bank has received the top ranking of Super Premier by Findley for ten consecutive years.Bauer Financial Reports, Inc.: Santa Cruz County Bank is rated 5-star "Superior" based upon its financial performance for every quarter in 2019.American Banker Magazine: Santa Cruz County Bank ranked 12thout of 601 institutions in American Banker Magazine's "Top Performing 200 Community Banks & Thrifts inthe United States" based upon 3-year average return on equity. The Bank ranked 4thout of 26 California banks. The Bank has ranked in the Top 200 Community Banks inthe United Statesfor six consecutive years.The Bank ranks 4thin the Silicon Valley for the number of SBA loans lent to Silicon Valley businesses for the SBA's 2019 fiscal year. COMMUNITY AWARDS AND RECOGNITION Santa Cruz Chamberof Commerce, 2018 Business of the Year Award.Farm Bureau ofSanta Cruz County, 2018 Al Smith Friend of Agriculture Awardfor support of the agricultural industry and providing access to capital.Second Harvest Food Bank, Platinum Level Award for the 2019 Holiday Food & Fund Drive.Santa Cruz Sentinel,2019Reader's Choice Award,number one bank in Santa Cruz County as voted by Santa Cruz Sentinel readers.Good Times, 2019 Best of Santa Cruz County Award,Voted"Best Bank" for the sevenconsecutive years.Santa Cruz Waves Magazine, 2019 Swellies Awards,Voted "Favorite Bank" in Santa Cruz County. This release may contain forward-looking statements that are subject to risks and uncertainties. Such risks and uncertainties may include but are not necessarily limited to fluctuations in interest rates, inflation, government regulations and general economic conditions, and competition within the business areas in which the Bank is conducting its operations, including the real estate market inCaliforniaand other factors beyond the Bank's control. Such risks and uncertainties could cause results for subsequent interim periods or for the entire year to differ materially from those indicated. Readers should not place undue reliance on the forward-looking statements, which reflect management's view only as of the date hereof. The Bank undertakes no obligation to publicly revise these forward-looking statements to reflect subsequent events or circumstances. Selected Financial Data (unaudited) Change Change Quarter ended 03/31/20 Quarter ended 03/31/19 $ % Quarter ended 12/31/19 $ % Balance Sheet Total assets $ 1,069,462,569 $ 668,097,706 $ 401,364,863 60% $ 1,070,983,369 $ (1,520,800) 0% Gross loans 752,562,735 484,895,169 267,667,566 55% 758,076,034 (5,513,299) -1% Allowance for loan losses 10,349,444 9,842,656 506,788 5% 10,296,230 53,214 1% Non interest-bearing deposits 356,715,560 250,817,502 105,898,058 42% 345,604,709 11,110,851 3% Total deposits 899,126,540 581,733,803 317,392,737 55% 904,348,022 (5,221,482) -1% Shareholders' equity 154,891,396 71,466,366 83,425,030 117% 151,098,368 3,793,028 3% Income Statement Change Three-months ended 3/31/20 Three-months ended 3/31/19 $ % Interest income $ 11,837,332 $ 8,162,809 3,674,523 45% $ 11,946,612 (109,280) -1% $ 11,837,332 $ 8,162,809 $ 3,674,523 45% Interest expense 792,154 407,380 384,774 94% 820,625 (28,471) -3% 792,154 407,380 384,774 94% Net interest income 11,045,178 7,755,429 3,289,749 42% 11,125,987 (80,809) -1% 11,045,178 7,755,429 3,289,749 42% Provision for loan losses 150,000 - 150,000 100% 150,000 - 0% 150,000 - 150,000 100% Non-interest income 1,017,884 863,975 153,909 18% 764,269 253,615 33% 1,017,884 863,975 153,909 18% Merger expense 65,950 - 65,950 100% 3,034,901 (2,968,951) 100% 65,950 - 65,950 100% Non-interest expense 5,668,715 4,458,201 1,210,514 27% 4,416,709 1,252,006 28% 5,668,715 4,458,201 1,210,514 27% Net income before taxes 6,178,397 4,161,203 2,017,194 48% 4,288,646 1,889,751 44% 6,178,397 4,161,203 2,017,194 48% Income tax expense 1,796,936 1,196,294 600,642 50% 1,272,789 524,147 41% 1,796,936 1,196,294 600,642 50% Net income after taxes $ 4,381,461 $ 2,964,909 1,416,552 48% $ 3,015,857 1,365,604 45% $ 4,381,461 $ 2,964,909 1,416,552 48% BASIC EARNINGS PER SHARE $ 1.14 $ 1.21 (0.07) -6% $ 0.85 0.29 34% $ 1.14 $ 1.21 $ (0.07) -6% DILUTED EARNINGS PER SHARE $ 1.13 $ 1.20 (0.07) -6% $ 0.85 0.28 33% $ 1.13 $ 1.20 $ (0.07) -6% Book value per share $ 40.22 $ 29.14 11.08 38% $ 39.25 0.97 2% $ 40.22 $ 29.14 $ 11.08 38% Tangible book value per share $ 32.15 $ 28.38 3.77 13% $ 31.13 1.02 3% $ 32.15 $ 28.38 $ 3.77 13% SHARES OUTSTANDING 3,851,041 2,452,294 3,849,841 Ratios Tier 1 leverage ratio 12.26% 10.74% 11.85% 12.26% 10.74% Net interest margin 4.51% 4.92% 4.38% 4.51% 4.92% Efficiency ratio 47.55% 51.72% 62.67% 47.55% 51.72% Return on average assets 1.67% 1.80% 1.12% 1.67% 1.80% Return on average equity 11.42% 17.07% 8.35% 11.42% 17.07% Return on tangible equity 14.23% 17.28% 9.99% 14.23% 17.28% % of non interest bearing to total deposits 40% 43% 38% SOURCE Santa Cruz County Bank Related Links http://www.sccountybank.com
Answer:
|
Santa Cruz County Bank Reports Record Earnings for the First Quarter Ended March 31, 2020 Net Income Increases 48% Compared To First Quarter 2019
|
SANTA CRUZ, Calif., April 22, 2020 /PRNewswire/ --Santa Cruz County Bank(OTC Pink: SCZC),with assetsover $1billion, is a top rated community bank headquartered inSanta Cruz County. Today the Bankannounced record unaudited net income for the first quarter ended March 31, 2020 of $4.4 million. This represents an increase of 48% compared to the first quarter 2019. For the quarter, basic earnings per share decreased $0.07, or 6% to $1.14, compared to the first quarter in 2019. The decline is reflective of the increased number of shares outstanding as the result of the Bank's merger with Lighthouse Bank in the fourth quarter of 2019. Pretax income for the quarter ended March 31, 2020 was $6.2 million, an increase of $2.0 million, 48%, compared to $4.2 million for the quarter ended March 31, 2019. President and CEO David V. Heald commented, "On behalf of the Board of Directors and Management team, I commend our entire staff for our first quarter performance and care for our customers and community. As an essential business, our team has gone above and beyond in delivering critical services to our community at the greatest time of need in the history of our Bank and undoubtedly, our careers. The quarter ended with two significant occurrences, our systems integration with Lighthouse Bank and concurrently being hit with the COVID 19 pandemic, which has dramatically altered the way we do business. To respond to the significant impact of this crisis on our community, we developed a Paycheck Protection Program loan application portal on our website, far ahead of the curve. Our dedicated team has worked long hours, nights and weekends to ensure Paycheck Protection Program funding supports small businesses and helps them keep employees on the payroll. Through these efforts, a total of approximately 29,218 jobs were saved, which speaks volumes about dedication and commitment to serving our community, whether in good times or during a crisis." Selected financial information is presented in the following table: Three-Months Ended, 03.31.20 12.31.19 03.31.19 Balance Sheet Total assets $1,069,462,569 $1,070,983,369 $668,097,706 Gross loans 752,562,735 758,076,034 484,895,169 Allowance for loan losses 10,349,444 10,296,230 9,842,656 Non interest-bearing deposits 356,715,560 345,604,709 250,817,502 Total deposits 899,126,540 904,348,022 581,733,803 Shareholders' equity 154,891,396 151,098,368 83,425,030 Net Income $4,381,461 $3,015,857 $2,964,909 Ratios Net interest margin 4.51% 4.38% 4.92% Tier 1 leverage ratio 12.26% 11.85% 10.74% Return on average assets 1.67% 1.12% 1.80% Return on average equity 11.42% 8.35% 17.07% Return on tangible equity 14.23% 9.99% 17.28% Efficiency ratio 47.55% 62.67% 51.72% Share and Per Share Data Basic earnings per common share $1.14 $0.85 $1.21 Diluted earnings per common share $1.13 $0.85 $1.20 Book value per common share $40.22 $39.25 $29.14 Tangible book value per share $32.15 $31.13 $28.38 Total common shares outstanding 3,851,041 3.849,841 2,452,294 First Quarter Financial Highlights: Net interest margin of 4.51% First quarter return on average assets and equity of 1.67% and 11.42%, respectively Well capitalized with a total risk based capital ratio of 16.65% Continued exceptional credit quality with no loans on non-accrual 55% growth in deposits, $317.4 million increase over the first quarter of 2019 Basic earnings per share decreased to $1.14 from $1.21 compared to the first quarter of 2019 and increased by $0.29 per share over the fourth quarter 2019, when the merger closed Book value per share after dividends increased by $11.08 or 38%, to $40.22 since the first quarter of 2019 Loans, Asset Quality & Deposits Total assets declined by $1.5 million to $1.069 billion in the first quarter but increased significantly by $401.4 million over the last twelve months. The Bank's asset quality remained exceptional. For the first quarter, gross loans were down $5.5 million (in part due to loan sales), but year over year increased $267.7 million, 55% to $752.6 million. Allowance for loan losses of $10.3 million at March 31, 2020 represents a 5% increase over the same period last year. Deposits declined by 1%, $5.2 million since December 31, 2019 and increased significantly by $317 million or 55% comparing the first quarter of 2020 to the same period in 2019. Non-Interest Income / Expense and Net Interest Margin A component of the Bank's core business is the origination and sale of loans generated by its top producing SBA Department which results in gains that are included in non-interest income. For the first quarter of 2020, the non-interest income total was $1.02 million which included $188 thousand of gains on loans sold. The variance from first quarter 2019 is due primarily to volume resulting from the merger. The variance from fourth quarter 2019 is attributable to the aforementioned gain on sale of loans. Non-interest expense for the three-month period ended March 31, 2020, increased 28% or $1.3 million compared to prior quarter and increased 27% or $1.2 million compared to the same period last year. The more recent variance is due primarily to the reversal of expense accrued in prior periods that was unused and then reversed during quarter four 2019. The year over year increase resulted from the combined non-interest expense of both banks. Net interest income of $11 million for the quarter ended March 31, 2020 was basically equivalent to prior quarter but exceeded the first quarter of 2019 by $3.3 million or 42%. The year over year increase again is due to the larger volume of the combined earning assets of both banks resulting from the merger. Shareholders' Equity Total shareholders' equity was $154.9 million at March 31, 2020, an $83.4 million, 117% increase over March 31, 2019. The majority of the increase was due to the issuance of common stock related to the merger and the value added to our shareholders due to continued strong earnings. Approximately $29 million of intangible value arising from the merger is included in the $83.4 million increase. This increase was reduced by the payout of quarterly cash dividends. Common stock cash dividends totaled $839 thousand in 2019 and $289 thousand or $0.075 per share for the quarter ended March 31, 2020. For the three month period ended March 31, 2020, the Bank's return on average equity was 11.42% (return on tangible equity 14.23%) and return on average assets was 1.67%. The book value per share of Santa Cruz County Bank's common stock at March 31, 2020 was $40.22, up from $29.14 for the same period in 2019. ANNUAL MEETING NOTICE The Bank's Annual Meeting of Shareholders has been set for August 18, 2020. Shareholders will be notified of the meeting time and format (virtual, in person or hybrid) for attendance through a proxy mailing scheduled for mid-July. ABOUTSANTA CRUZ COUNTYBANK Santa Cruz County Bank was founded in 2004. It is a top-rated, locally-owned and operated, full-service community bank headquartered inSanta Cruz, California. The bank has seven branchesAptos,Capitola,Cupertino,Santa Cruz(2),Scotts ValleyandWatsonvilleall of which are Green Business Certified in accordance with the Bank's commitment to the environment. Santa Cruz County Bank is distinguished from "big banks" by its relationship-based service, problem-solving focus, and direct access to decision makers. The bank is a leading SBA lender inSanta Cruz Countyand Silicon Valley, and a top USDA lender in the state of California.As a full-service bank, Santa Cruz County Bank offers competitive deposit and lending solutions for businesses and individuals; including business loans, lines of credit, commercial real estate financing, construction lending, agricultural loans, SBA and USDA government guaranteed loans, credit cards, merchant services, remote deposit capture, mobile and online banking, bill payment, and treasury management. True to its community roots, Santa Cruz County Bank has supported regional well-being by actively participating in and donating to local not-for-profit organizations. Santa Cruz County Bank stock is publicly traded on the OTC marketplace under the symbol SCZC. Stock purchase orders may be placed online, through a brokerage firm, or through Market Makers listed in the Investor Relations section of the bank's website. For more information about Santa Cruz County Bank, visitwww.sccountybank.com. NATIONAL, STATE, AND LOCAL RATINGS AND AWARDS S&P Global Top 100 Community Banks: Santa Cruz County Bank ranked 4thin the nation out of more than 4,200 banks with assets under$3 billionbased upon 2019 performance. The Bank has ranked in the Top 100 Community Banks by S&P Global for four consecutive years.Financial Management Consulting (FMC) Group: Santa Cruz County Bank has ranked in FMC's top ten banks inCaliforniafor the past five years.The Findley Reports, Inc.: The Bank has received the top ranking of Super Premier by Findley for ten consecutive years.Bauer Financial Reports, Inc.: Santa Cruz County Bank is rated 5-star "Superior" based upon its financial performance for every quarter in 2019.American Banker Magazine: Santa Cruz County Bank ranked 12thout of 601 institutions in American Banker Magazine's "Top Performing 200 Community Banks & Thrifts inthe United States" based upon 3-year average return on equity. The Bank ranked 4thout of 26 California banks. The Bank has ranked in the Top 200 Community Banks inthe United Statesfor six consecutive years.The Bank ranks 4thin the Silicon Valley for the number of SBA loans lent to Silicon Valley businesses for the SBA's 2019 fiscal year. COMMUNITY AWARDS AND RECOGNITION Santa Cruz Chamberof Commerce, 2018 Business of the Year Award.Farm Bureau ofSanta Cruz County, 2018 Al Smith Friend of Agriculture Awardfor support of the agricultural industry and providing access to capital.Second Harvest Food Bank, Platinum Level Award for the 2019 Holiday Food & Fund Drive.Santa Cruz Sentinel,2019Reader's Choice Award,number one bank in Santa Cruz County as voted by Santa Cruz Sentinel readers.Good Times, 2019 Best of Santa Cruz County Award,Voted"Best Bank" for the sevenconsecutive years.Santa Cruz Waves Magazine, 2019 Swellies Awards,Voted "Favorite Bank" in Santa Cruz County. This release may contain forward-looking statements that are subject to risks and uncertainties. Such risks and uncertainties may include but are not necessarily limited to fluctuations in interest rates, inflation, government regulations and general economic conditions, and competition within the business areas in which the Bank is conducting its operations, including the real estate market inCaliforniaand other factors beyond the Bank's control. Such risks and uncertainties could cause results for subsequent interim periods or for the entire year to differ materially from those indicated. Readers should not place undue reliance on the forward-looking statements, which reflect management's view only as of the date hereof. The Bank undertakes no obligation to publicly revise these forward-looking statements to reflect subsequent events or circumstances. Selected Financial Data (unaudited) Change Change Quarter ended 03/31/20 Quarter ended 03/31/19 $ % Quarter ended 12/31/19 $ % Balance Sheet Total assets $ 1,069,462,569 $ 668,097,706 $ 401,364,863 60% $ 1,070,983,369 $ (1,520,800) 0% Gross loans 752,562,735 484,895,169 267,667,566 55% 758,076,034 (5,513,299) -1% Allowance for loan losses 10,349,444 9,842,656 506,788 5% 10,296,230 53,214 1% Non interest-bearing deposits 356,715,560 250,817,502 105,898,058 42% 345,604,709 11,110,851 3% Total deposits 899,126,540 581,733,803 317,392,737 55% 904,348,022 (5,221,482) -1% Shareholders' equity 154,891,396 71,466,366 83,425,030 117% 151,098,368 3,793,028 3% Income Statement Change Three-months ended 3/31/20 Three-months ended 3/31/19 $ % Interest income $ 11,837,332 $ 8,162,809 3,674,523 45% $ 11,946,612 (109,280) -1% $ 11,837,332 $ 8,162,809 $ 3,674,523 45% Interest expense 792,154 407,380 384,774 94% 820,625 (28,471) -3% 792,154 407,380 384,774 94% Net interest income 11,045,178 7,755,429 3,289,749 42% 11,125,987 (80,809) -1% 11,045,178 7,755,429 3,289,749 42% Provision for loan losses 150,000 - 150,000 100% 150,000 - 0% 150,000 - 150,000 100% Non-interest income 1,017,884 863,975 153,909 18% 764,269 253,615 33% 1,017,884 863,975 153,909 18% Merger expense 65,950 - 65,950 100% 3,034,901 (2,968,951) 100% 65,950 - 65,950 100% Non-interest expense 5,668,715 4,458,201 1,210,514 27% 4,416,709 1,252,006 28% 5,668,715 4,458,201 1,210,514 27% Net income before taxes 6,178,397 4,161,203 2,017,194 48% 4,288,646 1,889,751 44% 6,178,397 4,161,203 2,017,194 48% Income tax expense 1,796,936 1,196,294 600,642 50% 1,272,789 524,147 41% 1,796,936 1,196,294 600,642 50% Net income after taxes $ 4,381,461 $ 2,964,909 1,416,552 48% $ 3,015,857 1,365,604 45% $ 4,381,461 $ 2,964,909 1,416,552 48% BASIC EARNINGS PER SHARE $ 1.14 $ 1.21 (0.07) -6% $ 0.85 0.29 34% $ 1.14 $ 1.21 $ (0.07) -6% DILUTED EARNINGS PER SHARE $ 1.13 $ 1.20 (0.07) -6% $ 0.85 0.28 33% $ 1.13 $ 1.20 $ (0.07) -6% Book value per share $ 40.22 $ 29.14 11.08 38% $ 39.25 0.97 2% $ 40.22 $ 29.14 $ 11.08 38% Tangible book value per share $ 32.15 $ 28.38 3.77 13% $ 31.13 1.02 3% $ 32.15 $ 28.38 $ 3.77 13% SHARES OUTSTANDING 3,851,041 2,452,294 3,849,841 Ratios Tier 1 leverage ratio 12.26% 10.74% 11.85% 12.26% 10.74% Net interest margin 4.51% 4.92% 4.38% 4.51% 4.92% Efficiency ratio 47.55% 51.72% 62.67% 47.55% 51.72% Return on average assets 1.67% 1.80% 1.12% 1.67% 1.80% Return on average equity 11.42% 17.07% 8.35% 11.42% 17.07% Return on tangible equity 14.23% 17.28% 9.99% 14.23% 17.28% % of non interest bearing to total deposits 40% 43% 38% SOURCE Santa Cruz County Bank Related Links http://www.sccountybank.com
|
edtsum6692
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MIDDLETON, Mass., Aug. 11, 2020 /PRNewswire/ -- Quadrant Knowledge Solutionsannounced today that it has named Device Authority, a leading provider of device-centric IoT IAM platform KeyScaler, as the 2020 technology leader in the SPARK Matrix analysis of the global IoT Identity and Access Management (IoT IAM) market. Quadrant Knowledge Solutions SPARK Matrix evaluation examined Device Authority and ten other vendors by evaluating the company's product portfolios, technology strategies, market presence, and customer value proposition. Quadrant Knowledge Solutions' SPARK Matrix provides a snapshot of key market participants and a visual representation of their positioning, along with strategic insights on how each vendor participant ranks related to its competitors along several axis representing a range of performance parameters coinciding with technology excellence and customer impact. IoT Identity & Access Management (IoT IAM) market consists of vendors that offer a scalable solution for deploying and managing security keys and certificates to enable device identity and integrity to be cryptographically proven and validated throughout its lifecycle. Securing IoT devices require a purpose-built device-centric IAM solution as traditional employee-centric IAM or customer IAM (CIAM) solutions are not capable of addressing IoT-specific challenges. A purpose-built IoT IAM solution capabilities, include massive scalability & availability to handle a wide variety and volume of IoT devices, secure device registration & provisioning, end-to-end data encryption, device authentication, compliance management, and centralized policy management. Driven by the impact of COVID-19, the global economy, along with industries, is facing significant challenges and negative growth. While COVID-19 has impacted the market for overall digital transformation projects and associated IoT security solution, the overall growth outlook looks promising for IoT IAM market. Despite the economic recession and negative impact on technology investments, the IoT IAM market is expected to continue its growth momentum in 2020, and during the forecasted years of 2020-2025. However, the forecasted growth rate for the year 2020 is significantly lower than our last year forecast for the same year. Quadrant analysts believe that from the year 2021 onwards, the technology investments will rise again mainly driven by the pent-up demand and economic recovery for the key industrial, energy, automotive, healthcare, connected cities and infrastructure market. The primary drivers for the IoT IAM market growth include continued emphasis and investments on digital transformation projects across industry sectors and geographical regions; increasing frequency of IoT-specific cybersecurity attacks, including DDoS, malware, spoofing, data breach, and others; growing confidence of purpose-built IoT IAM solutions with multiple successful demonstrations through pilot projects as well as full-scale deployments; continued investments by IAM leaders to their product strategy, marketing messaging, and technology innovation budgets to provide scalable IoT IAM solution; increasing partnership with IoT analytics and edge analytics platforms; growing popularity of next-generation of wireless technologies, such as LP-WAN, 5G, and Gigabit LTE; and such others. From a long-term trend perspective, IoT IAM market is expected to evolve towards an integrated IoT security solution to include the integrated solution for root-of-trust, device-centric identity and access management, end-to-end data security, comprehensive device visibility and granular access control, and such others. The IoT IAM researchby Quadrant Knowledge Solutions highlights that IoT IAM market is currently in the nascent stage with the presence of numerous traditional employee-centric IAM vendors as well as specialized IoT IAM providers. While a majority of these vendors often provide core functionalities for providing IAM solutions specific to IoT applications, the breadth and depth of these capabilities may differ significantly by different vendors offerings. Users should look for comprehensive device-centric IoT IAM solutions to support massive scalability requirements of IoT devices in the enterprise and industrial environment. "Device Authority KeyScaler platform offers a device-bound unified trust model by combining device and data security to meet the unified security requirements for critical IoT use cases. The platform provides robust functional capabilities to deploy and manage PKI for IoT devices at scale through automated device onboarding, zero-touch provisioning, authentication, credential management, and end-to-end policy data encryption," says Divya Baranawal, Research Director at Quadrant Knowledge Solutions. "Device Authority has received strong overall ratings against various performance parameters of technology excellence and customer impact and emerged as the technology leader in the 2020 SPARK Matrix analysis of the IoT IAM market," adds Baranawal. "We are delighted to be recognized by Quadrant Knowledge Solutions as a leader in the SPARK Matrix for the second year running, and exceptionally pleased to see our positioning has moved higher in the top quadrant," said Darron Antill, CEO at Device Authority. "As a leader we have always focused on the IoT market and developed technology which solves the challenges of security lifecycle management at IoT scale. Customers have deployed our KeyScaler platform in various industries including Healthcare, Industrial and Automotive, and we continue to help organizations on their IoT journey. Today's announcement solidifies the effort we have made to ensure our product is interoperable with leading IoT and security ecosystem partners such as Microsoft, PTC, nCipher Security and HID Global," he added. Additional Resources: Quadrant's Knowledge Brief: IoT IAM Market: Download here For more on KeyScaler Platform, please visit here About Device Authority Device Authority is a global leader in identity and access management (IAM) for the Internet of Things (IoT) and focuses on medical/healthcare, industrial, automotive and smart connected devices. Our KeyScaler platform provides trust for IoT devices and the IoT ecosystem to address the challenges of securing the Internet of Things. KeyScaler uses breakthrough technology, including Dynamic Device Key Generation (DDKG) and PKI Signature+ that delivers simplicity and trust to IoT devices. This solution delivers automated device provisioning, authentication, credential management, policy-based end-to-end data security/encryption and secure updates. With offices in Fremont, California, and Reading, UK, Device Authority partners with the leading IoT ecosystem providers, including AWS, DigiCert, Gemalto, HID Global, Microsoft, nCipher Security, PTC, Thales, Venafi, Wipro andmore. Keep updated by visitingwww.deviceauthority.com, following@DeviceAuthorityand subscribing to ourBrightTALK channel. About Quadrant Knowledge Solutions Quadrant Knowledge Solutions is a global advisory and consulting firm focused on helping clients in achieving business transformation goals with Strategic Business and Growth advisory services. At Quadrant Knowledge Solutions, our vision is to become an integral part of our client's business as a strategic knowledge partner. Our research and consulting deliverables are designed to provide comprehensive information and strategic insights for helping clients formulate growth strategies to survive and thrive in ever-changing business environments. For more available research, please visithttps://quadrant-solutions.com/market-research/ SOURCE Quadrant Knowledge Solutions
Answer:
|
Device Authority is Leader in SPARK Matrix: IoT Identity and Access Management (IoT IAM), 2020
|
MIDDLETON, Mass., Aug. 11, 2020 /PRNewswire/ -- Quadrant Knowledge Solutionsannounced today that it has named Device Authority, a leading provider of device-centric IoT IAM platform KeyScaler, as the 2020 technology leader in the SPARK Matrix analysis of the global IoT Identity and Access Management (IoT IAM) market. Quadrant Knowledge Solutions SPARK Matrix evaluation examined Device Authority and ten other vendors by evaluating the company's product portfolios, technology strategies, market presence, and customer value proposition. Quadrant Knowledge Solutions' SPARK Matrix provides a snapshot of key market participants and a visual representation of their positioning, along with strategic insights on how each vendor participant ranks related to its competitors along several axis representing a range of performance parameters coinciding with technology excellence and customer impact. IoT Identity & Access Management (IoT IAM) market consists of vendors that offer a scalable solution for deploying and managing security keys and certificates to enable device identity and integrity to be cryptographically proven and validated throughout its lifecycle. Securing IoT devices require a purpose-built device-centric IAM solution as traditional employee-centric IAM or customer IAM (CIAM) solutions are not capable of addressing IoT-specific challenges. A purpose-built IoT IAM solution capabilities, include massive scalability & availability to handle a wide variety and volume of IoT devices, secure device registration & provisioning, end-to-end data encryption, device authentication, compliance management, and centralized policy management. Driven by the impact of COVID-19, the global economy, along with industries, is facing significant challenges and negative growth. While COVID-19 has impacted the market for overall digital transformation projects and associated IoT security solution, the overall growth outlook looks promising for IoT IAM market. Despite the economic recession and negative impact on technology investments, the IoT IAM market is expected to continue its growth momentum in 2020, and during the forecasted years of 2020-2025. However, the forecasted growth rate for the year 2020 is significantly lower than our last year forecast for the same year. Quadrant analysts believe that from the year 2021 onwards, the technology investments will rise again mainly driven by the pent-up demand and economic recovery for the key industrial, energy, automotive, healthcare, connected cities and infrastructure market. The primary drivers for the IoT IAM market growth include continued emphasis and investments on digital transformation projects across industry sectors and geographical regions; increasing frequency of IoT-specific cybersecurity attacks, including DDoS, malware, spoofing, data breach, and others; growing confidence of purpose-built IoT IAM solutions with multiple successful demonstrations through pilot projects as well as full-scale deployments; continued investments by IAM leaders to their product strategy, marketing messaging, and technology innovation budgets to provide scalable IoT IAM solution; increasing partnership with IoT analytics and edge analytics platforms; growing popularity of next-generation of wireless technologies, such as LP-WAN, 5G, and Gigabit LTE; and such others. From a long-term trend perspective, IoT IAM market is expected to evolve towards an integrated IoT security solution to include the integrated solution for root-of-trust, device-centric identity and access management, end-to-end data security, comprehensive device visibility and granular access control, and such others. The IoT IAM researchby Quadrant Knowledge Solutions highlights that IoT IAM market is currently in the nascent stage with the presence of numerous traditional employee-centric IAM vendors as well as specialized IoT IAM providers. While a majority of these vendors often provide core functionalities for providing IAM solutions specific to IoT applications, the breadth and depth of these capabilities may differ significantly by different vendors offerings. Users should look for comprehensive device-centric IoT IAM solutions to support massive scalability requirements of IoT devices in the enterprise and industrial environment. "Device Authority KeyScaler platform offers a device-bound unified trust model by combining device and data security to meet the unified security requirements for critical IoT use cases. The platform provides robust functional capabilities to deploy and manage PKI for IoT devices at scale through automated device onboarding, zero-touch provisioning, authentication, credential management, and end-to-end policy data encryption," says Divya Baranawal, Research Director at Quadrant Knowledge Solutions. "Device Authority has received strong overall ratings against various performance parameters of technology excellence and customer impact and emerged as the technology leader in the 2020 SPARK Matrix analysis of the IoT IAM market," adds Baranawal. "We are delighted to be recognized by Quadrant Knowledge Solutions as a leader in the SPARK Matrix for the second year running, and exceptionally pleased to see our positioning has moved higher in the top quadrant," said Darron Antill, CEO at Device Authority. "As a leader we have always focused on the IoT market and developed technology which solves the challenges of security lifecycle management at IoT scale. Customers have deployed our KeyScaler platform in various industries including Healthcare, Industrial and Automotive, and we continue to help organizations on their IoT journey. Today's announcement solidifies the effort we have made to ensure our product is interoperable with leading IoT and security ecosystem partners such as Microsoft, PTC, nCipher Security and HID Global," he added. Additional Resources: Quadrant's Knowledge Brief: IoT IAM Market: Download here For more on KeyScaler Platform, please visit here About Device Authority Device Authority is a global leader in identity and access management (IAM) for the Internet of Things (IoT) and focuses on medical/healthcare, industrial, automotive and smart connected devices. Our KeyScaler platform provides trust for IoT devices and the IoT ecosystem to address the challenges of securing the Internet of Things. KeyScaler uses breakthrough technology, including Dynamic Device Key Generation (DDKG) and PKI Signature+ that delivers simplicity and trust to IoT devices. This solution delivers automated device provisioning, authentication, credential management, policy-based end-to-end data security/encryption and secure updates. With offices in Fremont, California, and Reading, UK, Device Authority partners with the leading IoT ecosystem providers, including AWS, DigiCert, Gemalto, HID Global, Microsoft, nCipher Security, PTC, Thales, Venafi, Wipro andmore. Keep updated by visitingwww.deviceauthority.com, following@DeviceAuthorityand subscribing to ourBrightTALK channel. About Quadrant Knowledge Solutions Quadrant Knowledge Solutions is a global advisory and consulting firm focused on helping clients in achieving business transformation goals with Strategic Business and Growth advisory services. At Quadrant Knowledge Solutions, our vision is to become an integral part of our client's business as a strategic knowledge partner. Our research and consulting deliverables are designed to provide comprehensive information and strategic insights for helping clients formulate growth strategies to survive and thrive in ever-changing business environments. For more available research, please visithttps://quadrant-solutions.com/market-research/ SOURCE Quadrant Knowledge Solutions
|
edtsum6695
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TORONTO--(BUSINESS WIRE)--Facedrive Inc. (Facedrive) (TSXV: FD), a Canadian people-and-planet first tech ecosystem, is pleased to announce that its food delivery vertical Facedrive Foods is expanding into the ethnic foods segment while also implementing new health and safety upgrades in response to burgeoning customer demand. Facedrive Foods continues to experience substantial growth, with orders exceeding 3,700 meal deliveries per day. Restaurant partners are now nearing 4,000 with over 220,000 active users registered on a platform that is now operational in 19 cities across Canada including Toronto, Montreal, Ottawa, Winnipeg, Kingston, London, Edmonton and Halifax, and with expansion plans to other cities in Canada and the USA anticipated soon. Facedrive Foods has capitalized on the dramatic shift in commerce patterns and consumer behavior in the wake of the pandemic. As storefronts and restaurants have limited their offerings to take out or delivery service exclusively, volumes of orders made through online on-demand food delivery platforms have soared. At the same time, the ethnically diverse North American market continues to demonstrate strong demand for authentic national cuisines. The tandem of these two trends has played strongly into the Facedrive Foods playbook and ambitious expansion plans. Facedrive Foods strategic expansion to ethnic foods segment is based on the popularity of ethnic cuisines and to increase customer access to authentic ethnic food, which is currently lacking in the market. Furthermore, Facedrive Foods is introducing a number of health and safety upgrades aimed at enhancing user health, safety and confidence as the second wave of the COVID-19 pandemic intensifies. One key safety precaution that has been rolled out throughout the Facedrive Foods platform is in-app temperature display. This function allows customers to see body temperature of the driver delivering their order and automatically disables drivers who exhibit above normal body temperatures. Another fundamental addition to the Facedrive Foods offering will be the integration of Facedrives proprietary TraceSCAN product, a standalone contact-tracing wearable solution built on cutting-edge Bluetooth technology and enabling functionality such as contact-tracing and social distancing alerts. Facedrive Foods will be the first food delivery platform to implement contact-tracing technology as a part of its COVID-19 prevention protocol. By Q1 2021, Facedrive Foods expects integration with TraceSCAN to be completed and for all Facedrive Foods drivers to be donning TraceSCAN wearables. We are thrilled to be expanding into the ethnic market to better serve the growing needs of our customers, said Di Han, General Manager of Facedrive Foods. We are also excited to implement in-app temperature readings as well as the TraceSCAN technology suite to ensure the safety of our drivers, customers, or restaurant workers. In this current situation, complying with stringent safety protocols is the only way to support restaurants and for our consumers to have peace of mind when using our delivery services. As such, health safety continues to be a critical element of our day-to-day operations and future outlook, added Han. About Facedrive Facedrive is a multi-faceted people-and-planet first tech ecosystem offering socially-responsible services to local communities with a strong commitment to doing business fairly, equitably and sustainably. As part of this commitment, Facedrives vision is to fulfil its mandate through a number of verticals that either leverage existing technologies of the Company or project synergies with existing lines of business (the Facedrive Verticals). The Facedrive Verticals include its rideshare business (Facedrive Rideshare), sustainable e-commerce platform (Facedrive Marketplace), food-delivery service (Facedrive Foods), e-social platform (Facedrive Social) and its contact-tracing and sustainable health services business (Facedrive Health). Facedrive Rideshare was among the first to offer a wide variety of environmentally and socially responsible solutions in the Transportation as a Service (TaaS) space, planting thousands of trees based on user consumption and offering choices between electric, hybrid and conventional vehicles (including, more recently, electric and hybrid vehicles on a subscription basis through Steer). Facedrive Marketplace offers curated merchandise created from sustainably sourced materials. Facedrive Foods offers contactless delivery of a wide variety of foods right to consumers doorsteps, with a focus on doing so in a socially and environmentally-conscious manner. Facedrive Social strives to keep people connected in a physically-distanced world through its HiQ and other e-socialization platforms that invite users to interact based on common interests and by offering gamification and mutual community support features. Facedrive Health strives to develop and offer innovative technological solutions to the most acute health challenges including its proprietary TraceSCAN wearable technology for contact tracing. Facedrive envisions changing the ridesharing, food delivery, e-commerce, social and health tech narratives for the better, for everyone, and is currently operational in Canada and the United States. For more about Facedrive, visit www.facedrive.com. Facedrive Inc. 100 Consilium Pl, Unit 400, Scarborough, ON, Canada M1H 3E3 www.facedrive.com Forward-Looking Statements Certain information in this press release contains forward-looking information. This information is based on managements reasonable assumptions and beliefs in light of the information currently available to us and are made as of the date of this press release. Actual results and the timing of events, such as those pertaining to the platform-wide rollout of the new TraceSCAN technology, may differ materially from those anticipated in the forward-looking information as a result of various factors. Information regarding our expectations of future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information. Statements containing forward-looking information are not facts but instead represent managements expectations, estimates and projections regarding future events or circumstances. Many factors could cause our actual results, level of activity, performance or achievements or future events or developments to differ materially from those expressed or implied by the forward-looking statements. See Forward-Looking Information and Risk Factors in the Corporations Filing Statement dated August 28, 2019 for a discussion of the uncertainties, risks and assumptions associated with these statements. Readers are urged to consider the uncertainties, risks and assumptions carefully in evaluating the forward-looking information and are cautioned not to place undue reliance on such information. We have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Answer:
|
Facedrive Foods Continues on Growth Trajectory, Expanding Into Ethnic Foods Segment and Enhancing Health & Safety Measures
|
TORONTO--(BUSINESS WIRE)--Facedrive Inc. (Facedrive) (TSXV: FD), a Canadian people-and-planet first tech ecosystem, is pleased to announce that its food delivery vertical Facedrive Foods is expanding into the ethnic foods segment while also implementing new health and safety upgrades in response to burgeoning customer demand. Facedrive Foods continues to experience substantial growth, with orders exceeding 3,700 meal deliveries per day. Restaurant partners are now nearing 4,000 with over 220,000 active users registered on a platform that is now operational in 19 cities across Canada including Toronto, Montreal, Ottawa, Winnipeg, Kingston, London, Edmonton and Halifax, and with expansion plans to other cities in Canada and the USA anticipated soon. Facedrive Foods has capitalized on the dramatic shift in commerce patterns and consumer behavior in the wake of the pandemic. As storefronts and restaurants have limited their offerings to take out or delivery service exclusively, volumes of orders made through online on-demand food delivery platforms have soared. At the same time, the ethnically diverse North American market continues to demonstrate strong demand for authentic national cuisines. The tandem of these two trends has played strongly into the Facedrive Foods playbook and ambitious expansion plans. Facedrive Foods strategic expansion to ethnic foods segment is based on the popularity of ethnic cuisines and to increase customer access to authentic ethnic food, which is currently lacking in the market. Furthermore, Facedrive Foods is introducing a number of health and safety upgrades aimed at enhancing user health, safety and confidence as the second wave of the COVID-19 pandemic intensifies. One key safety precaution that has been rolled out throughout the Facedrive Foods platform is in-app temperature display. This function allows customers to see body temperature of the driver delivering their order and automatically disables drivers who exhibit above normal body temperatures. Another fundamental addition to the Facedrive Foods offering will be the integration of Facedrives proprietary TraceSCAN product, a standalone contact-tracing wearable solution built on cutting-edge Bluetooth technology and enabling functionality such as contact-tracing and social distancing alerts. Facedrive Foods will be the first food delivery platform to implement contact-tracing technology as a part of its COVID-19 prevention protocol. By Q1 2021, Facedrive Foods expects integration with TraceSCAN to be completed and for all Facedrive Foods drivers to be donning TraceSCAN wearables. We are thrilled to be expanding into the ethnic market to better serve the growing needs of our customers, said Di Han, General Manager of Facedrive Foods. We are also excited to implement in-app temperature readings as well as the TraceSCAN technology suite to ensure the safety of our drivers, customers, or restaurant workers. In this current situation, complying with stringent safety protocols is the only way to support restaurants and for our consumers to have peace of mind when using our delivery services. As such, health safety continues to be a critical element of our day-to-day operations and future outlook, added Han. About Facedrive Facedrive is a multi-faceted people-and-planet first tech ecosystem offering socially-responsible services to local communities with a strong commitment to doing business fairly, equitably and sustainably. As part of this commitment, Facedrives vision is to fulfil its mandate through a number of verticals that either leverage existing technologies of the Company or project synergies with existing lines of business (the Facedrive Verticals). The Facedrive Verticals include its rideshare business (Facedrive Rideshare), sustainable e-commerce platform (Facedrive Marketplace), food-delivery service (Facedrive Foods), e-social platform (Facedrive Social) and its contact-tracing and sustainable health services business (Facedrive Health). Facedrive Rideshare was among the first to offer a wide variety of environmentally and socially responsible solutions in the Transportation as a Service (TaaS) space, planting thousands of trees based on user consumption and offering choices between electric, hybrid and conventional vehicles (including, more recently, electric and hybrid vehicles on a subscription basis through Steer). Facedrive Marketplace offers curated merchandise created from sustainably sourced materials. Facedrive Foods offers contactless delivery of a wide variety of foods right to consumers doorsteps, with a focus on doing so in a socially and environmentally-conscious manner. Facedrive Social strives to keep people connected in a physically-distanced world through its HiQ and other e-socialization platforms that invite users to interact based on common interests and by offering gamification and mutual community support features. Facedrive Health strives to develop and offer innovative technological solutions to the most acute health challenges including its proprietary TraceSCAN wearable technology for contact tracing. Facedrive envisions changing the ridesharing, food delivery, e-commerce, social and health tech narratives for the better, for everyone, and is currently operational in Canada and the United States. For more about Facedrive, visit www.facedrive.com. Facedrive Inc. 100 Consilium Pl, Unit 400, Scarborough, ON, Canada M1H 3E3 www.facedrive.com Forward-Looking Statements Certain information in this press release contains forward-looking information. This information is based on managements reasonable assumptions and beliefs in light of the information currently available to us and are made as of the date of this press release. Actual results and the timing of events, such as those pertaining to the platform-wide rollout of the new TraceSCAN technology, may differ materially from those anticipated in the forward-looking information as a result of various factors. Information regarding our expectations of future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information. Statements containing forward-looking information are not facts but instead represent managements expectations, estimates and projections regarding future events or circumstances. Many factors could cause our actual results, level of activity, performance or achievements or future events or developments to differ materially from those expressed or implied by the forward-looking statements. See Forward-Looking Information and Risk Factors in the Corporations Filing Statement dated August 28, 2019 for a discussion of the uncertainties, risks and assumptions associated with these statements. Readers are urged to consider the uncertainties, risks and assumptions carefully in evaluating the forward-looking information and are cautioned not to place undue reliance on such information. We have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
|
edtsum6698
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MEXICO CITY, April 26, 2021 /PRNewswire/ --Grupo LALA, S.A.B. de C.V., a Mexican Company focused on healthy and nutritious foods, ("LALA") (BMV: LALAB), today reported results for the first quarter of 2021. The following information has been presented based on International Financial Reporting Standards (IFRS) and in nominal terms. Quarter Highlights: +5.7% YOY increase in constant currency sales driven by Mexico and Brazil 10.5% consolidated EBITDA margin; +110 bps YOY improvement 12.8% reported EBITDA margin for Mexico; +180 bps YOY increase $519 m in Net Income; +130 bps net margin improvement YOY -0.8% Consolidated Working Capital; a -110 bps YOY improvement Leverage ratio: reported 3.0x Net Debt / EBITDA ESG Operating Committee created The following chart provides an abridged Income Statement, in millions of pesos. The margin for each figure represents its ratio to net sales for the quarter and the year ended on March 31, 2021 as compared to the same period in 2020. MXN$ in millions Q1'20 % Sales Q1'21 % Sales Var. % Var. bps Net Sales 19,405 100% 20,043 100% 3.3% Gross Profit 6,389 32.9% 6,681 33.3% 4.6% 40 bps Operating Income 1,045 5.4% 1,322 6.6% 26.4% 120 bps EBITDA(1) 1,831 9.4% 2,103 10.5% 14.9% 110 bps Net Income 258 1.3% 519 2.6% 100.8% 130 bps (1) EBITDA is defined as operating income before depreciation and amortization. MESSAGE FROM MANAGEMENT Arqumedes Celis, Grupo LALA's CEO, commented: "We began the year with continued strong performance despite COVID headwinds in certain markets, underscoring the particular resilience of LALA's Mexico business to drive growth, profitability, and enable us to further deleverage. Our differentiated results prove the strength of our business model, the value of our products and brands, and our capabilities as a company, reflected in sustained improvement in operational and financial metrics on a consolidated basis. The breadth and reach of our portfolio differentiate LALA, enabling us to swiftly leverage our omnichannel access to capitalize on ever-evolving consumer behaviors and preferences particularly at-home categories. As the world gradually transitions to a post-COVID era with each region progressing at its own pace the successful execution of our strategies will continue to drive long-term sustainable growth. Further, we remain focused on safeguarding our employees and partners to ensure consumers' seamless access to nutritious and affordable high-quality products." He continued, "We have also taken important steps to strengthen our environmental, governance, and social practices (ESG). Therefore, LALA's fundamentals, momentum and growth outlook remain strong. Our operational capabilities and our focus on performance, talent and on our quality product offering, enable us to drive future growth and build long-term value for our stakeholders." Please click on the following link for a PDF file containing the full text of the press release: http://www.lala.com.mx/en/wp-content/uploads/sites/9/2021/04/Earnings-Release-Q121-v5-1.pdf Please click on the following link for a PDF file containing the full text of the press release in Spanish: http://www.lala.com.mx/wp-content/uploads/2021/04/Reporte-Resultados-T121-v4-1.pdf CONFERENCE CALL Tuesday April 27, 2021, at 11:00am EST / 10:00am CST Led by: Arqumedes Celis (CEO), Alberto Arellano (CFO) and David Gonzlez (IRO) Webcast: http://public.viavid.com/index.php?id=144328 To participate, please dial-in ten minutes ahead of the scheduled time. Mexico: 01 800 522 0034 United States: +1 877 705 6003 (Toll-free) International: +1 201 493 6725 To access the replay service (7 days), please dial: United States: +1 844 512 2921 (Toll-free) International: +1 412 317 6671 PIN #: 13718668 CONTACT INVESTOR RELATIONS David Gonzlez Pelez and Israel Rentera, CFA Tel.: +52 (55) 3993 7193 [emailprotected] SOURCE Grupo LALA, S.A.B. de C.V.
Answer:
|
Grupo LALA Reports First Quarter 2021 Results
|
MEXICO CITY, April 26, 2021 /PRNewswire/ --Grupo LALA, S.A.B. de C.V., a Mexican Company focused on healthy and nutritious foods, ("LALA") (BMV: LALAB), today reported results for the first quarter of 2021. The following information has been presented based on International Financial Reporting Standards (IFRS) and in nominal terms. Quarter Highlights: +5.7% YOY increase in constant currency sales driven by Mexico and Brazil 10.5% consolidated EBITDA margin; +110 bps YOY improvement 12.8% reported EBITDA margin for Mexico; +180 bps YOY increase $519 m in Net Income; +130 bps net margin improvement YOY -0.8% Consolidated Working Capital; a -110 bps YOY improvement Leverage ratio: reported 3.0x Net Debt / EBITDA ESG Operating Committee created The following chart provides an abridged Income Statement, in millions of pesos. The margin for each figure represents its ratio to net sales for the quarter and the year ended on March 31, 2021 as compared to the same period in 2020. MXN$ in millions Q1'20 % Sales Q1'21 % Sales Var. % Var. bps Net Sales 19,405 100% 20,043 100% 3.3% Gross Profit 6,389 32.9% 6,681 33.3% 4.6% 40 bps Operating Income 1,045 5.4% 1,322 6.6% 26.4% 120 bps EBITDA(1) 1,831 9.4% 2,103 10.5% 14.9% 110 bps Net Income 258 1.3% 519 2.6% 100.8% 130 bps (1) EBITDA is defined as operating income before depreciation and amortization. MESSAGE FROM MANAGEMENT Arqumedes Celis, Grupo LALA's CEO, commented: "We began the year with continued strong performance despite COVID headwinds in certain markets, underscoring the particular resilience of LALA's Mexico business to drive growth, profitability, and enable us to further deleverage. Our differentiated results prove the strength of our business model, the value of our products and brands, and our capabilities as a company, reflected in sustained improvement in operational and financial metrics on a consolidated basis. The breadth and reach of our portfolio differentiate LALA, enabling us to swiftly leverage our omnichannel access to capitalize on ever-evolving consumer behaviors and preferences particularly at-home categories. As the world gradually transitions to a post-COVID era with each region progressing at its own pace the successful execution of our strategies will continue to drive long-term sustainable growth. Further, we remain focused on safeguarding our employees and partners to ensure consumers' seamless access to nutritious and affordable high-quality products." He continued, "We have also taken important steps to strengthen our environmental, governance, and social practices (ESG). Therefore, LALA's fundamentals, momentum and growth outlook remain strong. Our operational capabilities and our focus on performance, talent and on our quality product offering, enable us to drive future growth and build long-term value for our stakeholders." Please click on the following link for a PDF file containing the full text of the press release: http://www.lala.com.mx/en/wp-content/uploads/sites/9/2021/04/Earnings-Release-Q121-v5-1.pdf Please click on the following link for a PDF file containing the full text of the press release in Spanish: http://www.lala.com.mx/wp-content/uploads/2021/04/Reporte-Resultados-T121-v4-1.pdf CONFERENCE CALL Tuesday April 27, 2021, at 11:00am EST / 10:00am CST Led by: Arqumedes Celis (CEO), Alberto Arellano (CFO) and David Gonzlez (IRO) Webcast: http://public.viavid.com/index.php?id=144328 To participate, please dial-in ten minutes ahead of the scheduled time. Mexico: 01 800 522 0034 United States: +1 877 705 6003 (Toll-free) International: +1 201 493 6725 To access the replay service (7 days), please dial: United States: +1 844 512 2921 (Toll-free) International: +1 412 317 6671 PIN #: 13718668 CONTACT INVESTOR RELATIONS David Gonzlez Pelez and Israel Rentera, CFA Tel.: +52 (55) 3993 7193 [emailprotected] SOURCE Grupo LALA, S.A.B. de C.V.
|
edtsum6708
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON, March 24, 2020 /PRNewswire/ --Streetify(https://www.streetify.com), a new global shopping platform, is supporting government efforts around the globe to save local businesses during coronavirus-related lockdown orders. In this time of social distancing, brick-and-mortar shop owners are relying on takeaway and curbside delivery purchases, as well as online sales, to survive. On Streetify's virtual shopping boulevards, business owners can easily put messages in their storefront windows announcing deals, new hours, delivery options, what goods they have in stock, and more -- all for free for the year. Streetify provides virtual stores for every business' website, replicating the shopping experience but without the risk. Shoppers find out which shops are open, pre-order items for pick-up, or arrange for delivery, all from the safety of their homes. It is available free throughout the U.S., Canada, U.K., India and Australia as a website and free app for both iOS and Android, and will be rolling out elsewhere this year. "Since launching Streetify last week, we have now transformed over five million local stores and national websites into virtual stores so firms and consumers can respond to the difficult circumstances we find ourselves in," said founder Martin Banbury. "We hope many businesses and jobs can be saved with this new technology." Streetify has the most voucher codes, cashbacks and coupons of any online platform, searching over 50 top sites, like Groupon, Rakuten and Honey, for deals. It puts checked deal site links in store windows, after any store owner's messages. With Google and a couple of taps, consumers effortlessly create and organize multiple personalized avenues comprising their favorite stores.Choices can be shared via social media, and shoppers can even follow famous celebrities, buying from their favorite storesand sponsors. To enhance the feeling of realism, Streetify is geo-referenced so at night, the lights come on, and if it's raining in the real world, it will rain in the Streetify one, and so on. For more information, including for investors, visit Streetify.com (https://www.streetify.com). MEDIA CONTACTSDebbie Koke, [emailprotected] Martin Stein, [emailprotected]Orca Communications SOURCE Streetify Related Links http://www.streetify.com
Answer:
|
Every Shopping Street and Mall Goes Virtual, with Streetify
|
LONDON, March 24, 2020 /PRNewswire/ --Streetify(https://www.streetify.com), a new global shopping platform, is supporting government efforts around the globe to save local businesses during coronavirus-related lockdown orders. In this time of social distancing, brick-and-mortar shop owners are relying on takeaway and curbside delivery purchases, as well as online sales, to survive. On Streetify's virtual shopping boulevards, business owners can easily put messages in their storefront windows announcing deals, new hours, delivery options, what goods they have in stock, and more -- all for free for the year. Streetify provides virtual stores for every business' website, replicating the shopping experience but without the risk. Shoppers find out which shops are open, pre-order items for pick-up, or arrange for delivery, all from the safety of their homes. It is available free throughout the U.S., Canada, U.K., India and Australia as a website and free app for both iOS and Android, and will be rolling out elsewhere this year. "Since launching Streetify last week, we have now transformed over five million local stores and national websites into virtual stores so firms and consumers can respond to the difficult circumstances we find ourselves in," said founder Martin Banbury. "We hope many businesses and jobs can be saved with this new technology." Streetify has the most voucher codes, cashbacks and coupons of any online platform, searching over 50 top sites, like Groupon, Rakuten and Honey, for deals. It puts checked deal site links in store windows, after any store owner's messages. With Google and a couple of taps, consumers effortlessly create and organize multiple personalized avenues comprising their favorite stores.Choices can be shared via social media, and shoppers can even follow famous celebrities, buying from their favorite storesand sponsors. To enhance the feeling of realism, Streetify is geo-referenced so at night, the lights come on, and if it's raining in the real world, it will rain in the Streetify one, and so on. For more information, including for investors, visit Streetify.com (https://www.streetify.com). MEDIA CONTACTSDebbie Koke, [emailprotected] Martin Stein, [emailprotected]Orca Communications SOURCE Streetify Related Links http://www.streetify.com
|
edtsum6719
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK and CHICAGO, Dec. 9, 2020 /PRNewswire/ --Vestwell, the digital recordkeeping platform bringing the 401(k) and 403(b) industry into the modern Fintech era, today announced a partnership with Envestnet, Inc. (NYSE: ENV). (PRNewsfoto/Vestwell,Envestnet Retirement Solutions) Through this collaboration, Vestwell advisors can now access Envestnet's 3(38) investment management services, through Envestnet Retirement Solutions, LLC, to provide clients with a true turnkey solution. Over time the relationship will expand to include other Envestnet offerings, helping bring advisors closer to their clients while helping them further differentiate through greater customization. As the 3(38) investment manager, Envestnet will provide plan-level fiduciary services for Vestwell, which will handle recordkeeping and administration through its API-driven platform. Together, the tech-first providers will make it easier for advisors to effectively scale while focusing their attention on participation and outcomes for 401(k) plan provider clients versus set-up and implementation. "At Envestnet, we are dedicated to partnering with industry leaders like Vestwell to further the evolution of the art of recordkeeping for retirement plans, and to help advisors improve outcomes for plan participants," said Khash Sarrafi, Senior Vice President, Envestnet Retirement Solutions. "Our fiduciary 3(38) capabilities, powered by Envestnet | PMC, combined with Vestwell's transformative recordkeeping platform, will provide more advisors with the support they deserve to effectively and efficiently sell into, and service, small and medium-sized businesses. This is the latest step forward in our ongoing commitment to expand the essential advice which helps clients achieve financial wellnessand lays the groundwork for scalable practice growth."Both Vestwell and Envestnet are transforming the way financial advisors are running their businesses through the effective use of technology. The partnership unites the companies in their efforts to streamline retirement plan services, data aggregation, plan benchmarking, and investment selection and oversight."As we strive towards closing the retirement-savings gap, our efforts are hyper-focused on how we can help financial advisors more efficiently serve their clients," said Vestwell CEO Aaron Schumm. "We are thrilled to be partnering with Envestnet, which shares our mission to empower advisors to succeed through innovative technology. We look forward to continuing to broaden our partnership with Envestnet to offer advisors an expanded suite of retirement services."About Vestwell Vestwell is the digital recordkeeping platform bringing the 401(k) and 403(b) industry into the modern Fintech era. We have rearchitected the workplace retirement offering from the ground up and built an engine to power the $30T industry. Our customizable, open architecture, and white-labeled platform becomes a natural extension of financial services and payroll partners, while removing traditional friction points plaguing legacy recordkeeping. The result is an easier, more efficient, and all-around better experience for everyone, delivered at a fraction of the cost. Learn more at Vestwell.com and on Twitter @Vestwell.About EnvestnetEnvestnet, Inc. (NYSE: ENV) is transforming the way financial advice and wellness are delivered. Our mission is to empower advisors and financial service providers with innovative technology, solutions, and intelligence to make financial wellness a reality for everyone. Over 105,000 advisors across more than 5,100 companiesincluding 17 of the 20 largest U.S. banks, 47 of the 50 largest wealth management and brokerage firms, over 500 of the largest RIAs, and hundreds of Fintech companiesleverage the Envestnet platform to grow their businesses and client relationships.For more information on Envestnet, please visit www.envestnet.com, subscribe to our blog, and follow us on Twitter (@ENVintel) and LinkedIn. Vestwell and Envestnet are separate and unaffiliated firms, and are not responsible for each other's services or policies. This release should not be construed as a recommendation or endorsement of any particular product, service, or firm.Media ContactsDana TaorminaJConnelly for Envestnet973.647.4626[emailprotected]Abbey YvonVestwell917.979.5358[emailprotected]SOURCE Envestnet Retirement Solutions; Vestwell
Answer:
|
Vestwell Partners with Envestnet to Offer Turnkey Retirement Plan Solutions to Industry Advisors New offering leverages technology to help advisors deliver efficient 401(k) plan investment-management solutions across diverse client needs
|
NEW YORK and CHICAGO, Dec. 9, 2020 /PRNewswire/ --Vestwell, the digital recordkeeping platform bringing the 401(k) and 403(b) industry into the modern Fintech era, today announced a partnership with Envestnet, Inc. (NYSE: ENV). (PRNewsfoto/Vestwell,Envestnet Retirement Solutions) Through this collaboration, Vestwell advisors can now access Envestnet's 3(38) investment management services, through Envestnet Retirement Solutions, LLC, to provide clients with a true turnkey solution. Over time the relationship will expand to include other Envestnet offerings, helping bring advisors closer to their clients while helping them further differentiate through greater customization. As the 3(38) investment manager, Envestnet will provide plan-level fiduciary services for Vestwell, which will handle recordkeeping and administration through its API-driven platform. Together, the tech-first providers will make it easier for advisors to effectively scale while focusing their attention on participation and outcomes for 401(k) plan provider clients versus set-up and implementation. "At Envestnet, we are dedicated to partnering with industry leaders like Vestwell to further the evolution of the art of recordkeeping for retirement plans, and to help advisors improve outcomes for plan participants," said Khash Sarrafi, Senior Vice President, Envestnet Retirement Solutions. "Our fiduciary 3(38) capabilities, powered by Envestnet | PMC, combined with Vestwell's transformative recordkeeping platform, will provide more advisors with the support they deserve to effectively and efficiently sell into, and service, small and medium-sized businesses. This is the latest step forward in our ongoing commitment to expand the essential advice which helps clients achieve financial wellnessand lays the groundwork for scalable practice growth."Both Vestwell and Envestnet are transforming the way financial advisors are running their businesses through the effective use of technology. The partnership unites the companies in their efforts to streamline retirement plan services, data aggregation, plan benchmarking, and investment selection and oversight."As we strive towards closing the retirement-savings gap, our efforts are hyper-focused on how we can help financial advisors more efficiently serve their clients," said Vestwell CEO Aaron Schumm. "We are thrilled to be partnering with Envestnet, which shares our mission to empower advisors to succeed through innovative technology. We look forward to continuing to broaden our partnership with Envestnet to offer advisors an expanded suite of retirement services."About Vestwell Vestwell is the digital recordkeeping platform bringing the 401(k) and 403(b) industry into the modern Fintech era. We have rearchitected the workplace retirement offering from the ground up and built an engine to power the $30T industry. Our customizable, open architecture, and white-labeled platform becomes a natural extension of financial services and payroll partners, while removing traditional friction points plaguing legacy recordkeeping. The result is an easier, more efficient, and all-around better experience for everyone, delivered at a fraction of the cost. Learn more at Vestwell.com and on Twitter @Vestwell.About EnvestnetEnvestnet, Inc. (NYSE: ENV) is transforming the way financial advice and wellness are delivered. Our mission is to empower advisors and financial service providers with innovative technology, solutions, and intelligence to make financial wellness a reality for everyone. Over 105,000 advisors across more than 5,100 companiesincluding 17 of the 20 largest U.S. banks, 47 of the 50 largest wealth management and brokerage firms, over 500 of the largest RIAs, and hundreds of Fintech companiesleverage the Envestnet platform to grow their businesses and client relationships.For more information on Envestnet, please visit www.envestnet.com, subscribe to our blog, and follow us on Twitter (@ENVintel) and LinkedIn. Vestwell and Envestnet are separate and unaffiliated firms, and are not responsible for each other's services or policies. This release should not be construed as a recommendation or endorsement of any particular product, service, or firm.Media ContactsDana TaorminaJConnelly for Envestnet973.647.4626[emailprotected]Abbey YvonVestwell917.979.5358[emailprotected]SOURCE Envestnet Retirement Solutions; Vestwell
|
edtsum6726
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, May 27, 2020 /PRNewswire/ -- Exantas Capital Corp. (NYSE: XAN) (the "Company") announced today that due to the ongoing public health impact of the coronavirus (COVID-19) pandemic and to protect the safety of participants, the Annual Meeting of Stockholders to be held on Wednesday, June 10, 2020 (the "Annual Meeting"), will be held at 11:00 a.m. (Eastern Time) in a virtual meeting format only. Stockholders will not be able to attend the Annual Meeting in person. To be admitted to the annual meeting at www.virtualshareholdermeeting.com/XAN2020, stockholders must enter the control number found on their proxy card, voting instruction form or notice previously received. Stockholders are encouraged to access the annual meeting prior to the start time to leave ample time for check in. As described in the proxy materials for the Annual Meeting previously distributed, stockholders are entitled to participate in the Annual Meeting if they were a stockholder of the Company as of the close of business on April 17, 2020, the record date, or hold a legal proxy for the meeting provided by its bank, broker or nominee. Regardless of whether you plan to attend the Annual Meeting, we recommend that you vote and submit your proxy in advance of the Annual Meeting by one of the methods described in the proxy materials for the Annual Meeting. The proxy card or voting instruction form included with the proxy materials that were previously distributed to you will not be updated to reflect the change in location and may continue to be used to vote your shares in connection with the Annual Meeting. About Exantas Capital Corp. Exantas Capital Corp. is a real estate investment trust that is primarily focused on originating, holding and managing commercial real estate mortgage loans and other commercial real estate-related debt investments. The Company is externally managed by Exantas Capital Manager Inc., which is an indirect wholly-owned subsidiary ofC-III Capital Partners LLC, a leading commercial real estate investment management and services company engaged in a broad range of activities. For more information, please visit the Company's website atwww.exantas.comor contact investor relations at[emailprotected]. Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as "may," "trend," "will," "continue," "expect," "intend," "anticipate," "estimate," "believe," "look forward" or other similar words or terms. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from the expectations, intentions, beliefs, plans or predictions of the future expressed or implied by such forward-looking statements. Factors that can affect future results are discussed in the documents filed bythe Companyfrom time to time with theSecurities and Exchange Commission.The Companyundertakes no obligation to update or revise any forward-looking statement to reflect new or changing information or events after the date hereof or to reflect the occurrence of unanticipated events, except as may be required by law. SOURCE Exantas Capital Corp. Related Links http://www.exantas.com
Answer:
|
Exantas Capital Corp. Moves 2020 Annual Meeting of Stockholders to Virtual-Only Format
|
NEW YORK, May 27, 2020 /PRNewswire/ -- Exantas Capital Corp. (NYSE: XAN) (the "Company") announced today that due to the ongoing public health impact of the coronavirus (COVID-19) pandemic and to protect the safety of participants, the Annual Meeting of Stockholders to be held on Wednesday, June 10, 2020 (the "Annual Meeting"), will be held at 11:00 a.m. (Eastern Time) in a virtual meeting format only. Stockholders will not be able to attend the Annual Meeting in person. To be admitted to the annual meeting at www.virtualshareholdermeeting.com/XAN2020, stockholders must enter the control number found on their proxy card, voting instruction form or notice previously received. Stockholders are encouraged to access the annual meeting prior to the start time to leave ample time for check in. As described in the proxy materials for the Annual Meeting previously distributed, stockholders are entitled to participate in the Annual Meeting if they were a stockholder of the Company as of the close of business on April 17, 2020, the record date, or hold a legal proxy for the meeting provided by its bank, broker or nominee. Regardless of whether you plan to attend the Annual Meeting, we recommend that you vote and submit your proxy in advance of the Annual Meeting by one of the methods described in the proxy materials for the Annual Meeting. The proxy card or voting instruction form included with the proxy materials that were previously distributed to you will not be updated to reflect the change in location and may continue to be used to vote your shares in connection with the Annual Meeting. About Exantas Capital Corp. Exantas Capital Corp. is a real estate investment trust that is primarily focused on originating, holding and managing commercial real estate mortgage loans and other commercial real estate-related debt investments. The Company is externally managed by Exantas Capital Manager Inc., which is an indirect wholly-owned subsidiary ofC-III Capital Partners LLC, a leading commercial real estate investment management and services company engaged in a broad range of activities. For more information, please visit the Company's website atwww.exantas.comor contact investor relations at[emailprotected]. Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as "may," "trend," "will," "continue," "expect," "intend," "anticipate," "estimate," "believe," "look forward" or other similar words or terms. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from the expectations, intentions, beliefs, plans or predictions of the future expressed or implied by such forward-looking statements. Factors that can affect future results are discussed in the documents filed bythe Companyfrom time to time with theSecurities and Exchange Commission.The Companyundertakes no obligation to update or revise any forward-looking statement to reflect new or changing information or events after the date hereof or to reflect the occurrence of unanticipated events, except as may be required by law. SOURCE Exantas Capital Corp. Related Links http://www.exantas.com
|
edtsum6737
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: OKAYAMA, Japan, March 17, 2020 /PRNewswire/ -- Researchers at Okayama University have recently published a study in Cells in which they reduced the size of oral cancer tumors by damaging the blood vessels surrounding the tumor cells. Cancer cells have ingenious mechanisms of survival within the body. One strategy they adopt is developing a network of blood vessels around themselves as a source of blood supply. Scientists have long been investigating ways to prevent this blood flow to cancer cells. CXCR4 is a protein known to be closely involved with tumor growth. However, its exact role in tumor progression is unclear. A research team led by Assistant Professor KAWAI Hotaka and YOSHIDA Saori (graduate student, D.D.S.), Assistant Professor EGUCHI Takanori at Okayama University has now shown that CXCR4 is the main culprit maintaining the arrangement of tumor blood vessels. Firstly they found, immunohistochemistry on human clinical specimens revealed that tumor vesselsexpressed CXCR4 in human oral cancer specimens.The next question to arise was whether the CXCR4-rich blood vessels were promoting tumor growth. In order to investigate this further, the oral cancer cells were transplanted into mice. Once the tumor growed in mice body, they were given AMD3100a drug that antagonises CXCR4. When the tumors were subsequently observed under a microscope, several areas were found to necrotic. A characteristic pattern of necrosis was observed in which the tumor tissue that were at a distance away from the blood vessel was necrotic, leaving the tumor tissue close to the periphery of the blood vessel. This randomized pattern of tumor cell death was termed 'tumor angiogenic inhibition triggered necrosis' (TAITN) by the researchers. The widearea of tumor tissuealso showed a severe lack of oxygen which was accompanied by an impairment of angiogenesis. CXCR4 inhibition thus seemed to induce tumor necrosis by damaging the blood vessels and preventing the cells of a healthy oxygen supply. This study is the first to show the role of CXCR4 in promoting tumor growth by supplying cancer cells with a healthy, organized network of blood vessels. Strategies that can disrupt this network can be explored further as anti-cancer therapies. "CXCR4 plays a crucial role in tumor angiogenesis required for OSCC progression, whereas TAITN induced by CXCR4 antagonism could be an effective anti-angiogenic therapeutic strategy in OSCC treatment," concludes the team. Background CXCR4: CXCR4 is a protein vital in maintaining and growing the cells that produce blood within our body. In fetuses, CXCR4 is also responsible for the formation of certain blood vessels. Incidentally, CXCR4 is also present in various forms of cancers such as breast, liver, and oral cancer. Often, tumors which show the presence of CXCR4 tend to grow faster that those without. Given its link with blood vessels and cancer progression, the research team from Okayama University sought out to investigate whether CXCR4 directly promotes cancer growth by supplying tumors with blood. Reference Saori Yoshida, Hotaka Kawai*, Takanori Eguchi*, Shintaro Sukegawa, May Wathone Oo, Chang Anqi, Kiyofumi Takabatake, Keisuke Nakano, Kuniaki Okamoto, Hitoshi Nagatsuka. Tumor Angiogenic Inhibition Triggered Necrosis (TAITN) in Oral Cancer. Cell, 2019, 8(7), 761. DOI : 10.3390/cells8070761 https://www.mdpi.com/2073-4409/8/7/761 Correspondence to Assistant ProfessorKAWAI Hotaka, D.D.S.,Ph.D.Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Science,Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanE-mail: [emailprotected] Website: http://www.okayama-u.ac.jp/index_e.htmlOkayama Univ. e-Bulletin: http://www.okayama-u.ac.jp/user/kouhou/ebulletin/ Okayama University Medical Research UpdatesOU-MRU The whole volume : OU-MRU (1- )Vol.1Innovative non-invasive 'liquid biopsy' method to capture circulating tumor cells from blood samples for genetic testingVol.77Green leafy vegetables contain a compound which can fight cancer cells About Okayama University Okayama University is one of the largest comprehensive universities in Japan withroots going back to the Medical Training Place sponsored by the Lord of Okayama and established in 1870. Now with 1,300 faculty and 13,000 students, the University offers courses in specialties ranging from medicine and pharmacy to humanities and physical sciences. Okayama University is located in the heart of Japan approximately 3 hours west of Tokyo by Shinkansen. Website: http://www.okayama-u.ac.jp/index_e.html Further information Okayama University1-1-1 Tsushima-naka , Kita-ku , Okayama 700-8530, JapanPublic Relations DivisionE-mail: [emailprotected] SOURCE Okayama University
Answer:
|
Okayama University Research: Disrupting Blood Supply to Tumors as a New Strategy to Treat Oral Cancer
|
OKAYAMA, Japan, March 17, 2020 /PRNewswire/ -- Researchers at Okayama University have recently published a study in Cells in which they reduced the size of oral cancer tumors by damaging the blood vessels surrounding the tumor cells. Cancer cells have ingenious mechanisms of survival within the body. One strategy they adopt is developing a network of blood vessels around themselves as a source of blood supply. Scientists have long been investigating ways to prevent this blood flow to cancer cells. CXCR4 is a protein known to be closely involved with tumor growth. However, its exact role in tumor progression is unclear. A research team led by Assistant Professor KAWAI Hotaka and YOSHIDA Saori (graduate student, D.D.S.), Assistant Professor EGUCHI Takanori at Okayama University has now shown that CXCR4 is the main culprit maintaining the arrangement of tumor blood vessels. Firstly they found, immunohistochemistry on human clinical specimens revealed that tumor vesselsexpressed CXCR4 in human oral cancer specimens.The next question to arise was whether the CXCR4-rich blood vessels were promoting tumor growth. In order to investigate this further, the oral cancer cells were transplanted into mice. Once the tumor growed in mice body, they were given AMD3100a drug that antagonises CXCR4. When the tumors were subsequently observed under a microscope, several areas were found to necrotic. A characteristic pattern of necrosis was observed in which the tumor tissue that were at a distance away from the blood vessel was necrotic, leaving the tumor tissue close to the periphery of the blood vessel. This randomized pattern of tumor cell death was termed 'tumor angiogenic inhibition triggered necrosis' (TAITN) by the researchers. The widearea of tumor tissuealso showed a severe lack of oxygen which was accompanied by an impairment of angiogenesis. CXCR4 inhibition thus seemed to induce tumor necrosis by damaging the blood vessels and preventing the cells of a healthy oxygen supply. This study is the first to show the role of CXCR4 in promoting tumor growth by supplying cancer cells with a healthy, organized network of blood vessels. Strategies that can disrupt this network can be explored further as anti-cancer therapies. "CXCR4 plays a crucial role in tumor angiogenesis required for OSCC progression, whereas TAITN induced by CXCR4 antagonism could be an effective anti-angiogenic therapeutic strategy in OSCC treatment," concludes the team. Background CXCR4: CXCR4 is a protein vital in maintaining and growing the cells that produce blood within our body. In fetuses, CXCR4 is also responsible for the formation of certain blood vessels. Incidentally, CXCR4 is also present in various forms of cancers such as breast, liver, and oral cancer. Often, tumors which show the presence of CXCR4 tend to grow faster that those without. Given its link with blood vessels and cancer progression, the research team from Okayama University sought out to investigate whether CXCR4 directly promotes cancer growth by supplying tumors with blood. Reference Saori Yoshida, Hotaka Kawai*, Takanori Eguchi*, Shintaro Sukegawa, May Wathone Oo, Chang Anqi, Kiyofumi Takabatake, Keisuke Nakano, Kuniaki Okamoto, Hitoshi Nagatsuka. Tumor Angiogenic Inhibition Triggered Necrosis (TAITN) in Oral Cancer. Cell, 2019, 8(7), 761. DOI : 10.3390/cells8070761 https://www.mdpi.com/2073-4409/8/7/761 Correspondence to Assistant ProfessorKAWAI Hotaka, D.D.S.,Ph.D.Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Science,Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanE-mail: [emailprotected] Website: http://www.okayama-u.ac.jp/index_e.htmlOkayama Univ. e-Bulletin: http://www.okayama-u.ac.jp/user/kouhou/ebulletin/ Okayama University Medical Research UpdatesOU-MRU The whole volume : OU-MRU (1- )Vol.1Innovative non-invasive 'liquid biopsy' method to capture circulating tumor cells from blood samples for genetic testingVol.77Green leafy vegetables contain a compound which can fight cancer cells About Okayama University Okayama University is one of the largest comprehensive universities in Japan withroots going back to the Medical Training Place sponsored by the Lord of Okayama and established in 1870. Now with 1,300 faculty and 13,000 students, the University offers courses in specialties ranging from medicine and pharmacy to humanities and physical sciences. Okayama University is located in the heart of Japan approximately 3 hours west of Tokyo by Shinkansen. Website: http://www.okayama-u.ac.jp/index_e.html Further information Okayama University1-1-1 Tsushima-naka , Kita-ku , Okayama 700-8530, JapanPublic Relations DivisionE-mail: [emailprotected] SOURCE Okayama University
|
edtsum6746
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEWTON, Mass., Aug. 3, 2020 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), an innovation-driven pharmaceutical company, today announced that the Compensation Committee of Karyopharm's Board of Directors granted stock options to purchase an aggregate of 27,300 shares of Karyopharm's common stock to three newly-hired employees, with a grant date of July 31, 2020. The stock options were granted as inducements material to the new employees entering into employment with Karyopharm in accordance with Nasdaq Listing Rule 5635(c)(4). Each of the stock options has an exercise price of$16.05 per share, the closing price of Karyopharm's common stock on July 31, 2020. Each stock option vests over four years, with 25% of the total number of shares underlying the stock option vesting on the one-year anniversary of the applicable employee's employment commencement date and 1/48th of the total number of shares vesting monthly thereafter, subject to the employee's continued service as an employee of, or other service provider to, Karyopharm through the applicable vesting dates. In addition, each stock option will be immediately exercisable in full if, on or prior to the first anniversary of the consummation of a "change in control event," the employee's employment is terminated for "good reason" by the employee or terminated without "cause" by Karyopharm (as such terms are defined in the applicable stock option agreement). About Karyopharm Therapeutics Karyopharm Therapeutics Inc.(Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm's lead compound, XPOVIO (selinexor), received accelerated approval from theU.S. Food and Drug Administration(FDA) inJuly 2019in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. InJune 2020, XPOVIO was approved by the FDA as a treatment for patients with relapsed or refractory diffuse large B-cell lymphoma. A Marketing Authorization Application for selinexor for patients with heavily pretreated multiple myeloma is also currently under review by theEuropean Medicines Agency. In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development. For more information, please visitwww.karyopharm.com. SOURCE Karyopharm Therapeutics Inc. Related Links http://www.karyopharm.com
Answer:
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
NEWTON, Mass., Aug. 3, 2020 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), an innovation-driven pharmaceutical company, today announced that the Compensation Committee of Karyopharm's Board of Directors granted stock options to purchase an aggregate of 27,300 shares of Karyopharm's common stock to three newly-hired employees, with a grant date of July 31, 2020. The stock options were granted as inducements material to the new employees entering into employment with Karyopharm in accordance with Nasdaq Listing Rule 5635(c)(4). Each of the stock options has an exercise price of$16.05 per share, the closing price of Karyopharm's common stock on July 31, 2020. Each stock option vests over four years, with 25% of the total number of shares underlying the stock option vesting on the one-year anniversary of the applicable employee's employment commencement date and 1/48th of the total number of shares vesting monthly thereafter, subject to the employee's continued service as an employee of, or other service provider to, Karyopharm through the applicable vesting dates. In addition, each stock option will be immediately exercisable in full if, on or prior to the first anniversary of the consummation of a "change in control event," the employee's employment is terminated for "good reason" by the employee or terminated without "cause" by Karyopharm (as such terms are defined in the applicable stock option agreement). About Karyopharm Therapeutics Karyopharm Therapeutics Inc.(Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm's lead compound, XPOVIO (selinexor), received accelerated approval from theU.S. Food and Drug Administration(FDA) inJuly 2019in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. InJune 2020, XPOVIO was approved by the FDA as a treatment for patients with relapsed or refractory diffuse large B-cell lymphoma. A Marketing Authorization Application for selinexor for patients with heavily pretreated multiple myeloma is also currently under review by theEuropean Medicines Agency. In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development. For more information, please visitwww.karyopharm.com. SOURCE Karyopharm Therapeutics Inc. Related Links http://www.karyopharm.com
|
edtsum6747
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SEATTLE--(BUSINESS WIRE)--Visus Therapeutics Inc. today announced its launch and clinical development program for a novel eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia is the most common cause of vision impairment among adults1 and it affects billions globally. Visus lead product candidate is BRIMOCHOL, a proprietary formulation that combines two well-studied, FDA-approved pharmaceuticals: carbachol and brimonidine tartrate. Visus recently completed the acquisition of all patent assets underpinning the development of BRIMOCHOL, which is based on pioneering research led by Herb Kaufman, M.D., a celebrated ophthalmologist who is responsible for more than 15 landmark innovations in the field of eye care and beyond. Five clinical studies have been conducted evaluating the safety and efficacy of BRIMOCHOL. In the most recent clinical study of 57 patients, BRIMOCHOL demonstrated statistically significant improvement in near visual acuity of a 5 Jaeger-line or greater gain, with the effect lasting at least 12 hours. The same study found that BRIMOCHOL was well tolerated with no reports of headache or browache in this proprietary combination.4 Phase II trials are slated to commence in early 2021. The billions of people globally who suffer from presbyopia struggle with simple, everyday activities such as reading a menu in a restaurant or using a mobile phone representing a tremendous unmet need in the eye care segment, said Ben Bergo, co-founder, president and chief executive officer of Visus Therapeutics. We are very excited to advance the clinical development program for BRIMOCHOL with the hope of bringing the therapy to market and helping restore near vision for millions of adults globally. The previously published clinical studies and our own extensive non-clinical studies demonstrate that this proprietary formulation supports a robust and extended duration of effect of 8-12 hours4,5, said co-founder Rhett Schiffman, M.D., M.S., M.H.S.A., chief medical officer and head of research and development at Visus Therapeutics. The data also suggest that, unlike other combination drop candidates in this space, pivotal studies of BRIMOCHOL are expected to demonstrate that the individual drugs will contribute significantly to the overall effect of the combination product on near visual acuity. Visus brings deep ophthalmology experience to drive innovation for patients with presbyopia. Dr. Schiffman is a board-certified internist and ophthalmologist and uveitis-trained specialist; and Robert Sambursky, M.D., is a board-certified ophthalmologist with corneal and external disease specialty training. Schiffman previously served as vice president of global drug development and therapeutic area head of ophthalmology at Allergan Inc.; chief medical officer at Neurotech Pharmaceuticals Inc.; and chief medical officer and head of research and development at Envisia Therapeutics Inc., since acquired by Aerie Pharmaceuticals. Sambursky is also chairman of the board of directors and president and chief executive officer of Lumos Diagnostics, previously RPS Diagnostics. RPS Diagnostics and Planet Innovation were early investors for Visus. Visus also announces the formation of its clinical advisory board, appointing industry veteran Eric Donnenfeld, M.D., as its leader. Dr. Donnenfeld is an internationally recognized ophthalmologist, serving on the editorial board of nine journals and having participated in more than 40 FDA clinical studies. He is the founding partner of Ophthalmic Consultants of Long Island and Connecticut and also serves as Clinical Professor of Ophthalmology at New York University Medical Center. Dr. Donnenfeld is a past president of ASCRS and editor in chief of EyeWorld. I am very pleased to partner with the leadership team at Visus Therapeutics as they work to advance their pipeline of ophthalmic therapeutics, said Dr. Donnenfeld. BRIMOCHOL employs an innovative approach and the pharmacologic treatment of presbyopia would be a significant benefit for patients. About Presbyopia Presbyopia is the loss of near vision associated with aging, making it difficult to perform tasks like reading. It typically begins when adults are in their 40s, and becomes almost universal by age 50.2 Presbyopia impacts billions of people globally with approximately 123 million adults affected in the U.S. alone.3 While reading glasses are the most common solution, many people find glasses to be inconvenient and a detriment to their appearance. Currently, there are no FDA-approved medications for presbyopia. About Visus Therapeutics Visus Therapeutics is a clinical-stage company developing innovative medicines to improve vision for people around the world. With offices in Seattle and Orange County, Calif., its lead clinical candidate is BRIMOCHOL, an eye drop designed to restore the loss of near vision associated with presbyopia. In parallel, Visus Therapeutics is focused on advancing its pipeline of early-stage ophthalmic product candidates. For more information, visit: www.visustx.com and follow us on Twitter (@VisusTx) and on LinkedIn. 1 https://www.aao.org/editors-choice/study-reveals-significant-worldwide-burden-from-un 2 US Census data, www.census.gov, accessed 7 September, 2019. 3 Market Scope, Global Presbyopia-Correcting Surgery Market Report, April 2012 4 Abdelkader Int. J. Ophthalmic Res 2019 September; 5(1): 317-320 5 Abdelkader and Kaufman Eye and Vision (2016) 3:31
Answer:
|
Visus Therapeutics Launches and Announces Clinical Development Program for Novel Presbyopia Eye Drop Patent Assets Acquired from Acclaimed Ophthalmologist and Innovator Herb Kaufman, M.D., to Progress to Phase II Studies Eric Donnenfeld, M.D., Appointed Leader of Clinical Advisory Board, Bringing World-Class Ophthalmology Expertise as Company Moves Into Clinical Development
|
SEATTLE--(BUSINESS WIRE)--Visus Therapeutics Inc. today announced its launch and clinical development program for a novel eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia is the most common cause of vision impairment among adults1 and it affects billions globally. Visus lead product candidate is BRIMOCHOL, a proprietary formulation that combines two well-studied, FDA-approved pharmaceuticals: carbachol and brimonidine tartrate. Visus recently completed the acquisition of all patent assets underpinning the development of BRIMOCHOL, which is based on pioneering research led by Herb Kaufman, M.D., a celebrated ophthalmologist who is responsible for more than 15 landmark innovations in the field of eye care and beyond. Five clinical studies have been conducted evaluating the safety and efficacy of BRIMOCHOL. In the most recent clinical study of 57 patients, BRIMOCHOL demonstrated statistically significant improvement in near visual acuity of a 5 Jaeger-line or greater gain, with the effect lasting at least 12 hours. The same study found that BRIMOCHOL was well tolerated with no reports of headache or browache in this proprietary combination.4 Phase II trials are slated to commence in early 2021. The billions of people globally who suffer from presbyopia struggle with simple, everyday activities such as reading a menu in a restaurant or using a mobile phone representing a tremendous unmet need in the eye care segment, said Ben Bergo, co-founder, president and chief executive officer of Visus Therapeutics. We are very excited to advance the clinical development program for BRIMOCHOL with the hope of bringing the therapy to market and helping restore near vision for millions of adults globally. The previously published clinical studies and our own extensive non-clinical studies demonstrate that this proprietary formulation supports a robust and extended duration of effect of 8-12 hours4,5, said co-founder Rhett Schiffman, M.D., M.S., M.H.S.A., chief medical officer and head of research and development at Visus Therapeutics. The data also suggest that, unlike other combination drop candidates in this space, pivotal studies of BRIMOCHOL are expected to demonstrate that the individual drugs will contribute significantly to the overall effect of the combination product on near visual acuity. Visus brings deep ophthalmology experience to drive innovation for patients with presbyopia. Dr. Schiffman is a board-certified internist and ophthalmologist and uveitis-trained specialist; and Robert Sambursky, M.D., is a board-certified ophthalmologist with corneal and external disease specialty training. Schiffman previously served as vice president of global drug development and therapeutic area head of ophthalmology at Allergan Inc.; chief medical officer at Neurotech Pharmaceuticals Inc.; and chief medical officer and head of research and development at Envisia Therapeutics Inc., since acquired by Aerie Pharmaceuticals. Sambursky is also chairman of the board of directors and president and chief executive officer of Lumos Diagnostics, previously RPS Diagnostics. RPS Diagnostics and Planet Innovation were early investors for Visus. Visus also announces the formation of its clinical advisory board, appointing industry veteran Eric Donnenfeld, M.D., as its leader. Dr. Donnenfeld is an internationally recognized ophthalmologist, serving on the editorial board of nine journals and having participated in more than 40 FDA clinical studies. He is the founding partner of Ophthalmic Consultants of Long Island and Connecticut and also serves as Clinical Professor of Ophthalmology at New York University Medical Center. Dr. Donnenfeld is a past president of ASCRS and editor in chief of EyeWorld. I am very pleased to partner with the leadership team at Visus Therapeutics as they work to advance their pipeline of ophthalmic therapeutics, said Dr. Donnenfeld. BRIMOCHOL employs an innovative approach and the pharmacologic treatment of presbyopia would be a significant benefit for patients. About Presbyopia Presbyopia is the loss of near vision associated with aging, making it difficult to perform tasks like reading. It typically begins when adults are in their 40s, and becomes almost universal by age 50.2 Presbyopia impacts billions of people globally with approximately 123 million adults affected in the U.S. alone.3 While reading glasses are the most common solution, many people find glasses to be inconvenient and a detriment to their appearance. Currently, there are no FDA-approved medications for presbyopia. About Visus Therapeutics Visus Therapeutics is a clinical-stage company developing innovative medicines to improve vision for people around the world. With offices in Seattle and Orange County, Calif., its lead clinical candidate is BRIMOCHOL, an eye drop designed to restore the loss of near vision associated with presbyopia. In parallel, Visus Therapeutics is focused on advancing its pipeline of early-stage ophthalmic product candidates. For more information, visit: www.visustx.com and follow us on Twitter (@VisusTx) and on LinkedIn. 1 https://www.aao.org/editors-choice/study-reveals-significant-worldwide-burden-from-un 2 US Census data, www.census.gov, accessed 7 September, 2019. 3 Market Scope, Global Presbyopia-Correcting Surgery Market Report, April 2012 4 Abdelkader Int. J. Ophthalmic Res 2019 September; 5(1): 317-320 5 Abdelkader and Kaufman Eye and Vision (2016) 3:31
|
edtsum6750
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CHICAGO & DUBLIN--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that the European Commission (EC) has approved Ogluo (glucagon) injection for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The marketing authorisation is valid in all 27 countries of the European Union, plus Iceland, Norway, and Liechtenstein. As the EC decision was received after the end of the Brexit transition period, Xeris will complete a further administrative step in order to obtain a license in Great Britain. No re-examination of clinical data by the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) is expected. This EU approval for Ogluo is a major milestone for Xeris and a significant advancement in the treatment of severe hypoglycaemia for the diabetes community in Europe. Hypoglycaemia is the #1 side effect of insulin, and severe hypoglycaemia is the most urgent emergency any person with diabetes could face. Ogluo, the first pre-mixed auto-injector for severe hypoglycaemia, can help offset the inherent risk associated with insulin, said Paul R. Edick, Chairman and Chief Executive Officer of Xeris Pharmaceuticals. We are preparing to launch Ogluo later this year, while simultaneously seeking a commercialization partner in which to broaden the availability of Ogluo to more European countries. The EC approval was supported by data from a Phase 3, multi-centre, randomized controlled, non-inferiority study. The study was conducted among 132 adults with type 1 diabetes in Europe and North America to evaluate the liquid stable glucagon auto-injector as a treatment for severe hypoglycaemic events compared with Novo Nordisks GlucaGen HypoKit. The results demonstrated comparable efficacy between the two groups in achieving a plasma glucose of greater than 3.89 mmol/L (>70 mg/dL) or a relative increase of 1.11 mmol/L (20 mg/dL) in plasma glucose concentration within 30 minutes of administration. The study also found that time to resolution of hypoglycaemia symptoms as well as time to resolution of the overall feeling of hypoglycaemia were comparable. No safety or tolerability concerns were noted. In this study, the most common adverse reactions were nausea and vomiting. Hypoglycaemia is a neglected complication of glucose-lowering therapy in patients with diabetes mellitus. Attempts made at intensive glycaemic control invariably increases the risk of hypoglycaemia. In patients experiencing severe hypoglycaemia an increase in deaths up to six-fold has been associated to diabetes in comparison to those not experiencing severe hypoglycaemia. Patients with diabetes should be evaluated for the risk of clinically important hypoglycaemia and have access to ready-to-use glucagon, said Thomas Pieber, MD, Professor of Medicine, Chair, Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria. ABOUT GVOKE/OGLUO Gvoke PFS and Gvoke HypoPen (glucagon injection), the first prescription, ready-to-use, pre-mixed, pre-measured glucagon injection, were approved by the FDA in September 2019 for use in the United States. Gvoke is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages 2 years and above. Ogluo received a positive opinion from the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) in December 2020 and the European Commission (EC) granted the marketing authorisation on 11 February 2021. Ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. INDICATION AND IMPORTANT SAFETY INFORMATION FOR GVOKE Gvoke is indicated for the treatment of severe hypoglycaemia in adult and paediatric patients with diabetes ages 2 years and above. IMPORTANT SAFETY INFORMATION Contraindications Gvoke is contraindicated in patients with pheochromocytoma, insulinoma, and known hypersensitivity to glucagon or to any of the excipients in Gvoke. Allergic reactions have been reported with glucagon and include anaphylactic shock with breathing difficulties and hypotension. Warnings and Precautions Gvoke is contraindicated in patients with pheochromocytoma because glucagon may stimulate the release of catecholamines from the tumor. If the patient develops a dramatic increase in blood pressure and a previously undiagnosed pheochromocytoma is suspected, 5 to 10 mg of phentolamine mesylate, administered intravenously, has been shown to be effective in lowering blood pressure. In patients with insulinoma, administration of glucagon may produce an initial increase in blood glucose; however, Gvoke administration may directly or indirectly (through an initial rise in blood glucose) stimulate exaggerated insulin release from an insulinoma and cause hypoglycemia. Gvoke is contraindicated in patients with insulinoma. If a patient develops symptoms of hypoglycemia after a dose of Gvoke, give glucose orally or intravenously. Allergic reactions have been reported with glucagon. These include generalized rash, and in some cases, anaphylactic shock with breathing difficulties and hypotension. Gvoke is contraindicated in patients with a prior hypersensitivity reaction. Gvoke is effective in treating hypoglycemia only if sufficient hepatic glycogen is present. Patients in states of starvation, with adrenal insufficiency or chronic hypoglycemia, may not have adequate levels of hepatic glycogen for Gvoke administration to be effective. Patients with these conditions should be treated with glucose. Necrolytic migratory erythema (NME), a skin rash commonly associated with glucagonomas has been reported post-marketing following continuous glucagon infusion and resolved with discontinuation of the glucagon. Should NME occur, consider whether the benefits of continuous glucagon infusion outweigh the risks. Glucagon administered to patients with glucagonoma may cause secondary hypoglycemia. Adverse Reactions Most common (5%) adverse reactions associated with Gvoke are nausea, vomiting, injection site edema (raised 1 mm or greater), and hypoglycemia. Drug Interactions Patients taking beta-blockers may have a transient increase in pulse and blood pressure when given OGLUO. In patients taking indomethacin, Gvoke may lose its ability to raise blood glucose or may even produce hypoglycemia. Gvoke may increase the anticoagulant effect of warfarin. Please see full Prescribing Information for Gvoke on www.xerispharma.com. Manufactured for Xeris Pharmaceuticals, Inc. by Pyramid Laboratories Inc., Costa Mesa, CA 92626. About Glucagon Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keep blood glucose at the right level in healthy individuals. In people with diabetes who are dependent on insulin, this control system is disrupted, and insulin must be injected to avoid high levels of blood glucose (hyperglycemia). The opposite effect, or low blood glucose (hypoglycemia), is also prevalent in this population due to dysregulated glucagon secretion. Severe hypoglycemia is a serious condition and can lead to seizures, coma, potential brain injury and, if untreated, death. Glucagon is the standard of care for treating severe hypoglycemia. According to the American Diabetes Association, glucagon should be prescribed for all individuals at increased risk of clinically significant hypoglycemia, defined as blood glucose <54 mg/dL (3.0 mmol/L). Leveraging XeriSol, one of Xeris two proprietary formulation technology platforms, Xeris has the potential to provide the first ready-to-use, room-temperature stable liquid glucagon for use by people with diabetes and other conditions to prevent or manage various forms of hypoglycemia and improve glucose control. About Severe Hypoglycemia Hypoglycemic events of any severity are a daily concern for people with diabetes. Mild or moderate hypoglycemia can occur multiple times a month. Severe hypoglycemia is characterized by severe cognitive impairment, requiring external assistance for recovery, and can be extremely frightening for patients and caregivers. Severe hypoglycemia can result in cardiovascular disease, seizure, coma, and, if left untreated, death. These severe hypoglycemic events can occur multiple times a year. Such events require emergency assistance from another person or caregiver such as a family member, friend, or co-worker. About Xeris Pharmaceuticals, Inc. Xeris (Nasdaq: XERS) is a specialty pharmaceutical company delivering innovative solutions to simplify the experience of administering important therapies that people rely on every day around the world. With a novel technology platform that enables ready-to-use, room-temperature stable formulations of injectable and infusible therapies, the company is advancing a portfolio of solutions in various therapeutic categories, including its first U.S. commercial product, Gvoke. Its proprietary XeriSol and XeriJect formulation technologies have the potential to offer distinct advantages over conventional product formulations, including eliminating the need for reconstitution, enabling long-term, room-temperature stability, significantly reducing injection volume, and eliminating the requirement for intravenous (IV) infusion. With Xeris technology, new product formulations are designed to be easier to use by patients, caregivers, and health practitioners and help reduce costs for payers and the healthcare system. Xeris is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on Twitter, LinkedIn or Instagram. Forward-Looking Statements Any statements in this press release about future expectations, plans and prospects for Xeris Pharmaceuticals, Inc., including statements regarding the market and therapeutic potential of its products and product candidates, expectations regarding clinical data or results from planned clinical trials, the timing or likelihood of regulatory approval and commercialization of its product candidates, the timing or likelihood of expansion into additional markets, the timing or likelihood of identifying potential development and commercialization partnerships, the potential utility of its formulation platforms and other statements containing the words "will," "would," "continue," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including, without limitation, the impact of COVID-19 on its business operations, its reliance on third-party suppliers for Gvoke and Ogluo, the regulatory approval of its product candidates, its ability to market and sell its products, if approved, and other factors discussed in the "Risk Factors" section of the most recently filed Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission, as well as discussions of potential risks, uncertainties, and other important factors in Xeris subsequent filings with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Xeris expressly disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. The Company intends to use the investor relations portion of its website as a means of disclosing material non-public information and for complying with disclosure obligations under Regulation FD.
Answer:
|
Xeris Pharmaceuticals Receives European Commission Approval of Ogluo (glucagon) Injection for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Years and Over With Diabetes Mellitus OGLUO Europes first and only ready-to-use liquid glucagon for rescue First availability expected in the fourth quarter Approval supported by data from pivotal Phase 3 study
|
CHICAGO & DUBLIN--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that the European Commission (EC) has approved Ogluo (glucagon) injection for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The marketing authorisation is valid in all 27 countries of the European Union, plus Iceland, Norway, and Liechtenstein. As the EC decision was received after the end of the Brexit transition period, Xeris will complete a further administrative step in order to obtain a license in Great Britain. No re-examination of clinical data by the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) is expected. This EU approval for Ogluo is a major milestone for Xeris and a significant advancement in the treatment of severe hypoglycaemia for the diabetes community in Europe. Hypoglycaemia is the #1 side effect of insulin, and severe hypoglycaemia is the most urgent emergency any person with diabetes could face. Ogluo, the first pre-mixed auto-injector for severe hypoglycaemia, can help offset the inherent risk associated with insulin, said Paul R. Edick, Chairman and Chief Executive Officer of Xeris Pharmaceuticals. We are preparing to launch Ogluo later this year, while simultaneously seeking a commercialization partner in which to broaden the availability of Ogluo to more European countries. The EC approval was supported by data from a Phase 3, multi-centre, randomized controlled, non-inferiority study. The study was conducted among 132 adults with type 1 diabetes in Europe and North America to evaluate the liquid stable glucagon auto-injector as a treatment for severe hypoglycaemic events compared with Novo Nordisks GlucaGen HypoKit. The results demonstrated comparable efficacy between the two groups in achieving a plasma glucose of greater than 3.89 mmol/L (>70 mg/dL) or a relative increase of 1.11 mmol/L (20 mg/dL) in plasma glucose concentration within 30 minutes of administration. The study also found that time to resolution of hypoglycaemia symptoms as well as time to resolution of the overall feeling of hypoglycaemia were comparable. No safety or tolerability concerns were noted. In this study, the most common adverse reactions were nausea and vomiting. Hypoglycaemia is a neglected complication of glucose-lowering therapy in patients with diabetes mellitus. Attempts made at intensive glycaemic control invariably increases the risk of hypoglycaemia. In patients experiencing severe hypoglycaemia an increase in deaths up to six-fold has been associated to diabetes in comparison to those not experiencing severe hypoglycaemia. Patients with diabetes should be evaluated for the risk of clinically important hypoglycaemia and have access to ready-to-use glucagon, said Thomas Pieber, MD, Professor of Medicine, Chair, Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria. ABOUT GVOKE/OGLUO Gvoke PFS and Gvoke HypoPen (glucagon injection), the first prescription, ready-to-use, pre-mixed, pre-measured glucagon injection, were approved by the FDA in September 2019 for use in the United States. Gvoke is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages 2 years and above. Ogluo received a positive opinion from the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) in December 2020 and the European Commission (EC) granted the marketing authorisation on 11 February 2021. Ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. INDICATION AND IMPORTANT SAFETY INFORMATION FOR GVOKE Gvoke is indicated for the treatment of severe hypoglycaemia in adult and paediatric patients with diabetes ages 2 years and above. IMPORTANT SAFETY INFORMATION Contraindications Gvoke is contraindicated in patients with pheochromocytoma, insulinoma, and known hypersensitivity to glucagon or to any of the excipients in Gvoke. Allergic reactions have been reported with glucagon and include anaphylactic shock with breathing difficulties and hypotension. Warnings and Precautions Gvoke is contraindicated in patients with pheochromocytoma because glucagon may stimulate the release of catecholamines from the tumor. If the patient develops a dramatic increase in blood pressure and a previously undiagnosed pheochromocytoma is suspected, 5 to 10 mg of phentolamine mesylate, administered intravenously, has been shown to be effective in lowering blood pressure. In patients with insulinoma, administration of glucagon may produce an initial increase in blood glucose; however, Gvoke administration may directly or indirectly (through an initial rise in blood glucose) stimulate exaggerated insulin release from an insulinoma and cause hypoglycemia. Gvoke is contraindicated in patients with insulinoma. If a patient develops symptoms of hypoglycemia after a dose of Gvoke, give glucose orally or intravenously. Allergic reactions have been reported with glucagon. These include generalized rash, and in some cases, anaphylactic shock with breathing difficulties and hypotension. Gvoke is contraindicated in patients with a prior hypersensitivity reaction. Gvoke is effective in treating hypoglycemia only if sufficient hepatic glycogen is present. Patients in states of starvation, with adrenal insufficiency or chronic hypoglycemia, may not have adequate levels of hepatic glycogen for Gvoke administration to be effective. Patients with these conditions should be treated with glucose. Necrolytic migratory erythema (NME), a skin rash commonly associated with glucagonomas has been reported post-marketing following continuous glucagon infusion and resolved with discontinuation of the glucagon. Should NME occur, consider whether the benefits of continuous glucagon infusion outweigh the risks. Glucagon administered to patients with glucagonoma may cause secondary hypoglycemia. Adverse Reactions Most common (5%) adverse reactions associated with Gvoke are nausea, vomiting, injection site edema (raised 1 mm or greater), and hypoglycemia. Drug Interactions Patients taking beta-blockers may have a transient increase in pulse and blood pressure when given OGLUO. In patients taking indomethacin, Gvoke may lose its ability to raise blood glucose or may even produce hypoglycemia. Gvoke may increase the anticoagulant effect of warfarin. Please see full Prescribing Information for Gvoke on www.xerispharma.com. Manufactured for Xeris Pharmaceuticals, Inc. by Pyramid Laboratories Inc., Costa Mesa, CA 92626. About Glucagon Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keep blood glucose at the right level in healthy individuals. In people with diabetes who are dependent on insulin, this control system is disrupted, and insulin must be injected to avoid high levels of blood glucose (hyperglycemia). The opposite effect, or low blood glucose (hypoglycemia), is also prevalent in this population due to dysregulated glucagon secretion. Severe hypoglycemia is a serious condition and can lead to seizures, coma, potential brain injury and, if untreated, death. Glucagon is the standard of care for treating severe hypoglycemia. According to the American Diabetes Association, glucagon should be prescribed for all individuals at increased risk of clinically significant hypoglycemia, defined as blood glucose <54 mg/dL (3.0 mmol/L). Leveraging XeriSol, one of Xeris two proprietary formulation technology platforms, Xeris has the potential to provide the first ready-to-use, room-temperature stable liquid glucagon for use by people with diabetes and other conditions to prevent or manage various forms of hypoglycemia and improve glucose control. About Severe Hypoglycemia Hypoglycemic events of any severity are a daily concern for people with diabetes. Mild or moderate hypoglycemia can occur multiple times a month. Severe hypoglycemia is characterized by severe cognitive impairment, requiring external assistance for recovery, and can be extremely frightening for patients and caregivers. Severe hypoglycemia can result in cardiovascular disease, seizure, coma, and, if left untreated, death. These severe hypoglycemic events can occur multiple times a year. Such events require emergency assistance from another person or caregiver such as a family member, friend, or co-worker. About Xeris Pharmaceuticals, Inc. Xeris (Nasdaq: XERS) is a specialty pharmaceutical company delivering innovative solutions to simplify the experience of administering important therapies that people rely on every day around the world. With a novel technology platform that enables ready-to-use, room-temperature stable formulations of injectable and infusible therapies, the company is advancing a portfolio of solutions in various therapeutic categories, including its first U.S. commercial product, Gvoke. Its proprietary XeriSol and XeriJect formulation technologies have the potential to offer distinct advantages over conventional product formulations, including eliminating the need for reconstitution, enabling long-term, room-temperature stability, significantly reducing injection volume, and eliminating the requirement for intravenous (IV) infusion. With Xeris technology, new product formulations are designed to be easier to use by patients, caregivers, and health practitioners and help reduce costs for payers and the healthcare system. Xeris is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on Twitter, LinkedIn or Instagram. Forward-Looking Statements Any statements in this press release about future expectations, plans and prospects for Xeris Pharmaceuticals, Inc., including statements regarding the market and therapeutic potential of its products and product candidates, expectations regarding clinical data or results from planned clinical trials, the timing or likelihood of regulatory approval and commercialization of its product candidates, the timing or likelihood of expansion into additional markets, the timing or likelihood of identifying potential development and commercialization partnerships, the potential utility of its formulation platforms and other statements containing the words "will," "would," "continue," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including, without limitation, the impact of COVID-19 on its business operations, its reliance on third-party suppliers for Gvoke and Ogluo, the regulatory approval of its product candidates, its ability to market and sell its products, if approved, and other factors discussed in the "Risk Factors" section of the most recently filed Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission, as well as discussions of potential risks, uncertainties, and other important factors in Xeris subsequent filings with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Xeris expressly disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. The Company intends to use the investor relations portion of its website as a means of disclosing material non-public information and for complying with disclosure obligations under Regulation FD.
|
edtsum6753
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PITTSBURGH, May 1, 2020 /PRNewswire/ --While there's probably a valid concern about having to touch toilet seats in public restrooms, that same hesitation is not uncommon in private bathrooms as well. Fortunately, an inventor from Sands Point has found a way to solve that problem. He developed TOILET SEAT CONCEPT, patent pending, to provide an easy way to raise and lower a toilet seat without having to touch it. As such, it increases the likeliness that the seat will be kept clean and dry. At the same time, it reduces the chances of spreading germs and disease for maintenance of more sanitary conditions in the bathroom. It is also durable, practical and easy to install and use. Users will appreciate its Convenience, effectiveness and affordable price as well. In addition, its simple design minimizes production costs. The inventor's personal experience inspired the idea. "From my own observation, it was easy to conclude there had to be a more hygienic way to raise and lower a toilet seat without exposure to the germs that accumulate there," he said. The original design was submitted to the Long Island sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 18-LGI-2828, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com
Answer:
|
InventHelp Inventor Develops Toilet Seat Control System (LGI-2828)
|
PITTSBURGH, May 1, 2020 /PRNewswire/ --While there's probably a valid concern about having to touch toilet seats in public restrooms, that same hesitation is not uncommon in private bathrooms as well. Fortunately, an inventor from Sands Point has found a way to solve that problem. He developed TOILET SEAT CONCEPT, patent pending, to provide an easy way to raise and lower a toilet seat without having to touch it. As such, it increases the likeliness that the seat will be kept clean and dry. At the same time, it reduces the chances of spreading germs and disease for maintenance of more sanitary conditions in the bathroom. It is also durable, practical and easy to install and use. Users will appreciate its Convenience, effectiveness and affordable price as well. In addition, its simple design minimizes production costs. The inventor's personal experience inspired the idea. "From my own observation, it was easy to conclude there had to be a more hygienic way to raise and lower a toilet seat without exposure to the germs that accumulate there," he said. The original design was submitted to the Long Island sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 18-LGI-2828, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com
|
edtsum6755
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MINNEAPOLIS, April 1, 2021 /PRNewswire/ --Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO;OTCQX: VREOF), the science-focused, multi-state cannabis company, today announced that the sale of its former subsidiary, Ohio Medical Solutions, LLC, to Ayr Wellness, Inc. closed on March 31, 2021. In connection with the closing of the transaction, Vireo received cash proceeds of $1.15 million, and was relieved of $3.6 million in right of use liabilities affiliated with lease obligations. "The closing of this transaction was another important milestone in the successful execution of our core market strategy, which has been focused on increasing scale in our vertically-integrated markets of Arizona, Maryland, Minnesota, New Mexico, and New York," said Chairman & Chief Executive Officer, Dr. Kyle Kingsley. "Our improving strength in these markets, combined with more favorable regulatory environments at both the local and federal levels, has improved our confidence in the overall trajectory of our business and we no longer plan to consider further divestitures of our asset portfolio as we see greater opportunities to generate more compelling value for shareholders." About Vireo Health International, Inc. Vireo Health International, Inc. is a physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Vireo manufactures proprietary, branded cannabis products in environmentally friendly facilities, state-of-the-art cultivation sites and distributes its products through its growing network of Green Goods and other retail locations and third-party dispensaries. Vireo's team of more than 400 employees, led by scientists, engineers, and cultivation experts, is focused on efficiency and the creation of best-in-class products, while driving scientific innovation within the cannabis industry and developing meaningful intellectual property. Today, Vireo is licensed to grow and/or process cannabis in eight markets and operates 16 dispensaries nationwide. For more information about Vireo Health, please visit www.vireohealth.com. Forward Looking Statement Disclosure This press release contains "forward-looking information" within the meaning of applicable United States and Canadian securities legislation. To the extent any forward-looking information in this press release constitutes "financial outlooks" within the meaning of applicable United States or Canadian securities laws, such information is being provided as preliminary financial results and the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such financial outlooks. Forward-looking information contained in this press release may be identified by the use of words such as "potential," "plans," "is expected," "expects," "does not expect," "growing" or "foreseeable." Forward-looking information is based upon a number of estimates and assumptions of management, believed but not certain to be reasonable, in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits. Media Inquiries Investor Inquiries Albe Zakes Sam Gibbons Vice President, Corporate Communications Vice President, Investor Relations [emailprotected] [emailprotected] (267) 221-4800 (612) 314-8995 SOURCE Vireo Health International, Inc. Related Links www.vireohealth.com
Answer:
|
Vireo Health Announces Closing of Previously Announced Divestiture of Ohio Medical Solutions
|
MINNEAPOLIS, April 1, 2021 /PRNewswire/ --Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO;OTCQX: VREOF), the science-focused, multi-state cannabis company, today announced that the sale of its former subsidiary, Ohio Medical Solutions, LLC, to Ayr Wellness, Inc. closed on March 31, 2021. In connection with the closing of the transaction, Vireo received cash proceeds of $1.15 million, and was relieved of $3.6 million in right of use liabilities affiliated with lease obligations. "The closing of this transaction was another important milestone in the successful execution of our core market strategy, which has been focused on increasing scale in our vertically-integrated markets of Arizona, Maryland, Minnesota, New Mexico, and New York," said Chairman & Chief Executive Officer, Dr. Kyle Kingsley. "Our improving strength in these markets, combined with more favorable regulatory environments at both the local and federal levels, has improved our confidence in the overall trajectory of our business and we no longer plan to consider further divestitures of our asset portfolio as we see greater opportunities to generate more compelling value for shareholders." About Vireo Health International, Inc. Vireo Health International, Inc. is a physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Vireo manufactures proprietary, branded cannabis products in environmentally friendly facilities, state-of-the-art cultivation sites and distributes its products through its growing network of Green Goods and other retail locations and third-party dispensaries. Vireo's team of more than 400 employees, led by scientists, engineers, and cultivation experts, is focused on efficiency and the creation of best-in-class products, while driving scientific innovation within the cannabis industry and developing meaningful intellectual property. Today, Vireo is licensed to grow and/or process cannabis in eight markets and operates 16 dispensaries nationwide. For more information about Vireo Health, please visit www.vireohealth.com. Forward Looking Statement Disclosure This press release contains "forward-looking information" within the meaning of applicable United States and Canadian securities legislation. To the extent any forward-looking information in this press release constitutes "financial outlooks" within the meaning of applicable United States or Canadian securities laws, such information is being provided as preliminary financial results and the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such financial outlooks. Forward-looking information contained in this press release may be identified by the use of words such as "potential," "plans," "is expected," "expects," "does not expect," "growing" or "foreseeable." Forward-looking information is based upon a number of estimates and assumptions of management, believed but not certain to be reasonable, in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits. Media Inquiries Investor Inquiries Albe Zakes Sam Gibbons Vice President, Corporate Communications Vice President, Investor Relations [emailprotected] [emailprotected] (267) 221-4800 (612) 314-8995 SOURCE Vireo Health International, Inc. Related Links www.vireohealth.com
|
edtsum6758
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, May 18, 2020 /PRNewswire/ --The BNY Mellon U.S. Master Trust Universe returned a median -10.9% in the first quarter of 2020, reversing the trend of positive quarterly performance throughout 2019. The BNY Mellon U.S. Master Trust Universe offers peer comparisons of performance by plan type and size. It consists of 519 corporate, foundation, endowment, public, Taft-Hartley, and health care plans with a total market value of more than $1.9 trillion and an average plan size of over $6.4 billion. In aggregate, U.S. Master Trust Universe plans reported a one-year return of -2.65%, trailing the 3-year annualized return of +3.71% and 5-year annualized return of +4.01% respectively. Corporate Plans were the highest performing plan type for the quarter, benefitting from their higher allocations to U.S. Fixed Income than other plan types. Foundations underperformed other plan types due to having the lowest allocation to fixed income of any plan type. "In the first quarter of 2020, U.S. Fixed Income was the highest performing asset class, overweighting its peers by 22%. Due to Corporate Plans tendency to allocate more assets to Fixed Income than other plan types, this overweight resulted in Corporate Plans being the top performing plan type for the quarter," said Frances Barney, CFA, Head of Global Risk Solutions at BNY Mellon. Additional Q1 Highlights Less than 5% of plans posted positive results during the quarter Corporate Plans saw the highest median return (-8.64%), followed by Endowments (-11.54%) U.S. equities posted a quarterly median return of -21.28%, versus the Russell 3000 Index return of -20.90%. Non-U.S. equities saw a median return of -23.64%, compared to the FTSE Developed ex U.S. Net Index result of -23.17%. U.S. fixed income had a median return of +0.51%, versus the Barclays Capital U.S. Aggregate Bond Index return of +3.15%. Non-U.S. fixed income had a median return of -12.19%, versus the FTSE World Government Bond Non-US Index return of -1.88%. Real estate had a median return of +1.34%, versus the NCREIF Property Index result of +0.71%. BNY Mellon U.S. Master Trust Universe users are now able to take advantage of BNY Mellon Asset Strategy Viewas a separate service for additional analysis. BNY Mellon Asset Strategy View layers big data analytics onto detailed asset allocation, performance, and cash flow data for the majority of the BNY Mellon U.S. Master Trust Universe. It provides additional insight into underlying market trends and investor activity. BNY Mellon U.S. Master Trust Universe Median Plan Returns* Period Ending March 31, 2020 Universe Number of Participants 1Q 2020 One- Year Five-Years Ten-Years Master Trust Total Fund 519 (10.90) (2.65) 4.01 6.56 Corporate Plans 225 (8.64) 1.14 4.71 7.23 Foundations 79 (12.80) (5.03) 3.17 5.84 Endowments 73 (11.34) (3.86) 3.59 6.10 Public Plans 79 (12.54) (4.14) 3.88 6.61 Taft-Hartley Plans 33 (12.32) (4.87) 3.30 6.00 Health Care Plans 20 (9.56) (1.81) 3.79 - *All returns are posted gross of fee results. BNY Mellon Asset Allocation Medians of those invested by Asset Class Period Ending March 31, 2020 Asset Class Q1 2020 One Year Ago Three Years Ago Five Years Ago US Equity 18.35% 22.13% 23.09% 23.43% Non-US Equity 11.18% 14.01% 15.91% 15.07% Global Equity 5.04% 5.58% 5.80% 5.30% US Fixed Income 24.28% 23.37% 19.66% 21.23% Global Fixed Income 2.03% 2.15% 2.44% 1.89% Non-US Fixed Income 2.34% 2.44% 3.13% 3.38% TIPS/Inflation Linked Bonds 3.39% 3.43% 3.13% 3.22% Real Estate 12.62% 11.87% 14.79% 15.27% Private Equity 10.46% 8.59% 7.94% 8.14% Other Real Assets 5.61% 5.36% 5.12% 4.90% Hedge Funds 2.30% 2.32% 2.82% 3.48% Cash 1.51% 1.20% 1.23% 1.78% ABOUT BNY MELLONBNY Mellon is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle. Whether providing financial services for institutions, corporations or individual investors, BNY Mellon delivers informed investment management and investment services in 35 countries. As of March 31, 2020, BNY Mellon had $35.2 trillion in assets under custody and/or administration, and $1.8 trillion in assets under management. BNY Mellon can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute or restructure investments. BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Additional information is available on www.bnymellon.com. Follow us on Twitter @BNYMellon or visit our newsroom at www.bnymellon.com/newsroom for the latest company news. Barclays Capital U.S. Aggregate Bond Index Barclays Bank PLC 2016. This data is provided by Barclays Bank PLC all rights are reserved. FTSE Non-US World Government Bond, FTSE Developed x US Index, Russell 3000 Index:Source: London Stock Exchange Group plc and its group undertakings (collectively, the "LSE Group"). LSE Group 2019. FTSE Russell is a trading name of certain of the LSE Group companies. "FTSE" "Russell", are trade mark(s) of the relevant LSE Group companies and is/are used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company's express written Contact: Paul PatellaBNY Mellon Asset Servicing[emailprotected]+1 212 635 1378 SOURCE BNY Mellon Asset Servicing
Answer:
|
Median Total Master Trust Return Negative in Q1 2020 According to BNY Mellon U.S. Master Trust Universe Equity market sell off results in lowest median quarterly return since Q4 2008
|
NEW YORK, May 18, 2020 /PRNewswire/ --The BNY Mellon U.S. Master Trust Universe returned a median -10.9% in the first quarter of 2020, reversing the trend of positive quarterly performance throughout 2019. The BNY Mellon U.S. Master Trust Universe offers peer comparisons of performance by plan type and size. It consists of 519 corporate, foundation, endowment, public, Taft-Hartley, and health care plans with a total market value of more than $1.9 trillion and an average plan size of over $6.4 billion. In aggregate, U.S. Master Trust Universe plans reported a one-year return of -2.65%, trailing the 3-year annualized return of +3.71% and 5-year annualized return of +4.01% respectively. Corporate Plans were the highest performing plan type for the quarter, benefitting from their higher allocations to U.S. Fixed Income than other plan types. Foundations underperformed other plan types due to having the lowest allocation to fixed income of any plan type. "In the first quarter of 2020, U.S. Fixed Income was the highest performing asset class, overweighting its peers by 22%. Due to Corporate Plans tendency to allocate more assets to Fixed Income than other plan types, this overweight resulted in Corporate Plans being the top performing plan type for the quarter," said Frances Barney, CFA, Head of Global Risk Solutions at BNY Mellon. Additional Q1 Highlights Less than 5% of plans posted positive results during the quarter Corporate Plans saw the highest median return (-8.64%), followed by Endowments (-11.54%) U.S. equities posted a quarterly median return of -21.28%, versus the Russell 3000 Index return of -20.90%. Non-U.S. equities saw a median return of -23.64%, compared to the FTSE Developed ex U.S. Net Index result of -23.17%. U.S. fixed income had a median return of +0.51%, versus the Barclays Capital U.S. Aggregate Bond Index return of +3.15%. Non-U.S. fixed income had a median return of -12.19%, versus the FTSE World Government Bond Non-US Index return of -1.88%. Real estate had a median return of +1.34%, versus the NCREIF Property Index result of +0.71%. BNY Mellon U.S. Master Trust Universe users are now able to take advantage of BNY Mellon Asset Strategy Viewas a separate service for additional analysis. BNY Mellon Asset Strategy View layers big data analytics onto detailed asset allocation, performance, and cash flow data for the majority of the BNY Mellon U.S. Master Trust Universe. It provides additional insight into underlying market trends and investor activity. BNY Mellon U.S. Master Trust Universe Median Plan Returns* Period Ending March 31, 2020 Universe Number of Participants 1Q 2020 One- Year Five-Years Ten-Years Master Trust Total Fund 519 (10.90) (2.65) 4.01 6.56 Corporate Plans 225 (8.64) 1.14 4.71 7.23 Foundations 79 (12.80) (5.03) 3.17 5.84 Endowments 73 (11.34) (3.86) 3.59 6.10 Public Plans 79 (12.54) (4.14) 3.88 6.61 Taft-Hartley Plans 33 (12.32) (4.87) 3.30 6.00 Health Care Plans 20 (9.56) (1.81) 3.79 - *All returns are posted gross of fee results. BNY Mellon Asset Allocation Medians of those invested by Asset Class Period Ending March 31, 2020 Asset Class Q1 2020 One Year Ago Three Years Ago Five Years Ago US Equity 18.35% 22.13% 23.09% 23.43% Non-US Equity 11.18% 14.01% 15.91% 15.07% Global Equity 5.04% 5.58% 5.80% 5.30% US Fixed Income 24.28% 23.37% 19.66% 21.23% Global Fixed Income 2.03% 2.15% 2.44% 1.89% Non-US Fixed Income 2.34% 2.44% 3.13% 3.38% TIPS/Inflation Linked Bonds 3.39% 3.43% 3.13% 3.22% Real Estate 12.62% 11.87% 14.79% 15.27% Private Equity 10.46% 8.59% 7.94% 8.14% Other Real Assets 5.61% 5.36% 5.12% 4.90% Hedge Funds 2.30% 2.32% 2.82% 3.48% Cash 1.51% 1.20% 1.23% 1.78% ABOUT BNY MELLONBNY Mellon is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle. Whether providing financial services for institutions, corporations or individual investors, BNY Mellon delivers informed investment management and investment services in 35 countries. As of March 31, 2020, BNY Mellon had $35.2 trillion in assets under custody and/or administration, and $1.8 trillion in assets under management. BNY Mellon can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute or restructure investments. BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Additional information is available on www.bnymellon.com. Follow us on Twitter @BNYMellon or visit our newsroom at www.bnymellon.com/newsroom for the latest company news. Barclays Capital U.S. Aggregate Bond Index Barclays Bank PLC 2016. This data is provided by Barclays Bank PLC all rights are reserved. FTSE Non-US World Government Bond, FTSE Developed x US Index, Russell 3000 Index:Source: London Stock Exchange Group plc and its group undertakings (collectively, the "LSE Group"). LSE Group 2019. FTSE Russell is a trading name of certain of the LSE Group companies. "FTSE" "Russell", are trade mark(s) of the relevant LSE Group companies and is/are used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company's express written Contact: Paul PatellaBNY Mellon Asset Servicing[emailprotected]+1 212 635 1378 SOURCE BNY Mellon Asset Servicing
|
edtsum6759
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TORONTO, June 24, 2020 /PRNewswire/ -- World Health Organization director-general Tedros Adhanom Ghebreyesus today warned that Covid-19 misinformation spreads significantly quicker than truth online and is 70 percent more likely to be shared on some social platforms. Dr Tedros made the remarks at the 32,000-attendee Collision from Home, produced by the team behind Web Summit the world's largest tech conference. Dr Tedros spoke of WHO's partnerships with major tech companies to combat the spread of misinformation, something he said is "key" to fighting "the infodemic of misinformation and falsehoods". "Misinformation travels further, faster and sometimes deeper than the truth. On some social media platforms, falsehoods are 70 percent more likely to be shared than accurate news. To counter this, we have set up systems with digital firms to remain one step ahead. "For example the WHO Health Alert chatbot was launched in March, providing up to 2 billion people with accurate and lifesaving information in over 40 languages via WhatsApp, Facebook, Messenger, Viber and others," said Dr Tedros, adding that these initiatives are most critical in "fragile states" with health services under increasing strain. "Fifty percent of all Arabic users of the WhatsApp chatbot are from Yemen a country whose health system has collapsed," said Dr Tedros. With Covid-19 cases now numbering 8.8 million worldwide and more than 465,000 people losing their lives to the disease, Dr Tedros implored tech founders and CEOs to ensure the technology they develop improves public health outcomes for the majority of people worldwide. "Ask yourself every day if the technology you're working on will work for the poorest and most vulnerable, or the rich and privileged. Will it make the world fairer, or widen the gap between the haves and the have-nots?" said Dr Tedros, who told Collision from Home attendees to reject innovation for innovation's sake, saying that new technology should seek to reduce rather than widen inequality. "We must make sure that innovation and technology help reduce the inequalities in our world, instead of becoming another reason people are left behind. We must be guided by evidence, not seduced by every new gadget," said Dr Tedros. Download clips from the interview here and here. About Tedros Adhanom Ghebreyesus: Tedros Adhanom Ghebreyesus is an Ethiopian microbiologist and internationally recognised malaria researcher who has served since 2017 as director-general of the World Health Organization. About Collision: Collision is known by CBC as the "TIFF for tech", while Inc. Magazine calls it the "fastest-growing tech conference in North America". Collision is set to move online for 2020 with Collision from Home. Collision will return to Toronto as a physical event for the second year from June 21-24, 2021 at the Enercare Centre. About Web Summit: Forbes says Web Summit is "the best tech conference on the planet"; Bloomberg calls it "Davos for geeks"; Politico, "the Olympics of tech"; The Guardian, "Glastonbury for geeks"; and, in the words of Inc. Magazine, "Web Summit is the largest technology conference in the world". Whatever Web Summit is, it wouldn't be possible without an incredible team of over 200 employees based in Dublin, Lisbon, Toronto and Hong Kong, including world-class engineers, data scientists, designers, producers, marketers, salespeople, and more. They've disrupted an old industry by building incredible software and designing mind-blowing events, revolutionising how people and ideas come together to change the world. Useful links: Collision images: https://www.flickr.com/photos/collisionconf/Collision speaker lineup: https://collisionconf.com/speakers Collision schedule: https://collisionconf.com/schedule SOURCE Web Summit
Answer:
|
Collision from Home: WHO Director-General: Covid-19 Lies up to 70% More Likely to be Shared Online Than Truth
|
TORONTO, June 24, 2020 /PRNewswire/ -- World Health Organization director-general Tedros Adhanom Ghebreyesus today warned that Covid-19 misinformation spreads significantly quicker than truth online and is 70 percent more likely to be shared on some social platforms. Dr Tedros made the remarks at the 32,000-attendee Collision from Home, produced by the team behind Web Summit the world's largest tech conference. Dr Tedros spoke of WHO's partnerships with major tech companies to combat the spread of misinformation, something he said is "key" to fighting "the infodemic of misinformation and falsehoods". "Misinformation travels further, faster and sometimes deeper than the truth. On some social media platforms, falsehoods are 70 percent more likely to be shared than accurate news. To counter this, we have set up systems with digital firms to remain one step ahead. "For example the WHO Health Alert chatbot was launched in March, providing up to 2 billion people with accurate and lifesaving information in over 40 languages via WhatsApp, Facebook, Messenger, Viber and others," said Dr Tedros, adding that these initiatives are most critical in "fragile states" with health services under increasing strain. "Fifty percent of all Arabic users of the WhatsApp chatbot are from Yemen a country whose health system has collapsed," said Dr Tedros. With Covid-19 cases now numbering 8.8 million worldwide and more than 465,000 people losing their lives to the disease, Dr Tedros implored tech founders and CEOs to ensure the technology they develop improves public health outcomes for the majority of people worldwide. "Ask yourself every day if the technology you're working on will work for the poorest and most vulnerable, or the rich and privileged. Will it make the world fairer, or widen the gap between the haves and the have-nots?" said Dr Tedros, who told Collision from Home attendees to reject innovation for innovation's sake, saying that new technology should seek to reduce rather than widen inequality. "We must make sure that innovation and technology help reduce the inequalities in our world, instead of becoming another reason people are left behind. We must be guided by evidence, not seduced by every new gadget," said Dr Tedros. Download clips from the interview here and here. About Tedros Adhanom Ghebreyesus: Tedros Adhanom Ghebreyesus is an Ethiopian microbiologist and internationally recognised malaria researcher who has served since 2017 as director-general of the World Health Organization. About Collision: Collision is known by CBC as the "TIFF for tech", while Inc. Magazine calls it the "fastest-growing tech conference in North America". Collision is set to move online for 2020 with Collision from Home. Collision will return to Toronto as a physical event for the second year from June 21-24, 2021 at the Enercare Centre. About Web Summit: Forbes says Web Summit is "the best tech conference on the planet"; Bloomberg calls it "Davos for geeks"; Politico, "the Olympics of tech"; The Guardian, "Glastonbury for geeks"; and, in the words of Inc. Magazine, "Web Summit is the largest technology conference in the world". Whatever Web Summit is, it wouldn't be possible without an incredible team of over 200 employees based in Dublin, Lisbon, Toronto and Hong Kong, including world-class engineers, data scientists, designers, producers, marketers, salespeople, and more. They've disrupted an old industry by building incredible software and designing mind-blowing events, revolutionising how people and ideas come together to change the world. Useful links: Collision images: https://www.flickr.com/photos/collisionconf/Collision speaker lineup: https://collisionconf.com/speakers Collision schedule: https://collisionconf.com/schedule SOURCE Web Summit
|
edtsum6773
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SHANGHAI, Oct. 26, 2020 /PRNewswire/ -- On October 24, the International Forum on Zero Trans-Fat Oil, organized by the Grease Branch of the Chinese Cereals and Oils Association and Yihai Kerry Group, and co-organized by the oil provider Arawana Sunshine, was held in Shanghai. This was the response of the Chinese food sector to WHO's REPLACE action package. The emergence of trans-fat-free cooking oils indicates that China is about to enter the 5G oil era. Summary of Jennifer Coates' report Progress, Policies and Commitments to Eliminating Trans-Fats from the Global Food Supply Chain (PRNewsfoto/Yihai Kerry Group) Abstract of Risk Assessment of Dietary Trans-Fatty Acids Intake in the Chinese Population (PRNewsfoto/Yihai Kerry Group) Main Screen of the International Forum on Zero Trans-Fat Oil (PRNewsfoto/Yihai Kerry Group) The signing ceremony for Sunshine Arawana Global Joint Initiative for Zero Trans-Fat Oil (PRNewsfoto/Yihai Kerry Group) WHO estimates that every year, trans-fat intake results in more than 500,000 deaths caused by cardiovascular diseases. Professor Jennifer Coates, a WHO expert, explained at the Forum: more than 40,000 Chinese per 1 million of the population are at risk from intake of trans-fatty acids (TFA). According to the report Risk Assessment of Dietary Trans-Fatty Acids Intake in the Chinese Population released in 2012, about half the TFA intake of Chinese people in large cities came from cooking oils. Based on this, Yihai Kerry Group invested more than 200 million yuan in systematic and comprehensive research into green processing technology with precision and moderation factored in, and accelerated it into industrial application, thereby launching the healthy oil era of Arawana Sunshine Zero Trans-Fat Vegetable Oils. To date, Arawana Sunshine has marketed corn oil, sunflower seed oil, canola oil and soybean oil under the Sunshine brand. Professor Walter Willett of Harvard University said: "Arawana Sunshine zero trans-fat vegetable oils help China to control the intake of TFA at the source, thereby avoiding the health risks posed by TFA to 1.4 billion people." Now Arawana is pursuing a new international path with its Sunshine Zero Trans-Fat Vegetable Oils, seeking to implement the REPLACE action package and to offer more dining options for Chinesepeople. SOURCE Yihai Kerry Group
Answer:
|
WHO experts acclaim Arawana as an oil of the 5G era, and they recommend the consumption of trans-fat-free cooking oils USA - English France - Franais Deutschland - Deutsch
|
SHANGHAI, Oct. 26, 2020 /PRNewswire/ -- On October 24, the International Forum on Zero Trans-Fat Oil, organized by the Grease Branch of the Chinese Cereals and Oils Association and Yihai Kerry Group, and co-organized by the oil provider Arawana Sunshine, was held in Shanghai. This was the response of the Chinese food sector to WHO's REPLACE action package. The emergence of trans-fat-free cooking oils indicates that China is about to enter the 5G oil era. Summary of Jennifer Coates' report Progress, Policies and Commitments to Eliminating Trans-Fats from the Global Food Supply Chain (PRNewsfoto/Yihai Kerry Group) Abstract of Risk Assessment of Dietary Trans-Fatty Acids Intake in the Chinese Population (PRNewsfoto/Yihai Kerry Group) Main Screen of the International Forum on Zero Trans-Fat Oil (PRNewsfoto/Yihai Kerry Group) The signing ceremony for Sunshine Arawana Global Joint Initiative for Zero Trans-Fat Oil (PRNewsfoto/Yihai Kerry Group) WHO estimates that every year, trans-fat intake results in more than 500,000 deaths caused by cardiovascular diseases. Professor Jennifer Coates, a WHO expert, explained at the Forum: more than 40,000 Chinese per 1 million of the population are at risk from intake of trans-fatty acids (TFA). According to the report Risk Assessment of Dietary Trans-Fatty Acids Intake in the Chinese Population released in 2012, about half the TFA intake of Chinese people in large cities came from cooking oils. Based on this, Yihai Kerry Group invested more than 200 million yuan in systematic and comprehensive research into green processing technology with precision and moderation factored in, and accelerated it into industrial application, thereby launching the healthy oil era of Arawana Sunshine Zero Trans-Fat Vegetable Oils. To date, Arawana Sunshine has marketed corn oil, sunflower seed oil, canola oil and soybean oil under the Sunshine brand. Professor Walter Willett of Harvard University said: "Arawana Sunshine zero trans-fat vegetable oils help China to control the intake of TFA at the source, thereby avoiding the health risks posed by TFA to 1.4 billion people." Now Arawana is pursuing a new international path with its Sunshine Zero Trans-Fat Vegetable Oils, seeking to implement the REPLACE action package and to offer more dining options for Chinesepeople. SOURCE Yihai Kerry Group
|
edtsum6774
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BETHESDA, Md., Nov. 4, 2020 /PRNewswire/ --Walker & Dunlop, Inc.announced today that it completed the $60,000,000 sale of 416 on Broadway, a 115-unit Class A apartment community in the established Glendale submarket of Los Angeles, California. 416 on Broadway Originally built as for-sale condominiums in 2009, 416 on Broadway boasts exceptionally large floor plans, averaging 1,102 square feet. This unique feature has proven to be a significant advantage over the competition, as renters continue to work from home and desire extra space. In addition to spacious units, residents enjoy a boutique feel, an abundance of outdoor amenity space, including a fully renovated state-of-the-art fitness center, and convenient access to the retail, entertainment, and dining in Glendale. Its excellent location and unmatched offerings position 416 on Broadway to perform well for years to come. Walker & Dunlop's property sales team included Hunter Combsand Blake Rogers. The team represented both the buyer, Ron Nasch, and the seller, Essex Property Trust, serving as broker and advisor for the disposition. Said Mr. Combs, "416 on Broadway is a best-in-class asset located in the durable Glendale submarket. Although Glendale has seen an increase in multifamily inventory of about 11 percent since 2010, it has been able to consistently achieve occupancy rates north of 96 percent, as well as meaningful rent growth." Combs added, "Additionally, from a sale perspective, the submarket has only seen six institutional multifamily sales since 2009, adding a scarcity premium to opportunities that arise. Moreover, the lack of supply headwinds is particularly encouraging."Walker & Dunlop also arranged Fannie Mae acquisition debt on behalf of the buyer. The finance team was led by Brian Eisnerand Levi Brooker, who commented, "In spite of the challenges posed by the pandemic, Walker & Dunlop was extremely pleased to deliver a long-term interest only loan at a historically low interest rate."Walker & Dunlop is a top-ranked multifamily lender; the firm was the #1 Fannie Mae DUS multifamily lender and the #3 Freddie Mac Optigo lender by volume in 2019. The company has also achieved dramatic growth in its property sales group, with $5.4 billion in sales volume completed in 2019 and $3.3 billion completed year-to-date.For information about Walker & Dunlop's view on the apartment market, including expert perspectives on markets, leadership, and the road ahead, visit our Driven by Insightinformation center.About Walker & DunlopWalker & Dunlop(NYSE: WD), headquartered in Bethesda, Maryland, is one of the largest commercial real estate finance companies in the United States. The company provides a comprehensive range of capital solutions for all commercial real estate asset classes, as well as investment sales brokerage services to owners of multifamily properties. Walker & Dunlop is included on the S&P SmallCap 600 Index and was ranked as one of FORTUNE Magazine's Fastest Growing Companies in 2014, 2017, and 2018. Walker & Dunlop's 900+ professionals in 40 offices across the nation have an unyielding commitment to client satisfaction.SOURCE Walker & Dunlop, Inc. Related Links http://www.walkerdunlop.com
Answer:
|
Walker & Dunlop Completes $60 Million Sale and Financing for Unique Condo-to-Multifamily Redevelopment in Los Angeles
|
BETHESDA, Md., Nov. 4, 2020 /PRNewswire/ --Walker & Dunlop, Inc.announced today that it completed the $60,000,000 sale of 416 on Broadway, a 115-unit Class A apartment community in the established Glendale submarket of Los Angeles, California. 416 on Broadway Originally built as for-sale condominiums in 2009, 416 on Broadway boasts exceptionally large floor plans, averaging 1,102 square feet. This unique feature has proven to be a significant advantage over the competition, as renters continue to work from home and desire extra space. In addition to spacious units, residents enjoy a boutique feel, an abundance of outdoor amenity space, including a fully renovated state-of-the-art fitness center, and convenient access to the retail, entertainment, and dining in Glendale. Its excellent location and unmatched offerings position 416 on Broadway to perform well for years to come. Walker & Dunlop's property sales team included Hunter Combsand Blake Rogers. The team represented both the buyer, Ron Nasch, and the seller, Essex Property Trust, serving as broker and advisor for the disposition. Said Mr. Combs, "416 on Broadway is a best-in-class asset located in the durable Glendale submarket. Although Glendale has seen an increase in multifamily inventory of about 11 percent since 2010, it has been able to consistently achieve occupancy rates north of 96 percent, as well as meaningful rent growth." Combs added, "Additionally, from a sale perspective, the submarket has only seen six institutional multifamily sales since 2009, adding a scarcity premium to opportunities that arise. Moreover, the lack of supply headwinds is particularly encouraging."Walker & Dunlop also arranged Fannie Mae acquisition debt on behalf of the buyer. The finance team was led by Brian Eisnerand Levi Brooker, who commented, "In spite of the challenges posed by the pandemic, Walker & Dunlop was extremely pleased to deliver a long-term interest only loan at a historically low interest rate."Walker & Dunlop is a top-ranked multifamily lender; the firm was the #1 Fannie Mae DUS multifamily lender and the #3 Freddie Mac Optigo lender by volume in 2019. The company has also achieved dramatic growth in its property sales group, with $5.4 billion in sales volume completed in 2019 and $3.3 billion completed year-to-date.For information about Walker & Dunlop's view on the apartment market, including expert perspectives on markets, leadership, and the road ahead, visit our Driven by Insightinformation center.About Walker & DunlopWalker & Dunlop(NYSE: WD), headquartered in Bethesda, Maryland, is one of the largest commercial real estate finance companies in the United States. The company provides a comprehensive range of capital solutions for all commercial real estate asset classes, as well as investment sales brokerage services to owners of multifamily properties. Walker & Dunlop is included on the S&P SmallCap 600 Index and was ranked as one of FORTUNE Magazine's Fastest Growing Companies in 2014, 2017, and 2018. Walker & Dunlop's 900+ professionals in 40 offices across the nation have an unyielding commitment to client satisfaction.SOURCE Walker & Dunlop, Inc. Related Links http://www.walkerdunlop.com
|
edtsum6775
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--Property Solutions Acquisition Corp. II (the Company), a special purpose acquisition company, today announced the closing of its upsized initial public offering of 30,000,000 units at a price to the public of $10.00 per unit. The offering resulted in gross proceeds to the Company of $300 million. The units began trading on The Nasdaq Capital Market (Nasdaq) under the symbol PSAGU on March 4, 2021. Each unit consists of one share of Class A common stock and one-fourth of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one share of Class A common stock. Once the securities comprising the units begin separate trading, the Class A common stock and redeemable warrants are expected to be traded on Nasdaq under the symbols PSAG and PSAGW, respectively. EarlyBirdCapital, Inc. acted as the sole book-running manager for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any. Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of units, $300 million (or $10.00 per unit sold in the public offering) was placed in trust. An audited balance sheet of the Company as of March 8, 2020 reflecting receipt of the proceeds upon consummation of the initial public offering and the private placement will be included as an exhibit to a Current Report on Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission (the SEC). A registration statement relating to the securities became effective on March 3, 2021. The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained, when available, for free by visiting EDGAR on the SECs website at www.sec.gov. Alternatively, copies may be obtained, when available, from EarlyBirdCapital, Inc., 366 Madison Avenue, 8th Floor, New York, NY 10017, Attn: Syndicate Department, 212-661-0200. Copies of the registration statement can be accessed through the SECs website at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Property Solutions Acquisition Corp. II Property Solutions Acquisition Corp. II is a newly organized blank check company incorporated as a Delaware corporation for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. Although the Company may pursue a business combination opportunity in any business, industry, sector or geographical location it chooses, it currently intends to focus on target companies that service the real estate industry, including property technology. Cautionary Statement Concerning Forward-Looking Statements This press release contains statements that constitute forward-looking statements, including with respect to the initial public offering and search for a business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Companys registration statement and prospectus for the offering filed with the SEC. Copies are available on the SECs website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Answer:
|
Property Solutions Acquisition Corp. II Announces Closing of Upsized $300 Million Initial Public Offering
|
NEW YORK--(BUSINESS WIRE)--Property Solutions Acquisition Corp. II (the Company), a special purpose acquisition company, today announced the closing of its upsized initial public offering of 30,000,000 units at a price to the public of $10.00 per unit. The offering resulted in gross proceeds to the Company of $300 million. The units began trading on The Nasdaq Capital Market (Nasdaq) under the symbol PSAGU on March 4, 2021. Each unit consists of one share of Class A common stock and one-fourth of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one share of Class A common stock. Once the securities comprising the units begin separate trading, the Class A common stock and redeemable warrants are expected to be traded on Nasdaq under the symbols PSAG and PSAGW, respectively. EarlyBirdCapital, Inc. acted as the sole book-running manager for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any. Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of units, $300 million (or $10.00 per unit sold in the public offering) was placed in trust. An audited balance sheet of the Company as of March 8, 2020 reflecting receipt of the proceeds upon consummation of the initial public offering and the private placement will be included as an exhibit to a Current Report on Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission (the SEC). A registration statement relating to the securities became effective on March 3, 2021. The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained, when available, for free by visiting EDGAR on the SECs website at www.sec.gov. Alternatively, copies may be obtained, when available, from EarlyBirdCapital, Inc., 366 Madison Avenue, 8th Floor, New York, NY 10017, Attn: Syndicate Department, 212-661-0200. Copies of the registration statement can be accessed through the SECs website at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Property Solutions Acquisition Corp. II Property Solutions Acquisition Corp. II is a newly organized blank check company incorporated as a Delaware corporation for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. Although the Company may pursue a business combination opportunity in any business, industry, sector or geographical location it chooses, it currently intends to focus on target companies that service the real estate industry, including property technology. Cautionary Statement Concerning Forward-Looking Statements This press release contains statements that constitute forward-looking statements, including with respect to the initial public offering and search for a business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Companys registration statement and prospectus for the offering filed with the SEC. Copies are available on the SECs website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
|
edtsum6776
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Hydrogels - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The global market for Hydrogel is projected to reach US$15.3 billion by 2025, driven by their growing use in wound care products and drug delivery systems (DDS). Defined as a three-dimensional (3D) hydrophilic polymer capable of holding large amounts of water, hydrogel is valuable in biological applications as they resemble natural tissue and their high water content. Strong R&D interest is already underway for hydrogel biomaterials. New developments in hydrogel design and hydrogel synthesis are resulting in the development of hydrogels with mechanical properties. Superporous comb-type grafted hydrogels with fast response times; hybrid graft copolymers based self-assembling hydrogels; protein based hydrogels' and hybrid hydrogels are the emerging new future of smart hydrogel based biomaterials. Stimuli-sensitive hydrogels, especially polypeptide based responsive hydrogels hold promising potential. Protein hydrogel are more biocompatible than synthetic hydrogel as they do not require the use of oxic chemical crosslinkers. This represents a key growth opportunity in the market given that traditional hydrogels have been largely limited by their poor mechanical properties and slow response times to stimuli. Temperature-sensitive hydrogels especially will find attractive opportunities in biomedicine. Wound dressings currently remain a popular application area with hydrogel being effective for treating dry necrotic wounds and rapid healing of burn wounds. Hydrogel enables painless debridement of infected tissue and provides a moist wound environment for faster healing. Chitosan-based hydrogels, in this regard, are growing in popularity for their biocompatible, antimicrobial, and hemostatic effects. Acellular Hydrogel is especially valuable in accelerated healing of third-degree burn wounds and is a welcome substitute for complicated and infection prone skin grafts. Encouraging progress is being made in the use of hydrogels for targeted & controlled drug delivery. Hydrogels can prolong drug release kinetics. Their porosity and aqueous features make them perfect biocompatible drug delivery vehicles. Chitosan-based hydrogels can be loaded with active drug compounds like growth factors or stem cells that are important in providing scaffold for cell growth. The growing focus on controlled and targeted drug delivery systems in the field of cardiology, oncology, immunology, and pain management bodes well for future growth in the market. Some of the physical properties of hydrogel that can be manipulated and tuned to suit drug delivery needs include porosity, swelling and elasticity in response to stimuli such as temperature, solvent quality, pH, electric field; resistance to dissolution; free diffusion of solute molecules in water; among others. These properties help in controlled drug release and protect from drug degradation, thereby making them highly effective vehicles for drug delivery systems. Some of the types of hydrogels development for drug delivery include DNA-hydrogels; supramolecular hydrogels; bio-inspired hydrogels; and multi-functional and stimuli-responsive hydrogels. New emerging uses in contact lenses and tissue engineering will also benefit growth in the market in the coming years. The United States and Europe represent large markets worldwide with a combined share of 52.4% of the market. China ranks as the fastest growing market with a CAGR of 7.3% over the analysis period supported by the government's focus on revolutionizing biomedical engineering in the country. The country today ranks as the top country for biomedical research encouraged by a permissive regulatory climate. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE III. GEOGRAPHIC MARKET ANALYSIS UNITED STATES CANADA JAPAN CHINA FRANCE GERMANY ITALY UNITED KINGDOM SPAIN RUSSIA REST OF EUROPE ASIA-PACIFIC AUSTRALIA INDIA SOUTH KOREA REST OF ASIA-PACIFIC LATIN AMERICA ARGENTINA BRAZIL MEXICO REST OF LATIN AMERICA MIDDLE EAST IRAN ISRAEL SAUDI ARABIA UNITED ARAB EMIRATES REST OF MIDDLE EAST AFRICA IV. COMPETITION Total Companies Profiled: 59 For more information about this report visit https://www.researchandmarkets.com/r/9yfu7t
Answer:
|
Global $15.3 Bn Hydrogels Market Trajectory & Analytics to 2025 - ResearchAndMarkets.com
|
DUBLIN--(BUSINESS WIRE)--The "Hydrogels - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The global market for Hydrogel is projected to reach US$15.3 billion by 2025, driven by their growing use in wound care products and drug delivery systems (DDS). Defined as a three-dimensional (3D) hydrophilic polymer capable of holding large amounts of water, hydrogel is valuable in biological applications as they resemble natural tissue and their high water content. Strong R&D interest is already underway for hydrogel biomaterials. New developments in hydrogel design and hydrogel synthesis are resulting in the development of hydrogels with mechanical properties. Superporous comb-type grafted hydrogels with fast response times; hybrid graft copolymers based self-assembling hydrogels; protein based hydrogels' and hybrid hydrogels are the emerging new future of smart hydrogel based biomaterials. Stimuli-sensitive hydrogels, especially polypeptide based responsive hydrogels hold promising potential. Protein hydrogel are more biocompatible than synthetic hydrogel as they do not require the use of oxic chemical crosslinkers. This represents a key growth opportunity in the market given that traditional hydrogels have been largely limited by their poor mechanical properties and slow response times to stimuli. Temperature-sensitive hydrogels especially will find attractive opportunities in biomedicine. Wound dressings currently remain a popular application area with hydrogel being effective for treating dry necrotic wounds and rapid healing of burn wounds. Hydrogel enables painless debridement of infected tissue and provides a moist wound environment for faster healing. Chitosan-based hydrogels, in this regard, are growing in popularity for their biocompatible, antimicrobial, and hemostatic effects. Acellular Hydrogel is especially valuable in accelerated healing of third-degree burn wounds and is a welcome substitute for complicated and infection prone skin grafts. Encouraging progress is being made in the use of hydrogels for targeted & controlled drug delivery. Hydrogels can prolong drug release kinetics. Their porosity and aqueous features make them perfect biocompatible drug delivery vehicles. Chitosan-based hydrogels can be loaded with active drug compounds like growth factors or stem cells that are important in providing scaffold for cell growth. The growing focus on controlled and targeted drug delivery systems in the field of cardiology, oncology, immunology, and pain management bodes well for future growth in the market. Some of the physical properties of hydrogel that can be manipulated and tuned to suit drug delivery needs include porosity, swelling and elasticity in response to stimuli such as temperature, solvent quality, pH, electric field; resistance to dissolution; free diffusion of solute molecules in water; among others. These properties help in controlled drug release and protect from drug degradation, thereby making them highly effective vehicles for drug delivery systems. Some of the types of hydrogels development for drug delivery include DNA-hydrogels; supramolecular hydrogels; bio-inspired hydrogels; and multi-functional and stimuli-responsive hydrogels. New emerging uses in contact lenses and tissue engineering will also benefit growth in the market in the coming years. The United States and Europe represent large markets worldwide with a combined share of 52.4% of the market. China ranks as the fastest growing market with a CAGR of 7.3% over the analysis period supported by the government's focus on revolutionizing biomedical engineering in the country. The country today ranks as the top country for biomedical research encouraged by a permissive regulatory climate. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE III. GEOGRAPHIC MARKET ANALYSIS UNITED STATES CANADA JAPAN CHINA FRANCE GERMANY ITALY UNITED KINGDOM SPAIN RUSSIA REST OF EUROPE ASIA-PACIFIC AUSTRALIA INDIA SOUTH KOREA REST OF ASIA-PACIFIC LATIN AMERICA ARGENTINA BRAZIL MEXICO REST OF LATIN AMERICA MIDDLE EAST IRAN ISRAEL SAUDI ARABIA UNITED ARAB EMIRATES REST OF MIDDLE EAST AFRICA IV. COMPETITION Total Companies Profiled: 59 For more information about this report visit https://www.researchandmarkets.com/r/9yfu7t
|
edtsum6782
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--The MOCVD market is expected to grow by USD 84.93 million, progressing at a CAGR of over 5% during the forecast period. Click & Get Free Sample Report in Minutes The increasing focus on renewable energy is one of the major factors propelling market growth. However, factors such as trend of leasing MOCVD equipment will hamper the market growth. More details: https://www.technavio.com/report/MOCVD-market-industry-analysis MOCVD Market: End-user Landscape The optoelectronics segment includes devices such as LEDs, organic light-emitting diodes (OLEDs), laser diodes, and solar cells. MOCVD equipment is used during the production of optoelectronic devices. LED lighting applications have become the global standard in the private and public lighting markets owing to their energy efficiency. The growing investment in LED production plants will increase the orders of MOCVD equipment by LED manufacturers. The MOCVD market share growth by the optoelectronics will be significant during the forecast period. MOCVD Market: Geographic Landscape APAC will offer several growth opportunities to market vendors during the forecast period. 77% of the markets growth will originate from APAC during the forecast period. China, Japan, and Taiwan are the key markets for MOCVD in APAC. Market growth in this region will be faster than the growth of the market in other regions. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Related Reports on Information Technology Include: Global PLM Software Market in the Automotive Sector: The PLM software market size in the automotive sector has the potential to grow by USD 937.74 million during 2020-2024, and the markets growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes! Global Automotive Software Market: The automotive software market size has the potential to grow by USD 10.70 billion during 2020-2024, and the markets growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes! Companies Covered: What our reports offer: Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by End-user Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Answer:
|
Global MOCVD Market Report, History and Forecast 2020-2024, Breakdown Data by Companies, Key Regions, and End-Users | Technavio
|
LONDON--(BUSINESS WIRE)--The MOCVD market is expected to grow by USD 84.93 million, progressing at a CAGR of over 5% during the forecast period. Click & Get Free Sample Report in Minutes The increasing focus on renewable energy is one of the major factors propelling market growth. However, factors such as trend of leasing MOCVD equipment will hamper the market growth. More details: https://www.technavio.com/report/MOCVD-market-industry-analysis MOCVD Market: End-user Landscape The optoelectronics segment includes devices such as LEDs, organic light-emitting diodes (OLEDs), laser diodes, and solar cells. MOCVD equipment is used during the production of optoelectronic devices. LED lighting applications have become the global standard in the private and public lighting markets owing to their energy efficiency. The growing investment in LED production plants will increase the orders of MOCVD equipment by LED manufacturers. The MOCVD market share growth by the optoelectronics will be significant during the forecast period. MOCVD Market: Geographic Landscape APAC will offer several growth opportunities to market vendors during the forecast period. 77% of the markets growth will originate from APAC during the forecast period. China, Japan, and Taiwan are the key markets for MOCVD in APAC. Market growth in this region will be faster than the growth of the market in other regions. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Related Reports on Information Technology Include: Global PLM Software Market in the Automotive Sector: The PLM software market size in the automotive sector has the potential to grow by USD 937.74 million during 2020-2024, and the markets growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes! Global Automotive Software Market: The automotive software market size has the potential to grow by USD 10.70 billion during 2020-2024, and the markets growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes! Companies Covered: What our reports offer: Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by End-user Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
|
edtsum6784
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, Nov. 17, 2020 /PRNewswire/ -- The "Injection Molding Polyamide 6 Market by Grade (Reinforced PA6, Unreinforced PA6, Others), End-use Industry (Automotive, Electrical & Electronics, Industrial/Machinery, Consumer Goods & Appliances, Construction, Others), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The injection molding polyamide 6 market is projected to grow from USD 7.5 billion in 2020 to USD 10.4 billion by 2025, at a CAGR of 6.9% from 2020 to 2025. One of the key factors driving the growth of the injection molding polyamide 6 market includes the growing end-use industries in emerging economies. End-use industries such as automotive, electrical & electronics, industrial/machinery, consumer goods & appliances, and construction are expected to flourish in emerging economies, including China, India, and Thailand, during the forecast period. This, in turn, is expected to contribute to the growth of the injection molding polyamide 6 market. Polyamide 6 is also known as nylon 6 or polycaprolactam. It offers excellent surface finish, strength, stiffness, and chemical resistance to hydrocarbons. There are various grades of the injection moldable polyamide 6 available in the market, including glass fiber reinforced, carbon fiber reinforced, mineral reinforced, and others. Among all these grades, glass fiber reinforced polyamide 6 is most widely used around the world. Auto mirror housing brackets, clutch pedals, clutch master cylinders, ski bindings, steering wheels, levers, auto seat frames, door handles, and door lock mechanisms are some of the major applications of glass fiber reinforced polyamide 6 in the automotive industry. Reinforced PA6 is estimated to lead the injection molding polyamide 6 market, by grade in terms of value during the forecast period By grade, reinforced PA6 grade is estimated to be the largest segment in the injection molding polyamide 6 market in 2020, in terms of value. It is majorly due to the excellent properties offered by the reinforced PA 6 and high demand for glass fiber reinforced PA 6 from the automotive industry. The reinforcing of polyamide 6 makes it suitable to be used across applications in the automotive, electrical & electronics, construction, consumer goods & appliances industries. Automotive end-use industry is estimated to dominate the injection molding polyamide 6 market. By the end-use industry, the automotive segment dominated the injection molding polyamide 6 market in 2020, both in terms of value and volume. Injection molding polyamide 6 is used in the automotive industry for weight reduction of vehicles. It is also cheaper in unit cost in comparison to metals, and other grades of commonly used thermoplastics such as polyamide 66, making it an economical alternative. PA 6 has excellent tensile strength, stiffness, chemical resistance, heat resistance, wear resistance, and lubricity. Injection molding PA 6 is frequently used in the automotive parts manufacturing when a low-cost, high mechanical strength, rigid, and stable material is required. For example, PA 6 is extensively used in the door handles & radiator grills. Asia Pacific dominated the injection molding polyamide 6 market in 2019. Asia Pacific is estimated to account for the largest share of the injection molding polyamide 6 market in 2020. The growth of the automotive and electrical & electronics industries is responsible for driving the injection molding polyamide 6 market in this region. China is one of the key consumers of injection molding polyamide 6 in the region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 4.1 Attractive Opportunities In Injection Molding Polyamide 6 Market 4.2 Injection Molding Polyamide 6 Market, By End-Use Industry 4.3 Injection Molding Polyamide 6 Market, By Grade 4.4 Injection Molding Polyamide 6 Market, By Region 4.5 Asia Pacific Injection Molding Polyamide 6 Market, By Country & End-Use Industry 5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 High Demand From The Automotive Industry5.2.1.2 Shortage Of Polyamide 66 And Its Escalating Prices5.2.2 Restraints5.2.2.1 Increasing Competition From Substitutes5.2.3 Opportunities5.2.3.1 Growing Demand For Lightweight Vehicles5.2.3.2 Low Crude Oil Prices5.2.4 Challenges5.2.4.1 Low Thermal Stability And High Moisture Absorbing Nature Of Pa 65.2.4.2 Liquidity Crunch Due To Covid-19 Among End-use Industries5.3 Injection Molding Polyamide 6: Adjacent & Related Markets5.4 Porter's Five Forces Analysis5.4.1 Threat Of New Entrants5.4.2 Threat Of Substitutes5.4.3 Bargaining Power Of Suppliers5.4.4 Bargaining Power Of Buyers5.4.5 Intensity Of Competitive Rivalry6 Value Chain Analysis6.1 Introduction6.2 Value Chain Analysis6.2.1 Raw Material6.2.2 Research And Development6.2.3 Manufacturing6.2.4 Distribution Network6.2.5 End-use Industry7 Case Study7.1 Case Study Analysis8 Injection Molding Polyamide 6 Market, By Manufacturing Technology8.1 Introduction8.2 Injection Molding8.3 Key Parameters Impacting Quality Of Injection Molding Pa 6 Products9 Covid-19 Impact On Injection Molding Polyamide 6 Market9.1 Introduction9.2 Impact Of Covid-19 On Polyamide 6 Supply Chain9.2.1 Impact On Raw Material - Caprolactam9.2.1.1 Asia Pacific9.2.1.2 Europe9.2.1.3 North America9.2.2 Impact On Injection Molding Polyamide 6 (Pa 6/Nylon 6)9.2.2.1 Asia Pacific9.2.2.2 Europe9.2.2.3 North America9.2.3 End-use Industries9.2.3.1 Impact Of Covid-19 On The Automotive Industry9.2.3.2 Economic Impact Of Covid-19 On The Construction Industry10 Injection Molding Polyamide 6 Market, By Grade10.1 Introduction10.2 Reinforced Pa 610.3 Unreinforced Pa 610.4 Others11 Injection Molding Polyamide 6 Market, By End-use Industry11.1 Introduction11.2 Automotive11.2.1 Growing Demand For Lightweight Body Components And Efficient Fuel Systems In Automotive Industry Is Likely To Drive Market For Injection Molding Polyamide 611.3 Electrical & Electronics11.3.1 Electrical & Mechanical Properties Of Pa 6 Drive Its Demand In This Industry11.4 Industrial/Machinery11.4.1 Heavy-Duty Applications Of Injection Molding Polyamide 6 Drives Its Demand In Industrial/Machinery Industry11.5 Consumer Goods & Appliances11.5.1 Growing Replacement Of Metals With Engineered Plastics In Consumer Goods Industry Is Propelling The Growth Of Pa 6 Market11.6 Construction11.6.1 New Product Launches By Companies And Wide Applications Of Pa 6 Are Driving Its Demand In Construction Industry11.7 Others12 Injection Molding Polyamide 6 Market, By Region12.1 Introduction12.2 Asia Pacific12.3 Europe12.4 North America12.5 Middle East & Africa12.6 South America13 Competitive Landscape13.1 Overview13.2 Market Evaluation Framework13.3 Market Share Analysis13.3.1 Market Share Analysis Of Top Players In Injection Molding Polyamide 6 Market13.3.2 Revenue Analysis Of Top Market Players In Injection Molding Polyamide 6 Market13.4 Company Evaluation Quadrant Matrix Definitions And Methodology, 201913.4.1 Star13.4.2 Emerging Leaders13.4.3 Pervasive13.4.4 Participants13.5 Strength Of Product Portfolio13.6 Business Strategy Excellence13.7 Sme Matrix, 201913.7.1 Star13.7.2 Emerging Companies13.7.3 Pervasive13.7.4 Emerging Leaders13.8 Key Market Developments14 Company Profiles14.1 DSM14.2 BASF SE14.3 Domo Chemicals14.4 Radici Group14.5 Lanxess Corporation14.6 Toray Industries, Inc.14.7 Sabic14.8 RTP Company14.9 UBE Industries Limited14.10 Dupont14.11 Advansix14.12 Lyondellbasell Industries Holdings B.V.14.13 Addiplast Group14.14 Grupa Azoty14.15 Other Companies14.15.1 Ad Majoris14.15.2 Adell Plastics Inc.14.15.3 Akay Plastik14.15.4 Shanghai Pret Composites Co., Ltd.14.15.5 Yuh-Dean Enterprise Co., Ltd.15 Appendix For more information about this report visit https://www.researchandmarkets.com/r/jjhrsh Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer:
|
Worldwide Industry for Injection Molding Polyamide 6 to 2025 - Players Include DSM, BASF & Domo Chemicals Among Others
|
DUBLIN, Nov. 17, 2020 /PRNewswire/ -- The "Injection Molding Polyamide 6 Market by Grade (Reinforced PA6, Unreinforced PA6, Others), End-use Industry (Automotive, Electrical & Electronics, Industrial/Machinery, Consumer Goods & Appliances, Construction, Others), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The injection molding polyamide 6 market is projected to grow from USD 7.5 billion in 2020 to USD 10.4 billion by 2025, at a CAGR of 6.9% from 2020 to 2025. One of the key factors driving the growth of the injection molding polyamide 6 market includes the growing end-use industries in emerging economies. End-use industries such as automotive, electrical & electronics, industrial/machinery, consumer goods & appliances, and construction are expected to flourish in emerging economies, including China, India, and Thailand, during the forecast period. This, in turn, is expected to contribute to the growth of the injection molding polyamide 6 market. Polyamide 6 is also known as nylon 6 or polycaprolactam. It offers excellent surface finish, strength, stiffness, and chemical resistance to hydrocarbons. There are various grades of the injection moldable polyamide 6 available in the market, including glass fiber reinforced, carbon fiber reinforced, mineral reinforced, and others. Among all these grades, glass fiber reinforced polyamide 6 is most widely used around the world. Auto mirror housing brackets, clutch pedals, clutch master cylinders, ski bindings, steering wheels, levers, auto seat frames, door handles, and door lock mechanisms are some of the major applications of glass fiber reinforced polyamide 6 in the automotive industry. Reinforced PA6 is estimated to lead the injection molding polyamide 6 market, by grade in terms of value during the forecast period By grade, reinforced PA6 grade is estimated to be the largest segment in the injection molding polyamide 6 market in 2020, in terms of value. It is majorly due to the excellent properties offered by the reinforced PA 6 and high demand for glass fiber reinforced PA 6 from the automotive industry. The reinforcing of polyamide 6 makes it suitable to be used across applications in the automotive, electrical & electronics, construction, consumer goods & appliances industries. Automotive end-use industry is estimated to dominate the injection molding polyamide 6 market. By the end-use industry, the automotive segment dominated the injection molding polyamide 6 market in 2020, both in terms of value and volume. Injection molding polyamide 6 is used in the automotive industry for weight reduction of vehicles. It is also cheaper in unit cost in comparison to metals, and other grades of commonly used thermoplastics such as polyamide 66, making it an economical alternative. PA 6 has excellent tensile strength, stiffness, chemical resistance, heat resistance, wear resistance, and lubricity. Injection molding PA 6 is frequently used in the automotive parts manufacturing when a low-cost, high mechanical strength, rigid, and stable material is required. For example, PA 6 is extensively used in the door handles & radiator grills. Asia Pacific dominated the injection molding polyamide 6 market in 2019. Asia Pacific is estimated to account for the largest share of the injection molding polyamide 6 market in 2020. The growth of the automotive and electrical & electronics industries is responsible for driving the injection molding polyamide 6 market in this region. China is one of the key consumers of injection molding polyamide 6 in the region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 4.1 Attractive Opportunities In Injection Molding Polyamide 6 Market 4.2 Injection Molding Polyamide 6 Market, By End-Use Industry 4.3 Injection Molding Polyamide 6 Market, By Grade 4.4 Injection Molding Polyamide 6 Market, By Region 4.5 Asia Pacific Injection Molding Polyamide 6 Market, By Country & End-Use Industry 5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 High Demand From The Automotive Industry5.2.1.2 Shortage Of Polyamide 66 And Its Escalating Prices5.2.2 Restraints5.2.2.1 Increasing Competition From Substitutes5.2.3 Opportunities5.2.3.1 Growing Demand For Lightweight Vehicles5.2.3.2 Low Crude Oil Prices5.2.4 Challenges5.2.4.1 Low Thermal Stability And High Moisture Absorbing Nature Of Pa 65.2.4.2 Liquidity Crunch Due To Covid-19 Among End-use Industries5.3 Injection Molding Polyamide 6: Adjacent & Related Markets5.4 Porter's Five Forces Analysis5.4.1 Threat Of New Entrants5.4.2 Threat Of Substitutes5.4.3 Bargaining Power Of Suppliers5.4.4 Bargaining Power Of Buyers5.4.5 Intensity Of Competitive Rivalry6 Value Chain Analysis6.1 Introduction6.2 Value Chain Analysis6.2.1 Raw Material6.2.2 Research And Development6.2.3 Manufacturing6.2.4 Distribution Network6.2.5 End-use Industry7 Case Study7.1 Case Study Analysis8 Injection Molding Polyamide 6 Market, By Manufacturing Technology8.1 Introduction8.2 Injection Molding8.3 Key Parameters Impacting Quality Of Injection Molding Pa 6 Products9 Covid-19 Impact On Injection Molding Polyamide 6 Market9.1 Introduction9.2 Impact Of Covid-19 On Polyamide 6 Supply Chain9.2.1 Impact On Raw Material - Caprolactam9.2.1.1 Asia Pacific9.2.1.2 Europe9.2.1.3 North America9.2.2 Impact On Injection Molding Polyamide 6 (Pa 6/Nylon 6)9.2.2.1 Asia Pacific9.2.2.2 Europe9.2.2.3 North America9.2.3 End-use Industries9.2.3.1 Impact Of Covid-19 On The Automotive Industry9.2.3.2 Economic Impact Of Covid-19 On The Construction Industry10 Injection Molding Polyamide 6 Market, By Grade10.1 Introduction10.2 Reinforced Pa 610.3 Unreinforced Pa 610.4 Others11 Injection Molding Polyamide 6 Market, By End-use Industry11.1 Introduction11.2 Automotive11.2.1 Growing Demand For Lightweight Body Components And Efficient Fuel Systems In Automotive Industry Is Likely To Drive Market For Injection Molding Polyamide 611.3 Electrical & Electronics11.3.1 Electrical & Mechanical Properties Of Pa 6 Drive Its Demand In This Industry11.4 Industrial/Machinery11.4.1 Heavy-Duty Applications Of Injection Molding Polyamide 6 Drives Its Demand In Industrial/Machinery Industry11.5 Consumer Goods & Appliances11.5.1 Growing Replacement Of Metals With Engineered Plastics In Consumer Goods Industry Is Propelling The Growth Of Pa 6 Market11.6 Construction11.6.1 New Product Launches By Companies And Wide Applications Of Pa 6 Are Driving Its Demand In Construction Industry11.7 Others12 Injection Molding Polyamide 6 Market, By Region12.1 Introduction12.2 Asia Pacific12.3 Europe12.4 North America12.5 Middle East & Africa12.6 South America13 Competitive Landscape13.1 Overview13.2 Market Evaluation Framework13.3 Market Share Analysis13.3.1 Market Share Analysis Of Top Players In Injection Molding Polyamide 6 Market13.3.2 Revenue Analysis Of Top Market Players In Injection Molding Polyamide 6 Market13.4 Company Evaluation Quadrant Matrix Definitions And Methodology, 201913.4.1 Star13.4.2 Emerging Leaders13.4.3 Pervasive13.4.4 Participants13.5 Strength Of Product Portfolio13.6 Business Strategy Excellence13.7 Sme Matrix, 201913.7.1 Star13.7.2 Emerging Companies13.7.3 Pervasive13.7.4 Emerging Leaders13.8 Key Market Developments14 Company Profiles14.1 DSM14.2 BASF SE14.3 Domo Chemicals14.4 Radici Group14.5 Lanxess Corporation14.6 Toray Industries, Inc.14.7 Sabic14.8 RTP Company14.9 UBE Industries Limited14.10 Dupont14.11 Advansix14.12 Lyondellbasell Industries Holdings B.V.14.13 Addiplast Group14.14 Grupa Azoty14.15 Other Companies14.15.1 Ad Majoris14.15.2 Adell Plastics Inc.14.15.3 Akay Plastik14.15.4 Shanghai Pret Composites Co., Ltd.14.15.5 Yuh-Dean Enterprise Co., Ltd.15 Appendix For more information about this report visit https://www.researchandmarkets.com/r/jjhrsh Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
|
edtsum6786
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Automotive Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering. The automotive anti lock braking system (ABS) and electronic stability control (ESC) system market is expected to grow with a CAGR of 8% from 2019 to 2024. The future of the automotive anti lock braking system (ABS) and electronic stability control (ESC) system market looks promising with opportunities in the passenger car and commercial vehicle segments. The major drivers for this market are government legislation, new car assessment programs, focus on occupant safety, buyer's preferences for safety technologies, and an increasing number of auto collisions. A more than 150-page report is developed to help in your business decisions. To learn the scope of, benefits, companies researched and other details of the anti lock braking system (ABS) and electronic stability control (ESC) system market report then read this report. Some of the automotive anti lock braking system (ABS)and electronic stability control (ESC) system companies profiled in this report include Robert Bosch, Autoliv, TRW Automotive, Delphi Automotive, Denso Corporation, Continental, and Hyundai Mobis, and others. Some of the features of Automotive Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market 2019-2024: Trends, Forecast, and Opportunity Analysis include: This report answers the following 11 key questions: Key Topics Covered: 1. Executive Summary 2. Market Trends and Forecast Analysis from 2013 to 2024 2.1: Introduction, Background, and Classification 2.2: Supply Chain 2.3: Industry Drivers and Challenges 3. Market Trends and Forecast Analysis from 2013 to 2024 3.1: Macroeconomic Trends and Forecast 3.2: Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market: Trends and Forecast 3.3: Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market by Sub- Systems 3.3.1: Sensors 3.3.2: ECU 3.3.3: Hydraulic Unit 3.4: Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market by End Use 3.4.1: Small cars 3.4.2: Compact cars 3.4.3: Mid-Sized cars 3.4.4: Luxury cars 3.4.5: SUVs & Crossovers 3.4.6: Light commercial vehicles 4. Market Trends and Forecast Analysis by Region 5. Competitor Analysis 5.1: Product Portfolio Analysis 5.2: Market Share Analysis 5.3: Operational Integration 5.4: Geographical Reach 5.5: Porter's Five Forces Analysis 6. Growth Opportunities and Strategic Analysis 6.1: Growth Opportunity Analysis 6.1.1: Growth Opportunities for Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market by Sub-Systems. 6.1.2: Growth Opportunities for Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market by End Use 6.1.3: Growth Opportunities for Global Anti Lock Braking System (abs) and Electronic Stability Control (ESC) System Market by Region 6.2: Emerging Trends in Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market 6.3: Strategic Analysis 6.3.1: New Product Development 6.3.2: Capacity Expansion of Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market 6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market 6.3.4: Certification and Licensing 7. Company Profiles of Leading Players 7.1: Robert Bosch 7.2: Autoliv 7.3: TRW Automotive 7.4: Delphi Automotive 7.5: Denso corporation 7.6: Contenental 7.7: Hyundai Mobis For more information about this report visit https://www.researchandmarkets.com/r/qxelf2
Answer:
|
Global Automotive Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market Trends, Forecast and Competitive Analysis Report 2021 - ResearchAndMarkets.com
|
DUBLIN--(BUSINESS WIRE)--The "Automotive Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering. The automotive anti lock braking system (ABS) and electronic stability control (ESC) system market is expected to grow with a CAGR of 8% from 2019 to 2024. The future of the automotive anti lock braking system (ABS) and electronic stability control (ESC) system market looks promising with opportunities in the passenger car and commercial vehicle segments. The major drivers for this market are government legislation, new car assessment programs, focus on occupant safety, buyer's preferences for safety technologies, and an increasing number of auto collisions. A more than 150-page report is developed to help in your business decisions. To learn the scope of, benefits, companies researched and other details of the anti lock braking system (ABS) and electronic stability control (ESC) system market report then read this report. Some of the automotive anti lock braking system (ABS)and electronic stability control (ESC) system companies profiled in this report include Robert Bosch, Autoliv, TRW Automotive, Delphi Automotive, Denso Corporation, Continental, and Hyundai Mobis, and others. Some of the features of Automotive Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market 2019-2024: Trends, Forecast, and Opportunity Analysis include: This report answers the following 11 key questions: Key Topics Covered: 1. Executive Summary 2. Market Trends and Forecast Analysis from 2013 to 2024 2.1: Introduction, Background, and Classification 2.2: Supply Chain 2.3: Industry Drivers and Challenges 3. Market Trends and Forecast Analysis from 2013 to 2024 3.1: Macroeconomic Trends and Forecast 3.2: Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market: Trends and Forecast 3.3: Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market by Sub- Systems 3.3.1: Sensors 3.3.2: ECU 3.3.3: Hydraulic Unit 3.4: Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market by End Use 3.4.1: Small cars 3.4.2: Compact cars 3.4.3: Mid-Sized cars 3.4.4: Luxury cars 3.4.5: SUVs & Crossovers 3.4.6: Light commercial vehicles 4. Market Trends and Forecast Analysis by Region 5. Competitor Analysis 5.1: Product Portfolio Analysis 5.2: Market Share Analysis 5.3: Operational Integration 5.4: Geographical Reach 5.5: Porter's Five Forces Analysis 6. Growth Opportunities and Strategic Analysis 6.1: Growth Opportunity Analysis 6.1.1: Growth Opportunities for Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market by Sub-Systems. 6.1.2: Growth Opportunities for Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market by End Use 6.1.3: Growth Opportunities for Global Anti Lock Braking System (abs) and Electronic Stability Control (ESC) System Market by Region 6.2: Emerging Trends in Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market 6.3: Strategic Analysis 6.3.1: New Product Development 6.3.2: Capacity Expansion of Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market 6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Anti Lock Braking System (ABS) and Electronic Stability Control (ESC) System Market 6.3.4: Certification and Licensing 7. Company Profiles of Leading Players 7.1: Robert Bosch 7.2: Autoliv 7.3: TRW Automotive 7.4: Delphi Automotive 7.5: Denso corporation 7.6: Contenental 7.7: Hyundai Mobis For more information about this report visit https://www.researchandmarkets.com/r/qxelf2
|
edtsum6790
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SYDNEY--(BUSINESS WIRE)--The new version of the Philips dictation workflow solution for enterprise businesses, SpeechExec Enterprise 7.0 (SEE 7.0) is now available in Australia. The close collaboration between Nuance Communications and Speech Processing Solutions, the company behind Philips dictation solutions, SEE 7.0 offers cloud-based Nuance Dragon Professional speech recognition in addition to the workflow, allowing customers to edit or archive both audio and text files. To meet the requirements of modern work environments and flexible processes, for speech recognition, it must be combined with a workflow solution that tracks status updates and assigns priorities and tasks to dedicated personnel. "As market leaders in our respective fields, we combined the best of both worlds for our customers when it comes to speech recognition and workflow solutions. Customers who rely on speech technology will benefit from this close cooperation between SPS and Nuance, explained Yvonne Kirsch, Sales Director APAC, Speech Processing Solutions. Ed McGuiggan, General Manager, Dragon Professional, Nuance Communications, adds: "We are pleased to expand our long-lasting partnership with SPS. With the integration of Nuance Dragon Professional into Philips SpeechExec Enterprise 7.0, we created an easy to deploy product that fully meets the requirements of the modern workplace within large enterprise corporations. Together, we are accelerating the adoption and scalability of cloud-based speech recognition solutions to support collaborative work environments, regardless of where employees are located. SpeechExec Enterprise 7.0 integrates cloud-based speech recognition The new version SEE 7.0 supports state-of-the-art speech recognition technology by utilising cloud-based Nuance Dragon Professional speech recognition software. For front-end speech recognition, SpeechExec Enterprise connects to a dedicated Windows server either on site or in the cloud. The server is based in Australia, complying with Australian security standard, which allows the sensitive customer data to remain within the country. This allows authors to take advantage of Nuance's latest speech recognition engine with built-in deep learning technology for their digital dictation workflow. For the back-end speech recognition, files are sent from the Philips Voice Recorder App and mobile dictation devices (both Philips and non-Philips recorders) to a shared network folder. Philips Speech Recognition Server constantly monitors this folder, automatically retrieves new files, and converts them to text. Companies can use the new solution for a variety of use cases: For e-mails, memos and other short copy, stand-alone speech recognition with Nuance Dragon Professional Anywhere is sufficient. Longer copy and comprehensive briefs or contracts involving several people are handled by speech recognition in combination with a dictation workflow. From mobile dictation devices, all texts are processed through speech recognition and then finalized by in-house transcriptionists. About Speech Processing Solutions Speech Processing Solutions (SPS) is an international technology company and a global leader in dictation solutions. More than four million users worldwide work with speech-to-text solutions developed by SPS and sold under the Philips brand. These solutions include web-based and desktop workflow software as well as dictation devices. These smart solutions save users time and allow them to focus on their core tasks, making their business more efficient, customer-centric and profitable. Headquartered in Vienna, Austria, SPS has regional offices in the United States, Canada, Australia, the United Kingdom, Germany, France, Belgium and Austria, as well as a network of more than 1000 distribution and implementation partners worldwide.
Answer:
|
Speech Processing Solutions: Next-generation Workflow Solution With AI-powered Speech Recognition, Now in Australia Philips Dictation Australia and Nuance expands their partnership with SpeechExec Enterprise 7.0
|
SYDNEY--(BUSINESS WIRE)--The new version of the Philips dictation workflow solution for enterprise businesses, SpeechExec Enterprise 7.0 (SEE 7.0) is now available in Australia. The close collaboration between Nuance Communications and Speech Processing Solutions, the company behind Philips dictation solutions, SEE 7.0 offers cloud-based Nuance Dragon Professional speech recognition in addition to the workflow, allowing customers to edit or archive both audio and text files. To meet the requirements of modern work environments and flexible processes, for speech recognition, it must be combined with a workflow solution that tracks status updates and assigns priorities and tasks to dedicated personnel. "As market leaders in our respective fields, we combined the best of both worlds for our customers when it comes to speech recognition and workflow solutions. Customers who rely on speech technology will benefit from this close cooperation between SPS and Nuance, explained Yvonne Kirsch, Sales Director APAC, Speech Processing Solutions. Ed McGuiggan, General Manager, Dragon Professional, Nuance Communications, adds: "We are pleased to expand our long-lasting partnership with SPS. With the integration of Nuance Dragon Professional into Philips SpeechExec Enterprise 7.0, we created an easy to deploy product that fully meets the requirements of the modern workplace within large enterprise corporations. Together, we are accelerating the adoption and scalability of cloud-based speech recognition solutions to support collaborative work environments, regardless of where employees are located. SpeechExec Enterprise 7.0 integrates cloud-based speech recognition The new version SEE 7.0 supports state-of-the-art speech recognition technology by utilising cloud-based Nuance Dragon Professional speech recognition software. For front-end speech recognition, SpeechExec Enterprise connects to a dedicated Windows server either on site or in the cloud. The server is based in Australia, complying with Australian security standard, which allows the sensitive customer data to remain within the country. This allows authors to take advantage of Nuance's latest speech recognition engine with built-in deep learning technology for their digital dictation workflow. For the back-end speech recognition, files are sent from the Philips Voice Recorder App and mobile dictation devices (both Philips and non-Philips recorders) to a shared network folder. Philips Speech Recognition Server constantly monitors this folder, automatically retrieves new files, and converts them to text. Companies can use the new solution for a variety of use cases: For e-mails, memos and other short copy, stand-alone speech recognition with Nuance Dragon Professional Anywhere is sufficient. Longer copy and comprehensive briefs or contracts involving several people are handled by speech recognition in combination with a dictation workflow. From mobile dictation devices, all texts are processed through speech recognition and then finalized by in-house transcriptionists. About Speech Processing Solutions Speech Processing Solutions (SPS) is an international technology company and a global leader in dictation solutions. More than four million users worldwide work with speech-to-text solutions developed by SPS and sold under the Philips brand. These solutions include web-based and desktop workflow software as well as dictation devices. These smart solutions save users time and allow them to focus on their core tasks, making their business more efficient, customer-centric and profitable. Headquartered in Vienna, Austria, SPS has regional offices in the United States, Canada, Australia, the United Kingdom, Germany, France, Belgium and Austria, as well as a network of more than 1000 distribution and implementation partners worldwide.
|
edtsum6798
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--Matterkind, the activation intelligence company that connects people to what matters, today announced that its expanded affiliate business will help organizations deliver better marketing intelligence and measurable business results. This upgraded, more advanced service, which falls under the Outcome-Based Marketing practice, aligns with Matterkinds addressable strategy by embracing a unique people first, data-driven approach. This same approach is now possible through affiliate programs that enable brands to become smarter and more efficient at how they message their customers. Traditionally, affiliate marketing has been reliant on only a small number of partners and completely disconnected from media and advertising campaigns that often use media metrics as the determining factor of its success. By taking a more holistic data-driven approach, organizations can combine existing media and advertising campaigns with the crucial channel of affiliate marketing, tying both areas to real business outcomes and making direct impact in overall marketing efficiencies. Data driven and partnership focused strategy enables brands to streamline their marketing strategy and become more purposeful about their approach to reaching customers, said William Hamer-Jones, vice president of partnership at Matterkind. By allowing brands to pivot their affiliate program from a coupon and discount customer incentive strategy to a data-driven strategy, they can now heavily diversify this important revenue driver and eliminate the risk of overdependencies on a small group of third-party vendors. Matterkind is working with other Interpublic Group (IPG) companies to help brands embrace a data-driven affiliate program approach that can connect marketing silos and drive revenue. IPGs Open Architecture business model ensures that no matter who the lead agency on the account is, they can tap into capabilities across all of IPGs network to field the best team to service that account. To learn more about Matterkinds new outcome-based affiliate business service, visit wearematterkind.com/solutions. About Matterkind Matterkind connects people to what matters connecting brands to the right audiences, and people to the right content. We offer brands a strategic partner in creating lifetime customer value across addressable activation. In a fragmented media landscape, Matterkind leverages best-in-class technology to deliver comprehensive and optimal addressable solutions. Our proprietary data and tradecraft, combined with an audience-first approach, enables us to drive better business outcomes on behalf of agency partners and clients. Matterkind operates in over 70 markets worldwide. Learn more at www.weareMatterkind.com.
Answer:
|
Matterkind Expands Affiliate Business, Delivers Better Marketing Intelligence for Clients
|
NEW YORK--(BUSINESS WIRE)--Matterkind, the activation intelligence company that connects people to what matters, today announced that its expanded affiliate business will help organizations deliver better marketing intelligence and measurable business results. This upgraded, more advanced service, which falls under the Outcome-Based Marketing practice, aligns with Matterkinds addressable strategy by embracing a unique people first, data-driven approach. This same approach is now possible through affiliate programs that enable brands to become smarter and more efficient at how they message their customers. Traditionally, affiliate marketing has been reliant on only a small number of partners and completely disconnected from media and advertising campaigns that often use media metrics as the determining factor of its success. By taking a more holistic data-driven approach, organizations can combine existing media and advertising campaigns with the crucial channel of affiliate marketing, tying both areas to real business outcomes and making direct impact in overall marketing efficiencies. Data driven and partnership focused strategy enables brands to streamline their marketing strategy and become more purposeful about their approach to reaching customers, said William Hamer-Jones, vice president of partnership at Matterkind. By allowing brands to pivot their affiliate program from a coupon and discount customer incentive strategy to a data-driven strategy, they can now heavily diversify this important revenue driver and eliminate the risk of overdependencies on a small group of third-party vendors. Matterkind is working with other Interpublic Group (IPG) companies to help brands embrace a data-driven affiliate program approach that can connect marketing silos and drive revenue. IPGs Open Architecture business model ensures that no matter who the lead agency on the account is, they can tap into capabilities across all of IPGs network to field the best team to service that account. To learn more about Matterkinds new outcome-based affiliate business service, visit wearematterkind.com/solutions. About Matterkind Matterkind connects people to what matters connecting brands to the right audiences, and people to the right content. We offer brands a strategic partner in creating lifetime customer value across addressable activation. In a fragmented media landscape, Matterkind leverages best-in-class technology to deliver comprehensive and optimal addressable solutions. Our proprietary data and tradecraft, combined with an audience-first approach, enables us to drive better business outcomes on behalf of agency partners and clients. Matterkind operates in over 70 markets worldwide. Learn more at www.weareMatterkind.com.
|
edtsum6800
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, April 17, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between December 2, 2019 and September 25, 2020, inclusive (the "Class Period"), of the important April 30, 2021 lead plaintiff deadline. SO WHAT:If you purchased Aquestive securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Aquestive class action, go to http://www.rosenlegal.com/cases-register-2047.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [emailprotected] or [emailprotected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 30, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) data included in the Libervant Buccal Film for the management of seizure clusters ("Libervant") New Drug Application ("NDA") submission showed a lower drug exposure level than desired for certain weight groups; (2) the foregoing significantly decreased the Libervant NDA's approval prospects; (3) as a result, it was foreseeable that the U.S. Food and Drug Administration would not approve the Libervant NDA in its current form; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Aquestive class action, go to http://www.rosenlegal.com/cases-register-2047.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [emailprotected] or [emailprotected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [emailprotected] [emailprotected] [emailprotected] www.rosenlegal.com SOURCE Rosen Law Firm, P.A. Related Links www.rosenlegal.com
Answer:
|
AQST INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AQST
|
NEW YORK, April 17, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between December 2, 2019 and September 25, 2020, inclusive (the "Class Period"), of the important April 30, 2021 lead plaintiff deadline. SO WHAT:If you purchased Aquestive securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Aquestive class action, go to http://www.rosenlegal.com/cases-register-2047.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [emailprotected] or [emailprotected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 30, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) data included in the Libervant Buccal Film for the management of seizure clusters ("Libervant") New Drug Application ("NDA") submission showed a lower drug exposure level than desired for certain weight groups; (2) the foregoing significantly decreased the Libervant NDA's approval prospects; (3) as a result, it was foreseeable that the U.S. Food and Drug Administration would not approve the Libervant NDA in its current form; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Aquestive class action, go to http://www.rosenlegal.com/cases-register-2047.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [emailprotected] or [emailprotected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [emailprotected] [emailprotected] [emailprotected] www.rosenlegal.com SOURCE Rosen Law Firm, P.A. Related Links www.rosenlegal.com
|
edtsum6802
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: RANCHO PALOS VERDES,Calif., Oct. 28, 2020 /PRNewswire/ --Terranea Resortinvites guests to celebrate with its annual seaside Traditions, featuring festive offerings beginning with Thanksgiving and continuing through New Year's Day. In addition to its signature elements, the resort has also created new virtual experiences, digital gift options, holiday activity kits, gourmet meals to go, and more. These exclusive seasonal specialties are designed to promote a safe and memorable holiday for guests seeking an effortless and luxurious oceanside retreat, with 102-acres of Southern California sunshine, sparkling waves, and fresh ocean breezes. Terranea Resort Holiday Traditions A sampling of the memorable Traditions experiences is included below. For a complete listing of 2020 events, pricing, package details, and reservations, please visit the website or call 866.261.5873. New Experiences: Ongoing | DIY Holiday Activities - Kids Club Family Gratitude Boxes serve as the perfect gift to entertain friends and family with arts and crafts, games, gratitude conversation cards, and more. Additional DIY activity kits include Gingerbread Houses, Mandala Painting, Stargazing and S'mores, perfect for enjoying around one of the resort's 228 fireplaces and fire pits. Available for purchase in pointe discovery. Ongoing | Virtual Experiences Guests may enjoy fireside holiday stories read by a Terranea Elf and good tidings with a Peace and Tranquility resort channel showcasing the crashing waves and natural sounds of the Palos Verdes Peninsula. Virtual experiences are complimentary and available both in-room and accessible online. Ongoing | Digital Gift Guide Guests may give the ultimate gift with a digital getaway certificate for a stay in an Ocean View Guestroom or Ocean View Suite at Terranea. Once purchased, the certificate may be redeemed for a stay within the next 365 days and includes resort fees and taxes. Based on availability, restrictions may apply. Traditional gift cards are also available and can be used resort-wide for dining, golf, spa, activities, stays and more perfect for stocking stuffers or to be shipped to the gift recipient. Room Packages: Ongoing | Terranea Traditions - Celebrate the magic of the holiday spirit at Terranea this season with an overnight coastal getaway. Guests may enjoy breakfast for two and complimentary parking as they explore and immerse themselves in a variety of seasonal activities and adventure offerings, while connecting with nature at Los Angeles' hidden gem. October 1, 2020 January 5, 2021 | Promo code: TRADITIONS Ongoing | Third Night Free Guests may enjoy a Southern California winter vacation at Terranea and receive the third night free. Taking an escape from the winter chill and arriving in sunny Los Angeles, for a quick weekend getaway or an extended stay. Offerings include outdoor adventures, whale watching, hiking, plein air painting by the sea, family activities, stand up paddle boarding, and more. Guests may indulge in treatments at The Spa, a round of golf at The Links, or delicious dining al fresco. Free night is only valid on consecutive nights, with three-night minimum. Valid on stays through April 30, 2021 | Promo code: 3FREE November 27 | Black Friday Travel Deal Exclusive doorbuster deals are available for stays at Terranea in 2021, with the lowest rates available for purchase on Black Friday. Promo code: HOLIDAY2020. In addition, guests may get a head start on safely distanced holiday gift shopping with Black Friday promotions at marea, pointe discovery, and The Links. November 30 | Cyber Monday Travel Deal- Guests have no need to worry about waiting in lines or refreshing their shopping cart. Guests may save50 percent on the purchase of a digital getaway certificate for a future overnight stay at Terranea Resort. Restrictions may apply. Promo code: CYBERMONDAY. Holiday Dining: Ongoing | Holiday Dining Enjoy festive feasts in honor of Thanksgiving, Christmas, Hanukkah, and New Year's with bountiful menu selections and al fresco experiences at one of the resort's dining establishments. Guests can enjoy holiday classics set with an elegant backdrop of scenic views at mar'sel; holiday favorites served family style and traditional served buffets at catalina kitchen; Asian-inspired specialties at bashi; cozy and casual meals at Nelson's with panoramic views of the California coast; poolside turkey sandwiches at The Grill; holiday tapas platters at the Lobby Bar and Terrace; festive treats to satisfy any sweet tooth at sea beans; and in-room dining to indulge on their private terrace or patio. Gourmet Meals To Go- Enjoy a complete vegan or traditional holiday feast, prepared by Terranea's chefs with a fresh approach and an emphasis on seasonal and local ingredients. Order in advance by for curb-side pickup to entertain at home or in the comfort of your casita, bungalow, or villa. Holiday Experiences: November 26 | Turkey Day Hike - Embrace the changing of the seasons and the magical spirit of the holidays and take in the wonders of the natural landscape with a Turkey Day Hike. Work up an appetite by joining a Terranea naturalist for a picturesque guided hike around the 102-acre resort on Thanksgiving Day. 11:30am - 1:00pm | Advanced reservations required. November 27, December 13 & 20 | Mandala Ornament Decorating - Reflect on the true meaning of the holidays while painting two unique mandala ornaments and taking in the ocean views. Guided by a spiritual wellness coach, guests will learn the art of mandala meditation as they create their own unique holiday work of art keepsakes. December | Elf on the Shelf - Each day in December, guests may partake in a festive search for Terra, the Elf on the Shelf. A new holiday jingle is shared each day at pointe discovery that hints to Terra's location. Perfect for the whole family to participate in the fun. Wellness: December 1-25 | A Spa'tacular Holiday Retreat:Find time for wellness and an invigorating experience that will promote strength, relaxation, and an overall sense of well-being. Enjoy a customized 60-minute outdoor personal training session followed by a 60-minute massage treatment. Ongoing |Spa Treatments - Guests may choose to indulge with a 60-minute Skin Specifics Facial or a specialty 60 or 90-minute massage treatment. Massage options include CBD, Relaxing Classical, Therapeutics, Tranquility, Revitalizing Marine, and Crystal Reflections. Safe & Comfortable Holiday: Care Promise - The health and well-being of guests and associates is paramount. As part of Terranea's ongoing commitment, it has partnered with American Hotel & Lodging Association, California Hotel & Lodging Association, and Ecolab, to review and enhance its existing high standards of service and care to promote a safe and comfortable stay. Terranea has implemented the American Hotel & Lodging Association'sSafe Stayindustry-wide initiative, isClean + SafeCertified by the California Hotel & Lodging Association, and has incorporated recommendations from the Centers for Disease Control and Prevention, the California Department of Public Health, and county health departments. In addition, the resort has developed enhanced training and protocols, in partnership with cleaning industry expert Ecolab. To learn more, please visit www.terranea.com/promise. About Terranea ResortLocated on the Palos Verdes Peninsula, Terranea is the premier oceanfront resort in Southern California with102 acresof unparalleled Pacific Ocean views.Terranea opened in 2009 and proudly celebrates 11 years of service and memorable guest experiences in this scenic Southern California enclave. The resort also offers world-class accommodationsthat range from hotel suites to bungalows, oceanfront casitas, and luxurious villas. Amenities include The Links at Terranea, a nine-hole, par-3 golf course; award-winning 50,000 sq. ft. oceanfront spa, fitness, and wellness center; four swimming pools and a 140-foot waterslide; marea luxury boutique; 135,000 sq. ft. of meeting space; and nine dining venues showcasing its farm-to-Terranea culinaryphilosophyutilizing local and sustainable ingredients. Terranea's bountiful land boasts herb and vegetable gardens, lemon groves, bee hives, farm-fresh eggs, a Sea Salt Conservatory, and more.In addition, the resort's team of expert Experience Concierge members help guests discover and explore Terranea's rich terrain that includes miles of scenic coastal trails, a secluded beach cove, and ocean environments. Fun, enriching programs and activities such as falconry, archery, kayaking, and paddle boarding also abound. Terranea Resort is owned by a joint venture comprised ofLoweandJC Resorts, managed by CoralTree Hospitality Group,andisamember of the American Express Fine Hotels & Resorts program and Virtuoso Travel Network.Since its opening, TerraneaResort hasbeen named one ofTravel + Leisure's"500 Best Hotels in the World" andearned a spot onCond Nast Traveler's "Readers' Choice Awards" and "Gold List." The resort also receivedthe "Best of Award of Excellence" from Wine Spectator and has beenrecognized numerous times onU.S. News & World Report's "Best U.S. Hotels" list. Terranea is designated a Great Place To Work-Certified company by Great Place to Work. For additional information about Terranea Resort, visitwww.terranea.com, call866.261.5873,or follow Terranea onFacebook, Instagram, andTwitter.SOURCE Terranea Resort Related Links http://www.terranea.com
Answer:
|
Terranea Resort Celebrates Annual Seaside Traditions with Inventive New Experiences for a Safe and Memorable Holiday Season The luxury Southern California resort captures the spirit of the holiday season with curated, personalized, and virtual experiences from Thanksgiving through the New Year
|
RANCHO PALOS VERDES,Calif., Oct. 28, 2020 /PRNewswire/ --Terranea Resortinvites guests to celebrate with its annual seaside Traditions, featuring festive offerings beginning with Thanksgiving and continuing through New Year's Day. In addition to its signature elements, the resort has also created new virtual experiences, digital gift options, holiday activity kits, gourmet meals to go, and more. These exclusive seasonal specialties are designed to promote a safe and memorable holiday for guests seeking an effortless and luxurious oceanside retreat, with 102-acres of Southern California sunshine, sparkling waves, and fresh ocean breezes. Terranea Resort Holiday Traditions A sampling of the memorable Traditions experiences is included below. For a complete listing of 2020 events, pricing, package details, and reservations, please visit the website or call 866.261.5873. New Experiences: Ongoing | DIY Holiday Activities - Kids Club Family Gratitude Boxes serve as the perfect gift to entertain friends and family with arts and crafts, games, gratitude conversation cards, and more. Additional DIY activity kits include Gingerbread Houses, Mandala Painting, Stargazing and S'mores, perfect for enjoying around one of the resort's 228 fireplaces and fire pits. Available for purchase in pointe discovery. Ongoing | Virtual Experiences Guests may enjoy fireside holiday stories read by a Terranea Elf and good tidings with a Peace and Tranquility resort channel showcasing the crashing waves and natural sounds of the Palos Verdes Peninsula. Virtual experiences are complimentary and available both in-room and accessible online. Ongoing | Digital Gift Guide Guests may give the ultimate gift with a digital getaway certificate for a stay in an Ocean View Guestroom or Ocean View Suite at Terranea. Once purchased, the certificate may be redeemed for a stay within the next 365 days and includes resort fees and taxes. Based on availability, restrictions may apply. Traditional gift cards are also available and can be used resort-wide for dining, golf, spa, activities, stays and more perfect for stocking stuffers or to be shipped to the gift recipient. Room Packages: Ongoing | Terranea Traditions - Celebrate the magic of the holiday spirit at Terranea this season with an overnight coastal getaway. Guests may enjoy breakfast for two and complimentary parking as they explore and immerse themselves in a variety of seasonal activities and adventure offerings, while connecting with nature at Los Angeles' hidden gem. October 1, 2020 January 5, 2021 | Promo code: TRADITIONS Ongoing | Third Night Free Guests may enjoy a Southern California winter vacation at Terranea and receive the third night free. Taking an escape from the winter chill and arriving in sunny Los Angeles, for a quick weekend getaway or an extended stay. Offerings include outdoor adventures, whale watching, hiking, plein air painting by the sea, family activities, stand up paddle boarding, and more. Guests may indulge in treatments at The Spa, a round of golf at The Links, or delicious dining al fresco. Free night is only valid on consecutive nights, with three-night minimum. Valid on stays through April 30, 2021 | Promo code: 3FREE November 27 | Black Friday Travel Deal Exclusive doorbuster deals are available for stays at Terranea in 2021, with the lowest rates available for purchase on Black Friday. Promo code: HOLIDAY2020. In addition, guests may get a head start on safely distanced holiday gift shopping with Black Friday promotions at marea, pointe discovery, and The Links. November 30 | Cyber Monday Travel Deal- Guests have no need to worry about waiting in lines or refreshing their shopping cart. Guests may save50 percent on the purchase of a digital getaway certificate for a future overnight stay at Terranea Resort. Restrictions may apply. Promo code: CYBERMONDAY. Holiday Dining: Ongoing | Holiday Dining Enjoy festive feasts in honor of Thanksgiving, Christmas, Hanukkah, and New Year's with bountiful menu selections and al fresco experiences at one of the resort's dining establishments. Guests can enjoy holiday classics set with an elegant backdrop of scenic views at mar'sel; holiday favorites served family style and traditional served buffets at catalina kitchen; Asian-inspired specialties at bashi; cozy and casual meals at Nelson's with panoramic views of the California coast; poolside turkey sandwiches at The Grill; holiday tapas platters at the Lobby Bar and Terrace; festive treats to satisfy any sweet tooth at sea beans; and in-room dining to indulge on their private terrace or patio. Gourmet Meals To Go- Enjoy a complete vegan or traditional holiday feast, prepared by Terranea's chefs with a fresh approach and an emphasis on seasonal and local ingredients. Order in advance by for curb-side pickup to entertain at home or in the comfort of your casita, bungalow, or villa. Holiday Experiences: November 26 | Turkey Day Hike - Embrace the changing of the seasons and the magical spirit of the holidays and take in the wonders of the natural landscape with a Turkey Day Hike. Work up an appetite by joining a Terranea naturalist for a picturesque guided hike around the 102-acre resort on Thanksgiving Day. 11:30am - 1:00pm | Advanced reservations required. November 27, December 13 & 20 | Mandala Ornament Decorating - Reflect on the true meaning of the holidays while painting two unique mandala ornaments and taking in the ocean views. Guided by a spiritual wellness coach, guests will learn the art of mandala meditation as they create their own unique holiday work of art keepsakes. December | Elf on the Shelf - Each day in December, guests may partake in a festive search for Terra, the Elf on the Shelf. A new holiday jingle is shared each day at pointe discovery that hints to Terra's location. Perfect for the whole family to participate in the fun. Wellness: December 1-25 | A Spa'tacular Holiday Retreat:Find time for wellness and an invigorating experience that will promote strength, relaxation, and an overall sense of well-being. Enjoy a customized 60-minute outdoor personal training session followed by a 60-minute massage treatment. Ongoing |Spa Treatments - Guests may choose to indulge with a 60-minute Skin Specifics Facial or a specialty 60 or 90-minute massage treatment. Massage options include CBD, Relaxing Classical, Therapeutics, Tranquility, Revitalizing Marine, and Crystal Reflections. Safe & Comfortable Holiday: Care Promise - The health and well-being of guests and associates is paramount. As part of Terranea's ongoing commitment, it has partnered with American Hotel & Lodging Association, California Hotel & Lodging Association, and Ecolab, to review and enhance its existing high standards of service and care to promote a safe and comfortable stay. Terranea has implemented the American Hotel & Lodging Association'sSafe Stayindustry-wide initiative, isClean + SafeCertified by the California Hotel & Lodging Association, and has incorporated recommendations from the Centers for Disease Control and Prevention, the California Department of Public Health, and county health departments. In addition, the resort has developed enhanced training and protocols, in partnership with cleaning industry expert Ecolab. To learn more, please visit www.terranea.com/promise. About Terranea ResortLocated on the Palos Verdes Peninsula, Terranea is the premier oceanfront resort in Southern California with102 acresof unparalleled Pacific Ocean views.Terranea opened in 2009 and proudly celebrates 11 years of service and memorable guest experiences in this scenic Southern California enclave. The resort also offers world-class accommodationsthat range from hotel suites to bungalows, oceanfront casitas, and luxurious villas. Amenities include The Links at Terranea, a nine-hole, par-3 golf course; award-winning 50,000 sq. ft. oceanfront spa, fitness, and wellness center; four swimming pools and a 140-foot waterslide; marea luxury boutique; 135,000 sq. ft. of meeting space; and nine dining venues showcasing its farm-to-Terranea culinaryphilosophyutilizing local and sustainable ingredients. Terranea's bountiful land boasts herb and vegetable gardens, lemon groves, bee hives, farm-fresh eggs, a Sea Salt Conservatory, and more.In addition, the resort's team of expert Experience Concierge members help guests discover and explore Terranea's rich terrain that includes miles of scenic coastal trails, a secluded beach cove, and ocean environments. Fun, enriching programs and activities such as falconry, archery, kayaking, and paddle boarding also abound. Terranea Resort is owned by a joint venture comprised ofLoweandJC Resorts, managed by CoralTree Hospitality Group,andisamember of the American Express Fine Hotels & Resorts program and Virtuoso Travel Network.Since its opening, TerraneaResort hasbeen named one ofTravel + Leisure's"500 Best Hotels in the World" andearned a spot onCond Nast Traveler's "Readers' Choice Awards" and "Gold List." The resort also receivedthe "Best of Award of Excellence" from Wine Spectator and has beenrecognized numerous times onU.S. News & World Report's "Best U.S. Hotels" list. Terranea is designated a Great Place To Work-Certified company by Great Place to Work. For additional information about Terranea Resort, visitwww.terranea.com, call866.261.5873,or follow Terranea onFacebook, Instagram, andTwitter.SOURCE Terranea Resort Related Links http://www.terranea.com
|
edtsum6803
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global Niemann pick disease type C market is estimated to be valued at US$ 32.0 million in 2020 and is expected to exhibit a CAGR of 42.3% during the forecast period (2020-2027). Key Trends and Analysis of the Global Niemann Pick Disease Type C Market: Market players are conducting research and development in order to identify targets for the disease, against which a new treatment can be developed in the future. For instance, in 2018, Centogene AG Rostock, a genetic diagnostic company, initiated a clinical trial to prepare a cell culture from patients suffering from Niemann Pick disease type C for the identification of novel proteins involved in pathways that lead to disease progression. This would also aid in early diagnosis. The proteins can be targeted for the development of treatment options for NPC, which is expected to create conducive growth opportunities for market players. Furthermore, increasing approval of drugs for the NPC treatment is expected to drive the global Niemann pick disease type C market growth during the forecast period. For instance, in September 2020, Orphazyme A/S (a late-stage biopharmaceutical company) received the U.S. Food and Drug Administration (FDA) new drug application (NDA) acceptance with priority review for arimoclomol for the indication of Niemann-Pick disease Type C (NPC). Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4275 Furthermore, market players are also obtaining special status for drugs for the treatment of rare diseases, which is expected to support growth of the market during the forecast period. For instance, on May 18, 2017, CTD Holdings Inc. (now Cyclo Therapeutics a clinical-stage biotechnology company) announced that it received the fast track designation from the U.S FDA for fast testing of the safety and efficacy of Trappsol(R) Cyclo(TM), for the treatment of NPC. Moreover, the company also received Orphan Drug Designation in both the U.S and Europe and Rare Pediatric Disease Designation from the U.S. FDA for Trappsol(R) Cyclo(TM). Key Market Takeaways: The global Niemann pick disease type C market is expected to exhibit a CAGR of 42.3% over the forecast period. This is owing to increasing research and development activities for NPC. For instance, on September 30, 2020, IntraBio Inc. (a biopharmaceutical company with a late-stage drug pipeline that includes novel treatments for genetic and neurodegenerative diseases) announced positive results for the Phase II clinical trial, which is carried out for testing the safety and efficacy of drug candidate, IB1001, for the treatment of NPC. The clinical trial showed decrease in the severity of ataxia, a symptom of NPC and the trial also passed the endpoint for Clinical Impression of Change in Severity (CI-CS). Competitive Landscape: Key players operating in the global Niemann pick disease type C market include Orphazyme A/S, Cyclo Therapeutics, Inc., and Johnson & Johnson Buy-Now this Research Report for detailed market insights @ https://www.coherentmarketinsights.com/insight/buy-now/4275 Market Segmentation: About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
Answer:
|
Global Niemann Pick Disease Type C Market to Surpass US$ 378.8 Million by 2027, Says Coherent Market Insights (CMI)
|
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global Niemann pick disease type C market is estimated to be valued at US$ 32.0 million in 2020 and is expected to exhibit a CAGR of 42.3% during the forecast period (2020-2027). Key Trends and Analysis of the Global Niemann Pick Disease Type C Market: Market players are conducting research and development in order to identify targets for the disease, against which a new treatment can be developed in the future. For instance, in 2018, Centogene AG Rostock, a genetic diagnostic company, initiated a clinical trial to prepare a cell culture from patients suffering from Niemann Pick disease type C for the identification of novel proteins involved in pathways that lead to disease progression. This would also aid in early diagnosis. The proteins can be targeted for the development of treatment options for NPC, which is expected to create conducive growth opportunities for market players. Furthermore, increasing approval of drugs for the NPC treatment is expected to drive the global Niemann pick disease type C market growth during the forecast period. For instance, in September 2020, Orphazyme A/S (a late-stage biopharmaceutical company) received the U.S. Food and Drug Administration (FDA) new drug application (NDA) acceptance with priority review for arimoclomol for the indication of Niemann-Pick disease Type C (NPC). Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4275 Furthermore, market players are also obtaining special status for drugs for the treatment of rare diseases, which is expected to support growth of the market during the forecast period. For instance, on May 18, 2017, CTD Holdings Inc. (now Cyclo Therapeutics a clinical-stage biotechnology company) announced that it received the fast track designation from the U.S FDA for fast testing of the safety and efficacy of Trappsol(R) Cyclo(TM), for the treatment of NPC. Moreover, the company also received Orphan Drug Designation in both the U.S and Europe and Rare Pediatric Disease Designation from the U.S. FDA for Trappsol(R) Cyclo(TM). Key Market Takeaways: The global Niemann pick disease type C market is expected to exhibit a CAGR of 42.3% over the forecast period. This is owing to increasing research and development activities for NPC. For instance, on September 30, 2020, IntraBio Inc. (a biopharmaceutical company with a late-stage drug pipeline that includes novel treatments for genetic and neurodegenerative diseases) announced positive results for the Phase II clinical trial, which is carried out for testing the safety and efficacy of drug candidate, IB1001, for the treatment of NPC. The clinical trial showed decrease in the severity of ataxia, a symptom of NPC and the trial also passed the endpoint for Clinical Impression of Change in Severity (CI-CS). Competitive Landscape: Key players operating in the global Niemann pick disease type C market include Orphazyme A/S, Cyclo Therapeutics, Inc., and Johnson & Johnson Buy-Now this Research Report for detailed market insights @ https://www.coherentmarketinsights.com/insight/buy-now/4275 Market Segmentation: About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
|
edtsum6807
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SEATTLE, Feb. 12, 2021 /PRNewswire/ --(NASDAQ: RDFN) The median home sale price increased 15% year over year to $318,750, according to a new report from Redfin (redfin.com), the technology-powered real estate brokerage. Below are other key housing market takeaways for more than 400 U.S. metro areas during the 4-week period ending February 7. Asking prices of newly listed homes hit a new all-time high of $334,770, up 10% from the same time a year ago. In a typical year, asking prices do not surpass the previous year's peak until March. Pending home sales were up 29% year over year. New listings of homes for sale were down 11% from a year earlier. Active listings (the number of homes listed for sale at any point during the period) fell 37% from 2020 to a new all-time low. 52% of homes that went under contract had an accepted offer within the first two weeks on the market, well above the 43% rate during the same period a year ago. This is the first time the four-week average has surpassed 50% since at least 2012 (as far back as Redfin's data for this measure goes). During the week ending February 7, the rate was 57%. The average sale-to-list price ratio, which measures how close homes are selling to their asking prices, increased slightly to 99.3%1.6 percentage points higher than a year earlier. For the week ending February 7, the seasonally adjusted Redfin Homebuyer Demand Indexa measure of requests for home tours and other services from Redfin agentswas up 63% from the same period a year ago. Mortgage purchase applications decreased 5% week over week (seasonally adjusted) and were up 17% from a year earlier (unadjusted) during the week ending February 5. For the week ending February 4, 30-year mortgage rates were unchanged at 2.73%. "There is a serious lack of new listings, and although prices are through the roof, homeowners are reluctant to sell, because it's so hard to buy again unless you are moving to a less expensive area where you can afford to outbid other buyers," said Redfin chief economist Daryl Fairweather. "Sellers who are concerned about finding their next home are asking buyers for a rent-back agreement, which allows the seller to stay in the home until they can move into their next one. Offering a rent-back agreement can also be a winning strategy for buyers with flexible timelines." To view the full report, including charts and methodology, please visit: https://www.redfin.com/news/housing-market-update-over-half-of-homes-sold-in-2-weeks/ About Redfin Redfin (www.redfin.com) is a technology-powered residential real estate company, redefining real estate in the consumer's favor in a commission-driven industry. We do this by integrating every step of the home buying and selling process and pairing our own agents with our own technology, creating a service that is faster, better and costs less. We offer brokerage, iBuying, mortgage, and title services, and we are the #1 nationwide brokerage website, offering a host of online tools to consumers, including the Redfin Estimate. We represent people buying and selling homes in over 90 markets in the United States and Canada. Since our launch in 2006, we have saved our customers over $800 million and we've helped them buy or sell more than 235,000 homes worth more than $115 billion. For more information or to contact a local Redfin real estate agent, visit www.redfin.com. To learn about housing market trends and download data, visit the Redfin Data Center. To be added to Redfin's press release distribution list, email [emailprotected]. To view Redfin's press center, click here. SOURCE Redfin Related Links https://www.redfin.com
Answer:
|
A Record 52% of Homes Under Contract Within 2 Weeks Redfin reports median prices rose 15%, pending home sales were up 29%, and new listings fell 11% from the same period a year earlier.
|
SEATTLE, Feb. 12, 2021 /PRNewswire/ --(NASDAQ: RDFN) The median home sale price increased 15% year over year to $318,750, according to a new report from Redfin (redfin.com), the technology-powered real estate brokerage. Below are other key housing market takeaways for more than 400 U.S. metro areas during the 4-week period ending February 7. Asking prices of newly listed homes hit a new all-time high of $334,770, up 10% from the same time a year ago. In a typical year, asking prices do not surpass the previous year's peak until March. Pending home sales were up 29% year over year. New listings of homes for sale were down 11% from a year earlier. Active listings (the number of homes listed for sale at any point during the period) fell 37% from 2020 to a new all-time low. 52% of homes that went under contract had an accepted offer within the first two weeks on the market, well above the 43% rate during the same period a year ago. This is the first time the four-week average has surpassed 50% since at least 2012 (as far back as Redfin's data for this measure goes). During the week ending February 7, the rate was 57%. The average sale-to-list price ratio, which measures how close homes are selling to their asking prices, increased slightly to 99.3%1.6 percentage points higher than a year earlier. For the week ending February 7, the seasonally adjusted Redfin Homebuyer Demand Indexa measure of requests for home tours and other services from Redfin agentswas up 63% from the same period a year ago. Mortgage purchase applications decreased 5% week over week (seasonally adjusted) and were up 17% from a year earlier (unadjusted) during the week ending February 5. For the week ending February 4, 30-year mortgage rates were unchanged at 2.73%. "There is a serious lack of new listings, and although prices are through the roof, homeowners are reluctant to sell, because it's so hard to buy again unless you are moving to a less expensive area where you can afford to outbid other buyers," said Redfin chief economist Daryl Fairweather. "Sellers who are concerned about finding their next home are asking buyers for a rent-back agreement, which allows the seller to stay in the home until they can move into their next one. Offering a rent-back agreement can also be a winning strategy for buyers with flexible timelines." To view the full report, including charts and methodology, please visit: https://www.redfin.com/news/housing-market-update-over-half-of-homes-sold-in-2-weeks/ About Redfin Redfin (www.redfin.com) is a technology-powered residential real estate company, redefining real estate in the consumer's favor in a commission-driven industry. We do this by integrating every step of the home buying and selling process and pairing our own agents with our own technology, creating a service that is faster, better and costs less. We offer brokerage, iBuying, mortgage, and title services, and we are the #1 nationwide brokerage website, offering a host of online tools to consumers, including the Redfin Estimate. We represent people buying and selling homes in over 90 markets in the United States and Canada. Since our launch in 2006, we have saved our customers over $800 million and we've helped them buy or sell more than 235,000 homes worth more than $115 billion. For more information or to contact a local Redfin real estate agent, visit www.redfin.com. To learn about housing market trends and download data, visit the Redfin Data Center. To be added to Redfin's press release distribution list, email [emailprotected]. To view Redfin's press center, click here. SOURCE Redfin Related Links https://www.redfin.com
|
edtsum6809
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: GOTHENBURG, Sweden, Jan. 12, 2021 /PRNewswire/ --In the pursuit of accelerating sustainable mobility, Polestar, the electric performance car brand, today released a multi-episode video series featuring Golden Globe winner Oscar Isaac. A champion for climate justice, Isaac delves deeper into Polestar innovations which aim to improve today's society, and that of the future. Actor Oscar Isaac Stars in Video Series by Polestar Cars In partnership with The Wall Street Journal, "Making aNew" is a five-part mini docuseries which seeks the truths behind Polestar's ethos and advancements in sustainability, electrification and performance. The video series is available to view today at www.polestar.com/us/making-anew. "As the automotive world moves to electrification, important terms such as sustainability and clean energy are becoming generic slogans with diminished meaning," said Oscar Isaac. "After learning about the company, I feel better about driving a Polestar because the brand is transparent about how its cars are produced, accountable for its impact on the planet and taking action to truly offset the footprint of its vehicles." Since the launch of the brand in 2017, Polestar has become synonymous with the development of new technologies, harnessing refined performance and incorporating unconventional materials in the development of its vehicles. More recently, the brand began publishing detailed climate impact reports of its electric vehicles as they leave the production line, aiming to be the most transparent company in the automotive industry. As a proof point of this pledge, Polestar has published a full lifecycle analysis of the Polestar 2 Electric Fastback, and will release its first annual sustainability report in March of this year."We are determined to be the guiding star for our industry, accelerating the shift to more sustainable mobility. Innovation, clean energy, circular materials and transparency are areas of particular focus. A great example of this is the use of blockchain to improve the accountability of our cobalt supply chain," said Fredrika Klarn, Head of Sustainability at Polestar."Collaborating with visible activists like Oscar, who are as passionate about carbon-neutrality as we are, will help raise awareness and understanding, paving the path for a more sustainable future."For images and other media information, visit polestar.com/press. About PolestarPolestar is the independent Swedish premium electric performance car brand founded by Volvo Cars and GeelyHolding. Established in 2017, Polestar enjoys specific technological and engineering synergies with Volvo Cars and benefits from significant economies of scale as a result. The company is headquartered in Gothenburg, Sweden, and retails its vehicles in ten global markets across Europe and North America, and in China.Polestar produces two electric performance cars. The Polestar 1 is a low-volume electric performance hybrid GT with a carbon fiber body, 609 hp, 738 ft.-lb. and an electric-only range of 60 miles the longest of any hybrid car in the world. The Polestar 2 electric performance fastback is the company's first fully electric, high volume car. Polestar 2 launched in 2020 with an all-wheel drive electric powertrain that produces 408 hp and 487 ft.-lb., with a maximum range of 233 miles (292 miles WLTP). In the future, the Polestar 3 electric performance SUV will join the portfolio, as well as the Precept a design study vehicle released in 2020 that is slated for future production. Precept showcases the brand's future vision in terms of sustainability, digital technology and design.SOURCE Polestar
Answer:
|
Polestar Cars Drives Innovation and Awareness with Actor Oscar Isaac in New Video Series
|
GOTHENBURG, Sweden, Jan. 12, 2021 /PRNewswire/ --In the pursuit of accelerating sustainable mobility, Polestar, the electric performance car brand, today released a multi-episode video series featuring Golden Globe winner Oscar Isaac. A champion for climate justice, Isaac delves deeper into Polestar innovations which aim to improve today's society, and that of the future. Actor Oscar Isaac Stars in Video Series by Polestar Cars In partnership with The Wall Street Journal, "Making aNew" is a five-part mini docuseries which seeks the truths behind Polestar's ethos and advancements in sustainability, electrification and performance. The video series is available to view today at www.polestar.com/us/making-anew. "As the automotive world moves to electrification, important terms such as sustainability and clean energy are becoming generic slogans with diminished meaning," said Oscar Isaac. "After learning about the company, I feel better about driving a Polestar because the brand is transparent about how its cars are produced, accountable for its impact on the planet and taking action to truly offset the footprint of its vehicles." Since the launch of the brand in 2017, Polestar has become synonymous with the development of new technologies, harnessing refined performance and incorporating unconventional materials in the development of its vehicles. More recently, the brand began publishing detailed climate impact reports of its electric vehicles as they leave the production line, aiming to be the most transparent company in the automotive industry. As a proof point of this pledge, Polestar has published a full lifecycle analysis of the Polestar 2 Electric Fastback, and will release its first annual sustainability report in March of this year."We are determined to be the guiding star for our industry, accelerating the shift to more sustainable mobility. Innovation, clean energy, circular materials and transparency are areas of particular focus. A great example of this is the use of blockchain to improve the accountability of our cobalt supply chain," said Fredrika Klarn, Head of Sustainability at Polestar."Collaborating with visible activists like Oscar, who are as passionate about carbon-neutrality as we are, will help raise awareness and understanding, paving the path for a more sustainable future."For images and other media information, visit polestar.com/press. About PolestarPolestar is the independent Swedish premium electric performance car brand founded by Volvo Cars and GeelyHolding. Established in 2017, Polestar enjoys specific technological and engineering synergies with Volvo Cars and benefits from significant economies of scale as a result. The company is headquartered in Gothenburg, Sweden, and retails its vehicles in ten global markets across Europe and North America, and in China.Polestar produces two electric performance cars. The Polestar 1 is a low-volume electric performance hybrid GT with a carbon fiber body, 609 hp, 738 ft.-lb. and an electric-only range of 60 miles the longest of any hybrid car in the world. The Polestar 2 electric performance fastback is the company's first fully electric, high volume car. Polestar 2 launched in 2020 with an all-wheel drive electric powertrain that produces 408 hp and 487 ft.-lb., with a maximum range of 233 miles (292 miles WLTP). In the future, the Polestar 3 electric performance SUV will join the portfolio, as well as the Precept a design study vehicle released in 2020 that is slated for future production. Precept showcases the brand's future vision in terms of sustainability, digital technology and design.SOURCE Polestar
|
edtsum6811
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ST. JOHNS, Newfoundland and Labrador--(BUSINESS WIRE)--BPLI Holdings Inc. ("BPLI" or the "Company") (TSXV: BPLI) announced today that, pursuant to the previously announced plan of arrangement under the Canada Business Corporations Act (the "Arrangement"), Rizbollo Holdings Limited (Rizbollo) and Name 3 Capital Inc. (Name 3), acting through a wholly-owned subsidiary, 12491125 Canada Inc. (Acquisitionco), have indirectly acquired all of the issued and outstanding common shares of BPLI ("Shares") effective today at a price of C$0.23 per Share other than certain Shares beneficially owned or controlled by Rizbollo and Name 3 which were acquired for common shares of Acquisitionco. As part of the Arrangement, Acquisitionco and BPLI have amalgamated to form an amalgamated corporation which will carry on business as BPLI Holdings Inc. A detailed description of the Arrangement is set out in BPLI's management information circular dated February 25, 2021 (the "Circular"). Shareholders can obtain a copy of the Circular as filed with applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. A Letter of Transmittal was mailed to registered shareholders of BPLI ("Shareholders") along with the Circular and is also available on SEDAR at www.sedar.com. The Letter of Transmittal explains how Shareholders can deposit and obtain payment for their Shares. Shareholders must return their duly completed Letter of Transmittal to the depositary, Computershare Trust Company of Canada, in order to receive the consideration to which they are entitled for their Shares. Non-registered shareholders who hold Shares in brokerage accounts or with other financial intermediaries should carefully follow the instructions from any brokers or other financial intermediaries that hold Shares on their behalf. BPLI intends to apply to cease to be a reporting issuer under applicable securities laws. Shares will be delisted from trading on the TSX Venture Exchange (the "TSXV") at the close of business on April 19, 2021. About BPLI BPLI Holdings Inc. is the holding company for its investments in Bluedrop Training and Simulation and Bluedrop Learning Networks. Our companies are innovators in both the development of workplace e-learning and simulation as well as the way large organizations deliver, track and manage training. Our two divisions serve the worlds leading aerospace and defence organizations as well as broad cross sections of organizations focused on managing system wide health and safety and developing the skills of external workforces. BPLI is creating the workforce of the future by improving the effectiveness, speed and cost of training delivery and management. For more information, visit www.bpli.ca. You can follow us on Twitter: @Bluedrop_BPL. Forward-looking statements This news release may contain "forward-looking information" as defined in applicable Canadian securities legislation. Such forward-looking statements typically contain statements with words such as "anticipate," "expect," "intend," "estimate," "propose," or similar words suggesting future outcomes or statements regarding an outlook. More particularly and without limitation, this news release contains forward-looking information and statements concerning the timing and anticipated receipt of required regulatory approvals, anticipated timing for delisting of the Shares from the TSXV and BPLI's intention to apply to cease to be a reporting issuer under applicable Canadian securities laws. All statements other than statements of historical fact, included in this release, constitute forward-looking information that involve various known and unknown risks, uncertainties, and other factors outside management's control. Forward-looking information is based on a number of factors and assumptions which have been used to develop such information but which may prove to be incorrect. Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. There can be no assurance that such information will prove to be accurate and actual results and future events could differ materially from those anticipated in such forward-looking information. For additional information with respect to risk factors applicable to BPLI, reference should be made to BPLI's continuous disclosure materials filed from time to time with securities regulators. The forward-looking information contained in this release is made as of the date of this release and BPLI does not undertake to update publicly or revise the forward-looking information contained in this release, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. No regulatory authority has approved or disapproved the adequacy or accuracy of this news release.
Answer:
|
BPLI Holdings Inc. Completes Going-Private Transaction
|
ST. JOHNS, Newfoundland and Labrador--(BUSINESS WIRE)--BPLI Holdings Inc. ("BPLI" or the "Company") (TSXV: BPLI) announced today that, pursuant to the previously announced plan of arrangement under the Canada Business Corporations Act (the "Arrangement"), Rizbollo Holdings Limited (Rizbollo) and Name 3 Capital Inc. (Name 3), acting through a wholly-owned subsidiary, 12491125 Canada Inc. (Acquisitionco), have indirectly acquired all of the issued and outstanding common shares of BPLI ("Shares") effective today at a price of C$0.23 per Share other than certain Shares beneficially owned or controlled by Rizbollo and Name 3 which were acquired for common shares of Acquisitionco. As part of the Arrangement, Acquisitionco and BPLI have amalgamated to form an amalgamated corporation which will carry on business as BPLI Holdings Inc. A detailed description of the Arrangement is set out in BPLI's management information circular dated February 25, 2021 (the "Circular"). Shareholders can obtain a copy of the Circular as filed with applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. A Letter of Transmittal was mailed to registered shareholders of BPLI ("Shareholders") along with the Circular and is also available on SEDAR at www.sedar.com. The Letter of Transmittal explains how Shareholders can deposit and obtain payment for their Shares. Shareholders must return their duly completed Letter of Transmittal to the depositary, Computershare Trust Company of Canada, in order to receive the consideration to which they are entitled for their Shares. Non-registered shareholders who hold Shares in brokerage accounts or with other financial intermediaries should carefully follow the instructions from any brokers or other financial intermediaries that hold Shares on their behalf. BPLI intends to apply to cease to be a reporting issuer under applicable securities laws. Shares will be delisted from trading on the TSX Venture Exchange (the "TSXV") at the close of business on April 19, 2021. About BPLI BPLI Holdings Inc. is the holding company for its investments in Bluedrop Training and Simulation and Bluedrop Learning Networks. Our companies are innovators in both the development of workplace e-learning and simulation as well as the way large organizations deliver, track and manage training. Our two divisions serve the worlds leading aerospace and defence organizations as well as broad cross sections of organizations focused on managing system wide health and safety and developing the skills of external workforces. BPLI is creating the workforce of the future by improving the effectiveness, speed and cost of training delivery and management. For more information, visit www.bpli.ca. You can follow us on Twitter: @Bluedrop_BPL. Forward-looking statements This news release may contain "forward-looking information" as defined in applicable Canadian securities legislation. Such forward-looking statements typically contain statements with words such as "anticipate," "expect," "intend," "estimate," "propose," or similar words suggesting future outcomes or statements regarding an outlook. More particularly and without limitation, this news release contains forward-looking information and statements concerning the timing and anticipated receipt of required regulatory approvals, anticipated timing for delisting of the Shares from the TSXV and BPLI's intention to apply to cease to be a reporting issuer under applicable Canadian securities laws. All statements other than statements of historical fact, included in this release, constitute forward-looking information that involve various known and unknown risks, uncertainties, and other factors outside management's control. Forward-looking information is based on a number of factors and assumptions which have been used to develop such information but which may prove to be incorrect. Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. There can be no assurance that such information will prove to be accurate and actual results and future events could differ materially from those anticipated in such forward-looking information. For additional information with respect to risk factors applicable to BPLI, reference should be made to BPLI's continuous disclosure materials filed from time to time with securities regulators. The forward-looking information contained in this release is made as of the date of this release and BPLI does not undertake to update publicly or revise the forward-looking information contained in this release, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. No regulatory authority has approved or disapproved the adequacy or accuracy of this news release.
|
edtsum6814
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: RICHMOND, Va., June 9, 2020 /PRNewswire/ --Moonlighting, a leading mobile on-demand hiring platform, today announced it has partnered with Digital Turbine (Nasdaq: APPS), the #1 mobile platform connecting operators and OEMs with mobile advertisers, to accelerate the marketing of Moonlighting's app that connects new job opportunities and business tools to Americans whose businesses or jobs have been adversely affected by COVID-19's impact on the economy. In an effort to help displaced workers find jobs, Moonlightingrecently announced access to its jobs database, and business management tools is free until further notice. The company's searchable jobs database features more than two million gig, contract, part-time, freelance and independent work opportunities, including more than 200,000 work-from-home jobs. Key to the partnership, Digital Turbine will make available Moonlighting's Android app on select mobile devices in communities most affected by COVID-19. Digital Turbine's broad reach and leading technology platform enable brands and app developers to engage users through highly effective on-device media. Turnkey placement on newly activated devices provides easier, one-stop access and scale not available with other platforms. "Helping people whose jobs have been impacted by COVID-19 quickly find work is now our mission," said Jeff Tennery, Moonlighting's CEO & Founder. "By creating unique opportunities for users to discover content directly on devices, Digital Turbine's platform delivers a better user experience, unlike traditional media which is often noisy and inefficient." "I'm pleased to work together with Moonlighting to increase awareness of their app that assists those in need with job listings and support tools to quickly post gigs and help others find work," said Matt Tubergen, EVP of Digital Turbine Media. "Our platform engages users directly on deviceto be discovered when they want and how they want. It's simply a more direct and expedient route for getting apps directly in the hands of end-users." Founded in 2014 to serve the rapidly growing gig economy, Moonlighting has grown to serve more than 800,000 independent and freelance workers. It has also been featured in more than 150 news media sites and remains one of the fastest-growing independent worker platforms. About MoonlightingMoonlighting's on-demand hiring solution empowers people to earn money and hire talented professionals quickly, creating a virtual marketplace for freelancers and small businesses. With a blockchain-supported platform, Moonlighting provides a full turnkey solution with a suite of tools to empower millions of workers and recruiters worldwide. Moonlighting is a privately held, VA-based company built from the ground up for the gig economy. For more information, visithttps://www.moonlighting.com. About Digital Turbine Digital Turbine Simplifies content discovery and delivers it directly to the device. It'son-device media platformpowers frictionless appand content discovery, user acquisition and engagement, operational efficiency and monetization opportunities. Digital Turbine's technology platform has been adopted by more than40mobile operators and OEMs, and has delivered more thanthreebillion app preloads for tens of thousands advertising campaigns. The company is headquartered in Austin, Texas, with global offices inArlington, Durham, Mumbai, San Francisco, Singapore and Tel Aviv. For additional information visitwww.digitalturbine.com. SOURCE Moonlighting Related Links http://www.moonlighting.com/
Answer:
|
Moonlighting Partners with Digital Turbine to Grow Its App Users and Provide Access to Millions of Available Jobs and Free Business Tools Move further extends access to more than 200,000 work-from-home opportunities and more than two million gig, contract, part-time, freelance, and independent work opportunities.
|
RICHMOND, Va., June 9, 2020 /PRNewswire/ --Moonlighting, a leading mobile on-demand hiring platform, today announced it has partnered with Digital Turbine (Nasdaq: APPS), the #1 mobile platform connecting operators and OEMs with mobile advertisers, to accelerate the marketing of Moonlighting's app that connects new job opportunities and business tools to Americans whose businesses or jobs have been adversely affected by COVID-19's impact on the economy. In an effort to help displaced workers find jobs, Moonlightingrecently announced access to its jobs database, and business management tools is free until further notice. The company's searchable jobs database features more than two million gig, contract, part-time, freelance and independent work opportunities, including more than 200,000 work-from-home jobs. Key to the partnership, Digital Turbine will make available Moonlighting's Android app on select mobile devices in communities most affected by COVID-19. Digital Turbine's broad reach and leading technology platform enable brands and app developers to engage users through highly effective on-device media. Turnkey placement on newly activated devices provides easier, one-stop access and scale not available with other platforms. "Helping people whose jobs have been impacted by COVID-19 quickly find work is now our mission," said Jeff Tennery, Moonlighting's CEO & Founder. "By creating unique opportunities for users to discover content directly on devices, Digital Turbine's platform delivers a better user experience, unlike traditional media which is often noisy and inefficient." "I'm pleased to work together with Moonlighting to increase awareness of their app that assists those in need with job listings and support tools to quickly post gigs and help others find work," said Matt Tubergen, EVP of Digital Turbine Media. "Our platform engages users directly on deviceto be discovered when they want and how they want. It's simply a more direct and expedient route for getting apps directly in the hands of end-users." Founded in 2014 to serve the rapidly growing gig economy, Moonlighting has grown to serve more than 800,000 independent and freelance workers. It has also been featured in more than 150 news media sites and remains one of the fastest-growing independent worker platforms. About MoonlightingMoonlighting's on-demand hiring solution empowers people to earn money and hire talented professionals quickly, creating a virtual marketplace for freelancers and small businesses. With a blockchain-supported platform, Moonlighting provides a full turnkey solution with a suite of tools to empower millions of workers and recruiters worldwide. Moonlighting is a privately held, VA-based company built from the ground up for the gig economy. For more information, visithttps://www.moonlighting.com. About Digital Turbine Digital Turbine Simplifies content discovery and delivers it directly to the device. It'son-device media platformpowers frictionless appand content discovery, user acquisition and engagement, operational efficiency and monetization opportunities. Digital Turbine's technology platform has been adopted by more than40mobile operators and OEMs, and has delivered more thanthreebillion app preloads for tens of thousands advertising campaigns. The company is headquartered in Austin, Texas, with global offices inArlington, Durham, Mumbai, San Francisco, Singapore and Tel Aviv. For additional information visitwww.digitalturbine.com. SOURCE Moonlighting Related Links http://www.moonlighting.com/
|
edtsum6825
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LEXINGTON, Ky., Feb. 1, 2021 /PRNewswire/ -- Lexmark, a global imaging solutions leader, today announced that Vishal Gupta has joined its executive team as senior vice president and chief information and technology officer. In this role, he will be responsible for corporate IT, corporate strategy, and all software and analytics powering Lexmark's offerings. Gupta replaces Tom Eade, who is retiring."Tom has been with Lexmark since its inception in 1991 and had a tremendous impact on our company," saidAllenWaugerman, Lexmark president and CEO."We wish him the best in his retirement." (PRNewsfoto/Lexmark) "We are pleased to welcome Vishal to the Lexmark executive team," Waugerman added. "His leadership attributes, strategic vision and deep expertise in IoT, cybersecurity, artificial intelligence, machine learning, hybrid cloud, and development of award-winning products and platforms make him an ideal fit for Lexmark as we transform our company for the future." Guptacomes to Lexmark from Unisys, where he led a team of more than 1,500 engineers and was responsible for all products and platforms. Beforejoining Unisysin 2018,Guptaserved as senior vice presidentofengineering at Symantec Corporation, overseeing global teams for end-to-end engineering, architecture and product management for multiple product lines across security software offerings. Prior to his tenure at Symantec, Vishal was chief product and IoT officer for Silent Circle, a cybersecurity and privacy company in the mobile communications space. He previously held senior leadership roles with Cisco Systems, including vice president of Vertical IoT Solutions. Guptaholds abachelor's degree in electricaland electronicsengineeringfromtheBirla Institute of Technology and ScienceinPilani, India,amaster'sdegreein computer engineeringfrom Dartmouth College,and an MBA from The Wharton School at the University of Pennsylvania where he was a Palmer scholar."Lexmark's combination of software products, information technology, data science,and corporate strategy is unique and powerful and willdrivethe company's expansion into core adjacencies and beyond," Gupta said. "I look forward to helpingadvance Lexmark's missionand accelerate itstransformation for our customers, partners and employees." About LexmarkLexmarkcreates innovative IoT- and cloud-enabled imaging technologies that help customers worldwide achieve their vision of print simplicity, security, savings and sustainability.SOURCE Lexmark Related Links http://www.lexmark.com
Answer:
|
Lexmark Names Vishal Gupta Senior Vice President and Chief Information and Technology Officer
|
LEXINGTON, Ky., Feb. 1, 2021 /PRNewswire/ -- Lexmark, a global imaging solutions leader, today announced that Vishal Gupta has joined its executive team as senior vice president and chief information and technology officer. In this role, he will be responsible for corporate IT, corporate strategy, and all software and analytics powering Lexmark's offerings. Gupta replaces Tom Eade, who is retiring."Tom has been with Lexmark since its inception in 1991 and had a tremendous impact on our company," saidAllenWaugerman, Lexmark president and CEO."We wish him the best in his retirement." (PRNewsfoto/Lexmark) "We are pleased to welcome Vishal to the Lexmark executive team," Waugerman added. "His leadership attributes, strategic vision and deep expertise in IoT, cybersecurity, artificial intelligence, machine learning, hybrid cloud, and development of award-winning products and platforms make him an ideal fit for Lexmark as we transform our company for the future." Guptacomes to Lexmark from Unisys, where he led a team of more than 1,500 engineers and was responsible for all products and platforms. Beforejoining Unisysin 2018,Guptaserved as senior vice presidentofengineering at Symantec Corporation, overseeing global teams for end-to-end engineering, architecture and product management for multiple product lines across security software offerings. Prior to his tenure at Symantec, Vishal was chief product and IoT officer for Silent Circle, a cybersecurity and privacy company in the mobile communications space. He previously held senior leadership roles with Cisco Systems, including vice president of Vertical IoT Solutions. Guptaholds abachelor's degree in electricaland electronicsengineeringfromtheBirla Institute of Technology and ScienceinPilani, India,amaster'sdegreein computer engineeringfrom Dartmouth College,and an MBA from The Wharton School at the University of Pennsylvania where he was a Palmer scholar."Lexmark's combination of software products, information technology, data science,and corporate strategy is unique and powerful and willdrivethe company's expansion into core adjacencies and beyond," Gupta said. "I look forward to helpingadvance Lexmark's missionand accelerate itstransformation for our customers, partners and employees." About LexmarkLexmarkcreates innovative IoT- and cloud-enabled imaging technologies that help customers worldwide achieve their vision of print simplicity, security, savings and sustainability.SOURCE Lexmark Related Links http://www.lexmark.com
|
edtsum6840
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NORMAN, Okla., Oct. 21, 2020 /PRNewswire/ -- NextepFounder and CEOBrian Fayakannounced the Nextep Charitable Foundation would be donating $50,000 to local organizations supporting the Black community. Through this initiative, Nextep Charitable Foundation is donating $10,000 to five nonprofits to further the impact each organization is making and create awareness around the work they're doing in the community. Continue Reading The Nextep Charitable Foundation is excited to donate $10,000 to The Education and Employment Ministry, TEEM. TEEM uses job training, education, mentorship, and social services to help individuals who are or have been incarcerated get back on their feet. Nextep Charitable Foundation is thrilled to announce that one of these $10,000 donations is going to The Education and Employment Ministry, TEEM. TEEM uses job training, education, mentorship, and social services to help individuals get back on their feet during or after incarceration. "The Education and Employment Ministry, also known as TEEM, is a 501(c)(3) nonprofit organization dedicated to breaking cycles of incarceration and poverty through education, personal development, and work readiness training."TEEM TEEM helps individuals from the pretrial process to re-entering life and work after incarceration. With TEEM's pretrial services, a participant has access to an attorney, courtroom advocacy, resources for housing and sober living homes, transportation, education, and cognitive behavioral classes.This organization also serves individuals once they're no longer incarcerated. Once a participant joins the reentry program, they will attend an Empower class for two to three weeks. At this class, they'll build a resume, practice interviewing, learn skills for entering the workforce, and make a plan moving forward. TEEM also helps participants with housing, transportation, social skills, mentoring, and job placement. Case managers follow up with participants up to a year after release."Oklahoma incarcerates more women and more people of color per capita than any other state in the nation," says Brittney Berling, Development Coordinator at TEEM. "Right now, we rank third in overall incarceration rates." TEEM focuses theirefforts on helping individuals re-enter life and work after incarceration to break the cycle of incarceration and poverty.You can support TEEM by donatingto and following the work they're doing in Oklahoma (Instagram: @okcteem). The Nextep Charitable Foundation is proud to have the opportunity to support this incredible organization.To learn more about the other nonprofits selected, visit nextep.com/blog.About NextepAs a Professional Employer Organization (PEO), Nextep works with companies to provide outsourced services, including payroll, benefits, HR, compliance, and more. Since its beginnings, Nextep and its employees have had a heart for giving back. So, Nextep formed the Nextep Charitable Foundation to create an even stronger platform to donate, volunteer, and give back. In partnership with the Pledge 1% movement, Nextep donates money, offers free services to nonprofits, and the employees volunteer their time, both in and outside of work.Nextep, Inc. 1800 N. Interstate Dr. Norman, OK 73072 www.nextep.com Phone 888.811.5150 [emailprotected] ContactChristyHrencher Office 405.928.2318 [emailprotected] Related Imagesnextep-donates-10-000-to-teem.jpg Nextep Donates $10,000 to TEEM The Nextep Charitable Foundation is excited to donate $10,000 to The Education and Employment Ministry, TEEM. TEEM uses job training, education, mentorship, and social services to help individuals who are or have been incarcerated get back on their feet. SOURCE Nextep
Answer:
|
Nextep Charitable Foundation Donates $10,000 to TEEM to Support Local Black Community
|
NORMAN, Okla., Oct. 21, 2020 /PRNewswire/ -- NextepFounder and CEOBrian Fayakannounced the Nextep Charitable Foundation would be donating $50,000 to local organizations supporting the Black community. Through this initiative, Nextep Charitable Foundation is donating $10,000 to five nonprofits to further the impact each organization is making and create awareness around the work they're doing in the community. Continue Reading The Nextep Charitable Foundation is excited to donate $10,000 to The Education and Employment Ministry, TEEM. TEEM uses job training, education, mentorship, and social services to help individuals who are or have been incarcerated get back on their feet. Nextep Charitable Foundation is thrilled to announce that one of these $10,000 donations is going to The Education and Employment Ministry, TEEM. TEEM uses job training, education, mentorship, and social services to help individuals get back on their feet during or after incarceration. "The Education and Employment Ministry, also known as TEEM, is a 501(c)(3) nonprofit organization dedicated to breaking cycles of incarceration and poverty through education, personal development, and work readiness training."TEEM TEEM helps individuals from the pretrial process to re-entering life and work after incarceration. With TEEM's pretrial services, a participant has access to an attorney, courtroom advocacy, resources for housing and sober living homes, transportation, education, and cognitive behavioral classes.This organization also serves individuals once they're no longer incarcerated. Once a participant joins the reentry program, they will attend an Empower class for two to three weeks. At this class, they'll build a resume, practice interviewing, learn skills for entering the workforce, and make a plan moving forward. TEEM also helps participants with housing, transportation, social skills, mentoring, and job placement. Case managers follow up with participants up to a year after release."Oklahoma incarcerates more women and more people of color per capita than any other state in the nation," says Brittney Berling, Development Coordinator at TEEM. "Right now, we rank third in overall incarceration rates." TEEM focuses theirefforts on helping individuals re-enter life and work after incarceration to break the cycle of incarceration and poverty.You can support TEEM by donatingto and following the work they're doing in Oklahoma (Instagram: @okcteem). The Nextep Charitable Foundation is proud to have the opportunity to support this incredible organization.To learn more about the other nonprofits selected, visit nextep.com/blog.About NextepAs a Professional Employer Organization (PEO), Nextep works with companies to provide outsourced services, including payroll, benefits, HR, compliance, and more. Since its beginnings, Nextep and its employees have had a heart for giving back. So, Nextep formed the Nextep Charitable Foundation to create an even stronger platform to donate, volunteer, and give back. In partnership with the Pledge 1% movement, Nextep donates money, offers free services to nonprofits, and the employees volunteer their time, both in and outside of work.Nextep, Inc. 1800 N. Interstate Dr. Norman, OK 73072 www.nextep.com Phone 888.811.5150 [emailprotected] ContactChristyHrencher Office 405.928.2318 [emailprotected] Related Imagesnextep-donates-10-000-to-teem.jpg Nextep Donates $10,000 to TEEM The Nextep Charitable Foundation is excited to donate $10,000 to The Education and Employment Ministry, TEEM. TEEM uses job training, education, mentorship, and social services to help individuals who are or have been incarcerated get back on their feet. SOURCE Nextep
|
edtsum6841
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN CARLOS, Calif. & CHICAGO--(BUSINESS WIRE)--GradableTM, one of the leading technology and services provider that facilitates the scoring, sourcing, and pricing of Low-Carbon Grain from farm-to-fork, today announced the appointment of the Gradable Environmental Advisory Board, which includes representatives from the Environmental Defense Fund, Argonne National Laboratory, The Nature Conservancy, and the Foundation for Food & Agriculture Research (FFAR). Gradable enables comprehensive environmental transparency, and supports a market for premium, environmentally-scored grain. Gradable also provides buying intelligence software that directly connects farmers with consumer packaged goods companies, animal feed providers, biofuel makers and the worlds other major grain buyers. The Gradable Environmental Advisory Board will provide third-party scientific, agronomic, and economic counsel for Gradable initiatives. These efforts help maximize the positive environmental impacts of these campaigns and assist Gradable in aligning stakeholders in the agriculture supply chain, from farmers to grain buyers to consumer packaged goods companies to policymakers around practical solutions. Board members represent numerous world-class research organizations and environmental groups around the globe. The Board includes Jenny Ahlen, Senior Director of Sustainable Food and Products for the Environmental Defense Funds EDF+Business program. She works with leading consumer goods companies and retailers to reduce the climate impacts of global supply chains. EDF, one of the worlds leading international nonprofit organizations, creates transformational solutions to the most serious environmental problems. To do so, EDF links science, economics, law and innovative-private sector partnerships. We see enormous opportunities for supply chain and policy innovations that reward farmers for climate-smart practices, Ahlen said. By increasing conservation data availability and transparency, Gradable can enable solutions that deliver results for farmers, businesses and the planet. We're excited to be part of this effort. The Nature Conservancy's director of agriculture innovation, Rene Vassilos, has also joined the Board. Vassilos manages the organizations investments in innovative companies working to scale regenerative agriculture practices. The Nature Conservancy is one of the worlds leading global conservation organizations dedicated to conserving the lands and waters upon which all life depends. If we are truly going to ensure the long-term food security of billions around the world, profitable livelihoods for growers, farmers, and ranchers, and a healthy environment, innovation in regenerative agriculture must be a business imperative, said Vassilos. Taking proactive steps to innovate the global food supply chain, while also implementing policy solutions that reward growers for adopting climate-friendly practices, is a win-win for agriculture and the environment. Michael Wang, a Distinguished Fellow, Senior Scientist, and Director of the Systems Assessment Center of the Energy Systems Division at Argonne National Laboratory, also joined the Board. At Argonne, he oversees the evaluation of energy and environmental impacts of vehicle technologies, transportation fuels, and energy systems. He is the original developer of Argonnes GREET model, which is used by industries and government agencies. Argonne is a multidisciplinary science and engineering research center that seeks solutions to pressing national problems, with a focus on understanding the planet, climate and cosmos. I am pleased to see that Gradable is benefitting from the GREET model and its results. Credible, transparent carbon footprint results are key to encourage farmers to pursue sustainable farming practices, Wang added. Dr. LaKisha Odom, Scientific Program Director at the Foundation for Food & Agriculture Research (FFAR) brings expertise on soil health to the board. Founded in 2014, FFAR builds partnerships to address todays food and agriculture challenges, seeking to enhance the economic and environmental resilience of our food supply. Were proud to welcome the distinguished environmental leaders to our board, said Devin Lammers, CEO of Gradable. Theyll bring unparalleled experience and expertise to ensure Gradable maximizes its positive impact on the environment, farmers, rural economies, and beyond. The Gradable Environmental Advisory Board will begin by assisting the company in solidifying a carbon intensity scoring model for grain, and will counsel on topics such as soil health, traceability, regenerative agriculture certifications, and farm-level financial instruments. About Gradable: Gradable, launched by Farmers Business Network, Inc. (FBN), provides new technology and services that facilitate the scoring, sourcing, and pricing of Low-Carbon Grain, making environmental transparency in the grain industry a reality now. Gradable enables comprehensive environmental transparency and supports a market for premium, environmentally-scored grain. Gradable also provides buying intelligence software that directly connects farmers with consumer packaged goods companies, animal feed providers, biofuel makers and the worlds other major grain buyers. To learn more, visit www.gradable.com About FBN: Farmers Business Network, Inc. is an independent ag tech platform and farmer-to-farmer network with a mission to power the prosperity of family farmers around the world, while working towards a sustainable future. Its Farmers First promise has attracted over 24,000 members to the network with a common goal of maximizing their farms profit potential. FBN has set out to redefine value and convenience for farmers by helping reduce the cost of production and maximize the value of their crops. The FBN network has grown to cover more than 67 million acres of member farms in the U.S., Canada and Australia. Blending the best of Midwestern agricultural roots and Silicon Valley technology, the company has over 600 personnel and offices in San Carlos, Calif., Chicago, Ill., Sioux Falls, S.D., a Canadian Headquarters in High River, Alberta and an Australian Headquarters in Perth. To learn more, visit: www.fbn.com. *Fees may apply for certain product and service offerings other than FBN membership. The sprout logo, Farmers Business Network, FBN, FBN Direct and Farmers First are registered trademarks or service marks of Farmers Business Network, Inc. GREET is a registered trademark of the Argonne National Laboratory. All other marks are the property of their respective owners.
Answer:
|
GradableTM Forms Environmental Advisory Board, Appoints Representatives From EDF, Argonne National Lab, and The Nature Conservancy Board to help development of initiatives to maximize positive environmental impacts from sustainable farming and low-carbon grain market
|
SAN CARLOS, Calif. & CHICAGO--(BUSINESS WIRE)--GradableTM, one of the leading technology and services provider that facilitates the scoring, sourcing, and pricing of Low-Carbon Grain from farm-to-fork, today announced the appointment of the Gradable Environmental Advisory Board, which includes representatives from the Environmental Defense Fund, Argonne National Laboratory, The Nature Conservancy, and the Foundation for Food & Agriculture Research (FFAR). Gradable enables comprehensive environmental transparency, and supports a market for premium, environmentally-scored grain. Gradable also provides buying intelligence software that directly connects farmers with consumer packaged goods companies, animal feed providers, biofuel makers and the worlds other major grain buyers. The Gradable Environmental Advisory Board will provide third-party scientific, agronomic, and economic counsel for Gradable initiatives. These efforts help maximize the positive environmental impacts of these campaigns and assist Gradable in aligning stakeholders in the agriculture supply chain, from farmers to grain buyers to consumer packaged goods companies to policymakers around practical solutions. Board members represent numerous world-class research organizations and environmental groups around the globe. The Board includes Jenny Ahlen, Senior Director of Sustainable Food and Products for the Environmental Defense Funds EDF+Business program. She works with leading consumer goods companies and retailers to reduce the climate impacts of global supply chains. EDF, one of the worlds leading international nonprofit organizations, creates transformational solutions to the most serious environmental problems. To do so, EDF links science, economics, law and innovative-private sector partnerships. We see enormous opportunities for supply chain and policy innovations that reward farmers for climate-smart practices, Ahlen said. By increasing conservation data availability and transparency, Gradable can enable solutions that deliver results for farmers, businesses and the planet. We're excited to be part of this effort. The Nature Conservancy's director of agriculture innovation, Rene Vassilos, has also joined the Board. Vassilos manages the organizations investments in innovative companies working to scale regenerative agriculture practices. The Nature Conservancy is one of the worlds leading global conservation organizations dedicated to conserving the lands and waters upon which all life depends. If we are truly going to ensure the long-term food security of billions around the world, profitable livelihoods for growers, farmers, and ranchers, and a healthy environment, innovation in regenerative agriculture must be a business imperative, said Vassilos. Taking proactive steps to innovate the global food supply chain, while also implementing policy solutions that reward growers for adopting climate-friendly practices, is a win-win for agriculture and the environment. Michael Wang, a Distinguished Fellow, Senior Scientist, and Director of the Systems Assessment Center of the Energy Systems Division at Argonne National Laboratory, also joined the Board. At Argonne, he oversees the evaluation of energy and environmental impacts of vehicle technologies, transportation fuels, and energy systems. He is the original developer of Argonnes GREET model, which is used by industries and government agencies. Argonne is a multidisciplinary science and engineering research center that seeks solutions to pressing national problems, with a focus on understanding the planet, climate and cosmos. I am pleased to see that Gradable is benefitting from the GREET model and its results. Credible, transparent carbon footprint results are key to encourage farmers to pursue sustainable farming practices, Wang added. Dr. LaKisha Odom, Scientific Program Director at the Foundation for Food & Agriculture Research (FFAR) brings expertise on soil health to the board. Founded in 2014, FFAR builds partnerships to address todays food and agriculture challenges, seeking to enhance the economic and environmental resilience of our food supply. Were proud to welcome the distinguished environmental leaders to our board, said Devin Lammers, CEO of Gradable. Theyll bring unparalleled experience and expertise to ensure Gradable maximizes its positive impact on the environment, farmers, rural economies, and beyond. The Gradable Environmental Advisory Board will begin by assisting the company in solidifying a carbon intensity scoring model for grain, and will counsel on topics such as soil health, traceability, regenerative agriculture certifications, and farm-level financial instruments. About Gradable: Gradable, launched by Farmers Business Network, Inc. (FBN), provides new technology and services that facilitate the scoring, sourcing, and pricing of Low-Carbon Grain, making environmental transparency in the grain industry a reality now. Gradable enables comprehensive environmental transparency and supports a market for premium, environmentally-scored grain. Gradable also provides buying intelligence software that directly connects farmers with consumer packaged goods companies, animal feed providers, biofuel makers and the worlds other major grain buyers. To learn more, visit www.gradable.com About FBN: Farmers Business Network, Inc. is an independent ag tech platform and farmer-to-farmer network with a mission to power the prosperity of family farmers around the world, while working towards a sustainable future. Its Farmers First promise has attracted over 24,000 members to the network with a common goal of maximizing their farms profit potential. FBN has set out to redefine value and convenience for farmers by helping reduce the cost of production and maximize the value of their crops. The FBN network has grown to cover more than 67 million acres of member farms in the U.S., Canada and Australia. Blending the best of Midwestern agricultural roots and Silicon Valley technology, the company has over 600 personnel and offices in San Carlos, Calif., Chicago, Ill., Sioux Falls, S.D., a Canadian Headquarters in High River, Alberta and an Australian Headquarters in Perth. To learn more, visit: www.fbn.com. *Fees may apply for certain product and service offerings other than FBN membership. The sprout logo, Farmers Business Network, FBN, FBN Direct and Farmers First are registered trademarks or service marks of Farmers Business Network, Inc. GREET is a registered trademark of the Argonne National Laboratory. All other marks are the property of their respective owners.
|
edtsum6844
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, April 6, 2021 /PRNewswire/ --CIT Group Inc.(NYSE: CIT) today announced that its Healthcare Financebusiness served as sole lead arranger on an $18.5 million loan to finance the acquisition of the Singing River Cancer Center in Florence, Alabama. The borrower, Cypress West Partners is an experienced and successful owner and manager of healthcare properties that has a long history of acquisition financing with CIT. The Singing River Cancer Center, a 45,900-square-foot medical office building, opened in the fall of 2020 and is fully leased to complementary tenants that provide cancer care, oncology and imaging services. "Singing River Cancer Center is a modern, well-designed and efficient medical facility in an attractive and convenient location," said Christopher J. Cumella, CEO, Cypress West Partners. "We are pleased to add this very solid asset to our growing medical office portfolio and are grateful for our acquisition financing relationship with CIT." "It was a pleasure to work with the Cypress West team once again to meet their financing needs as they continue to build their portfolio of outstanding medical office buildings," said William Douglass, managing director and group head for CIT's Healthcare Financebusiness. "We look forward to future opportunities to support their continued growth." CIT's Healthcare Financeunit, part of the Commercial Financedivision, provides comprehensive financing and banking solutions to middle market healthcare companies across the U.S. By using a client-focused and industry-centric model, the Healthcare Finance team can tailor its products and services to help clients meet their needs for growth capital. About CIT CIT is a leading national bank focused on empowering businesses and personal savers with the financial agility to navigate their goals. CIT Group Inc. (NYSE: CIT) is a financial holding company with over a century of experience and operates a principal bank subsidiary, CIT Bank, N.A. (Member FDIC, Equal Housing Lender). The company's commercial banking segment includes commercial financing, community association banking, middle market banking, equipment and vendor financing, factoring, railcar financing, treasury and payments services, and capital markets and asset management. CIT's consumer banking segment includes a national direct bank and regional branch network. Discover more at cit.com/about. MEDIA RELATIONS:John M. Moran212-461-5507[emailprotected] SOURCE CIT Group Inc. Related Links www.cit.com
Answer:
|
CIT Serves as Sole Lead Arranger on $18.5 Million Financing for Alabama Cancer Center
|
NEW YORK, April 6, 2021 /PRNewswire/ --CIT Group Inc.(NYSE: CIT) today announced that its Healthcare Financebusiness served as sole lead arranger on an $18.5 million loan to finance the acquisition of the Singing River Cancer Center in Florence, Alabama. The borrower, Cypress West Partners is an experienced and successful owner and manager of healthcare properties that has a long history of acquisition financing with CIT. The Singing River Cancer Center, a 45,900-square-foot medical office building, opened in the fall of 2020 and is fully leased to complementary tenants that provide cancer care, oncology and imaging services. "Singing River Cancer Center is a modern, well-designed and efficient medical facility in an attractive and convenient location," said Christopher J. Cumella, CEO, Cypress West Partners. "We are pleased to add this very solid asset to our growing medical office portfolio and are grateful for our acquisition financing relationship with CIT." "It was a pleasure to work with the Cypress West team once again to meet their financing needs as they continue to build their portfolio of outstanding medical office buildings," said William Douglass, managing director and group head for CIT's Healthcare Financebusiness. "We look forward to future opportunities to support their continued growth." CIT's Healthcare Financeunit, part of the Commercial Financedivision, provides comprehensive financing and banking solutions to middle market healthcare companies across the U.S. By using a client-focused and industry-centric model, the Healthcare Finance team can tailor its products and services to help clients meet their needs for growth capital. About CIT CIT is a leading national bank focused on empowering businesses and personal savers with the financial agility to navigate their goals. CIT Group Inc. (NYSE: CIT) is a financial holding company with over a century of experience and operates a principal bank subsidiary, CIT Bank, N.A. (Member FDIC, Equal Housing Lender). The company's commercial banking segment includes commercial financing, community association banking, middle market banking, equipment and vendor financing, factoring, railcar financing, treasury and payments services, and capital markets and asset management. CIT's consumer banking segment includes a national direct bank and regional branch network. Discover more at cit.com/about. MEDIA RELATIONS:John M. Moran212-461-5507[emailprotected] SOURCE CIT Group Inc. Related Links www.cit.com
|
edtsum6855
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CHARLOTTE, N.C.--(BUSINESS WIRE)--Bojangles Opco, LLC, known for its iconic Southern food in more than 760 restaurants throughout the Southeast, today announced a development deal with a longtime franchisee dedicated to growing and investing in the brand, Jeff Rigsby of BOJ of WNC, LLC. The deal between the pair outlines a plan to open 45 new locations over the next seven years. Rigsby recently marked his 20th year as a Bojangles franchisee and is celebrating the anniversary with this substantial expansion agreement. The restaurants will be developed around Rigsbys core markets, including Georgia, Kentucky, North Carolina, South Carolina and Tennessee, along with a new Bojangles market: Columbus, Ohio, which is slated for 15 locations. In connection with the planned development of 45 new restaurants, Rigsby has also acquired 16 company-operated restaurants from Bojangles, making him the largest franchisee in the system. Jeff has been a valued partner of the Bojangles brand for over 20 years, and we could not be more thrilled to extend this business relationship to 45 new locations, including expansion into a new market for our brand, said Jose Costa, chief development officer for Bojangles. He embodies what it means to proudly represent this beloved chain, and we are looking forward to many more years of success for Jeff. Rigsby currently operates 92 locations, including the 16 recently acquired restaurants. He also has nine approved locations projected to open in 2021, which means he is anticipated to hit 100 stores by 2022. Over the past 20 years, my partnership with Bojangles has been rewarding and full of growth, and this major milestone and accompanying investment deal is a perfect indicator of that, said Rigsby. Im grateful for what weve accomplished together, and Im excited for whats to come. Rigsby joined the chicken-and-biscuits chain in 1994 as an area supervisor in Greenville, South Carolina. He was later promoted to director of operationsa role in which he oversaw more than 35 stores throughout the Carolinas. In 2001, Rigsby harnessed his entrepreneurial spirit and became a franchisee, buying six stores in Asheville, North Carolina. Since that time, his Bojangles franchise has seen exponential growth across five states. Rigsby attributes his success with Bojangles to a focus on operating his restaurants at the highest level, developing team members as the most important asset, and giving back to the community. About BOJ of WNC, LLC and BOJ of TN, LLC. Bojangles franchisees BOJ of WNC, LLC and BOJ of TN, LLC are based in Arden, North Carolina. The franchise groups own and operate 92 restaurants in Western North Carolina, South Carolina, Tennessee, Georgia and Kentucky. The franchise group began with six locations in Asheville, North Carolina in 2001 and has grown to serve Bojangles menu items, including delicious chicken; made-from-scratch buttermilk biscuits; flavorful fixins and Legendary Iced Tea to five, soon-to-be-six, states. About Bojangles Opco, LLC Bojangles Opco, LLC. is a highly differentiated and growing restaurant operator and franchisor dedicated to serving customers high-quality, craveable food made from our Southern recipes, including breakfast served All Day, Every Day. Founded in 1977 in Charlotte, N.C., Bojangles serves menu items such as made-from-scratch biscuit breakfast sandwiches, delicious hand-breaded bone-in chicken, flavorful fixins (sides) and Legendary Iced Tea. Currently, Bojangles has approximately 760 system-wide restaurants in 11 states. For more information, visit www.bojangles.com or follow Bojangles on Facebook, Instagram and Twitter.
Answer:
|
Bojangles Opco, LLC Strikes 45-Location Expansion Deal with Existing Franchisee Franchisee Jeff Rigsby of BOJ of WNC, LLC Expected to Hit 100 Store Mark by 2022
|
CHARLOTTE, N.C.--(BUSINESS WIRE)--Bojangles Opco, LLC, known for its iconic Southern food in more than 760 restaurants throughout the Southeast, today announced a development deal with a longtime franchisee dedicated to growing and investing in the brand, Jeff Rigsby of BOJ of WNC, LLC. The deal between the pair outlines a plan to open 45 new locations over the next seven years. Rigsby recently marked his 20th year as a Bojangles franchisee and is celebrating the anniversary with this substantial expansion agreement. The restaurants will be developed around Rigsbys core markets, including Georgia, Kentucky, North Carolina, South Carolina and Tennessee, along with a new Bojangles market: Columbus, Ohio, which is slated for 15 locations. In connection with the planned development of 45 new restaurants, Rigsby has also acquired 16 company-operated restaurants from Bojangles, making him the largest franchisee in the system. Jeff has been a valued partner of the Bojangles brand for over 20 years, and we could not be more thrilled to extend this business relationship to 45 new locations, including expansion into a new market for our brand, said Jose Costa, chief development officer for Bojangles. He embodies what it means to proudly represent this beloved chain, and we are looking forward to many more years of success for Jeff. Rigsby currently operates 92 locations, including the 16 recently acquired restaurants. He also has nine approved locations projected to open in 2021, which means he is anticipated to hit 100 stores by 2022. Over the past 20 years, my partnership with Bojangles has been rewarding and full of growth, and this major milestone and accompanying investment deal is a perfect indicator of that, said Rigsby. Im grateful for what weve accomplished together, and Im excited for whats to come. Rigsby joined the chicken-and-biscuits chain in 1994 as an area supervisor in Greenville, South Carolina. He was later promoted to director of operationsa role in which he oversaw more than 35 stores throughout the Carolinas. In 2001, Rigsby harnessed his entrepreneurial spirit and became a franchisee, buying six stores in Asheville, North Carolina. Since that time, his Bojangles franchise has seen exponential growth across five states. Rigsby attributes his success with Bojangles to a focus on operating his restaurants at the highest level, developing team members as the most important asset, and giving back to the community. About BOJ of WNC, LLC and BOJ of TN, LLC. Bojangles franchisees BOJ of WNC, LLC and BOJ of TN, LLC are based in Arden, North Carolina. The franchise groups own and operate 92 restaurants in Western North Carolina, South Carolina, Tennessee, Georgia and Kentucky. The franchise group began with six locations in Asheville, North Carolina in 2001 and has grown to serve Bojangles menu items, including delicious chicken; made-from-scratch buttermilk biscuits; flavorful fixins and Legendary Iced Tea to five, soon-to-be-six, states. About Bojangles Opco, LLC Bojangles Opco, LLC. is a highly differentiated and growing restaurant operator and franchisor dedicated to serving customers high-quality, craveable food made from our Southern recipes, including breakfast served All Day, Every Day. Founded in 1977 in Charlotte, N.C., Bojangles serves menu items such as made-from-scratch biscuit breakfast sandwiches, delicious hand-breaded bone-in chicken, flavorful fixins (sides) and Legendary Iced Tea. Currently, Bojangles has approximately 760 system-wide restaurants in 11 states. For more information, visit www.bojangles.com or follow Bojangles on Facebook, Instagram and Twitter.
|
edtsum6862
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NETANYA, Israel, Feb. 9, 2021 /PRNewswire/ -- Jungo, a leader in driver and occupancy monitoring AI software, announced today over 1,300% high growth year-over-yearin DMS software shipments. With the growing awareness that driver monitoring software is becoming a critical function in all vehicles, DMS software has become a must have element for car OEM markets as well as aftermarket service providers and fleets. Jungo has been selected by top players in the automotive OEM and aftermarket industry, resulting in deployment at scale, with rapid growth in shipments, marking Jungo as a global leader in this space. "Despite COVID-19 setting shockwaves across the automotive industry, Jungo saw unprecedented growth of 1,300% in its DMS software deliveries in production," said Ophir Herbst, CEO of Jungo. "This reinforces both the importance and adoption of driver monitoring AI technology, and Jungo's global leadership in this domain." AboutJungo Jungo is a global leader of in-cabin sensing AI software, offering CoDriver, an advanced driver monitoring and in-cabin monitoring software. Learn more: www.jungo.com SOURCE Jungo Related Links https://www.jungo.com/
Answer:
|
Jungo Announces 1,300% Growth in DMS Shipments in 2020 USA - English USA - English
|
NETANYA, Israel, Feb. 9, 2021 /PRNewswire/ -- Jungo, a leader in driver and occupancy monitoring AI software, announced today over 1,300% high growth year-over-yearin DMS software shipments. With the growing awareness that driver monitoring software is becoming a critical function in all vehicles, DMS software has become a must have element for car OEM markets as well as aftermarket service providers and fleets. Jungo has been selected by top players in the automotive OEM and aftermarket industry, resulting in deployment at scale, with rapid growth in shipments, marking Jungo as a global leader in this space. "Despite COVID-19 setting shockwaves across the automotive industry, Jungo saw unprecedented growth of 1,300% in its DMS software deliveries in production," said Ophir Herbst, CEO of Jungo. "This reinforces both the importance and adoption of driver monitoring AI technology, and Jungo's global leadership in this domain." AboutJungo Jungo is a global leader of in-cabin sensing AI software, offering CoDriver, an advanced driver monitoring and in-cabin monitoring software. Learn more: www.jungo.com SOURCE Jungo Related Links https://www.jungo.com/
|
edtsum6864
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)-- FORM 8.5 (EPT/NON-RI) - Amendment to Purchase and Sales PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (RI) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE) Rule 8.5 of the Takeover Code (the Code) 1. KEY INFORMATION NO: 2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) (1) 21,828,763 2.08% 1,876,070 0.18% (2) 1,668,062 0.16% 21,181,271 2.02% (3) 0 0.00% 0 0.00% 23,496,825 2.24% 23,057,341 2.20% All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security 10p ordinary Purchase 458,063 2.6800 GBP 2.6713 GBP 10p ordinary Sale 552,645 2.6850 GBP 2.6707 GBP (b) Cash-settled derivative transactions Class of Product Nature of dealing Number of Price per relevant description reference unit security securities 10p ordinary SWAP Long 8,839 2.6847 GBP 10p ordinary CFD Long 25,945 2.6647 GBP 10p ordinary SWAP Long 40,609 2.6749 GBP 10p ordinary SWAP Long 48,224 2.6780 GBP 10p ordinary SWAP Long 63,246 2.6738 GBP 10p ordinary SWAP Long 70,041 2.6734 GBP 10p ordinary SWAP Long 163,330 2.6733 GBP 10p ordinary CFD Short 860 2.6778 GBP 10p ordinary SWAP Short 5,611 2.6739 GBP 10p ordinary SWAP Short 14,021 2.6740 GBP 10p ordinary SWAP Short 14,511 2.6780 GBP 10p ordinary SWAP Short 25,362 2.6800 GBP 10p ordinary CFD Short 29,822 2.6742 GBP 10p ordinary SWAP Short 38,100 2.6762 GBP 10p ordinary CFD Short 49,182 2.6739 GBP 10p ordinary SWAP Short 92,129 2.6726 GBP (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none None (c) Attachments NO 18 Nov 2020 Large Holdings Regulatory Operations 020 3134 7213 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
Answer:
|
FORM 8.5 (EPT/NON-RI) - WILLIAM HILL PLC - Amendment
|
LONDON--(BUSINESS WIRE)-- FORM 8.5 (EPT/NON-RI) - Amendment to Purchase and Sales PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (RI) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE) Rule 8.5 of the Takeover Code (the Code) 1. KEY INFORMATION NO: 2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) (1) 21,828,763 2.08% 1,876,070 0.18% (2) 1,668,062 0.16% 21,181,271 2.02% (3) 0 0.00% 0 0.00% 23,496,825 2.24% 23,057,341 2.20% All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security 10p ordinary Purchase 458,063 2.6800 GBP 2.6713 GBP 10p ordinary Sale 552,645 2.6850 GBP 2.6707 GBP (b) Cash-settled derivative transactions Class of Product Nature of dealing Number of Price per relevant description reference unit security securities 10p ordinary SWAP Long 8,839 2.6847 GBP 10p ordinary CFD Long 25,945 2.6647 GBP 10p ordinary SWAP Long 40,609 2.6749 GBP 10p ordinary SWAP Long 48,224 2.6780 GBP 10p ordinary SWAP Long 63,246 2.6738 GBP 10p ordinary SWAP Long 70,041 2.6734 GBP 10p ordinary SWAP Long 163,330 2.6733 GBP 10p ordinary CFD Short 860 2.6778 GBP 10p ordinary SWAP Short 5,611 2.6739 GBP 10p ordinary SWAP Short 14,021 2.6740 GBP 10p ordinary SWAP Short 14,511 2.6780 GBP 10p ordinary SWAP Short 25,362 2.6800 GBP 10p ordinary CFD Short 29,822 2.6742 GBP 10p ordinary SWAP Short 38,100 2.6762 GBP 10p ordinary CFD Short 49,182 2.6739 GBP 10p ordinary SWAP Short 92,129 2.6726 GBP (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none None (c) Attachments NO 18 Nov 2020 Large Holdings Regulatory Operations 020 3134 7213 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
|
edtsum6865
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PETACH-TIKVA, Israel and CUPERTINO, Calif., Aug. 11, 2020 /PRNewswire/ --Sensifree LTD, a medical device company developing advanced patient monitoring solutions ("Sensifree"), today announced that Sensifree and Dreamtech Co., LTD ("Dreamtech") have launched a joint development program supported by the Korea-Israel Research and Development Foundation (KORIL-RDF), to develop an innovative non-invasive blood pressure and other vital signs monitoring solutions for professional use. Corporate logo The purpose of the grant is to develop commercial, paradigm-shifting products for continuous monitoring of blood pressure and additional vital signs in hospitals and other clinical settings, using Sensifree's innovative, proprietary technology and Dreamtech's commercialization capabilities. These products will help to improve quality of care, patient safety and medical outcome. "The launch of this program is a major milestone as we move towards regulatory clearance and market entry," said Eran Agmon, Chief Executive Officer and co-founder of Sensifree. "Dreamtech's design and production capabilities are a great addition to our efforts of bringing products to the market. We thank Dreamtech and KORIL-RDF for providing development and manufacturing expertise and financial support necessary for our vision to improve clinicians practice and patient's medical outcome." "We believe that this joint effort will provide commercially and clinically viable solutions. We are impressed with Sensifree's technology and found it very suitable for our growth strategy," said DY Choi, Senior VP and Managing Director at Dreamtech's Convergence Division.Ilan Barak, CTO and co-founder of Sensifree, added, "We're very proud to be one of the select companies who've received the KORIL-RDF grant. This lends further credibility and support to our unique technology. We believe that our work with Dreamtech and KORIL-RDF will be beneficial to our vision to improve patient safety and medical outcome."Dr. Tae Hoon Choi, Chief Executive of KORIL-RDF, explained on the selection of the Sensifree-Dreamtech project: "Bio-convergence, an approach that integrates life sciences with additional engineering disciplines, is becoming a new wave in Korea and Israel to overcome the COVID-19 pandemic era. To enhance the cooperation between the two countries, KORIL-RDF is currently planning to promote "Bio-convergence" specifically. The project between Sensifree and Dreamtech well fits our strategy. We were impressed with the use case, the technology, and expect to have a technologically and commercially innovative outcome."About SensifreeSensifree is a medical device company developing products based on its patent pending, proprietary technology for advanced hemodynamic monitoring. The Company's first product, a continuous, non-invasive blood pressure (cNIBP) monitor, is designed for use in hospital's critical care settings. cNIBP monitoring would allow to identify episodes of low BP, which is a major risk factor in the development of post-surgical complications and mortality. For more information please visit www.sensifree.comAbout KORIL-RDFKorea Israel Industrial R&D Foundation (KORIL-RDF) is a bi-national foundation, created by the governments of the Republic of Korea and the State of Israel, whose mission is to promote & support technological collaboration in innovative R&D between commercial companies in both countries.About DreamtechFounded in 1998, the Company engages in the design and manufacturing of modular / finished solutions for mobile, automotive, and medical devices. Working closely with customers from the product development phase, the Company develops customized products that satisfy the customers' functional and quality needs while meeting necessary cost requirements. Its major products include integrated printed board assembly, fingerprint sensor modules, LED modules for automobiles, and smart medical devices such as wireless ECG monitoring patches and sensors for orthopedic surgery.SOURCE Sensifree
Answer:
|
Sensifree and Dreamtech Partner on Product Development Supported by the KORIL-RDF Foundation English English
|
PETACH-TIKVA, Israel and CUPERTINO, Calif., Aug. 11, 2020 /PRNewswire/ --Sensifree LTD, a medical device company developing advanced patient monitoring solutions ("Sensifree"), today announced that Sensifree and Dreamtech Co., LTD ("Dreamtech") have launched a joint development program supported by the Korea-Israel Research and Development Foundation (KORIL-RDF), to develop an innovative non-invasive blood pressure and other vital signs monitoring solutions for professional use. Corporate logo The purpose of the grant is to develop commercial, paradigm-shifting products for continuous monitoring of blood pressure and additional vital signs in hospitals and other clinical settings, using Sensifree's innovative, proprietary technology and Dreamtech's commercialization capabilities. These products will help to improve quality of care, patient safety and medical outcome. "The launch of this program is a major milestone as we move towards regulatory clearance and market entry," said Eran Agmon, Chief Executive Officer and co-founder of Sensifree. "Dreamtech's design and production capabilities are a great addition to our efforts of bringing products to the market. We thank Dreamtech and KORIL-RDF for providing development and manufacturing expertise and financial support necessary for our vision to improve clinicians practice and patient's medical outcome." "We believe that this joint effort will provide commercially and clinically viable solutions. We are impressed with Sensifree's technology and found it very suitable for our growth strategy," said DY Choi, Senior VP and Managing Director at Dreamtech's Convergence Division.Ilan Barak, CTO and co-founder of Sensifree, added, "We're very proud to be one of the select companies who've received the KORIL-RDF grant. This lends further credibility and support to our unique technology. We believe that our work with Dreamtech and KORIL-RDF will be beneficial to our vision to improve patient safety and medical outcome."Dr. Tae Hoon Choi, Chief Executive of KORIL-RDF, explained on the selection of the Sensifree-Dreamtech project: "Bio-convergence, an approach that integrates life sciences with additional engineering disciplines, is becoming a new wave in Korea and Israel to overcome the COVID-19 pandemic era. To enhance the cooperation between the two countries, KORIL-RDF is currently planning to promote "Bio-convergence" specifically. The project between Sensifree and Dreamtech well fits our strategy. We were impressed with the use case, the technology, and expect to have a technologically and commercially innovative outcome."About SensifreeSensifree is a medical device company developing products based on its patent pending, proprietary technology for advanced hemodynamic monitoring. The Company's first product, a continuous, non-invasive blood pressure (cNIBP) monitor, is designed for use in hospital's critical care settings. cNIBP monitoring would allow to identify episodes of low BP, which is a major risk factor in the development of post-surgical complications and mortality. For more information please visit www.sensifree.comAbout KORIL-RDFKorea Israel Industrial R&D Foundation (KORIL-RDF) is a bi-national foundation, created by the governments of the Republic of Korea and the State of Israel, whose mission is to promote & support technological collaboration in innovative R&D between commercial companies in both countries.About DreamtechFounded in 1998, the Company engages in the design and manufacturing of modular / finished solutions for mobile, automotive, and medical devices. Working closely with customers from the product development phase, the Company develops customized products that satisfy the customers' functional and quality needs while meeting necessary cost requirements. Its major products include integrated printed board assembly, fingerprint sensor modules, LED modules for automobiles, and smart medical devices such as wireless ECG monitoring patches and sensors for orthopedic surgery.SOURCE Sensifree
|
edtsum6870
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--The household cleaning products market is poised to grow by USD 15.7 billion during 2020-2024 progressing at a CAGR of over 5% during the forecast period. The report on the household cleaning products market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing primary and secondary housing markets. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis The household cleaning products market analysis include product segment and geographic landscapes. This study identifies the growing demand for premium products as one of the prime reasons driving the household cleaning products market growth during the next few years. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The household cleaning products market covers the following areas: Household Cleaning Products Market Sizing Household Cleaning Products Market Forecast Household Cleaning Products Market Industry Analysis Companies Mentioned Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Product Market Segmentation by Distribution channel Customer landscape Geographic Landscape Drivers, Challenges, and Trends Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Answer:
|
Global Household Cleaning Products Market - Featuring Church & Dwight Co. Inc., Colgate-Palmolive Co., and Godrej Consumer Products Ltd. Among Others | Technavio
|
LONDON--(BUSINESS WIRE)--The household cleaning products market is poised to grow by USD 15.7 billion during 2020-2024 progressing at a CAGR of over 5% during the forecast period. The report on the household cleaning products market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing primary and secondary housing markets. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis The household cleaning products market analysis include product segment and geographic landscapes. This study identifies the growing demand for premium products as one of the prime reasons driving the household cleaning products market growth during the next few years. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The household cleaning products market covers the following areas: Household Cleaning Products Market Sizing Household Cleaning Products Market Forecast Household Cleaning Products Market Industry Analysis Companies Mentioned Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Product Market Segmentation by Distribution channel Customer landscape Geographic Landscape Drivers, Challenges, and Trends Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
|
edtsum6872
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This "Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2020" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Spleen Tyrosine Kinase (SYK) Inhibitors pipeline landscape. SYK is a 72 kDa non-receptor tyrosine kinase, which contains two SRC homology 2 (SH2)-domains and a kinase domain, and is most highly expressed by haematopoietic cells. Mammals also express a SYK homologue, ZAP70, which is mostly restricted to T- and NK-lineage cells. SYK-related kinases are also found in invertebrates. Structure and Signaling of the SYK Receptor SYK contains two tandem SH2 domains and a C-terminal tyrosine kinase domain. These domains are linked by two linker regions: interdomain A between the two SH2 domains and interdomain B between the C-terminal SH2 domain and the kinase domain. An alternatively spliced form of SYK (known as SYK-B) lacks 23 amino acids of interdomain B, including a nuclear localization signal. The SYK signalling pathway was initially thought to be restricted to classical immunoreceptors of the adaptive immune response. However, later studies showing that glycoprotein VI (GpVI), a collagen-receptor expressed by platelets, also signals by a similar mechanism2, and that thepetechiated appearance of SYK-deficient embryos was due to a defect in lymphatic vascular development3 provided evidence for the role of SYK outside the adaptive immune response. Expression SYK is highly expressed by all haematopoietic lineage cells. Though the expression of SYK is tightly regulated the mechanism of this regulation, or that of the generation of the SYK-B isoform, is poorly understood. Mammals also express the SYK-related molecule ZAP70, the expression of which is mostly confined to the T and NK cell lineages. Spleen Tyrosine Kinase (SYK) Inhibitors While SYK inhibitors have shown positive effects in allergy, autoimmune diseases and B-lineage malignancies, the mechanism of their action is incompletely understood. This is in part due to the diverse roles of SYK in immunological functions. As an example, B-cell-mediated antigen presentation and autoantibody formation, Fc-receptor-mediated myeloid cell functions and ?2 integrin-mediated leukocyte activation have all been implicated in the pathogenesis of rheumatoid arthritis and they all have been shown to require SYK. Spleen Tyrosine Kinase (SYK) Inhibitors Emerging Drugs Chapters This segment of the Spleen Tyrosine Kinase (SYK) Inhibitors report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases. Spleen Tyrosine Kinase (SYK) Inhibitors Emerging Drugs Cevidoplenib dimesylate: Genosco The dimesylate salt of cevidoplenib, an orally available inhibitor of spleen tyrosine kinase (SYK), with potential anti-inflammatory and immunomodulating activities. Upon oral administration, cevidoplenib binds to and inhibits the activity of SYK, blocking Fc receptor and B-cell receptor (BCR)-mediated signaling in inflammatory cells, including macrophages, neutrophils, mast cells, natural killer (NK) cells and B cells. This leads to the inhibition of the activation of these inflammatory cells, and the related inflammatory responses and tissue damage. HMPL-523: Hutchison MediPharma An orally available inhibitor of spleen tyrosine kinase (Syk), with potential immune-modulating and antineoplastic activities. Upon oral administration of Syk inhibitor HMPL-523, this agent binds to and inhibits the activity of Syk. This inhibits B-cell receptor (BCR) signaling, which leads to the inhibition of B-cell activation, and prevents tumor cell activation, migration, adhesion and proliferation. Spleen Tyrosine Kinase (SYK) Inhibitors: Therapeutic Assessment This segment of the report provides insights about the different Spleen Tyrosine Kinase (SYK) Inhibitors drugs segregated based on following parameters that define the scope of the report, such as: Major Players in Spleen Tyrosine Kinase (SYK) Inhibitors There are approx. 10+ key companies which are developing the therapies for Spleen Tyrosine Kinase (SYK) Inhibitors. The companies which have their Spleen Tyrosine Kinase (SYK) Inhibitors drug candidates in the most advanced stage, i.e. phase II and Phase II/III include, Rigel Pharmaceuticals, TopiVert etc. Key Players Key Products For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/awxzof
Answer:
|
Global Spleen Tyrosine Kinase (SYK) Inhibitors Pipeline Insight Report 2020 Featuring Genosco, Portola Pharmaceuticals, GlaxoSmithKline, FUJIFILM, TopiVert, Takeda Oncology & Asana BioSciences - ResearchAndMarkets.com
|
DUBLIN--(BUSINESS WIRE)--The "Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This "Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2020" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Spleen Tyrosine Kinase (SYK) Inhibitors pipeline landscape. SYK is a 72 kDa non-receptor tyrosine kinase, which contains two SRC homology 2 (SH2)-domains and a kinase domain, and is most highly expressed by haematopoietic cells. Mammals also express a SYK homologue, ZAP70, which is mostly restricted to T- and NK-lineage cells. SYK-related kinases are also found in invertebrates. Structure and Signaling of the SYK Receptor SYK contains two tandem SH2 domains and a C-terminal tyrosine kinase domain. These domains are linked by two linker regions: interdomain A between the two SH2 domains and interdomain B between the C-terminal SH2 domain and the kinase domain. An alternatively spliced form of SYK (known as SYK-B) lacks 23 amino acids of interdomain B, including a nuclear localization signal. The SYK signalling pathway was initially thought to be restricted to classical immunoreceptors of the adaptive immune response. However, later studies showing that glycoprotein VI (GpVI), a collagen-receptor expressed by platelets, also signals by a similar mechanism2, and that thepetechiated appearance of SYK-deficient embryos was due to a defect in lymphatic vascular development3 provided evidence for the role of SYK outside the adaptive immune response. Expression SYK is highly expressed by all haematopoietic lineage cells. Though the expression of SYK is tightly regulated the mechanism of this regulation, or that of the generation of the SYK-B isoform, is poorly understood. Mammals also express the SYK-related molecule ZAP70, the expression of which is mostly confined to the T and NK cell lineages. Spleen Tyrosine Kinase (SYK) Inhibitors While SYK inhibitors have shown positive effects in allergy, autoimmune diseases and B-lineage malignancies, the mechanism of their action is incompletely understood. This is in part due to the diverse roles of SYK in immunological functions. As an example, B-cell-mediated antigen presentation and autoantibody formation, Fc-receptor-mediated myeloid cell functions and ?2 integrin-mediated leukocyte activation have all been implicated in the pathogenesis of rheumatoid arthritis and they all have been shown to require SYK. Spleen Tyrosine Kinase (SYK) Inhibitors Emerging Drugs Chapters This segment of the Spleen Tyrosine Kinase (SYK) Inhibitors report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases. Spleen Tyrosine Kinase (SYK) Inhibitors Emerging Drugs Cevidoplenib dimesylate: Genosco The dimesylate salt of cevidoplenib, an orally available inhibitor of spleen tyrosine kinase (SYK), with potential anti-inflammatory and immunomodulating activities. Upon oral administration, cevidoplenib binds to and inhibits the activity of SYK, blocking Fc receptor and B-cell receptor (BCR)-mediated signaling in inflammatory cells, including macrophages, neutrophils, mast cells, natural killer (NK) cells and B cells. This leads to the inhibition of the activation of these inflammatory cells, and the related inflammatory responses and tissue damage. HMPL-523: Hutchison MediPharma An orally available inhibitor of spleen tyrosine kinase (Syk), with potential immune-modulating and antineoplastic activities. Upon oral administration of Syk inhibitor HMPL-523, this agent binds to and inhibits the activity of Syk. This inhibits B-cell receptor (BCR) signaling, which leads to the inhibition of B-cell activation, and prevents tumor cell activation, migration, adhesion and proliferation. Spleen Tyrosine Kinase (SYK) Inhibitors: Therapeutic Assessment This segment of the report provides insights about the different Spleen Tyrosine Kinase (SYK) Inhibitors drugs segregated based on following parameters that define the scope of the report, such as: Major Players in Spleen Tyrosine Kinase (SYK) Inhibitors There are approx. 10+ key companies which are developing the therapies for Spleen Tyrosine Kinase (SYK) Inhibitors. The companies which have their Spleen Tyrosine Kinase (SYK) Inhibitors drug candidates in the most advanced stage, i.e. phase II and Phase II/III include, Rigel Pharmaceuticals, TopiVert etc. Key Players Key Products For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/awxzof
|
edtsum6875
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CHICAGO, April 26, 2020 /PRNewswire/ -- Boeing [NYSE: BA] today completed another COVID-19 transport mission, using a Boeing Dreamlifter to bring personal protective equipment (PPE) from Hong Kong to the United States. Working in partnership with Prisma Health, Atlas Air Worldwideand DiscommonFounder Neil Ferrier, the company transported 1.5 million medical-grade face masks bound for healthcare professionals at Prisma Health in South Carolina. (PRNewsfoto/Boeing) (PRNewsfoto/Boeing) (PRNewsfoto/Boeing) (PRNewsfoto/Boeing) Discommon, the importer of record for the delivery, secured production of the PPE from trusted manufacturers in China and turned to Boeing to facilitate their transport to Prisma Health, the largest healthcare system in South Carolina. Boeing donated the cost of the mission transport, with Atlas Air operating the flights on behalf of Boeing. The Dreamlifter, a converted Boeing 747-400 Large Cargo Freighter, flew from Hong Kong to Greenville, South Carolina, with the face masks in its lower lobe. Following the delivery, the Dreamlifter will return to its home base in North Charleston, South Carolina, and deliver 787 Dreamliner parts in support of the global aerospace supply chain. Boeing continues to support local communitiesand the heroic healthcare professionalsworking tirelessly to stop the spread of COVID-19. Additional airlift transport missions with the Boeing Dreamlifter and ecoDemonstrator are planned in the future. Boeing is coordinating closely with U.S. government officials on how to best assist areas with the greatest need.Leadership Support"Ten years ago, Boeing came to South Carolina investing a significant amount of resources in our economy and creating jobs for our people. Today, Boeing is making another significant investment in our state by partnering with other South Carolina businesses to help combat this deadly virus. South Carolinians are unique in their compassion and care for one another. The businesses that have collaborated to make this delivery possible are an embodiment of those qualities, and we owe a debt of gratitude to each of them." South Carolina Governor Henry McMaster"We owe it to our men and women on the front lines of our healthcare system to have the necessary resources to fight the COVID-19 virus. I want to thank Prisma Health, Discommon, Atlas Air and Boeing for stepping up to facilitate this important shipment of medical masks to South Carolina." Sen. Lindsey Graham"Battling COVID-19 has required an unprecedented response from all levels of government, the private sector, and American families. One of the most significant challenges facing communities across the country is ensuring our front-line healthcare workers have enough Personal Protective Equipment so they can both treat patients and keep themselves healthy. This public-private partnership between the White House, Boeing, Discommon and Atlas Air has cut through supply issues and red tape to bring 1.5 million medical-grade masks to South Carolina and will go a long way towards keeping our medical professionals safe. I offer my sincerest gratitude to all involved." Sen. Tim Scott"Today's delivery of medical masks for Prisma Health is tremendous news! The entire Palmetto State is thankful to Boeing, Atlas Air, and Discommon Concepts for making this shipment a reality in order to equip our medical personnel during these unprecedented times. It's partnerships like these led by companies in South Carolina that will ensure we are fully prepared to defeat COVID-19." Rep. Jeff Duncan (SC-03)"Today, we proudly welcome Boeing and Atlas Air to Greenville. When I was first approached by Discommon in Greenville, I knew these masks would make a huge difference for our healthcare workers at Prisma Health, who are on the front lines fighting the COVID-19 pandemic. We immediately got to work to make this happen. Today's delivery showcases the good that can be done when businesses, non-profits, and the government join together. This PPE will go a long way for folks here in the Upstate and across the Midlands." Rep. William Timmons (SC-04)"It's a win-win for South Carolina healthcare providers and a perfect example of private companies working with elected officials to help healthcare workers and the people they serve. We very much appreciate Boeing's support during these challenging times of securing necessary supplies. By standing together, we all stand stronger. In recognition of Boeing's delivery of our supplies, we are donating 100,000 of these masks to our colleagues at the Medical University of South Carolina, which is located near Boeing's manufacturing plant." Mark O'Halla, president and CEO, Prisma Health"I'm incredibly grateful to be part of this project the wild path to getting here is movie worthy. While every step of this logistics process has been incredibly daunting, Boeing and Atlas Air have been astonishing throughout, with both companies 100% committed to making today's transport mission possible. It's incredible that South Carolina has the backing of companies that can lend their vital transportation logistics support to this very complex challenge. Although this project isn't in our typical wheelhouse of industrial design and manufacturing, the ultimate goal of design is to solve problems beautifully, and we've all come together to do just that." Neil Ferrier, Founder, Discommon "Atlas Air is honored to be part of this vital mission. We thank the front-line responders who continue to meet the overwhelming needs of South Carolinians. The healthcare professionals in the Prisma Health System have been relentless and resilient, and transporting the critical equipment they need is one small way to thank them." John W. Dietrich, president and CEO, Atlas Air Worldwide"Boeing is proud to be part of this historic flight to bring vital PPE to healthcare workers across South Carolina. I want to offer my personal thanks to the Boeing team and our Atlas Air partners for what they've done to support this essential mission and ensure our frontline healthcare workers have the equipment they critically need." Dave Calhoun, president and CEO, BoeingBoeing Contact:[emailprotected]Prisma Health Contacts:Tammie Epps803-318-1598[emailprotected]Sandy Dees864-303-4115[emailprotected]SOURCE Boeing Related Links http://www.boeing.com
Answer:
|
Boeing Dreamlifter Transports 1.5M Face Masks for COVID-19 Response
|
CHICAGO, April 26, 2020 /PRNewswire/ -- Boeing [NYSE: BA] today completed another COVID-19 transport mission, using a Boeing Dreamlifter to bring personal protective equipment (PPE) from Hong Kong to the United States. Working in partnership with Prisma Health, Atlas Air Worldwideand DiscommonFounder Neil Ferrier, the company transported 1.5 million medical-grade face masks bound for healthcare professionals at Prisma Health in South Carolina. (PRNewsfoto/Boeing) (PRNewsfoto/Boeing) (PRNewsfoto/Boeing) (PRNewsfoto/Boeing) Discommon, the importer of record for the delivery, secured production of the PPE from trusted manufacturers in China and turned to Boeing to facilitate their transport to Prisma Health, the largest healthcare system in South Carolina. Boeing donated the cost of the mission transport, with Atlas Air operating the flights on behalf of Boeing. The Dreamlifter, a converted Boeing 747-400 Large Cargo Freighter, flew from Hong Kong to Greenville, South Carolina, with the face masks in its lower lobe. Following the delivery, the Dreamlifter will return to its home base in North Charleston, South Carolina, and deliver 787 Dreamliner parts in support of the global aerospace supply chain. Boeing continues to support local communitiesand the heroic healthcare professionalsworking tirelessly to stop the spread of COVID-19. Additional airlift transport missions with the Boeing Dreamlifter and ecoDemonstrator are planned in the future. Boeing is coordinating closely with U.S. government officials on how to best assist areas with the greatest need.Leadership Support"Ten years ago, Boeing came to South Carolina investing a significant amount of resources in our economy and creating jobs for our people. Today, Boeing is making another significant investment in our state by partnering with other South Carolina businesses to help combat this deadly virus. South Carolinians are unique in their compassion and care for one another. The businesses that have collaborated to make this delivery possible are an embodiment of those qualities, and we owe a debt of gratitude to each of them." South Carolina Governor Henry McMaster"We owe it to our men and women on the front lines of our healthcare system to have the necessary resources to fight the COVID-19 virus. I want to thank Prisma Health, Discommon, Atlas Air and Boeing for stepping up to facilitate this important shipment of medical masks to South Carolina." Sen. Lindsey Graham"Battling COVID-19 has required an unprecedented response from all levels of government, the private sector, and American families. One of the most significant challenges facing communities across the country is ensuring our front-line healthcare workers have enough Personal Protective Equipment so they can both treat patients and keep themselves healthy. This public-private partnership between the White House, Boeing, Discommon and Atlas Air has cut through supply issues and red tape to bring 1.5 million medical-grade masks to South Carolina and will go a long way towards keeping our medical professionals safe. I offer my sincerest gratitude to all involved." Sen. Tim Scott"Today's delivery of medical masks for Prisma Health is tremendous news! The entire Palmetto State is thankful to Boeing, Atlas Air, and Discommon Concepts for making this shipment a reality in order to equip our medical personnel during these unprecedented times. It's partnerships like these led by companies in South Carolina that will ensure we are fully prepared to defeat COVID-19." Rep. Jeff Duncan (SC-03)"Today, we proudly welcome Boeing and Atlas Air to Greenville. When I was first approached by Discommon in Greenville, I knew these masks would make a huge difference for our healthcare workers at Prisma Health, who are on the front lines fighting the COVID-19 pandemic. We immediately got to work to make this happen. Today's delivery showcases the good that can be done when businesses, non-profits, and the government join together. This PPE will go a long way for folks here in the Upstate and across the Midlands." Rep. William Timmons (SC-04)"It's a win-win for South Carolina healthcare providers and a perfect example of private companies working with elected officials to help healthcare workers and the people they serve. We very much appreciate Boeing's support during these challenging times of securing necessary supplies. By standing together, we all stand stronger. In recognition of Boeing's delivery of our supplies, we are donating 100,000 of these masks to our colleagues at the Medical University of South Carolina, which is located near Boeing's manufacturing plant." Mark O'Halla, president and CEO, Prisma Health"I'm incredibly grateful to be part of this project the wild path to getting here is movie worthy. While every step of this logistics process has been incredibly daunting, Boeing and Atlas Air have been astonishing throughout, with both companies 100% committed to making today's transport mission possible. It's incredible that South Carolina has the backing of companies that can lend their vital transportation logistics support to this very complex challenge. Although this project isn't in our typical wheelhouse of industrial design and manufacturing, the ultimate goal of design is to solve problems beautifully, and we've all come together to do just that." Neil Ferrier, Founder, Discommon "Atlas Air is honored to be part of this vital mission. We thank the front-line responders who continue to meet the overwhelming needs of South Carolinians. The healthcare professionals in the Prisma Health System have been relentless and resilient, and transporting the critical equipment they need is one small way to thank them." John W. Dietrich, president and CEO, Atlas Air Worldwide"Boeing is proud to be part of this historic flight to bring vital PPE to healthcare workers across South Carolina. I want to offer my personal thanks to the Boeing team and our Atlas Air partners for what they've done to support this essential mission and ensure our frontline healthcare workers have the equipment they critically need." Dave Calhoun, president and CEO, BoeingBoeing Contact:[emailprotected]Prisma Health Contacts:Tammie Epps803-318-1598[emailprotected]Sandy Dees864-303-4115[emailprotected]SOURCE Boeing Related Links http://www.boeing.com
|
edtsum6876
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TEL AVIV, Israel, July 23, 2020 /PRNewswire/ -- Vulcan Cyber, the vulnerability remediation company, today announced the release of a new eBook titled, "The Vulnerability Remediation Maturity Model." The eBook provides security and IT operations teams with a blueprint for transforming inefficient vulnerability management programs into agile, effective vulnerability remediation programs that scale to the needs of the business. The eBook is available for download here. Continue Reading The Vulnerability Remediation Maturity Model "Most vulnerability management programs are paper tigers -- they generate a mountain of data and work but have negligible benefit to enterprise security," said Yaniv Bar-Dayan, co-founder and CEO of Vulcan Cyber. "We created the vulnerability remediation maturity model after consulting with hundreds of CISOs, security and IT professionals to understand shortcomings in vulnerability management programs. The model helps companies design outcome-driven vulnerability remediation programs through a unique approach to people, process and tool alignment. We've seen it help companies like Snowflake, Comcast and Informatica get fix done." The vulnerability remediation maturity model, combined with the Vulcan vulnerability remediation orchestration platform, is also used by managed security providers (MSPs) and consultancies to help teams improve vulnerability management program results. "We provide managed detection and response services for a wide array of companies, and outcome-driven vulnerability management is a substantial pain point for our customers," said Cecil Pineda, Senior Director at Critical Start and former CISO of the Dallas Fort Worth International Airport. "The Vulcan maturity model creates clarity and focus for vulnerability management programs while defining the best path to vulnerability remediation results. We applaud this initiative as we work with Vulcan Cyber to help our customers transition from simply managing vulnerabilities to actually remediating them."The Vulcan Cyber eBook establishes the first vulnerability management maturity model to advance beyond simple vulnerability scanning or prioritization. Consisting of four stages, or maturity levels, it defines a results-based framework for driving vulnerability management programs to a transformative state of cyber hygiene control. This model is laser focused on end-to-end vulnerability remediation.The four stages of The Vulnerability Remediation Maturity Model include:Stage 1 - Reactive: Most enterprises find themselves at this maturity level, where vulnerability management programs are tactical, reactive, siloed and most often do not deliver remediation.Stage 2 - Data-driven vulnerability management: The enterprise security team and its allies have learned to normalize diverse scanner outputs and enrich them with other data streams in order to derive prioritized, actionable vulnerability insights. The security team's data-driven, strategic vulnerability decisions are now based on a real-time understanding of asset status and criticality, compliance requirements, and threat intelligence.Stage 3 - Orchestrated vulnerability remediation: All vulnerability remediation program stakeholders (security, IT operations, engineering, business unit owners) break down existing silos. Their processes and practices become visible and their separate tech stacks are integrated so that they can collaborate across fluid, optimized, and automated remediation workflows.Stage 4 - Transformative cyber hygiene: Transformative vulnerability remediation unites multiple cross-functional teams in a distributed framework in which vulnerability remediation is a democratized process. While security teams are ultimately accountable for vulnerability elimination, key stakeholders across teams are given the tools, remedies and intelligent insight they need to make decisions and take action to achieve cyber hygiene.Learn moreDownload The Vulnerability Remediation Maturity Model eBook here. Or to learn about the maturity model in action attend a Vulcan Cyber webinar with cyber security professionals from Bank of America and Snowflake.About Vulcan CyberVulcan Cyber has developed the industry's first vulnerability remediation platform, built to help cybersecurity and IT operations teams collaboratively secure digital business. The Vulcan SaaS platform closes the gap between detection and remediation to reduce vulnerability dwell time and associated business risk. Vulcan Cyber orchestrates the full remediation lifecycle from identifying and prioritizing vulnerabilities to curating and delivering the best remedies, to automating processes and fixes through the last mile of remediation. It's unique ability to "get fix done" has garnered Vulcan Cyber recognition as a 2019 Gartner Cool Vendor and an RSAC Innovation Sandbox 2020 finalist. Based in Tel Aviv and San Francisco, Vulcan Cyber is privately funded by cybersecurity specialists YL Ventures and TenEleven Ventures. For more information please visit https://vulcan.io.Contact:Elizabeth Safran408-348-1214[emailprotected]SOURCE Vulcan Cyber Related Links https://vulcan.io/
Answer:
|
Vulcan Cyber Maturity Model Challenges Vulnerability Management Programs to Evolve English English New Vulcan Cyber eBook provides a blueprint for achieving advanced levels of cyber hygiene by progressing from vulnerability management to vulnerability remediation
|
TEL AVIV, Israel, July 23, 2020 /PRNewswire/ -- Vulcan Cyber, the vulnerability remediation company, today announced the release of a new eBook titled, "The Vulnerability Remediation Maturity Model." The eBook provides security and IT operations teams with a blueprint for transforming inefficient vulnerability management programs into agile, effective vulnerability remediation programs that scale to the needs of the business. The eBook is available for download here. Continue Reading The Vulnerability Remediation Maturity Model "Most vulnerability management programs are paper tigers -- they generate a mountain of data and work but have negligible benefit to enterprise security," said Yaniv Bar-Dayan, co-founder and CEO of Vulcan Cyber. "We created the vulnerability remediation maturity model after consulting with hundreds of CISOs, security and IT professionals to understand shortcomings in vulnerability management programs. The model helps companies design outcome-driven vulnerability remediation programs through a unique approach to people, process and tool alignment. We've seen it help companies like Snowflake, Comcast and Informatica get fix done." The vulnerability remediation maturity model, combined with the Vulcan vulnerability remediation orchestration platform, is also used by managed security providers (MSPs) and consultancies to help teams improve vulnerability management program results. "We provide managed detection and response services for a wide array of companies, and outcome-driven vulnerability management is a substantial pain point for our customers," said Cecil Pineda, Senior Director at Critical Start and former CISO of the Dallas Fort Worth International Airport. "The Vulcan maturity model creates clarity and focus for vulnerability management programs while defining the best path to vulnerability remediation results. We applaud this initiative as we work with Vulcan Cyber to help our customers transition from simply managing vulnerabilities to actually remediating them."The Vulcan Cyber eBook establishes the first vulnerability management maturity model to advance beyond simple vulnerability scanning or prioritization. Consisting of four stages, or maturity levels, it defines a results-based framework for driving vulnerability management programs to a transformative state of cyber hygiene control. This model is laser focused on end-to-end vulnerability remediation.The four stages of The Vulnerability Remediation Maturity Model include:Stage 1 - Reactive: Most enterprises find themselves at this maturity level, where vulnerability management programs are tactical, reactive, siloed and most often do not deliver remediation.Stage 2 - Data-driven vulnerability management: The enterprise security team and its allies have learned to normalize diverse scanner outputs and enrich them with other data streams in order to derive prioritized, actionable vulnerability insights. The security team's data-driven, strategic vulnerability decisions are now based on a real-time understanding of asset status and criticality, compliance requirements, and threat intelligence.Stage 3 - Orchestrated vulnerability remediation: All vulnerability remediation program stakeholders (security, IT operations, engineering, business unit owners) break down existing silos. Their processes and practices become visible and their separate tech stacks are integrated so that they can collaborate across fluid, optimized, and automated remediation workflows.Stage 4 - Transformative cyber hygiene: Transformative vulnerability remediation unites multiple cross-functional teams in a distributed framework in which vulnerability remediation is a democratized process. While security teams are ultimately accountable for vulnerability elimination, key stakeholders across teams are given the tools, remedies and intelligent insight they need to make decisions and take action to achieve cyber hygiene.Learn moreDownload The Vulnerability Remediation Maturity Model eBook here. Or to learn about the maturity model in action attend a Vulcan Cyber webinar with cyber security professionals from Bank of America and Snowflake.About Vulcan CyberVulcan Cyber has developed the industry's first vulnerability remediation platform, built to help cybersecurity and IT operations teams collaboratively secure digital business. The Vulcan SaaS platform closes the gap between detection and remediation to reduce vulnerability dwell time and associated business risk. Vulcan Cyber orchestrates the full remediation lifecycle from identifying and prioritizing vulnerabilities to curating and delivering the best remedies, to automating processes and fixes through the last mile of remediation. It's unique ability to "get fix done" has garnered Vulcan Cyber recognition as a 2019 Gartner Cool Vendor and an RSAC Innovation Sandbox 2020 finalist. Based in Tel Aviv and San Francisco, Vulcan Cyber is privately funded by cybersecurity specialists YL Ventures and TenEleven Ventures. For more information please visit https://vulcan.io.Contact:Elizabeth Safran408-348-1214[emailprotected]SOURCE Vulcan Cyber Related Links https://vulcan.io/
|
edtsum6877
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, July 8, 2020 /PRNewswire/ --Rokt, the global leader in e-commerce marketing technology, today announced that global entrepreneurs, Katie May and Phit Lian Chong have joined the Rokt Board of Directors. Both May and Chong are celebrated business leaders with extensive experience in fast growth businesses. They join the board at a significant moment, as Rokt's growth is further accelerated in a world where e-commerce has become more essential than ever. Katie May joins the Rokt Board of Directors. Phit Lian Chong joins the Rokt Board of Directors. Founder of kidspot.com.au and previous CEO of ShippingEasy.com, May brings to the board a wealth of knowledge in e-commerce having built both from the ground up into multi-million dollar businesses. With deep expertise in SaaS, B2B and B2C, plus a long career in Marketing including CMO of seek.com.au, May's experience will be invaluable to the Rokt team as they forge ahead to become a billion dollar company. "Rokt has quickly become an essential part of so many marque e-commerce tech stacks and I am delighted to be joining the Board at this pivotal moment in their journey," said Katie May. "Having seen first-hand the massive growth opportunity that exists in e-commerce, I was drawn to Rokt's AI, and their passion to make e-commerce smarter, faster and better for both the consumers and companies they touch." Chong, former CEO of Jetstar Asia and one of Singapore's most lauded entrepreneurs, brings to the board extensive experience in scaling and developing major corporations. She has previously held the role of President and Chief Executive Officer at The Singapore Mint, CEO of Orange Star Group (Jetstar Asia)/ValuAir Ltd., CEO and Board member of Singbridge Corporate Pte Ltd, as well as numerous additional board and corporate advisory roles including Eu Yan Sang International Ltd, Tianjin Everbest Gear Company, TigerAirways Ltd, Temasek International Advisors, Mega Fortris Pte Ltd (an investment of Singapore Economic Development Board International), Singapore Polytechnic International and Singapore Science Centre Global. "As both a Global business leader and entrepreneur, I am incredibly excited to be joining the Rokt Board of Directors and look forward to helping scale the business from a USD$100m ARR to fantastically higher heights," said Phit Lian Chong. "Alongside the other Board members, I am confident that Rokt will continue to deliver above and beyond expectations while transforming the experience and effectiveness of e-commerce.""Both Katie May and Phit Lian Chong join Rokt at an incredibly exciting time as we go from strength to strength in revolutionizing e-commerce and the Transaction Moment," commented CEO and Chairperson of the Rokt Board, Bruce Buchanan. "The entire Board of Directors is committed to rapid expansion into new markets, deeper technical expertise and a deeper understanding of our clients' needs. With the global and entrepreneurial strength of our Board we are confident that we can deliver this."May and Chong join existing board members Steve Krenzer (ex-Groupon), Bruce Buchanan (CEO and Chairperson), Tom Cowan (from TDM Growth Partners), John Ho (from Janchor Partners) and Bill Magnuson (from Braze) on the board of directors effective immediately. In addition, board members Tushar Roy (from Square Peg Capital) and Tek Heng (Company Secretary) will be stepping down from the board with the company's thanks for having contributed enormously to Rokt's success to date. Paul Bassat (Square Peg Capital) remains an alternate.Rokt, who recently closed US$48m in their Series C investment round, has transformed e-commerce in over 11 countries by identifying that when customers are buying online as a consumer or on behalf of a business, they increasingly expect more personalized and relevant experiences. Rokt's proprietary technology, machine learning and AI makes e-commerce smarter, faster and better. By unlocking the hidden potential in every single Transaction Moment, Rokt enables clients to stay ahead of their competition, and deliver a more relevant customer experience. Rokt currently solves complex e-commerce challenges for global clients including Live Nation, Staples, Groupon, GoDaddy, Expedia and Wells Fargo. For more information on Rokt, please visit rokt.com.ABOUT ROKTRokt makes e-commerce smarter, faster and better. When customers are buying online, they increasingly expect more personalized and relevant experiences. Rokt uses real time data and decisioning to deliver the next best action for each person in each Transaction Moment.Founded in Sydney, Rokt now operates in the US, Canada, UK, France, Germany, Australia, New Zealand, Singapore, The Netherlands, Spain and Japan. Our clients include Live Nation, Staples, Groupon, GoDaddy, Expedia, Wells Fargo, Vistaprint and HelloFresh. Rokt unlocks the hidden potential in every single Transaction Moment. Learn more at rokt.com. SOURCE Rokt
Answer:
|
Rokt adds Global Entrepreneurs Katie May and Phit Lian Chong to Board of Directors New appointments bring further strength of entrepreneurialism to the board of the rapidly growing e-commerce technology company.
|
NEW YORK, July 8, 2020 /PRNewswire/ --Rokt, the global leader in e-commerce marketing technology, today announced that global entrepreneurs, Katie May and Phit Lian Chong have joined the Rokt Board of Directors. Both May and Chong are celebrated business leaders with extensive experience in fast growth businesses. They join the board at a significant moment, as Rokt's growth is further accelerated in a world where e-commerce has become more essential than ever. Katie May joins the Rokt Board of Directors. Phit Lian Chong joins the Rokt Board of Directors. Founder of kidspot.com.au and previous CEO of ShippingEasy.com, May brings to the board a wealth of knowledge in e-commerce having built both from the ground up into multi-million dollar businesses. With deep expertise in SaaS, B2B and B2C, plus a long career in Marketing including CMO of seek.com.au, May's experience will be invaluable to the Rokt team as they forge ahead to become a billion dollar company. "Rokt has quickly become an essential part of so many marque e-commerce tech stacks and I am delighted to be joining the Board at this pivotal moment in their journey," said Katie May. "Having seen first-hand the massive growth opportunity that exists in e-commerce, I was drawn to Rokt's AI, and their passion to make e-commerce smarter, faster and better for both the consumers and companies they touch." Chong, former CEO of Jetstar Asia and one of Singapore's most lauded entrepreneurs, brings to the board extensive experience in scaling and developing major corporations. She has previously held the role of President and Chief Executive Officer at The Singapore Mint, CEO of Orange Star Group (Jetstar Asia)/ValuAir Ltd., CEO and Board member of Singbridge Corporate Pte Ltd, as well as numerous additional board and corporate advisory roles including Eu Yan Sang International Ltd, Tianjin Everbest Gear Company, TigerAirways Ltd, Temasek International Advisors, Mega Fortris Pte Ltd (an investment of Singapore Economic Development Board International), Singapore Polytechnic International and Singapore Science Centre Global. "As both a Global business leader and entrepreneur, I am incredibly excited to be joining the Rokt Board of Directors and look forward to helping scale the business from a USD$100m ARR to fantastically higher heights," said Phit Lian Chong. "Alongside the other Board members, I am confident that Rokt will continue to deliver above and beyond expectations while transforming the experience and effectiveness of e-commerce.""Both Katie May and Phit Lian Chong join Rokt at an incredibly exciting time as we go from strength to strength in revolutionizing e-commerce and the Transaction Moment," commented CEO and Chairperson of the Rokt Board, Bruce Buchanan. "The entire Board of Directors is committed to rapid expansion into new markets, deeper technical expertise and a deeper understanding of our clients' needs. With the global and entrepreneurial strength of our Board we are confident that we can deliver this."May and Chong join existing board members Steve Krenzer (ex-Groupon), Bruce Buchanan (CEO and Chairperson), Tom Cowan (from TDM Growth Partners), John Ho (from Janchor Partners) and Bill Magnuson (from Braze) on the board of directors effective immediately. In addition, board members Tushar Roy (from Square Peg Capital) and Tek Heng (Company Secretary) will be stepping down from the board with the company's thanks for having contributed enormously to Rokt's success to date. Paul Bassat (Square Peg Capital) remains an alternate.Rokt, who recently closed US$48m in their Series C investment round, has transformed e-commerce in over 11 countries by identifying that when customers are buying online as a consumer or on behalf of a business, they increasingly expect more personalized and relevant experiences. Rokt's proprietary technology, machine learning and AI makes e-commerce smarter, faster and better. By unlocking the hidden potential in every single Transaction Moment, Rokt enables clients to stay ahead of their competition, and deliver a more relevant customer experience. Rokt currently solves complex e-commerce challenges for global clients including Live Nation, Staples, Groupon, GoDaddy, Expedia and Wells Fargo. For more information on Rokt, please visit rokt.com.ABOUT ROKTRokt makes e-commerce smarter, faster and better. When customers are buying online, they increasingly expect more personalized and relevant experiences. Rokt uses real time data and decisioning to deliver the next best action for each person in each Transaction Moment.Founded in Sydney, Rokt now operates in the US, Canada, UK, France, Germany, Australia, New Zealand, Singapore, The Netherlands, Spain and Japan. Our clients include Live Nation, Staples, Groupon, GoDaddy, Expedia, Wells Fargo, Vistaprint and HelloFresh. Rokt unlocks the hidden potential in every single Transaction Moment. Learn more at rokt.com. SOURCE Rokt
|
edtsum6879
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LITCHFIELD, Ill., June 18, 2020 /PRNewswire/ -- Schutt Sports, one of the world's leading manufacturers of protective equipment, announces an exclusive distribution agreement for the Python Face Mask. The new five-layer facemask features a replaceable filtration system that can be purchased with a variety of filter level options, with up to 95% filtration. This provides a unique balance between enhanced breathability and filtration, specifically designed for athletic or workout use. The Python Face Mask provides a unique balance between enhanced breathability and filtration, specifically designed for athletic or workout use. "There are many basic, non-performance face masks being sold in today's marketplace," stated Jim Stutts, president of Schutt Sports. "When developing and designing this face mask, we united the three critical elements of technology, performance and comfort to create what we feel is the best performing, comfortable mask being sold." Although designed for athletes, the wide array of filters can suit individuals, environmental conditions, activities and occupations.This mask can be worn and used by anyone with multiple sizes available. Schutt will offer the Python Face Mask for purchase in July, both through their dealer network and online.The Python Face Mask's unique design combines a five-layer enhanced filtration and inhalation/exhalation system with a silicone stabilization system on the inner layer.The silicone provides a tight seal over the face without the abrasion one gets from a traditional mask.This enhances the security of the mask during activities.The combination of the over-the-ear construction combined with an adjustable Velcro backstrap design allows for a customized, secure fit and all-day comfort. The patented multi-layer construction wicks moisture from the mouth and evaporates to the outer layer, while the adjustable nose bridge provides a custom fit and seal around the nose. The filter of the mask is replaceable, and the mask is reusable. The mask can be washed and dried, and the material has an inherent memory retention due to its wrap knit fabrication versus the polyester or woven materials of the competition.Schutt Sports also recently launched the Schutt Splash Shield for football players, which offers some protection for football players from harmful droplets caused by talking, sneezing and coughing in close proximity.Not only will the new Splash Shield fit all configurations of football helmets, but these guards are light weight, easy to attach and clean and inexpensive enough to be disposable."We are extremely excited about the launch of the Python Face Mask and the Splash Shield as technology continues to drive our products at Schutt Sports," Stutts added. "We need all sports and activities to resume to the new normal in today's world. By creating these new products, we are hoping that the new normal will occur sooner versus later."About Schutt Sports Schutt Sports is one of the leading manufacturers of protective equipment in the world, including football helmets, shoulder pads, protective apparel and padding, and much more. Over 33% of the players in the NFL wear Schutt products including over 50% of the skill position players in the league. Schutt Sports is the only major helmet manufacturer to advance beyond traditional foam padding, instead using TPU (thermoplastic urethane) Cushioning, which has been proven to absorb more impact across a wider variety of temperatures than any other helmet system on the field. Schutt Sports is also the Official Base Supplier to Major League Baseball and is the largest domestic maker of batters helmets in the USA. www.schuttsports.comSOURCE Schutt Sports Related Links https://www.schuttsports.com
Answer:
|
Schutt Sports Launches New Python Face Mask for Germ Protection New mask features replaceable filtration system, nanofiber technology
|
LITCHFIELD, Ill., June 18, 2020 /PRNewswire/ -- Schutt Sports, one of the world's leading manufacturers of protective equipment, announces an exclusive distribution agreement for the Python Face Mask. The new five-layer facemask features a replaceable filtration system that can be purchased with a variety of filter level options, with up to 95% filtration. This provides a unique balance between enhanced breathability and filtration, specifically designed for athletic or workout use. The Python Face Mask provides a unique balance between enhanced breathability and filtration, specifically designed for athletic or workout use. "There are many basic, non-performance face masks being sold in today's marketplace," stated Jim Stutts, president of Schutt Sports. "When developing and designing this face mask, we united the three critical elements of technology, performance and comfort to create what we feel is the best performing, comfortable mask being sold." Although designed for athletes, the wide array of filters can suit individuals, environmental conditions, activities and occupations.This mask can be worn and used by anyone with multiple sizes available. Schutt will offer the Python Face Mask for purchase in July, both through their dealer network and online.The Python Face Mask's unique design combines a five-layer enhanced filtration and inhalation/exhalation system with a silicone stabilization system on the inner layer.The silicone provides a tight seal over the face without the abrasion one gets from a traditional mask.This enhances the security of the mask during activities.The combination of the over-the-ear construction combined with an adjustable Velcro backstrap design allows for a customized, secure fit and all-day comfort. The patented multi-layer construction wicks moisture from the mouth and evaporates to the outer layer, while the adjustable nose bridge provides a custom fit and seal around the nose. The filter of the mask is replaceable, and the mask is reusable. The mask can be washed and dried, and the material has an inherent memory retention due to its wrap knit fabrication versus the polyester or woven materials of the competition.Schutt Sports also recently launched the Schutt Splash Shield for football players, which offers some protection for football players from harmful droplets caused by talking, sneezing and coughing in close proximity.Not only will the new Splash Shield fit all configurations of football helmets, but these guards are light weight, easy to attach and clean and inexpensive enough to be disposable."We are extremely excited about the launch of the Python Face Mask and the Splash Shield as technology continues to drive our products at Schutt Sports," Stutts added. "We need all sports and activities to resume to the new normal in today's world. By creating these new products, we are hoping that the new normal will occur sooner versus later."About Schutt Sports Schutt Sports is one of the leading manufacturers of protective equipment in the world, including football helmets, shoulder pads, protective apparel and padding, and much more. Over 33% of the players in the NFL wear Schutt products including over 50% of the skill position players in the league. Schutt Sports is the only major helmet manufacturer to advance beyond traditional foam padding, instead using TPU (thermoplastic urethane) Cushioning, which has been proven to absorb more impact across a wider variety of temperatures than any other helmet system on the field. Schutt Sports is also the Official Base Supplier to Major League Baseball and is the largest domestic maker of batters helmets in the USA. www.schuttsports.comSOURCE Schutt Sports Related Links https://www.schuttsports.com
|
edtsum6884
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--The drug discovery informatics market is poised to grow by $ 2.54 bn during 2020-2024, progressing at a CAGR of over 14% during the forecast period. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis The report on the drug discovery informatics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by R&D investment by pharmaceutical companies. The drug discovery informatics market analysis includes mode segment and geography landscape. This study identifies the increasing outsourcing activities for drug discovery as one of the prime reasons driving the drug discovery informatics market growth during the next few years. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The drug discovery informatics market covers the following areas: Drug Discovery Informatics Market Sizing Drug Discovery Informatics Market Forecast Drug Discovery Informatics Market Analysis Companies Mentioned Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Mode Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Answer:
|
The Drug Discovery Informatics Market- Certara LP, Collaborative Drug Discovery Inc., Dassault Systemes SE, among others to contribute to the market growth | Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2024
|
LONDON--(BUSINESS WIRE)--The drug discovery informatics market is poised to grow by $ 2.54 bn during 2020-2024, progressing at a CAGR of over 14% during the forecast period. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis The report on the drug discovery informatics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by R&D investment by pharmaceutical companies. The drug discovery informatics market analysis includes mode segment and geography landscape. This study identifies the increasing outsourcing activities for drug discovery as one of the prime reasons driving the drug discovery informatics market growth during the next few years. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The drug discovery informatics market covers the following areas: Drug Discovery Informatics Market Sizing Drug Discovery Informatics Market Forecast Drug Discovery Informatics Market Analysis Companies Mentioned Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Mode Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
|
edtsum6887
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ --Cognoptix, a leading medical device/diagnostics company dedicated to the early detection of Alzheimer's disease (AD), announced today that Dr. Susanne Wilke, the Company's President and Chief Executive Officer, will present a "Spotlight Showcase" of Cognoptix under the title "Early-Stage Detection of Alzheimer's Disease A Simple Eye Scan" on Wednesday, April 28th at 12:10pm ET. Millions of people are living with Alzheimer's and many millions more are at risk of developing the disease. Damaging forms of beta-amyloid begin building up in the brain 20 years before people begin to show signs of memory loss and confusion. At this time, amyloid PET brain scans are the only way to test for these damaging protein deposits while they are costly and time consuming. Moreover, in-office clinical diagnosis of AD is only about 60-70% accurate at the moment and is usually performed at a late-stage when major brain damage has already occurred. Diagnostic tools aimed to differentiate earlier forms of dementia are crucial to segment dementias caused by AD versus other forms of dementia that may have existing treatments or are even reversible. Cognoptix' Sapphire II system is looking to meet this large unmet medical need with an easily accessible, non-invasive, safe, cost-effective, and in-office diagnostic medical device. The Sapphire II provides physicians with a reliable test that can be performed quickly and accurately, allowing not only improved clinical diagnosis, but also utterly necessary patient segmentation. Even more, the Sapphire II provides the ability for continued patient disease progression monitoring from early cognitive symptoms. It also will play a vital role in helping to select the correct patient population for new, upcoming amyloid-targeting therapeutics. The Sapphire II technology is based on extensive scientific research and advanced clinical data with two compelling proof-of-concept studies. Next clinical steps include a pivotal study, FDA approval and eventual commercialization. "The Sapphire II system is poised to be the breakthrough diagnostic for early detection of Alzheimer's disease by measuring amyloid through the ocular lens. Cognoptix aims to lessen this incredible health burden and give patients more insight into their brain health needs," states Dr. Wilke. The Company's presentation will be available on demand during the conference to registered participants through Sachs Forum website. It will also be accessible via social media one week after the meeting. To register in advance, please visit www.sachsforum.com. Dr. Susanne Wilke will also be available for 1x1 meetings during the forum between April 26th and April 30th. For more about Cognoptix, visit: https://www.cognoptix.com Inquiries, contact:Justine LaVoyeDirector of Marketing & Communications[emailprotected] Cognoptix, Inc.33 Boston Post Rd W, Suite 140Marlborough, MA 01752(508)251-1546 Safe Harbor DisclaimerThis press release may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities. SOURCE Cognoptix
Answer:
|
Cognoptix President & CEO, Susanne Wilke, PhD, MBA, to Present at Sachs 4th Annual Neuroscience Innovation Forum
|
MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ --Cognoptix, a leading medical device/diagnostics company dedicated to the early detection of Alzheimer's disease (AD), announced today that Dr. Susanne Wilke, the Company's President and Chief Executive Officer, will present a "Spotlight Showcase" of Cognoptix under the title "Early-Stage Detection of Alzheimer's Disease A Simple Eye Scan" on Wednesday, April 28th at 12:10pm ET. Millions of people are living with Alzheimer's and many millions more are at risk of developing the disease. Damaging forms of beta-amyloid begin building up in the brain 20 years before people begin to show signs of memory loss and confusion. At this time, amyloid PET brain scans are the only way to test for these damaging protein deposits while they are costly and time consuming. Moreover, in-office clinical diagnosis of AD is only about 60-70% accurate at the moment and is usually performed at a late-stage when major brain damage has already occurred. Diagnostic tools aimed to differentiate earlier forms of dementia are crucial to segment dementias caused by AD versus other forms of dementia that may have existing treatments or are even reversible. Cognoptix' Sapphire II system is looking to meet this large unmet medical need with an easily accessible, non-invasive, safe, cost-effective, and in-office diagnostic medical device. The Sapphire II provides physicians with a reliable test that can be performed quickly and accurately, allowing not only improved clinical diagnosis, but also utterly necessary patient segmentation. Even more, the Sapphire II provides the ability for continued patient disease progression monitoring from early cognitive symptoms. It also will play a vital role in helping to select the correct patient population for new, upcoming amyloid-targeting therapeutics. The Sapphire II technology is based on extensive scientific research and advanced clinical data with two compelling proof-of-concept studies. Next clinical steps include a pivotal study, FDA approval and eventual commercialization. "The Sapphire II system is poised to be the breakthrough diagnostic for early detection of Alzheimer's disease by measuring amyloid through the ocular lens. Cognoptix aims to lessen this incredible health burden and give patients more insight into their brain health needs," states Dr. Wilke. The Company's presentation will be available on demand during the conference to registered participants through Sachs Forum website. It will also be accessible via social media one week after the meeting. To register in advance, please visit www.sachsforum.com. Dr. Susanne Wilke will also be available for 1x1 meetings during the forum between April 26th and April 30th. For more about Cognoptix, visit: https://www.cognoptix.com Inquiries, contact:Justine LaVoyeDirector of Marketing & Communications[emailprotected] Cognoptix, Inc.33 Boston Post Rd W, Suite 140Marlborough, MA 01752(508)251-1546 Safe Harbor DisclaimerThis press release may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities. SOURCE Cognoptix
|
edtsum6889
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: HOUSTON, June 2, 2020 /PRNewswire/ --CITGO Petroleum Corporation (the "Company") today announced that it has priced $1.125 billion aggregate principal amount of 7.00% senior secured notes due 2025 in a private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The principal amount of the offering was increased from the previously announced offering size of $750 million. The closing of the offering is expected to occur on June 9, 2020, subject to customary closing conditions. The Company intends to use the net proceeds from the sale of the notes to repay all $614 million outstanding under the Company's term loan B due 2021 and accrued and unpaid interest under the term loan B due 2021, pay all fees and expenses in connection with the offering, and for working capital and general corporate purposes. This press release does not constitute an offer to sell or the solicitation of an offer to buy the notes, nor will there be any sale of the notes in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful. The offer and sale of the notes have not been and will not be registered under the Securities Act, or the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. The notes are being offered only to qualified institutional buyers under Rule 144A under the Securities Act and to non-U.S. persons in offshore transactions in compliance with Regulation S under the Securities Act. About CITGO Petroleum Corporation Headquartered in Houston, Texas, CITGO Petroleum Corporation owns and operates three large-scale, highly complex refineries, with a combined crude capacity of approximately 769,000 barrels-per-day, located in Corpus Christi, Texas; Lake Charles, Louisiana; and Lemont, Illinois, has ownership/equity interest in 41 active refined product storage and transfer terminals, and has access to over 120 third-party and related party terminals through exchange, terminaling and similar arrangements. Forward-Looking Statements Certain information included in this release may be deemed to be "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995. These statements relate to, among other things, expectations regarding the notes offering and the use of proceeds therefrom. These statements also relate to our industry, business strategy, goals and expectations concerning our market position and future operations. We have used the words "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar terms and phrases to identify forward-looking statements, which speak only as of the date of this release. Any forward-looking statements are not guarantees of future events and are subject to risks and uncertainties that could cause actual events, developments and business decisions to differ materially from those contemplated by these forward-looking statements. These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions (including current market conditions), expected future developments and other factors they believe to be appropriate. Although we believe the assumptions upon which these forward-looking statements are based are reasonable, any of these assumptions could prove to be inaccurate, and the forward-looking statements based on these assumptions could be incorrect. In addition, our business and operations involve numerous risks and uncertainties, many of which are beyond our control, which could result in our expectations not being realized or could otherwise materially affect our financial condition, results of operations and cash flows. We caution readers that these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from the results that are projected, expressed or implied. These risks and uncertainties include, among others, risks related to the notes offering, including the effect of the debt markets on the notes offering, and our ability to satisfy the closing conditions to the notes offering, as well as general economic activity, developments in international and domestic petroleum markets and refinery turnarounds and operations. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements contained in this release are made only as of the date of this release. We disclaim any duty to update any forward-looking statements. SOURCE CITGO Corporation Related Links www.citgo.com
Answer:
|
CITGO Announces Pricing of Upsized $1.125 Billion Senior Secured Notes Private Offering
|
HOUSTON, June 2, 2020 /PRNewswire/ --CITGO Petroleum Corporation (the "Company") today announced that it has priced $1.125 billion aggregate principal amount of 7.00% senior secured notes due 2025 in a private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The principal amount of the offering was increased from the previously announced offering size of $750 million. The closing of the offering is expected to occur on June 9, 2020, subject to customary closing conditions. The Company intends to use the net proceeds from the sale of the notes to repay all $614 million outstanding under the Company's term loan B due 2021 and accrued and unpaid interest under the term loan B due 2021, pay all fees and expenses in connection with the offering, and for working capital and general corporate purposes. This press release does not constitute an offer to sell or the solicitation of an offer to buy the notes, nor will there be any sale of the notes in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful. The offer and sale of the notes have not been and will not be registered under the Securities Act, or the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. The notes are being offered only to qualified institutional buyers under Rule 144A under the Securities Act and to non-U.S. persons in offshore transactions in compliance with Regulation S under the Securities Act. About CITGO Petroleum Corporation Headquartered in Houston, Texas, CITGO Petroleum Corporation owns and operates three large-scale, highly complex refineries, with a combined crude capacity of approximately 769,000 barrels-per-day, located in Corpus Christi, Texas; Lake Charles, Louisiana; and Lemont, Illinois, has ownership/equity interest in 41 active refined product storage and transfer terminals, and has access to over 120 third-party and related party terminals through exchange, terminaling and similar arrangements. Forward-Looking Statements Certain information included in this release may be deemed to be "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995. These statements relate to, among other things, expectations regarding the notes offering and the use of proceeds therefrom. These statements also relate to our industry, business strategy, goals and expectations concerning our market position and future operations. We have used the words "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar terms and phrases to identify forward-looking statements, which speak only as of the date of this release. Any forward-looking statements are not guarantees of future events and are subject to risks and uncertainties that could cause actual events, developments and business decisions to differ materially from those contemplated by these forward-looking statements. These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions (including current market conditions), expected future developments and other factors they believe to be appropriate. Although we believe the assumptions upon which these forward-looking statements are based are reasonable, any of these assumptions could prove to be inaccurate, and the forward-looking statements based on these assumptions could be incorrect. In addition, our business and operations involve numerous risks and uncertainties, many of which are beyond our control, which could result in our expectations not being realized or could otherwise materially affect our financial condition, results of operations and cash flows. We caution readers that these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from the results that are projected, expressed or implied. These risks and uncertainties include, among others, risks related to the notes offering, including the effect of the debt markets on the notes offering, and our ability to satisfy the closing conditions to the notes offering, as well as general economic activity, developments in international and domestic petroleum markets and refinery turnarounds and operations. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements contained in this release are made only as of the date of this release. We disclaim any duty to update any forward-looking statements. SOURCE CITGO Corporation Related Links www.citgo.com
|
edtsum6893
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: COLUMBIA, S.C.--(BUSINESS WIRE)--Seibels is pleased to announce another successful implementation for its client, Gulfstream Property and Casualty Insurance Company, as their latest deployment went live on March 1, 2021. A Guidewire Preferred BPO Provider, Seibels launched Guidewire for policy administration, billing, and digital engagement, positioning Gulfstream to offer their agents and policyholders an enhanced user experience built on world-class technology. My experience with the Seibels team and their deployment of Guidewire for our Florida insureds has been one of the most collaborative and team-oriented projects Ive ever worked on, said Gulfstream Director of Product Operations, Jeff Karam. From the very beginning of the process, Seibels has been all-hands-on-deck, in lock step with our internal resources, and with amazing response times. Were proud to partner with Gulfstream and provide solutions and servicing on modernized platforms allowing them to adapt quickly to market changes and reduce the complexities of ancillary operations, said Seibels Chairman and CEO, Rex Huggins. Gulfstream CEO Ron Natherson added, Our partnership with Seibels has allowed us to drive digital transformation and build for the future. Seibels insurance servicing expertise gives us the confidence and peace of mind knowing our agents and policyholders are taken care of at every step of the policy life cycle. About Seibels Seibels offers the Property and Casualty insurance industry business process services (BPS) and third-party administration (TPA) services powered by world-class technology. Streamlined operations, improved efficiencies and predictable, managed costs are just some of the benefits clients receive when working with Seibels. By leveraging a strong combination of insurance experience and industry-leading technology, Seibels best-in-class insurance services allow insurance carriers and risk managers to simplify business processes and maximize opportunities so they can focus on growth and development. Seibels services support Commercial and Personal lines of business. Since its founding in 1869, Seibels has recognized the value of quality customer service, strong client relations, continuous innovation and integrity. For more information, please visit www.seibels.com. Follow us on Twitter: @SeibelsITS. About Gulfstream Gulfstream Property and Casualty Insurance Company insures more than 73,000 families throughout Florida, Louisiana, Mississippi, Alabama, Texas and South Carolina providing homeowners, condominium-unit owners, renters and dwelling fire insurance coverage. Launching operations in Florida in 2004 and later expanding to Louisiana in 2010, Gulfstream has helped customers through 32 named storms, and settled over 54,000 claims. They have continually maintained a Financial Stability Rating of A, Exceptional from Demotech. Gulfstream management includes seasoned professionals with vast experience in insurance. For more information, please visit www.gspcic.com. About Guidewire Software Guidewire is the platform P&C insurers trust to engage, innovate, and grow efficiently. We combine digital, core, analytics, and AI to deliver our platform as a cloud service. More than 400 insurers, from new ventures to the largest and most complex in the world, run on Guidewire. As a partner to our customers, we continually evolve to enable their success. We are proud of our unparalleled implementation track record, with 1,000+ successful projects, supported by the largest R&D team and partner ecosystem in the industry. Our marketplace provides hundreds of applications that accelerate integration, localization, and innovation. For more information, please visit www.guidewire.com and follow us on Twitter: @Guidewire_PandC.
Answer:
|
Seibels Completes Guidewire Implementation for Gulfstream Insurance in Florida
|
COLUMBIA, S.C.--(BUSINESS WIRE)--Seibels is pleased to announce another successful implementation for its client, Gulfstream Property and Casualty Insurance Company, as their latest deployment went live on March 1, 2021. A Guidewire Preferred BPO Provider, Seibels launched Guidewire for policy administration, billing, and digital engagement, positioning Gulfstream to offer their agents and policyholders an enhanced user experience built on world-class technology. My experience with the Seibels team and their deployment of Guidewire for our Florida insureds has been one of the most collaborative and team-oriented projects Ive ever worked on, said Gulfstream Director of Product Operations, Jeff Karam. From the very beginning of the process, Seibels has been all-hands-on-deck, in lock step with our internal resources, and with amazing response times. Were proud to partner with Gulfstream and provide solutions and servicing on modernized platforms allowing them to adapt quickly to market changes and reduce the complexities of ancillary operations, said Seibels Chairman and CEO, Rex Huggins. Gulfstream CEO Ron Natherson added, Our partnership with Seibels has allowed us to drive digital transformation and build for the future. Seibels insurance servicing expertise gives us the confidence and peace of mind knowing our agents and policyholders are taken care of at every step of the policy life cycle. About Seibels Seibels offers the Property and Casualty insurance industry business process services (BPS) and third-party administration (TPA) services powered by world-class technology. Streamlined operations, improved efficiencies and predictable, managed costs are just some of the benefits clients receive when working with Seibels. By leveraging a strong combination of insurance experience and industry-leading technology, Seibels best-in-class insurance services allow insurance carriers and risk managers to simplify business processes and maximize opportunities so they can focus on growth and development. Seibels services support Commercial and Personal lines of business. Since its founding in 1869, Seibels has recognized the value of quality customer service, strong client relations, continuous innovation and integrity. For more information, please visit www.seibels.com. Follow us on Twitter: @SeibelsITS. About Gulfstream Gulfstream Property and Casualty Insurance Company insures more than 73,000 families throughout Florida, Louisiana, Mississippi, Alabama, Texas and South Carolina providing homeowners, condominium-unit owners, renters and dwelling fire insurance coverage. Launching operations in Florida in 2004 and later expanding to Louisiana in 2010, Gulfstream has helped customers through 32 named storms, and settled over 54,000 claims. They have continually maintained a Financial Stability Rating of A, Exceptional from Demotech. Gulfstream management includes seasoned professionals with vast experience in insurance. For more information, please visit www.gspcic.com. About Guidewire Software Guidewire is the platform P&C insurers trust to engage, innovate, and grow efficiently. We combine digital, core, analytics, and AI to deliver our platform as a cloud service. More than 400 insurers, from new ventures to the largest and most complex in the world, run on Guidewire. As a partner to our customers, we continually evolve to enable their success. We are proud of our unparalleled implementation track record, with 1,000+ successful projects, supported by the largest R&D team and partner ecosystem in the industry. Our marketplace provides hundreds of applications that accelerate integration, localization, and innovation. For more information, please visit www.guidewire.com and follow us on Twitter: @Guidewire_PandC.
|
edtsum6901
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DELRAY BEACH, Fla., March 9, 2021 /PRNewswire/ -- Delivery Dudes, South Florida's own local, born-in-Delray Beach service known for their fast, friendly on-demand food delivery has entered into an agreement to sell substantially all of its assets to Waitr, a publicly traded company that shares the same love for the serving the community that Delivery Dudes has offered South Florida for over 11 years. We expect this transaction to close next week. Waitr is on board to help Delivery Dudes do everything its always done, but better. Customers will still visit DeliveryDudes.com, use the Delivery Dudes app, or call (561) 900-7060 to place an order. What customers may notice is a slew of new improvements that should make Delivery Dudes even better. "We're excited to take South Florida's finest delivery service to the next level by joining the Waitr team. They recognize the level of customer service that we provide and the deep relationships we have with all the best restaurants within our service areas," said Jayson Koss, founder of Delivery Dudes. "With Waitr's resources, we'll get to do delivery bigger and better for all our South Florida customers and fans." For more information about Delivery Dudes visit www.deliverydudes.com. About Delivery DudesEstablished in 2009 in Delray Beach, Florida, Delivery Dudes gives customers in more than 50 cities in Florida, the food they want, from the restaurants they love, with the goal of making life better, one delivery at a time. Their well-trained, friendly and reliable drivers deliver fresh, accurate meals from restaurants that care as much about their food as you do. To learn more about Delivery Dudes or to find out what cities they operate in, please visit www.deliverydudes.com, 'Like' Delivery Dudes on Facebook, or follow @Delivery Dudes on Instagram and Twitter. Media Contact: Britt Bradford [emailprotected] 561-998-1995 SOURCE Delivery Dudes
Answer:
|
Delivery Dudes Steps It Up With Agreement To Sell Assets To Waitr South Florida Delivery Company will Remain the Same Dedicated Local Team with Added Resources to Get Even Better
|
DELRAY BEACH, Fla., March 9, 2021 /PRNewswire/ -- Delivery Dudes, South Florida's own local, born-in-Delray Beach service known for their fast, friendly on-demand food delivery has entered into an agreement to sell substantially all of its assets to Waitr, a publicly traded company that shares the same love for the serving the community that Delivery Dudes has offered South Florida for over 11 years. We expect this transaction to close next week. Waitr is on board to help Delivery Dudes do everything its always done, but better. Customers will still visit DeliveryDudes.com, use the Delivery Dudes app, or call (561) 900-7060 to place an order. What customers may notice is a slew of new improvements that should make Delivery Dudes even better. "We're excited to take South Florida's finest delivery service to the next level by joining the Waitr team. They recognize the level of customer service that we provide and the deep relationships we have with all the best restaurants within our service areas," said Jayson Koss, founder of Delivery Dudes. "With Waitr's resources, we'll get to do delivery bigger and better for all our South Florida customers and fans." For more information about Delivery Dudes visit www.deliverydudes.com. About Delivery DudesEstablished in 2009 in Delray Beach, Florida, Delivery Dudes gives customers in more than 50 cities in Florida, the food they want, from the restaurants they love, with the goal of making life better, one delivery at a time. Their well-trained, friendly and reliable drivers deliver fresh, accurate meals from restaurants that care as much about their food as you do. To learn more about Delivery Dudes or to find out what cities they operate in, please visit www.deliverydudes.com, 'Like' Delivery Dudes on Facebook, or follow @Delivery Dudes on Instagram and Twitter. Media Contact: Britt Bradford [emailprotected] 561-998-1995 SOURCE Delivery Dudes
|
edtsum6916
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BANGALORE, India, March 31, 2020 /PRNewswire/ -- The global Mobile Robots market size was valued at USD 14960 Million in 2019 and is projected to reach USD 51100 Million by 2026, growing at a CAGR of 19.0% from 2021 to 2026. This study focuses on the status of the mobile robots market size and share, future predictions, opportunities for growth, key markets, and key players. The report also covers regional markets like North America, Europe, China, Japan, Southeast Asia, India and Central & South America. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-1K257/mobile-robots-market TRENDS INFLUENCING THE MOBILE ROBOTS MARKET SIZE Robots cover a wide variety of applications in the healthcare industry, with the advancement in robotics development and improved versatility in robotics use. Medical equipment manufacturers use robots in hospitals, clinics, and pharmaceutical firms. Increased adoption of mobile robots in the healthcare industry is expected to increase the market size. Growth is driven by the dropping prices of robotic components such as sensors, actuators, etc. that are aggravating the global sale of mobile robots. In addition, growth in the global market for mobile robots can be due to breakthrough technological advances and the increasing footprint of aerial, land, and marine mobile robots in hazardous defense operations, agricultural activities, warehouse automation, and a range of domestic applications. Other notable factors positively influencing the market forecast for mobile robotics include a growing need for human life protection and a rise in demand from online retailers for mobile logistics. Get Free Sample Report (Mention the customization you want in the report): https://reports.valuates.com/request/sample/QYRE-Othe-1K257/mobile_robots_market MARKET SEGMENT BY TYPE: Unmanned Ground Vehicles (UGV) Unmanned Aerial Vehicles (UAV) Unmanned Surface Vehicles (USV) MARKET SEGMENT BY APPLICATION : Logistics & Warehousing Defense Healthcare Field Applications Inquire for Regional Report (Mention the Country or Region of Focus) : https://reports.valuates.com/request/regional/QYRE-Othe-1K257/mobile_robots_market THE KEY PLAYERS COVERED IN THIS STUDY iRobot Northrop Grumman Amazon KUKA LEGO Honda ECA Group Adept Technology Geosystems Google General Dynamics Others Buy Now: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Othe-1K257 SIMILAR REPORTS : AUTONOMOUS MOBILE ROBOTS MARKET The Global Autonomous Mobile Robots market size in 2019 was estimated at USD 356.3 million and is expected to hit USD 1011.8 million by 2026, at a CAGR of 15.9% over the forecast period. An autonomous mobile robot (AMR) is any robot capable of understanding and traveling around its environment without an operator directly supervising them. This is usually accomplished via an array of sophisticated onboard sensors, computers, and maps that enable AMRs to understand and interpret their environment to act as an asynchronous mode of transport. The Global Autonomous Mobile Robots Report analyses the status and outlook, including power, production, value, consumption, growth rate (CAGR), market share, and history. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-4R209/autonomous-mobile-robots-market ROBOTICS TECHNOLOGY MARKET The Robotics Technology Market size is projected to hit USD 82.7 billion by 2020, showing a 10.11% CAGR between 2014 and 2020. Robotics technology is a mixture of systems, tools, and computer software used for various tasks like the design, manufacture, and other robotics software. Using robotics technology, customers can automate procedures, increase efficiency, improve quality, and reduce human errors. The report offers an in-depth review of the robotics engineering market with current and future trend developments to elucidate the imminent pockets of investment in the industry. View Full Report: https://reports.valuates.com/market-reports/ALLI-Manu-3S15/robotics-technology-market MOBILE ROBOTICS SOFTWARE MARKET Increasing robotics utilization across various applications, including healthcare, logistics, and military & defense, is expected to increase the mobile robotics software market size. This report studies the market size of Mobile Robotics Software by players, countries, product types and end markets. Furthermore, this study analyses the global competitive environment, market drivers and patterns, opportunities and challenges, risks and entry barriers, distribution channels, distributors, and Porter's Five Forces Analysis. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-4N210/mobile-robots-software-market SLAM IN MOBILE ROBOTS AND SMART AR MARKET This report studies the market size of SLAM in mobile robots and smart AR by players, countries, product types and end markets, historical data 2013- and 2018- forecast data. Furthermore, the study analyses the global competitive environment, market drivers and patterns, opportunities and challenges, risks and entry barriers, distribution channels, distributors and Porter's Five Forces Analysis. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-0N218/slam-in-mobile-robots-and-smart-ar-market SECURITY MOBILE ROBOTS MARKET The Security Mobile Robots Market study covers both sales and revenues, and analyses the implementations, products, services, and regions segments. The research report also examines the competitive environment present on the global Security Mobile Robots market in order to determine the potential of the market. The Security Mobile Robots Market is segmented into North America, Europe, China, Japan, and South Korea based on region. Asia Pacific has a large population, which makes this region a market with a significant opportunity. It is the region with the highest growth and most income in the global economy. View Full Report : https://reports.valuates.com/market-reports/QYRE-Othe-0U219/security-mobile-robots-market SMART MOBILE ROBOTS MARKET This Smart Mobile Robots Market Report studies the size (value and volume) of the Smart Mobile Robots market by players, countries, product types and end industries, 2014-2018 historical data and 2019-2025 forecast data. Additionally, this report analyses the global competitive environment, market drivers and patterns, opportunities and challenges, risks and entry barriers, distribution channels, distributors, and Porter's Five Forces Analysis. View Ful Report: https://reports.valuates.com/market-reports/QYRE-Othe-4A211/smart-mobile-robots-market ABOUT US: Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs. Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs. Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision. We are based out of Silicon Valley of India (Bengaluru) and provide 24/6 online and offline support to all our customers and just a phone call away. CONTACT US:Valuates Reports[emailprotected]For U.S. Toll Free Call 1-(315)-215-3225For IST Call +91-8040957137WhatsApp : +91-9945648335Website:https://reports.valuates.com Twitter - https://twitter.com/valuatesreportsLinkedin - https://in.linkedin.com/company/valuatesreportsYoutube - https://www.youtube.com/channel/UCH4wNXynaTZbiD5m92WQI4AFacebook - https://www.facebook.com/valuatesreports/ SOURCE Valuates Reports
Answer:
|
Mobile Robots Market Size is Projected to Reach USD 51100 Million by 2026, at a CAGR of 19.0% | Valuates Reports English English
|
BANGALORE, India, March 31, 2020 /PRNewswire/ -- The global Mobile Robots market size was valued at USD 14960 Million in 2019 and is projected to reach USD 51100 Million by 2026, growing at a CAGR of 19.0% from 2021 to 2026. This study focuses on the status of the mobile robots market size and share, future predictions, opportunities for growth, key markets, and key players. The report also covers regional markets like North America, Europe, China, Japan, Southeast Asia, India and Central & South America. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-1K257/mobile-robots-market TRENDS INFLUENCING THE MOBILE ROBOTS MARKET SIZE Robots cover a wide variety of applications in the healthcare industry, with the advancement in robotics development and improved versatility in robotics use. Medical equipment manufacturers use robots in hospitals, clinics, and pharmaceutical firms. Increased adoption of mobile robots in the healthcare industry is expected to increase the market size. Growth is driven by the dropping prices of robotic components such as sensors, actuators, etc. that are aggravating the global sale of mobile robots. In addition, growth in the global market for mobile robots can be due to breakthrough technological advances and the increasing footprint of aerial, land, and marine mobile robots in hazardous defense operations, agricultural activities, warehouse automation, and a range of domestic applications. Other notable factors positively influencing the market forecast for mobile robotics include a growing need for human life protection and a rise in demand from online retailers for mobile logistics. Get Free Sample Report (Mention the customization you want in the report): https://reports.valuates.com/request/sample/QYRE-Othe-1K257/mobile_robots_market MARKET SEGMENT BY TYPE: Unmanned Ground Vehicles (UGV) Unmanned Aerial Vehicles (UAV) Unmanned Surface Vehicles (USV) MARKET SEGMENT BY APPLICATION : Logistics & Warehousing Defense Healthcare Field Applications Inquire for Regional Report (Mention the Country or Region of Focus) : https://reports.valuates.com/request/regional/QYRE-Othe-1K257/mobile_robots_market THE KEY PLAYERS COVERED IN THIS STUDY iRobot Northrop Grumman Amazon KUKA LEGO Honda ECA Group Adept Technology Geosystems Google General Dynamics Others Buy Now: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Othe-1K257 SIMILAR REPORTS : AUTONOMOUS MOBILE ROBOTS MARKET The Global Autonomous Mobile Robots market size in 2019 was estimated at USD 356.3 million and is expected to hit USD 1011.8 million by 2026, at a CAGR of 15.9% over the forecast period. An autonomous mobile robot (AMR) is any robot capable of understanding and traveling around its environment without an operator directly supervising them. This is usually accomplished via an array of sophisticated onboard sensors, computers, and maps that enable AMRs to understand and interpret their environment to act as an asynchronous mode of transport. The Global Autonomous Mobile Robots Report analyses the status and outlook, including power, production, value, consumption, growth rate (CAGR), market share, and history. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-4R209/autonomous-mobile-robots-market ROBOTICS TECHNOLOGY MARKET The Robotics Technology Market size is projected to hit USD 82.7 billion by 2020, showing a 10.11% CAGR between 2014 and 2020. Robotics technology is a mixture of systems, tools, and computer software used for various tasks like the design, manufacture, and other robotics software. Using robotics technology, customers can automate procedures, increase efficiency, improve quality, and reduce human errors. The report offers an in-depth review of the robotics engineering market with current and future trend developments to elucidate the imminent pockets of investment in the industry. View Full Report: https://reports.valuates.com/market-reports/ALLI-Manu-3S15/robotics-technology-market MOBILE ROBOTICS SOFTWARE MARKET Increasing robotics utilization across various applications, including healthcare, logistics, and military & defense, is expected to increase the mobile robotics software market size. This report studies the market size of Mobile Robotics Software by players, countries, product types and end markets. Furthermore, this study analyses the global competitive environment, market drivers and patterns, opportunities and challenges, risks and entry barriers, distribution channels, distributors, and Porter's Five Forces Analysis. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-4N210/mobile-robots-software-market SLAM IN MOBILE ROBOTS AND SMART AR MARKET This report studies the market size of SLAM in mobile robots and smart AR by players, countries, product types and end markets, historical data 2013- and 2018- forecast data. Furthermore, the study analyses the global competitive environment, market drivers and patterns, opportunities and challenges, risks and entry barriers, distribution channels, distributors and Porter's Five Forces Analysis. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-0N218/slam-in-mobile-robots-and-smart-ar-market SECURITY MOBILE ROBOTS MARKET The Security Mobile Robots Market study covers both sales and revenues, and analyses the implementations, products, services, and regions segments. The research report also examines the competitive environment present on the global Security Mobile Robots market in order to determine the potential of the market. The Security Mobile Robots Market is segmented into North America, Europe, China, Japan, and South Korea based on region. Asia Pacific has a large population, which makes this region a market with a significant opportunity. It is the region with the highest growth and most income in the global economy. View Full Report : https://reports.valuates.com/market-reports/QYRE-Othe-0U219/security-mobile-robots-market SMART MOBILE ROBOTS MARKET This Smart Mobile Robots Market Report studies the size (value and volume) of the Smart Mobile Robots market by players, countries, product types and end industries, 2014-2018 historical data and 2019-2025 forecast data. Additionally, this report analyses the global competitive environment, market drivers and patterns, opportunities and challenges, risks and entry barriers, distribution channels, distributors, and Porter's Five Forces Analysis. View Ful Report: https://reports.valuates.com/market-reports/QYRE-Othe-4A211/smart-mobile-robots-market ABOUT US: Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs. Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs. Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision. We are based out of Silicon Valley of India (Bengaluru) and provide 24/6 online and offline support to all our customers and just a phone call away. CONTACT US:Valuates Reports[emailprotected]For U.S. Toll Free Call 1-(315)-215-3225For IST Call +91-8040957137WhatsApp : +91-9945648335Website:https://reports.valuates.com Twitter - https://twitter.com/valuatesreportsLinkedin - https://in.linkedin.com/company/valuatesreportsYoutube - https://www.youtube.com/channel/UCH4wNXynaTZbiD5m92WQI4AFacebook - https://www.facebook.com/valuatesreports/ SOURCE Valuates Reports
|
edtsum6927
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NESS ZIONA, Israel--(BUSINESS WIRE)--Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today that its wholly owned subsidiary, Eye-Net Mobile Ltd., has signed a commercial cooperation agreement with SaverOne 2014 Ltd. (TASE: SAVR), a leader in providing an effective solution for cell phone distracted driving. Subject to certain tests and criteria to be determined by the parties, Eye-Net will integrate its Eye-Net Protect solution in SaverOnes product designed to prevent the use of texting applications by the driver while the vehicle is in motion. Cell phone distracted driving is a leading cause of road accidents. According to research by the National Safety Council, 1.6 million car accidents in the United States are caused every year by texting while driving and 25% of all car crashes in the United States involve the use of a cell phone. According to the agreement, the Eye-Net Protect solution will be integrated in the SaverOne solution in order to offer an additional protection layer and enhance its ability to prevent accidents by alerting drivers about potential collisions. Eye-Nets integration in the SaverOne solution presents shared revenue stream potential that could be derived from offering optional features for an annual license fee. The agreement also contemplates that SaverOne will introduce Eye-Net to certain companies with which it has business relationships, in consideration for 10% of the revenues received by Eye-Net under a commercial transaction with a third party introduced by SaverOne. In turn, Eye-Net will introduce SaverOne to Japanese vehicle manufacturers and business entities with which Eye-Net has business relationships. We are pleased to announce our joint venture with Eye-Net, SaverOnes first partnership with a technology company, whose activities are also based on saving lives and reducing road accidents. The joint venture with Eye-Net will allow SaverOne to offer its customers a comprehensive safety suite that includes additional safety-related and accident prevention services, said Ori Gilboa, CEO of SaverOne. Eye-Net is expanding its presence in the automotive world with this new commercial partnership with SaverOne, offering the integrated solution to various vehicle fleets. The synergy between the two companies and their products enhances driver protection, on top of existing Advanced Driver Assistance Systems (ADAS), potentially reducing the rate of road accidents and saving lives, said Dror Elbaz, COO & Deputy CEO of Eye-Net Mobile. Furthermore, I believe this Israeli collaboration will establish a new standard in tackling the number one distraction for drivers by reducing the use of mobile phones while driving. Eye-Net Protect is an intuitive and easy-to-use mobile application that provides real-time pre-collision alerts to drivers and vulnerable road users. The Eye-Net solution suite enhances road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information about Eye-Net Mobile, please visit www.eyenet-mobile.com, or follow the Companys LinkedIn page, Eye-Net Mobile; Twitter, @EyeNetMobile1; and Instagram channel, Eyenetmobile1, the contents of which are not incorporated into this press release. About SaverOne SaverOne Ltd. (TASE: SAVR) is a technology company that offers a driver distraction prevention system, limiting the use of any mobile phone in the drivers vicinity. SaverOnes patented breakthrough solution creates a safer driving environment by preventing access to distracting applications while enabling access to other applications, as defined by each organizations safety policy. Such policy is being enforced seamlessly on any mobile phone in the drivers vicinity, without the need for the drivers cooperation, while leaving other mobiles phones in the vehicle unaffected. For more information about SaverOne, visit www.saver.one, or join SaverOne on LinkedIn. About Foresight Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the companys wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both in-line-of-sight vision systems and beyond-line-of-sight accident-prevention solutions. Foresights vision solutions include modules of automatic calibration, sensor fusion and dense 3D point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobiles cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.foresightauto.com, follow @ForesightAuto1 on Twitter, or join Foresight Automotive on LinkedIn. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses its agreement and collaboration with SaverOne, the integration of Eye-Net Protect solution in the SaverOne solution, and introductions to be made my SaverOne between Eye-Net and other companies. Because such statements deal with future events and are based on Foresights current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Foresight's annual report on Form 20-F filed with the Securities and Exchange Commission ("SEC") on March 31, 2020, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the contents of third party websites.
Answer:
|
Foresight: Eye-Net Signs First Commercial Agreement with SaverOne to Integrate and Commercialize Eye-Net Protect Eye-Net and SaverOne will promote the partnership worldwide through an integrated accident prevention solution
|
NESS ZIONA, Israel--(BUSINESS WIRE)--Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today that its wholly owned subsidiary, Eye-Net Mobile Ltd., has signed a commercial cooperation agreement with SaverOne 2014 Ltd. (TASE: SAVR), a leader in providing an effective solution for cell phone distracted driving. Subject to certain tests and criteria to be determined by the parties, Eye-Net will integrate its Eye-Net Protect solution in SaverOnes product designed to prevent the use of texting applications by the driver while the vehicle is in motion. Cell phone distracted driving is a leading cause of road accidents. According to research by the National Safety Council, 1.6 million car accidents in the United States are caused every year by texting while driving and 25% of all car crashes in the United States involve the use of a cell phone. According to the agreement, the Eye-Net Protect solution will be integrated in the SaverOne solution in order to offer an additional protection layer and enhance its ability to prevent accidents by alerting drivers about potential collisions. Eye-Nets integration in the SaverOne solution presents shared revenue stream potential that could be derived from offering optional features for an annual license fee. The agreement also contemplates that SaverOne will introduce Eye-Net to certain companies with which it has business relationships, in consideration for 10% of the revenues received by Eye-Net under a commercial transaction with a third party introduced by SaverOne. In turn, Eye-Net will introduce SaverOne to Japanese vehicle manufacturers and business entities with which Eye-Net has business relationships. We are pleased to announce our joint venture with Eye-Net, SaverOnes first partnership with a technology company, whose activities are also based on saving lives and reducing road accidents. The joint venture with Eye-Net will allow SaverOne to offer its customers a comprehensive safety suite that includes additional safety-related and accident prevention services, said Ori Gilboa, CEO of SaverOne. Eye-Net is expanding its presence in the automotive world with this new commercial partnership with SaverOne, offering the integrated solution to various vehicle fleets. The synergy between the two companies and their products enhances driver protection, on top of existing Advanced Driver Assistance Systems (ADAS), potentially reducing the rate of road accidents and saving lives, said Dror Elbaz, COO & Deputy CEO of Eye-Net Mobile. Furthermore, I believe this Israeli collaboration will establish a new standard in tackling the number one distraction for drivers by reducing the use of mobile phones while driving. Eye-Net Protect is an intuitive and easy-to-use mobile application that provides real-time pre-collision alerts to drivers and vulnerable road users. The Eye-Net solution suite enhances road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information about Eye-Net Mobile, please visit www.eyenet-mobile.com, or follow the Companys LinkedIn page, Eye-Net Mobile; Twitter, @EyeNetMobile1; and Instagram channel, Eyenetmobile1, the contents of which are not incorporated into this press release. About SaverOne SaverOne Ltd. (TASE: SAVR) is a technology company that offers a driver distraction prevention system, limiting the use of any mobile phone in the drivers vicinity. SaverOnes patented breakthrough solution creates a safer driving environment by preventing access to distracting applications while enabling access to other applications, as defined by each organizations safety policy. Such policy is being enforced seamlessly on any mobile phone in the drivers vicinity, without the need for the drivers cooperation, while leaving other mobiles phones in the vehicle unaffected. For more information about SaverOne, visit www.saver.one, or join SaverOne on LinkedIn. About Foresight Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the companys wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both in-line-of-sight vision systems and beyond-line-of-sight accident-prevention solutions. Foresights vision solutions include modules of automatic calibration, sensor fusion and dense 3D point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobiles cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.foresightauto.com, follow @ForesightAuto1 on Twitter, or join Foresight Automotive on LinkedIn. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses its agreement and collaboration with SaverOne, the integration of Eye-Net Protect solution in the SaverOne solution, and introductions to be made my SaverOne between Eye-Net and other companies. Because such statements deal with future events and are based on Foresights current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Foresight's annual report on Form 20-F filed with the Securities and Exchange Commission ("SEC") on March 31, 2020, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the contents of third party websites.
|
edtsum6930
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MGE Appoints Ray Pineault as Chief Operating Officer (COO) to Further Support U.S. Innovation and International Growth PlansUNCASVILLE, Conn., July 23, 2020 /PRNewswire/ -- Mohegan Gaming & Entertainment (MGE), a master developer of awe-inspiring integrated entertainment resorts (IER) worldwide, today announced the newest member of its executive leadership team to further sustain and enhance the organization's positive performance and guide MGE through unprecedented times. Ray Pineault has been named Chief Operating Officer (COO) pending regulatory approval. The addition to MGE's C-Suite marks an exciting new chapter for the brand as it successfully navigates the ever-evolving world of integrated entertainment. (PRNewsfoto/Mohegan Gaming & Entertainment) "The entertainment industry has faced challenges this year due to the pandemic, but I am proud of the way our team members have stepped up and set MGE on a path of positive momentum, with strong performance across all properties since our reopenings," said Mario Kontomerkos, Chief Executive Officer (CEO) and President of Mohegan Gaming & Entertainment. "From the beginning, it has been our mission to build the best executive team in the industry, and I believe we are on our way to achieving that status with a veteran like Ray at the helm." Ray Pineault, COO After nearly 20 years of service to the Mohegan Tribe as President and General Manager of the brand's flagship property, Mohegan Sun Connecticut, and most recently as Regional President of MGE, Ray Pineault brings a wealth of legal and business knowledge with him to the role of Chief Operating Officer (COO). In this role, Ray will oversee MGE's regional presidents to ensure the operational success of each of the nine properties in MGE's portfolio in the US, Canada and South Korea. As COO, Ray will ensure that each of MGE's properties around the world meets or exceeds operational, employee engagement, guest service, cultural, strategic and fiscal plans, while maintaining the higheststandards of regulatorycompliance. Ray fills the COO position previously held by Michael Silberling who vacated the position in July.ABOUT MOHEGAN GAMING & ENTERTAINMENTMohegan Gaming & Entertainment (MGE) is a master developer and operator of premier global integrated entertainment resorts, including Mohegan Sun in Uncasville, Connecticut, Inspire in Incheon, South Korea and Niagara Casinos in Niagara, Canada. MGE is owner, developer, and/or manager of integrated entertainment resorts throughout the United States, including Connecticut, New Jersey, Washington, Pennsylvania, Louisiana, as well as Northern Asia and Niagara Falls, Canada, and coming soon pending regulatory approval, Las Vegas, Nevada. MGE is owner and operator of Connecticut Sun, a professional basketball team in the WNBA and New England Black Wolves, a professional lacrosse team in the National Lacrosse League. For more information on MGE and our properties, visitwww.mohegangaming.com.Mohegan Gaming & Entertainment PR, [emailprotected]SOURCE Mohegan Gaming & Entertainment Related Links http://www.mohegangaming.com
Answer:
|
Mohegan Gaming & Entertainment (MGE) Announces New Executive Leadership Team Member to Sustain Positive Momentum
|
MGE Appoints Ray Pineault as Chief Operating Officer (COO) to Further Support U.S. Innovation and International Growth PlansUNCASVILLE, Conn., July 23, 2020 /PRNewswire/ -- Mohegan Gaming & Entertainment (MGE), a master developer of awe-inspiring integrated entertainment resorts (IER) worldwide, today announced the newest member of its executive leadership team to further sustain and enhance the organization's positive performance and guide MGE through unprecedented times. Ray Pineault has been named Chief Operating Officer (COO) pending regulatory approval. The addition to MGE's C-Suite marks an exciting new chapter for the brand as it successfully navigates the ever-evolving world of integrated entertainment. (PRNewsfoto/Mohegan Gaming & Entertainment) "The entertainment industry has faced challenges this year due to the pandemic, but I am proud of the way our team members have stepped up and set MGE on a path of positive momentum, with strong performance across all properties since our reopenings," said Mario Kontomerkos, Chief Executive Officer (CEO) and President of Mohegan Gaming & Entertainment. "From the beginning, it has been our mission to build the best executive team in the industry, and I believe we are on our way to achieving that status with a veteran like Ray at the helm." Ray Pineault, COO After nearly 20 years of service to the Mohegan Tribe as President and General Manager of the brand's flagship property, Mohegan Sun Connecticut, and most recently as Regional President of MGE, Ray Pineault brings a wealth of legal and business knowledge with him to the role of Chief Operating Officer (COO). In this role, Ray will oversee MGE's regional presidents to ensure the operational success of each of the nine properties in MGE's portfolio in the US, Canada and South Korea. As COO, Ray will ensure that each of MGE's properties around the world meets or exceeds operational, employee engagement, guest service, cultural, strategic and fiscal plans, while maintaining the higheststandards of regulatorycompliance. Ray fills the COO position previously held by Michael Silberling who vacated the position in July.ABOUT MOHEGAN GAMING & ENTERTAINMENTMohegan Gaming & Entertainment (MGE) is a master developer and operator of premier global integrated entertainment resorts, including Mohegan Sun in Uncasville, Connecticut, Inspire in Incheon, South Korea and Niagara Casinos in Niagara, Canada. MGE is owner, developer, and/or manager of integrated entertainment resorts throughout the United States, including Connecticut, New Jersey, Washington, Pennsylvania, Louisiana, as well as Northern Asia and Niagara Falls, Canada, and coming soon pending regulatory approval, Las Vegas, Nevada. MGE is owner and operator of Connecticut Sun, a professional basketball team in the WNBA and New England Black Wolves, a professional lacrosse team in the National Lacrosse League. For more information on MGE and our properties, visitwww.mohegangaming.com.Mohegan Gaming & Entertainment PR, [emailprotected]SOURCE Mohegan Gaming & Entertainment Related Links http://www.mohegangaming.com
|
edtsum6934
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of MDC Partners Inc. (NASDAQ: MDCA) and Stagwell Media LP is fair to MDC shareholders. Stagwell and its affiliates are expected to hold approximately 79% of the common equity of the combined company after closing. Halper Sadeh encourages MDC shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether MDC and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for MDC shareholders; and (2) disclose all material information necessary for MDC shareholders to adequately assess and value the merger. On behalf of MDC shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. Halper Sadeh encourages MDC shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
Answer:
|
MDC Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of MDC Partners Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm MDCA
|
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of MDC Partners Inc. (NASDAQ: MDCA) and Stagwell Media LP is fair to MDC shareholders. Stagwell and its affiliates are expected to hold approximately 79% of the common equity of the combined company after closing. Halper Sadeh encourages MDC shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether MDC and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for MDC shareholders; and (2) disclose all material information necessary for MDC shareholders to adequately assess and value the merger. On behalf of MDC shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. Halper Sadeh encourages MDC shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
|
edtsum6941
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: HONG KONG, Nov. 9, 2020 /PRNewswire/ -- The first ever edition of Cosmoprof Asia Digital Week goes live today, welcoming the world's companies and operators looking for new business solutions in the Asia-Pacific region. Cosmoprof Asia Digital Week Opens Today! The makeup demo Playful Nun by MAYs will create a fresh and mixed perception of NUN on face. The CosmoTrends report highlights 21 products selected by trend agency BEAUTYSTREAMS. For five days up to November 13, some 650 exhibitors will connect virtually with an expected 10,000 buyers from 104 countries and regions, sharing the latest, state-of-the-art products and services representing every segment of beauty: packaging, machinery, print and label, OEM and ODM, ingredients, colour cosmetics, skincare, nails and hair, clean and hygiene and all things organic and natural. This world-class, online one-stop-shop event has been expressly designed to facilitate networking with established and new business contacts, sharing exciting new projects, defining retail orders, and evaluating trends and strategies. 15 Country and Group Pavilionsare showcasing innovative products and trends from around the world in Cosmoprof Asia Digital Week, participating with the support from governments and trade associations: Italy (ITA - Italian Trade Agency), Spain (ICEX), Greece (Enterprise Greece), Switzerland (Switzerland Global Enterprise), Poland (POLCHARM), United Kingdom (Birmingham Chamber of Commerce), China (Guangzhou Municipal Commerce Bureau and Yiwu Municipal Bureau of Commerce) as well as seven pavilions from Korea including the largest group supported by KOTRA as well as IBITA (International Beauty Industry Trade Association), KIF (Korea Innovation Foundation), KOBITA (Korea Beauty Industry Trade Association), KOSME Jeju (Korea SMEs and Startups Agency Jeju), SNIP (Seongnam Industry Promotion Agency) and WMIT (Wonju Medical Industry Techno-Valley).Cosmoprof Asia Digital Week is the largest and last beauty B2B online trading event of 2020-- don't miss the chance to grow your business and get a head start on 2021.Business opportunities on every pageThe strategic event of the year, Cosmoprof Asia Digital Week is the perfect stage not only for companies already operating in the Asia-Pacific region but also those interested in evaluating new opportunities for future developments. The innovative AI-powered Match & Meet software facilitates the matching of supply and demand and allows independently managed business meetings via video call and chat. Increasing your network, exploring new collaborations, discovering innovative services and initiating new proposals will be easy for all, whether companies, buyers, distributors or retailers. Experts have already predicted that Asia-Pacific will play a vital role in the post-pandemic economic recovery. Cosmoprof Asia Digital Week is therefore the most strategic and essential step for attendees interested in monitoring one of the most exciting and fast-evolving regions of the global cosmetics industry. Cosmoprof Asia Digital Week insights and initiativesSpecific updates and sharing initiatives are scheduled throughout Cosmoprof Asia Digital Week's Cosmotalks. The Virtual Series of 20 webinars hosts experts and executives from key industry companies as they share insights into the most in-vogue topics each day, from the most impactful marketing strategies and emerging trends to innovations in packaging and sustainable design. Those on the evolution of e-commerce and new digital technologies for the retail sector, in particular focusing on the regulations of the beauty market in China, will no doubt be especially popular. View the complete calendar and register: https://digital-week.cosmoprof-asia.com/en-us/Education/CosmoTalks-The-Virtual-SeriesCosmo Virtual Stagewelcomes beauty professionals and top industry influencers to witness some of the latest product recommendations and the trend-setting techniques of the region's most talented and creative hairstylists and make-up artists. Don't miss performances by Shiseido Professional and GAMA Professional, May's stylish focus on makeup and NAILHOLIC's spectacular presentation for the nail sector. Let's Relax yoga and stretching sessions are also scheduled to help recharge your batteries. For information and to access the contents, https://digital-week.cosmoprof-asia.com/en-us/Events/Cosmo-Virtual-StageInfluencers and KOLs keep their fingers on the pulse of the beauty market, and five of Asia-Pacific's most followed take part in the renowned #BeautyHunt as it goes virtual this year. Identifying and reviewing the latest make-up, hair, skincare and body care products, the most high-tech devices and the best performing accessories are Marco Chan (Hong Kong), International Session Hairstylist; Kalam (Hong Kong), Make-up Artist; Jeniffer Harn (Korea), Beauty YouTuber; Kim Dao (Australia), Beauty Content Creator; Alicia Tan (Malaysia), Beauty Content Creator. Tune i963n to #BeautyHunt Channel at 5pm daily for recommendations of the next big trend.Today, Monday, November 9, the CosmoTrends report launches, highlighting 21 products selected by trend agency BEAUTYSTREAMS. This overview of trends most influencing consumer behaviour highlights the most significant innovations likely to sway the industry's development in the coming months.Take a sneak peek at the highlights on our intro video https://www.youtube.com/watch?v=XLmzhfIZpQcand thenvisit our website to save your place: https://www.cosmoprof-asia.com/en-us/Digital-WeekRegister nowto join us-- we look forward to seeing you online.NOTES TO EDITORS:COSMOPROF ASIA DIGITAL WEEK Date: 9-13 November 2020 Time: 09.00-18.00 (HKT/UTC +8), matching platform opens 24hrsWebsite:www.cosmoprof-asia.com/digital-week Buyer Registration:https://bit.ly/3jcuueJHigh-resolution images can be downloaded fromhttps://bit.ly/3eGxDD1ABOUT THE ORGANISERS: Cosmoprof Asia is organised by Cosmoprof Asia Ltd, a joint-venture company between BolognaFiere Group and Informa Markets Asia Ltd.ABOUT BOLOGNAFIERE GROUP (www.bolognafiere.it)BolognaFiere Group is the world's leading trade show organiser in cosmetics, fashion, architecture, building, art and culture. The Group has more than 80 international exhibitions within its portfolio, notably Cosmoprof Worldwide Bologna, the most important meeting point in the world for beauty professionals, established in 1967 and held in Bologna, Italy. For the 2019 edition, Cosmoprof registered more than 265.000 attendees from 150 countries in the world, with an increase by 10% of foreign professionals, and 3,033 exhibitors from 70 countries. The Cosmoprof platform extends throughout the entire world, with its events in Bologna, Las Vegas, Mumbai, and Hong Kong, China (with Cosmoprof Worldwide Bologna, Cosmoprof North America, Cosmoprof India, and Cosmoprof Asia). Recently the fifth exhibition of the network has been announced: Cosmoprof CBE ASEAN, in Thailand, will focus on the cosmetic industry in South-East Asia. In 2020, South China Beauty Expo, a new show in Shenzhen, China was held in July. The Cosmoprof platform will reinforce its influence in Europe, thanks to the acquisition of the German group Health and Beauty, in South America, thanks to the collaboration with Beauty Fair -Feira Internacional De Beleza Profissional, and in Asia.ABOUT INFORMA MARKETS (www.informamarkets.com) Informa Markets Beauty has an extensive network powered by B2B events across 11 cities in Asia (Bangkok, Chengdu, Ho Chi Minh City, Hong Kong, Jakarta, Kuala Lumpur, Manila, Mumbai, Shanghai, Shenzhen, Tokyo), the world's fastest growing markets. By further expanding its strength, the Beauty Portfolio now includes a new B2B event in Miami 2021 serving the East Coast and USA, South America and Caribbean Islands regions. Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. We provide marketplace participants around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, targeted digital services and actionable data solutions. We connect buyers and sellers across more than a dozen global verticals, including Pharmaceuticals, Food, Medical Technology and Infrastructure. As the world's leading market-making company, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.SOURCE Cosmoprof Asia
Answer:
|
Cosmoprof Asia Digital Week Goes Live Today
|
HONG KONG, Nov. 9, 2020 /PRNewswire/ -- The first ever edition of Cosmoprof Asia Digital Week goes live today, welcoming the world's companies and operators looking for new business solutions in the Asia-Pacific region. Cosmoprof Asia Digital Week Opens Today! The makeup demo Playful Nun by MAYs will create a fresh and mixed perception of NUN on face. The CosmoTrends report highlights 21 products selected by trend agency BEAUTYSTREAMS. For five days up to November 13, some 650 exhibitors will connect virtually with an expected 10,000 buyers from 104 countries and regions, sharing the latest, state-of-the-art products and services representing every segment of beauty: packaging, machinery, print and label, OEM and ODM, ingredients, colour cosmetics, skincare, nails and hair, clean and hygiene and all things organic and natural. This world-class, online one-stop-shop event has been expressly designed to facilitate networking with established and new business contacts, sharing exciting new projects, defining retail orders, and evaluating trends and strategies. 15 Country and Group Pavilionsare showcasing innovative products and trends from around the world in Cosmoprof Asia Digital Week, participating with the support from governments and trade associations: Italy (ITA - Italian Trade Agency), Spain (ICEX), Greece (Enterprise Greece), Switzerland (Switzerland Global Enterprise), Poland (POLCHARM), United Kingdom (Birmingham Chamber of Commerce), China (Guangzhou Municipal Commerce Bureau and Yiwu Municipal Bureau of Commerce) as well as seven pavilions from Korea including the largest group supported by KOTRA as well as IBITA (International Beauty Industry Trade Association), KIF (Korea Innovation Foundation), KOBITA (Korea Beauty Industry Trade Association), KOSME Jeju (Korea SMEs and Startups Agency Jeju), SNIP (Seongnam Industry Promotion Agency) and WMIT (Wonju Medical Industry Techno-Valley).Cosmoprof Asia Digital Week is the largest and last beauty B2B online trading event of 2020-- don't miss the chance to grow your business and get a head start on 2021.Business opportunities on every pageThe strategic event of the year, Cosmoprof Asia Digital Week is the perfect stage not only for companies already operating in the Asia-Pacific region but also those interested in evaluating new opportunities for future developments. The innovative AI-powered Match & Meet software facilitates the matching of supply and demand and allows independently managed business meetings via video call and chat. Increasing your network, exploring new collaborations, discovering innovative services and initiating new proposals will be easy for all, whether companies, buyers, distributors or retailers. Experts have already predicted that Asia-Pacific will play a vital role in the post-pandemic economic recovery. Cosmoprof Asia Digital Week is therefore the most strategic and essential step for attendees interested in monitoring one of the most exciting and fast-evolving regions of the global cosmetics industry. Cosmoprof Asia Digital Week insights and initiativesSpecific updates and sharing initiatives are scheduled throughout Cosmoprof Asia Digital Week's Cosmotalks. The Virtual Series of 20 webinars hosts experts and executives from key industry companies as they share insights into the most in-vogue topics each day, from the most impactful marketing strategies and emerging trends to innovations in packaging and sustainable design. Those on the evolution of e-commerce and new digital technologies for the retail sector, in particular focusing on the regulations of the beauty market in China, will no doubt be especially popular. View the complete calendar and register: https://digital-week.cosmoprof-asia.com/en-us/Education/CosmoTalks-The-Virtual-SeriesCosmo Virtual Stagewelcomes beauty professionals and top industry influencers to witness some of the latest product recommendations and the trend-setting techniques of the region's most talented and creative hairstylists and make-up artists. Don't miss performances by Shiseido Professional and GAMA Professional, May's stylish focus on makeup and NAILHOLIC's spectacular presentation for the nail sector. Let's Relax yoga and stretching sessions are also scheduled to help recharge your batteries. For information and to access the contents, https://digital-week.cosmoprof-asia.com/en-us/Events/Cosmo-Virtual-StageInfluencers and KOLs keep their fingers on the pulse of the beauty market, and five of Asia-Pacific's most followed take part in the renowned #BeautyHunt as it goes virtual this year. Identifying and reviewing the latest make-up, hair, skincare and body care products, the most high-tech devices and the best performing accessories are Marco Chan (Hong Kong), International Session Hairstylist; Kalam (Hong Kong), Make-up Artist; Jeniffer Harn (Korea), Beauty YouTuber; Kim Dao (Australia), Beauty Content Creator; Alicia Tan (Malaysia), Beauty Content Creator. Tune i963n to #BeautyHunt Channel at 5pm daily for recommendations of the next big trend.Today, Monday, November 9, the CosmoTrends report launches, highlighting 21 products selected by trend agency BEAUTYSTREAMS. This overview of trends most influencing consumer behaviour highlights the most significant innovations likely to sway the industry's development in the coming months.Take a sneak peek at the highlights on our intro video https://www.youtube.com/watch?v=XLmzhfIZpQcand thenvisit our website to save your place: https://www.cosmoprof-asia.com/en-us/Digital-WeekRegister nowto join us-- we look forward to seeing you online.NOTES TO EDITORS:COSMOPROF ASIA DIGITAL WEEK Date: 9-13 November 2020 Time: 09.00-18.00 (HKT/UTC +8), matching platform opens 24hrsWebsite:www.cosmoprof-asia.com/digital-week Buyer Registration:https://bit.ly/3jcuueJHigh-resolution images can be downloaded fromhttps://bit.ly/3eGxDD1ABOUT THE ORGANISERS: Cosmoprof Asia is organised by Cosmoprof Asia Ltd, a joint-venture company between BolognaFiere Group and Informa Markets Asia Ltd.ABOUT BOLOGNAFIERE GROUP (www.bolognafiere.it)BolognaFiere Group is the world's leading trade show organiser in cosmetics, fashion, architecture, building, art and culture. The Group has more than 80 international exhibitions within its portfolio, notably Cosmoprof Worldwide Bologna, the most important meeting point in the world for beauty professionals, established in 1967 and held in Bologna, Italy. For the 2019 edition, Cosmoprof registered more than 265.000 attendees from 150 countries in the world, with an increase by 10% of foreign professionals, and 3,033 exhibitors from 70 countries. The Cosmoprof platform extends throughout the entire world, with its events in Bologna, Las Vegas, Mumbai, and Hong Kong, China (with Cosmoprof Worldwide Bologna, Cosmoprof North America, Cosmoprof India, and Cosmoprof Asia). Recently the fifth exhibition of the network has been announced: Cosmoprof CBE ASEAN, in Thailand, will focus on the cosmetic industry in South-East Asia. In 2020, South China Beauty Expo, a new show in Shenzhen, China was held in July. The Cosmoprof platform will reinforce its influence in Europe, thanks to the acquisition of the German group Health and Beauty, in South America, thanks to the collaboration with Beauty Fair -Feira Internacional De Beleza Profissional, and in Asia.ABOUT INFORMA MARKETS (www.informamarkets.com) Informa Markets Beauty has an extensive network powered by B2B events across 11 cities in Asia (Bangkok, Chengdu, Ho Chi Minh City, Hong Kong, Jakarta, Kuala Lumpur, Manila, Mumbai, Shanghai, Shenzhen, Tokyo), the world's fastest growing markets. By further expanding its strength, the Beauty Portfolio now includes a new B2B event in Miami 2021 serving the East Coast and USA, South America and Caribbean Islands regions. Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. We provide marketplace participants around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, targeted digital services and actionable data solutions. We connect buyers and sellers across more than a dozen global verticals, including Pharmaceuticals, Food, Medical Technology and Infrastructure. As the world's leading market-making company, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.SOURCE Cosmoprof Asia
|
edtsum6947
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BOSTON, Jan. 19, 2021 /PRNewswire/ --NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that it has entered into securities purchase agreements with certain institutional and accredited investors to raise $10.0 million through the issuance of an aggregate 2,500,000 shares of its common stock and warrants to purchase up to an aggregate of 2,500,000 shares of common stock, at a purchase price of $4.00 per share of common stock and associated warrant in a private placement. The closing of the private placement is expected to occur on or about January 21, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The warrants have an exercise price of $6.03 per share, are exercisable commencing six months following the issuance date and have a term of five and one-half years. The Company intends to use the net proceeds for working capital, capital expenditures and general corporate purposes. The offer and sale of the foregoing securities are being made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Under an agreement with the investors, the Company is required to file an initial registration statement with the Securities and Exchange Commission covering the resale of the shares of common stock to be issued to the investors no later than January 25, 2021 and to use its best efforts to have the registration statement declared effective as promptly as practical thereafter, and in any event no later than 90 days after today in the event of a "full review" by the Securities and Exchange Commission. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state. About NeuroBo Pharmaceuticals NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases,has a current portfolio of four drug candidates. The company's recently acquired ANA-001 candidate is a proprietary oral niclosamide formulation in development as a treatment for patients with moderate to severe COVID-19 (patients not requiring ventilators). Niclosamide is a potential oral antiviral and anti-inflammatory agent with a long history of use and a well-understood safety profile in humans. ANA-001 is currently being studied in a 60-subject Phase 2/3 clinical trial conducted at up to 20 clinical sites in the U.S. Niclosamide has demonstrated both antiviral and immunomodulatory activity with possible downstream effects on coagulation abnormalities observed in COVID-19. The company's NB-01 candidate has been shown in a Phase 2 study to significantly reduce pain symptoms associated with painful diabetic neuropathy (PDN), with a superior safety profile when compared to currently available treatments. Due to global COVID-19 crisis, a planned Phase 3 study was postponed. In the interim, NeuroBo is exploring a potential orphan drug indication targeting chronic pain for NB-01. NeuroBo's NB-02 drug candidate is focused on the treatment of Alzheimer's disease and neurodegenerative diseases associated with the pathological dysfunction of tau proteins in the brain. In addition, the Company's Gemcabene product candidate was developed for the treatment of dyslipidemia, a serious medical condition that increases the risk of life-threatening cardiovascular disease. For more information visit:https://www.neurobopharma.com. Forward-looking Statements Any statements in this press release that are not statements of historical fact constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, statements regarding the completion of the private placement, the satisfaction of customary closing conditions related to the private placement and the intended use of net proceeds from the private placement as well as the development of NeuroBo's product candidates and the therapeutic potential, timing and nature of clinical trials and potential regulatory approval of NeuroBo's clinical programs and pipeline.Forward-looking statements are usually identified by the use of words, such as "believes," "anticipates," "expects," "intends," "plans," "may," "potential," "will," "could" and similar expressions. Actual results may differ materially from those indicated by forward-looking statements as a result of various important factors and risks. These factors, risks and uncertainties include, but are not limited to: the timing, size and completion of the private placement, market and other conditions, the occurrence of health epidemics or contagious diseases, such as COVID19, and potential effects on NeuroBo's business, clinical trial sites, supply chain and manufacturing facilities; NeuroBo's ability to continue as a going concern; the timing of completion of NeuroBo's planned clinical trials; the timing of the availability of data from NeuroBo's clinical trials; NeuroBo's plans to research, develop and commercialize its current and future product candidates, including with respect to ANA-001; NeuroBo's ability to successfully collaborate with existing collaborators or enter into new collaborations and to fulfill its obligations under any such collaboration agreements; the clinical utility, potential benefits and market acceptance of NeuroBo's product candidates; the impact of government laws and regulations; NeuroBo's ability to protect its intellectual property position; and NeuroBo's need for additional financing to fulfill its stated goals; and other factors discussed in the"Risk Factors" section of NeuroBo's Annual Report on Form 10-K and in our other filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent NeuroBo's views as of the date hereof. NeuroBo anticipates that subsequent events and developments will cause its views to change. However, while NeuroBo may elect to update these forward-looking statements at some point in the future, NeuroBo specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing NeuroBo's views as of any date subsequent to the date hereof. Contacts: Rx Communications GroupMichael Miller+1-917-633-6086[emailprotected] SOURCE NeuroBo Pharmaceuticals, Inc. Related Links https://www.neurobopharma.com
Answer:
|
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
|
BOSTON, Jan. 19, 2021 /PRNewswire/ --NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that it has entered into securities purchase agreements with certain institutional and accredited investors to raise $10.0 million through the issuance of an aggregate 2,500,000 shares of its common stock and warrants to purchase up to an aggregate of 2,500,000 shares of common stock, at a purchase price of $4.00 per share of common stock and associated warrant in a private placement. The closing of the private placement is expected to occur on or about January 21, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The warrants have an exercise price of $6.03 per share, are exercisable commencing six months following the issuance date and have a term of five and one-half years. The Company intends to use the net proceeds for working capital, capital expenditures and general corporate purposes. The offer and sale of the foregoing securities are being made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Under an agreement with the investors, the Company is required to file an initial registration statement with the Securities and Exchange Commission covering the resale of the shares of common stock to be issued to the investors no later than January 25, 2021 and to use its best efforts to have the registration statement declared effective as promptly as practical thereafter, and in any event no later than 90 days after today in the event of a "full review" by the Securities and Exchange Commission. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state. About NeuroBo Pharmaceuticals NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases,has a current portfolio of four drug candidates. The company's recently acquired ANA-001 candidate is a proprietary oral niclosamide formulation in development as a treatment for patients with moderate to severe COVID-19 (patients not requiring ventilators). Niclosamide is a potential oral antiviral and anti-inflammatory agent with a long history of use and a well-understood safety profile in humans. ANA-001 is currently being studied in a 60-subject Phase 2/3 clinical trial conducted at up to 20 clinical sites in the U.S. Niclosamide has demonstrated both antiviral and immunomodulatory activity with possible downstream effects on coagulation abnormalities observed in COVID-19. The company's NB-01 candidate has been shown in a Phase 2 study to significantly reduce pain symptoms associated with painful diabetic neuropathy (PDN), with a superior safety profile when compared to currently available treatments. Due to global COVID-19 crisis, a planned Phase 3 study was postponed. In the interim, NeuroBo is exploring a potential orphan drug indication targeting chronic pain for NB-01. NeuroBo's NB-02 drug candidate is focused on the treatment of Alzheimer's disease and neurodegenerative diseases associated with the pathological dysfunction of tau proteins in the brain. In addition, the Company's Gemcabene product candidate was developed for the treatment of dyslipidemia, a serious medical condition that increases the risk of life-threatening cardiovascular disease. For more information visit:https://www.neurobopharma.com. Forward-looking Statements Any statements in this press release that are not statements of historical fact constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, statements regarding the completion of the private placement, the satisfaction of customary closing conditions related to the private placement and the intended use of net proceeds from the private placement as well as the development of NeuroBo's product candidates and the therapeutic potential, timing and nature of clinical trials and potential regulatory approval of NeuroBo's clinical programs and pipeline.Forward-looking statements are usually identified by the use of words, such as "believes," "anticipates," "expects," "intends," "plans," "may," "potential," "will," "could" and similar expressions. Actual results may differ materially from those indicated by forward-looking statements as a result of various important factors and risks. These factors, risks and uncertainties include, but are not limited to: the timing, size and completion of the private placement, market and other conditions, the occurrence of health epidemics or contagious diseases, such as COVID19, and potential effects on NeuroBo's business, clinical trial sites, supply chain and manufacturing facilities; NeuroBo's ability to continue as a going concern; the timing of completion of NeuroBo's planned clinical trials; the timing of the availability of data from NeuroBo's clinical trials; NeuroBo's plans to research, develop and commercialize its current and future product candidates, including with respect to ANA-001; NeuroBo's ability to successfully collaborate with existing collaborators or enter into new collaborations and to fulfill its obligations under any such collaboration agreements; the clinical utility, potential benefits and market acceptance of NeuroBo's product candidates; the impact of government laws and regulations; NeuroBo's ability to protect its intellectual property position; and NeuroBo's need for additional financing to fulfill its stated goals; and other factors discussed in the"Risk Factors" section of NeuroBo's Annual Report on Form 10-K and in our other filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent NeuroBo's views as of the date hereof. NeuroBo anticipates that subsequent events and developments will cause its views to change. However, while NeuroBo may elect to update these forward-looking statements at some point in the future, NeuroBo specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing NeuroBo's views as of any date subsequent to the date hereof. Contacts: Rx Communications GroupMichael Miller+1-917-633-6086[emailprotected] SOURCE NeuroBo Pharmaceuticals, Inc. Related Links https://www.neurobopharma.com
|
edtsum6950
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SEATTLE, May 28, 2020 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Jefferies 2020 Healthcare Conference at 2:30 p.m. EDT. The conference will be held in a virtual meeting format. Presentation details: Event: Jefferies 2020 Healthcare Conference Date: Thursday, Jun. 4 Time: 2:30 p.m. EDT The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com. AboutCTI BioPharma Corp. We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. We are headquartered in Seattle, Washington. CTI BioPharma Investor Contacts: Argot Partners Maeve Conneighton/Maghan Meyers+1-212-600-1902[emailprotected] SOURCE CTI BioPharma Corp. Related Links http://www.ctibiopharma.com
Answer:
|
CTI BioPharma to Present at the Jefferies 2020 Healthcare Conference on Thursday, Jun. 4
|
SEATTLE, May 28, 2020 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Jefferies 2020 Healthcare Conference at 2:30 p.m. EDT. The conference will be held in a virtual meeting format. Presentation details: Event: Jefferies 2020 Healthcare Conference Date: Thursday, Jun. 4 Time: 2:30 p.m. EDT The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com. AboutCTI BioPharma Corp. We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. We are headquartered in Seattle, Washington. CTI BioPharma Investor Contacts: Argot Partners Maeve Conneighton/Maghan Meyers+1-212-600-1902[emailprotected] SOURCE CTI BioPharma Corp. Related Links http://www.ctibiopharma.com
|
edtsum6951
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PORTLAND, Oregon, May 11, 2020 /PRNewswire/ -- Allied Market Research recently published a report, "Burn Care Market by Product (Advanced Burn Care, Biologics, Traditional Burn Care, and Others), Depth of Burn (Minor Burns, Partial-thickness Burns, and Full-thickness Burns), and End User (Hospitals, Physician Offices, Home Care, and Others): Global Opportunity Analysis and Industry Forecast, 20202027". According to the report, the global burn care industry was pegged at $1.99 billion in 2019, and is expected to reach $3.13 billion by 2027, growing at a CAGR of 5.6% from 2020 to 2027. Major determinants for the market growth Increase in incidence of burn injuries, rise in government expenditure on healthcare, and advancements in burn care products have boosted the growth of the global burn care market. However, high cost of advanced burn care products hampers the market growth. On the contrary, untapped markets and high growth potential in developing economies are expected to create lucrative opportunities for the market players in the coming years. Request Sample Report at https://www.alliedmarketresearch.com/request-sample/4395 COVID-19 scenario: The outbreak of COVID-19 has hugely affected the global burn care industry. Dearth of materials or finished goods coming from logistical hubs in impacted areas has impacted the supply chain, which hampered the market sale. Labor shortage due to illness or mobility restriction and shutdown in various countries have negatively impacted the production, which hindered the market growth. The advanced burn care segment held largest share The advanced burn care segment dominated the market, accounting for nearly half of the market. Moreover, the segment is expected to register the highest CAGR of 6.4% during the forecast period. This is owing to advancements in burn care products, rise in awareness programs for advanced burn care treatment & management, surge in healthcare expenditure, and increase in incidence of burn cases around the globe. Partial-thickness burns segment to manifest the fastest CAGR through 2027 The partial-thickness burns segment is projected to portray the highest CAGR of 6.1% during the study period. Moreover, the segment held the largest share in 2019, accounting for more than two-fifths of the market. This is due torise in incidence of burns & burn-related injuries, rise in usage of advanced dressings & biologics such as skin grafts & substitutes, advancements in burn care products, and increase in awareness toward the usage of advanced burn care products. North America dominated the market The market across North America held the largest share in 2019, contributing to nearly two-fifths of the market. This is due to development of technological advanced burn care products, upsurge in adoption of burn care products for the treatment of burns & burn-related injuries, change in preferences from traditional burn care products to advanced burn care products.However, the market across Asia-Pacific is expected to register the highest CAGR of 7.5% during the forecast period. This is due to rise in demand for advanced burn care products, improvement in health awareness, development in healthcare infrastructure, rise in number of laboratories with advanced medical facilities, surge in healthcare reforms, and increase in number of target population suffering from burns & burn-related injuries in emerging economies. For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4395 Major market players 3M (Acelity Inc.) Coloplast A/S B Braun Melsungen AG Essity AB (BSN Medical Gmbh) ConvaTec Group Plc Investor AB (Mlnlycke Health Care AB) Integra Lifesciences (Derma Sciences) Medtronic Plc. (Covidien) Medline Industries, Inc. Smith & Nephew Plc. Avenue Basic Plan | Library Access | 1 Year Subscription | Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan. Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter Get more information: https://www.alliedmarketresearch.com/library-access Similar Reports: Tissue Engineered Skin Substitutes Market- Global Opportunity Analysis and Industry Forecast, 2020-2027 Scar Dressings Market- Global Opportunity Analysis and Industry Forecast, 2020-2027 World Wound Care Market - Opportunities and Forecasts, 2020-2027 About Us Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact:David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesUSA/Canada (Toll Free):1-800-792-5285, 1-503-894-6022, 1-503-446-1141UK:+44-845-528-1300Hong Kong:+852-301-84916India (Pune):+91-20-66346060Fax:+1(855)550-5975[emailprotected]Web: https://www.alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research SOURCE Allied Market Research
Answer:
|
Burn Care Market to Garner $3.13 Bn, Globally, by 2027 at 5.6% CAGR: Allied Market Research Increase in incidence of burn injuries, rise in government expenditure on healthcare, and advancements in burn care products have boosted the growth of the global burn care market
|
PORTLAND, Oregon, May 11, 2020 /PRNewswire/ -- Allied Market Research recently published a report, "Burn Care Market by Product (Advanced Burn Care, Biologics, Traditional Burn Care, and Others), Depth of Burn (Minor Burns, Partial-thickness Burns, and Full-thickness Burns), and End User (Hospitals, Physician Offices, Home Care, and Others): Global Opportunity Analysis and Industry Forecast, 20202027". According to the report, the global burn care industry was pegged at $1.99 billion in 2019, and is expected to reach $3.13 billion by 2027, growing at a CAGR of 5.6% from 2020 to 2027. Major determinants for the market growth Increase in incidence of burn injuries, rise in government expenditure on healthcare, and advancements in burn care products have boosted the growth of the global burn care market. However, high cost of advanced burn care products hampers the market growth. On the contrary, untapped markets and high growth potential in developing economies are expected to create lucrative opportunities for the market players in the coming years. Request Sample Report at https://www.alliedmarketresearch.com/request-sample/4395 COVID-19 scenario: The outbreak of COVID-19 has hugely affected the global burn care industry. Dearth of materials or finished goods coming from logistical hubs in impacted areas has impacted the supply chain, which hampered the market sale. Labor shortage due to illness or mobility restriction and shutdown in various countries have negatively impacted the production, which hindered the market growth. The advanced burn care segment held largest share The advanced burn care segment dominated the market, accounting for nearly half of the market. Moreover, the segment is expected to register the highest CAGR of 6.4% during the forecast period. This is owing to advancements in burn care products, rise in awareness programs for advanced burn care treatment & management, surge in healthcare expenditure, and increase in incidence of burn cases around the globe. Partial-thickness burns segment to manifest the fastest CAGR through 2027 The partial-thickness burns segment is projected to portray the highest CAGR of 6.1% during the study period. Moreover, the segment held the largest share in 2019, accounting for more than two-fifths of the market. This is due torise in incidence of burns & burn-related injuries, rise in usage of advanced dressings & biologics such as skin grafts & substitutes, advancements in burn care products, and increase in awareness toward the usage of advanced burn care products. North America dominated the market The market across North America held the largest share in 2019, contributing to nearly two-fifths of the market. This is due to development of technological advanced burn care products, upsurge in adoption of burn care products for the treatment of burns & burn-related injuries, change in preferences from traditional burn care products to advanced burn care products.However, the market across Asia-Pacific is expected to register the highest CAGR of 7.5% during the forecast period. This is due to rise in demand for advanced burn care products, improvement in health awareness, development in healthcare infrastructure, rise in number of laboratories with advanced medical facilities, surge in healthcare reforms, and increase in number of target population suffering from burns & burn-related injuries in emerging economies. For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4395 Major market players 3M (Acelity Inc.) Coloplast A/S B Braun Melsungen AG Essity AB (BSN Medical Gmbh) ConvaTec Group Plc Investor AB (Mlnlycke Health Care AB) Integra Lifesciences (Derma Sciences) Medtronic Plc. (Covidien) Medline Industries, Inc. Smith & Nephew Plc. Avenue Basic Plan | Library Access | 1 Year Subscription | Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan. Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter Get more information: https://www.alliedmarketresearch.com/library-access Similar Reports: Tissue Engineered Skin Substitutes Market- Global Opportunity Analysis and Industry Forecast, 2020-2027 Scar Dressings Market- Global Opportunity Analysis and Industry Forecast, 2020-2027 World Wound Care Market - Opportunities and Forecasts, 2020-2027 About Us Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact:David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesUSA/Canada (Toll Free):1-800-792-5285, 1-503-894-6022, 1-503-446-1141UK:+44-845-528-1300Hong Kong:+852-301-84916India (Pune):+91-20-66346060Fax:+1(855)550-5975[emailprotected]Web: https://www.alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research SOURCE Allied Market Research
|
edtsum6958
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Dyes and Pigments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global dyes and pigments market grew at a CAGR of around 6% during 2014-2019. Looking forward, the publisher expects the global dyes and pigments market to continue its moderate growth during the next five years. Dyes and pigments refer to various coloring agents used for adding colors to commercially used textiles, papers, leathers, rubbers and other beverages. Dyes are water-soluble substances that are majorly used in a liquid form on plastics, fabrics, leather, paper and wood products. Some of the commonly available variants include disperse, reactive, azo, vat, sulfur- and solvent-based dyes. On the other hand, pigments are coloring agents available in the form of small insoluble particles that disperse in liquid paint or ink. They are usually mixed with a dispersing agent that sticks the pigment onto the surface of the material. Significant growth in the construction, chemical and pharmaceutical industries is one of the key factors creating a positive outlook for the market. Furthermore, widespread product adoption for paint and coating applications is also driving the market growth. For instance, in the textile industry, disperse dyes are primarily used to color polyesters, and cotton fabrics are colored using vat, reactive and direct dyes. The construction industry utilizes dyes and pigments for dying pavers, concrete masonry, tiles, pipes, panels and precast walls as they aid in enhancing the overall aesthetic appeal, opacity and durability of the products. Additionally, increasing environmental consciousness among the masses and the development of organic dyes and pigments are also contributing to the market growth. In comparison to the traditionally used petroleum-based inorganic dyes, natural variants are manufactured using plant-based compounds and carbon chains that do not cause pollution. This, along with various product innovations, such as the development of corrosion and ultraviolet (UV)-resistant variants, is projected to drive the market further. Companies Mentioned Key Questions Answered in This Report: Key Topics Covered: 1 Preface 2 Scope and Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Dyes and Pigments Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product Type 6.1 Dyes 6.1.1 Market Trends 6.1.2 Market Breakup by Type 6.1.2.1 Reactive Dyes 6.1.2.1.1 Market Trends 6.1.2.1.2 Market Forecast 6.1.2.2 Disperse Dye 6.1.2.2.1 Market Trends 6.1.2.2.2 Market Forecast 6.1.2.3 Sulfur Dye 6.1.2.3.1 Market Trends 6.1.2.3.2 Market Forecast 6.1.2.4 Vat Dye 6.1.2.4.1 Market Trends 6.1.2.4.2 Market Forecast 6.1.2.5 Azo Dye 6.1.2.5.1 Market Trends 6.1.2.5.2 Market Forecast 6.1.2.6 Others 6.1.2.3.1 Market Trends 6.1.2.3.2 Market Forecast 6.1.3 Market Forecast 6.2 Pigments 6.2.1 Market Trends 6.2.2 Market Breakup by Type 6.2.2.1 Organic 6.2.2.1.1 Market Trends 6.2.2.1.2 Market Forecast 6.2.2.2 Inorganic 6.2.2.2.1 Market Trends 6.2.2.2.2 Market Forecast 6.2.3 Market Forecast 7 Market Breakup by Application 7.1 Paints and Coatings 7.2 Textile 7.3 Printing Inks 7.4 Plastic Coloring 7.5 Construction Materials 7.6 Others 8 Market Breakup by Region 8.1 North America 8.2 Asia Pacific 8.3 Europe 8.4 Latin America 8.5 Middle East and Africa 9 SWOT Analysis 10 Value Chain Analysis 11 Porters Five Forces Analysis 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players For more information about this report visit https://www.researchandmarkets.com/r/vh6zqj
Answer:
|
Global Dyes and Pigments Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com
|
DUBLIN--(BUSINESS WIRE)--The "Dyes and Pigments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global dyes and pigments market grew at a CAGR of around 6% during 2014-2019. Looking forward, the publisher expects the global dyes and pigments market to continue its moderate growth during the next five years. Dyes and pigments refer to various coloring agents used for adding colors to commercially used textiles, papers, leathers, rubbers and other beverages. Dyes are water-soluble substances that are majorly used in a liquid form on plastics, fabrics, leather, paper and wood products. Some of the commonly available variants include disperse, reactive, azo, vat, sulfur- and solvent-based dyes. On the other hand, pigments are coloring agents available in the form of small insoluble particles that disperse in liquid paint or ink. They are usually mixed with a dispersing agent that sticks the pigment onto the surface of the material. Significant growth in the construction, chemical and pharmaceutical industries is one of the key factors creating a positive outlook for the market. Furthermore, widespread product adoption for paint and coating applications is also driving the market growth. For instance, in the textile industry, disperse dyes are primarily used to color polyesters, and cotton fabrics are colored using vat, reactive and direct dyes. The construction industry utilizes dyes and pigments for dying pavers, concrete masonry, tiles, pipes, panels and precast walls as they aid in enhancing the overall aesthetic appeal, opacity and durability of the products. Additionally, increasing environmental consciousness among the masses and the development of organic dyes and pigments are also contributing to the market growth. In comparison to the traditionally used petroleum-based inorganic dyes, natural variants are manufactured using plant-based compounds and carbon chains that do not cause pollution. This, along with various product innovations, such as the development of corrosion and ultraviolet (UV)-resistant variants, is projected to drive the market further. Companies Mentioned Key Questions Answered in This Report: Key Topics Covered: 1 Preface 2 Scope and Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Dyes and Pigments Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product Type 6.1 Dyes 6.1.1 Market Trends 6.1.2 Market Breakup by Type 6.1.2.1 Reactive Dyes 6.1.2.1.1 Market Trends 6.1.2.1.2 Market Forecast 6.1.2.2 Disperse Dye 6.1.2.2.1 Market Trends 6.1.2.2.2 Market Forecast 6.1.2.3 Sulfur Dye 6.1.2.3.1 Market Trends 6.1.2.3.2 Market Forecast 6.1.2.4 Vat Dye 6.1.2.4.1 Market Trends 6.1.2.4.2 Market Forecast 6.1.2.5 Azo Dye 6.1.2.5.1 Market Trends 6.1.2.5.2 Market Forecast 6.1.2.6 Others 6.1.2.3.1 Market Trends 6.1.2.3.2 Market Forecast 6.1.3 Market Forecast 6.2 Pigments 6.2.1 Market Trends 6.2.2 Market Breakup by Type 6.2.2.1 Organic 6.2.2.1.1 Market Trends 6.2.2.1.2 Market Forecast 6.2.2.2 Inorganic 6.2.2.2.1 Market Trends 6.2.2.2.2 Market Forecast 6.2.3 Market Forecast 7 Market Breakup by Application 7.1 Paints and Coatings 7.2 Textile 7.3 Printing Inks 7.4 Plastic Coloring 7.5 Construction Materials 7.6 Others 8 Market Breakup by Region 8.1 North America 8.2 Asia Pacific 8.3 Europe 8.4 Latin America 8.5 Middle East and Africa 9 SWOT Analysis 10 Value Chain Analysis 11 Porters Five Forces Analysis 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players For more information about this report visit https://www.researchandmarkets.com/r/vh6zqj
|
edtsum6964
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: JUPITER, Fla., Dec. 18, 2020 /PRNewswire/ -- G4S, the world's leading integrated global security company, today published its Asia Emerging Risks report. The report provides a comprehensive tactical overview of the preeminent risks impacting 19 of Asia's top destinations to enable organizations to deploy risk-mitigation strategies to protect their employees and assets, especially during travel. "Asia continues to be one of the world's most diverse and complicated regions with many security challenges and business opportunities, including the rise of China as an economic superpower, the impact of U.S. foreign and trade policy, internal conflicts in some countries, the COVID-19 pandemic and climate change," said Robert Dodge, President of G4S Corporate Risk Services. "Our high-level analysis is designed to provide our global clients with a relevant and accurate picture of the major and emerging security risks across the region." Produced in collaboration with Hill & Associates, a G4S company with offices and analysts across Asia, and the G4S Corporate Risk Services analyst team at the Security Risk Operations Center (SROC) in Jupiter, Florida, the report breaks down each country assessment by risk types: political stability, crime, terrorism/insurgency, civil unrest, emergency response capabilities, health and environmental threats. The Asia Emerging Risks report is the second in an annual series that highlights the highly refined analytics and global reporting capabilities of G4S Corporate Risk Services, and is a follow up to the team's Latin America Emerging Travel Risks 2019 report. G4S enables customers to gain security efficiencies by combining its offerings through the G4S Integrated Security Solutions approach. G4S works with customers to implement the Security Risk Management Model, a risk-based, data-driven approach used to oversee enterprise security and helps determine the resources clients want to protect, the potential risk exposure to these resources and the possible resolutions. About G4SG4S is the leading global, integrated security company, specializing in the provision of security services and solutions to customers. Our mission is to create material, sustainable value for our customers and shareholders by being the supply partner of choice in all our markets. G4S is quoted on the London Stock Exchange and has a secondary stock exchange listing in Copenhagen. G4S is active in around 80 countries and has around 533,000 employees. For more information about G4S, visitg4s.us. SOURCE G4S Related Links http://www.g4s.us/en-US
Answer:
|
G4S Publishes Asia Emerging Risks Report 2020 Country-by-country analysis of major and emerging travel security risks
|
JUPITER, Fla., Dec. 18, 2020 /PRNewswire/ -- G4S, the world's leading integrated global security company, today published its Asia Emerging Risks report. The report provides a comprehensive tactical overview of the preeminent risks impacting 19 of Asia's top destinations to enable organizations to deploy risk-mitigation strategies to protect their employees and assets, especially during travel. "Asia continues to be one of the world's most diverse and complicated regions with many security challenges and business opportunities, including the rise of China as an economic superpower, the impact of U.S. foreign and trade policy, internal conflicts in some countries, the COVID-19 pandemic and climate change," said Robert Dodge, President of G4S Corporate Risk Services. "Our high-level analysis is designed to provide our global clients with a relevant and accurate picture of the major and emerging security risks across the region." Produced in collaboration with Hill & Associates, a G4S company with offices and analysts across Asia, and the G4S Corporate Risk Services analyst team at the Security Risk Operations Center (SROC) in Jupiter, Florida, the report breaks down each country assessment by risk types: political stability, crime, terrorism/insurgency, civil unrest, emergency response capabilities, health and environmental threats. The Asia Emerging Risks report is the second in an annual series that highlights the highly refined analytics and global reporting capabilities of G4S Corporate Risk Services, and is a follow up to the team's Latin America Emerging Travel Risks 2019 report. G4S enables customers to gain security efficiencies by combining its offerings through the G4S Integrated Security Solutions approach. G4S works with customers to implement the Security Risk Management Model, a risk-based, data-driven approach used to oversee enterprise security and helps determine the resources clients want to protect, the potential risk exposure to these resources and the possible resolutions. About G4SG4S is the leading global, integrated security company, specializing in the provision of security services and solutions to customers. Our mission is to create material, sustainable value for our customers and shareholders by being the supply partner of choice in all our markets. G4S is quoted on the London Stock Exchange and has a secondary stock exchange listing in Copenhagen. G4S is active in around 80 countries and has around 533,000 employees. For more information about G4S, visitg4s.us. SOURCE G4S Related Links http://www.g4s.us/en-US
|
edtsum6967
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BANGALORE, India, Aug. 26, 2020 /PRNewswire/ -- Major factors that are driving the Small Cell 5G Network Market size are increased network densification, increased mobile data traffic, and the introduction of the Citizens Broadband Radio Service (CBRS) band. Furthermore, the increased spending in 5G networks by many countries also boosts the market growth. The small cell 5G network market size was valued at USD 344 Million in 2018 and is projected to reach USD 6,876 Million by 2026, growing at a CAGR of 45.3% from 2019 to 2026. View Full Report: https://reports.valuates.com/market-reports/ALLI-Manu-0A12/small-cell-5g-network COVID IMPACT ON MAJOR REGIONS In North America, the COVID-19 outbreak is expected to heavily impact the US small cell 5G network market due to its dependence on China as a major supplier of chips and equipment to the telecommunications industry. Furthermore, the blacklisting of Huawei Technologies has led to high tensions between the two countries, which will further affect market growth. In APAC, China has retained its dominant position as a global 5G pioneer, despite being the epicenter of COVID-19. The number of COVID-19 cases slowing down in China, the country is relaxing restrictions, and manufacturing firms are resuming their manufacturing facilities. Coronavirus outbreak is expected to result in increasing industrial automation implementation across processes and separate manufacturing, eCommerce, and the logistics and transport sectors. Get Detailed Analysis of COVID-19 Impact Small Cell 5G Network Market: https://reports.valuates.com/request/sample/ALLI-Manu-0A12/small_cell_5g_network TRENDS INFLUENCING THE SMALL CELL 5G NETWORK MARKET SIZE Many of the biggest countries, such as the US and China, are projected to invest heavily in health care. Furthermore, the COVID-19 pandemic has encouraged many key countries to develop more robust healthcare capabilities by investing in advanced technologies such as 5G networks. Thus, the demand to deliver constant data connectivity in telemedicine and remote patient surgeries is expected to drive the growth of small cell 5G network market size. The CBRS (Citizens Broadband Radio Service) band is the main component that drives the demand for the small cell 5G network market. Using CBRS indoor spectrum band frees up precious licensed spectrum that would otherwise need to be reserved for indoor use. CBRS small cell allows multi-operator support and provides cost-effective mobile coverage solutions for third party neutral network providers and large businesses. CBRS's small cell network simplifies network integration activities and offers a better user experience. The growing adoption of 5G technology drives the small cell 5g market size. Small cells blend well with the 5 G transition as they have improved storage efficiency and support mobile providers in reducing operating costs by minimizing costly roof structures and upgrades or leasing costs. The small cell 5G network also helps improve mobile phones' efficiency, as it transmits at a lower frequency, which essentially decreases the capacity of cell phones and improves their battery life. The advent of the Internet of Things (IoT) and preference for ultra-reliable low-latency communications are expected to provide lucrative market expansion opportunities. Small cell backhaul issues and small cell implementation problems are likely to impede the development of the small cell 5 G network industry. Inquire for Regional Report: https://reports.valuates.com/request/regional/ALLI-Manu-0A12/small_cell_5g_network SMALL CELL 5G NETWORK MARKET SHARE ANALYSIS North America held the largest small cell 5G network market share in 2018 and is expected to remain dominant during the forecast period as well. This region's dominance is attributed to the rise in strategic trails to launch 5G technologies and equipment in this region. Asia-Pacific is expected to grow at the fastest pace during the forecast period. This is attributed to a steady rise in mobile usage. Further, the increase in demand for higher bandwidth applications creates the need for 5G technology, thereby increasing the small cell 5G network market size. SMALL CELL 5G NETWORK MARKET KEY SEGMENTS BY COMPONENT Solution Service BY RADIO TECHNOLOGY Standalone Non-standalone BY FREQUENCY BAND Low-band Mid-band Millimeter Wave BY CELL TYPE Femtocells Picocells Microcells BY APPLICATION Indoor Applications Outdoor Applications KEY MARKET PLAYERS Airspan Networks Inc. Cisco Systems, Inc. CommScope Ericsson Fujitsu Limited Huawei Technologies NEC Corporation Nokia Corporation Samsung Electronics Co., Ltd. ZTE Corporation Buy Now for Single User: https://reports.valuates.com/api/directpaytoken?rcode=ALLI-Manu-0A12&lic=single-user Buy Now for Enterprise License: https://reports.valuates.com/api/directpaytoken?rcode=ALLI-Manu-0A12&lic=enterprise-license SIMILAR REPORTS : 5G Technology Market Report The global 5g technology market size is anticipated to be at USD 5.53 Billion in 2020 and is projected to reach USD 667.90 Billion by 2026, registering a CAGR of 122.3% from 2021 to 2026. Asia-Pacific would be the highest contributor to the global market, with USD 2.20 Billion in 2020, and is estimated to reach USD 329.09 Billion by 2026, registering a CAGR of 130.7% during the forecast period. View Full Report: https://reports.valuates.com/market-reports/ALLI-Manu-1C7/5g-technology 5G Infrastructure Market Report The global 5G infrastructure market size was valued at USD 371.4 Million in 2017 and is projected to reach USD 58,174.6 Million by 2025, growing at a CAGR of 95.8% from 2018 to 2025. The key drivers for the development of 5G technology market size are reduced latency, accelerated penetration of modern telecommunications network architecture, and a rise in mobile data traffic. The surge in M2M connectivity across various sectors is also projected to fuel the development of 5G Infrastructure during the predicted time frame. View Full Report: https://reports.valuates.com/market-reports/ALLI-Manu-1Z2/5g-infrastructure 5G Base Station Market Report This study analyzes the market size of 5G Base Stations by regions, nations, device types, and end industries. It also analyzes the global economic landscape, business trends and developments, prospects and threats, risks, and obstacles to competition, sales networks, retailers, and Porter's Five Powers Research. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-0E151/global-5g-base-station 5G Market Report The global 5G market size in 2020 will be 4296 Million dollars and is anticipated to grow exponentially by 2024, with a 56.7 % CAGR in 2020-2024 Increasing demand for mobile consumer bandwidth and connectivity for IoT and sensor devices for smart city applications, together with emerging applications such as Augmented Reality (AR) and self-driving cars, fuel the growth of the 5G market size during the forecast period. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-0Z147/global-5g Picocell and Femtocell Market Report The less power consumption of femtocell networks is expected to be the major factor driving Picocell and Femtocell Market size during the forecast period. View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-7Q1304/global-picocell-femtocell-and-microcell Mobile Phones based 5G Network Market Report View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-9A1236/global-mobile-phones-based-5g-network ABOUT US: Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs. Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs. To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources CONTACT US:Valuates Reports[emailprotected] For U.S. Toll-Free Call 1-(315)-215-3225For IST Call +91-8040957137WhatsApp : +91 9945648335Website:https://reports.valuates.comTwitter - https://twitter.com/valuatesreportsLinkedin - https://in.linkedin.com/company/valuatesreportsFacebook - https://www.facebook.com/valuatesreports SOURCE Valuates Reports
Answer:
|
Small Cell 5G Network Market Size is Projected to Reach USD 6,876 Million by 2026 - Valuates Reports English English
|
BANGALORE, India, Aug. 26, 2020 /PRNewswire/ -- Major factors that are driving the Small Cell 5G Network Market size are increased network densification, increased mobile data traffic, and the introduction of the Citizens Broadband Radio Service (CBRS) band. Furthermore, the increased spending in 5G networks by many countries also boosts the market growth. The small cell 5G network market size was valued at USD 344 Million in 2018 and is projected to reach USD 6,876 Million by 2026, growing at a CAGR of 45.3% from 2019 to 2026. View Full Report: https://reports.valuates.com/market-reports/ALLI-Manu-0A12/small-cell-5g-network COVID IMPACT ON MAJOR REGIONS In North America, the COVID-19 outbreak is expected to heavily impact the US small cell 5G network market due to its dependence on China as a major supplier of chips and equipment to the telecommunications industry. Furthermore, the blacklisting of Huawei Technologies has led to high tensions between the two countries, which will further affect market growth. In APAC, China has retained its dominant position as a global 5G pioneer, despite being the epicenter of COVID-19. The number of COVID-19 cases slowing down in China, the country is relaxing restrictions, and manufacturing firms are resuming their manufacturing facilities. Coronavirus outbreak is expected to result in increasing industrial automation implementation across processes and separate manufacturing, eCommerce, and the logistics and transport sectors. Get Detailed Analysis of COVID-19 Impact Small Cell 5G Network Market: https://reports.valuates.com/request/sample/ALLI-Manu-0A12/small_cell_5g_network TRENDS INFLUENCING THE SMALL CELL 5G NETWORK MARKET SIZE Many of the biggest countries, such as the US and China, are projected to invest heavily in health care. Furthermore, the COVID-19 pandemic has encouraged many key countries to develop more robust healthcare capabilities by investing in advanced technologies such as 5G networks. Thus, the demand to deliver constant data connectivity in telemedicine and remote patient surgeries is expected to drive the growth of small cell 5G network market size. The CBRS (Citizens Broadband Radio Service) band is the main component that drives the demand for the small cell 5G network market. Using CBRS indoor spectrum band frees up precious licensed spectrum that would otherwise need to be reserved for indoor use. CBRS small cell allows multi-operator support and provides cost-effective mobile coverage solutions for third party neutral network providers and large businesses. CBRS's small cell network simplifies network integration activities and offers a better user experience. The growing adoption of 5G technology drives the small cell 5g market size. Small cells blend well with the 5 G transition as they have improved storage efficiency and support mobile providers in reducing operating costs by minimizing costly roof structures and upgrades or leasing costs. The small cell 5G network also helps improve mobile phones' efficiency, as it transmits at a lower frequency, which essentially decreases the capacity of cell phones and improves their battery life. The advent of the Internet of Things (IoT) and preference for ultra-reliable low-latency communications are expected to provide lucrative market expansion opportunities. Small cell backhaul issues and small cell implementation problems are likely to impede the development of the small cell 5 G network industry. Inquire for Regional Report: https://reports.valuates.com/request/regional/ALLI-Manu-0A12/small_cell_5g_network SMALL CELL 5G NETWORK MARKET SHARE ANALYSIS North America held the largest small cell 5G network market share in 2018 and is expected to remain dominant during the forecast period as well. This region's dominance is attributed to the rise in strategic trails to launch 5G technologies and equipment in this region. Asia-Pacific is expected to grow at the fastest pace during the forecast period. This is attributed to a steady rise in mobile usage. Further, the increase in demand for higher bandwidth applications creates the need for 5G technology, thereby increasing the small cell 5G network market size. SMALL CELL 5G NETWORK MARKET KEY SEGMENTS BY COMPONENT Solution Service BY RADIO TECHNOLOGY Standalone Non-standalone BY FREQUENCY BAND Low-band Mid-band Millimeter Wave BY CELL TYPE Femtocells Picocells Microcells BY APPLICATION Indoor Applications Outdoor Applications KEY MARKET PLAYERS Airspan Networks Inc. Cisco Systems, Inc. CommScope Ericsson Fujitsu Limited Huawei Technologies NEC Corporation Nokia Corporation Samsung Electronics Co., Ltd. ZTE Corporation Buy Now for Single User: https://reports.valuates.com/api/directpaytoken?rcode=ALLI-Manu-0A12&lic=single-user Buy Now for Enterprise License: https://reports.valuates.com/api/directpaytoken?rcode=ALLI-Manu-0A12&lic=enterprise-license SIMILAR REPORTS : 5G Technology Market Report The global 5g technology market size is anticipated to be at USD 5.53 Billion in 2020 and is projected to reach USD 667.90 Billion by 2026, registering a CAGR of 122.3% from 2021 to 2026. Asia-Pacific would be the highest contributor to the global market, with USD 2.20 Billion in 2020, and is estimated to reach USD 329.09 Billion by 2026, registering a CAGR of 130.7% during the forecast period. View Full Report: https://reports.valuates.com/market-reports/ALLI-Manu-1C7/5g-technology 5G Infrastructure Market Report The global 5G infrastructure market size was valued at USD 371.4 Million in 2017 and is projected to reach USD 58,174.6 Million by 2025, growing at a CAGR of 95.8% from 2018 to 2025. The key drivers for the development of 5G technology market size are reduced latency, accelerated penetration of modern telecommunications network architecture, and a rise in mobile data traffic. The surge in M2M connectivity across various sectors is also projected to fuel the development of 5G Infrastructure during the predicted time frame. View Full Report: https://reports.valuates.com/market-reports/ALLI-Manu-1Z2/5g-infrastructure 5G Base Station Market Report This study analyzes the market size of 5G Base Stations by regions, nations, device types, and end industries. It also analyzes the global economic landscape, business trends and developments, prospects and threats, risks, and obstacles to competition, sales networks, retailers, and Porter's Five Powers Research. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-0E151/global-5g-base-station 5G Market Report The global 5G market size in 2020 will be 4296 Million dollars and is anticipated to grow exponentially by 2024, with a 56.7 % CAGR in 2020-2024 Increasing demand for mobile consumer bandwidth and connectivity for IoT and sensor devices for smart city applications, together with emerging applications such as Augmented Reality (AR) and self-driving cars, fuel the growth of the 5G market size during the forecast period. View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-0Z147/global-5g Picocell and Femtocell Market Report The less power consumption of femtocell networks is expected to be the major factor driving Picocell and Femtocell Market size during the forecast period. View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-7Q1304/global-picocell-femtocell-and-microcell Mobile Phones based 5G Network Market Report View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-9A1236/global-mobile-phones-based-5g-network ABOUT US: Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs. Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs. To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources CONTACT US:Valuates Reports[emailprotected] For U.S. Toll-Free Call 1-(315)-215-3225For IST Call +91-8040957137WhatsApp : +91 9945648335Website:https://reports.valuates.comTwitter - https://twitter.com/valuatesreportsLinkedin - https://in.linkedin.com/company/valuatesreportsFacebook - https://www.facebook.com/valuatesreports SOURCE Valuates Reports
|
edtsum6969
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON, March 8, 2021 /PRNewswire/ -Seaspan Corporation ("Seaspan"), a wholly owned subsidiary of Atlas Corp. ("Atlas") (NYSE: ATCO), today announced that it has entered into agreements with a major shipyard for six 15,000 TEU containership newbuilds. The modern high-quality containerships are anticipated to begin deliveries in the fourth quarter of 2023, and upon completion will enter long-term charters with a global liner. Bing Chen, Chairman, President and CEO of Seaspan, commented, "With our recently announced 31 newbuilds, it is a strong testament to the trust our customers have in our long-term partnerships. I am extremely proud of our team who has flawlessly executed these complex projects leveraging our operational excellence and fully integrated platform. I am confident that the relentless focus on our core competencies prove our resiliency and ability to achieve quality growth despite all market challenges and cycles." The containerships are anticipated to be financed from existing liquidity and additional borrowings. Seaspan continues to enhance its fleet composition with continued focus on its core 10,000 to 15,000 TEU size category. Since December 2020 and including this announcement, Seaspan has announced 31 newbuild orders and the acquisition of two second-hand vessels built in 2019. Newbuilds Secondary Market Total Vessels Total TEU 12,000 TEU 4 - 4 48,000 12,200 TEU 5 - 5 61,000 15,000 TEU 10 2 12 180,000 15,000 TEU LNG 10 - 10 150,000 24,000 TEU 2 - 2 48,000 Total 31 2 33 487,000 About Atlas Atlas is a leading global asset management company, differentiated by its position as a best-in-class owner and operator with a focus on deploying capital to create sustainable shareholder value. Atlas brings together an experienced asset management team with deep operational and capital allocation experience. We target long-term, risk adjusted returns across high-quality infrastructure assets in the maritime sector, energy sector and other infrastructure verticals. Our two portfolio companies, Seaspan Corporation and APR Energy are unique, industry-leading operating platforms in the global maritime and energy spaces, respectively. For more information visit atlascorporation.com About Seaspan Seaspan is a leading independent owner and operator of containerships with industry leading ship management services. We charter our vessels primarily pursuant to long-term, fixed-rate, time charters to the world's largest container shipping liners. As of September 30, 2020, Seaspan's fleet consists of 127 containerships, representing total capacity of approximately 1,073,000 TEU. Seaspan's operating fleet of vessels has an average age of approximately seven years and an average remaining lease period of approximately four years, on a TEU-weighted basis. For more information visit seaspancorp.com Cautionary Note Regarding Forward-Looking Statements This release contains certain forward-looking statements (as such term is defined in Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events, including forward-looking statements regarding the expected benefits of the newbuild orders to Atlas's financial condition and results from operations. Statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "expects", "anticipates", "intends", "plans", "believes", "estimates", "projects", "forecasts", "will", "may", "potential", "should", and similar expressions are forward-looking statements. These forward-looking statements reflect management's current expectations only as of the date of this release. As a result, you are cautioned not to rely on any forward-looking statements. Although these statements are based upon assumptions we believe to be reasonable based upon available information, they are subject to risks and uncertainties. These risks and uncertainties include but are not limited to: the potential for early termination of the charters and Seaspan's inability to replace them; the possibility that we will not be able to continue to execute on our growth strategy; and other factors detailed from time to time in our periodic reports and filings with the Securities and Exchange Commission, including Atlas's Annual Report on Form 20-F for the year ended December 31, 2019. We expressly disclaim any obligation to update or revise any of these forward-looking statements, whether because of future events, new information, a change in our views or expectations, or otherwise. We make no prediction or statement about the performance of any of our securities. SOURCE Atlas Corp. Related Links http://www.seaspancorp.com/
Answer:
|
Seaspan Continues to Execute Quality Growth Strategy with Order for Six Containership Newbuilds
|
LONDON, March 8, 2021 /PRNewswire/ -Seaspan Corporation ("Seaspan"), a wholly owned subsidiary of Atlas Corp. ("Atlas") (NYSE: ATCO), today announced that it has entered into agreements with a major shipyard for six 15,000 TEU containership newbuilds. The modern high-quality containerships are anticipated to begin deliveries in the fourth quarter of 2023, and upon completion will enter long-term charters with a global liner. Bing Chen, Chairman, President and CEO of Seaspan, commented, "With our recently announced 31 newbuilds, it is a strong testament to the trust our customers have in our long-term partnerships. I am extremely proud of our team who has flawlessly executed these complex projects leveraging our operational excellence and fully integrated platform. I am confident that the relentless focus on our core competencies prove our resiliency and ability to achieve quality growth despite all market challenges and cycles." The containerships are anticipated to be financed from existing liquidity and additional borrowings. Seaspan continues to enhance its fleet composition with continued focus on its core 10,000 to 15,000 TEU size category. Since December 2020 and including this announcement, Seaspan has announced 31 newbuild orders and the acquisition of two second-hand vessels built in 2019. Newbuilds Secondary Market Total Vessels Total TEU 12,000 TEU 4 - 4 48,000 12,200 TEU 5 - 5 61,000 15,000 TEU 10 2 12 180,000 15,000 TEU LNG 10 - 10 150,000 24,000 TEU 2 - 2 48,000 Total 31 2 33 487,000 About Atlas Atlas is a leading global asset management company, differentiated by its position as a best-in-class owner and operator with a focus on deploying capital to create sustainable shareholder value. Atlas brings together an experienced asset management team with deep operational and capital allocation experience. We target long-term, risk adjusted returns across high-quality infrastructure assets in the maritime sector, energy sector and other infrastructure verticals. Our two portfolio companies, Seaspan Corporation and APR Energy are unique, industry-leading operating platforms in the global maritime and energy spaces, respectively. For more information visit atlascorporation.com About Seaspan Seaspan is a leading independent owner and operator of containerships with industry leading ship management services. We charter our vessels primarily pursuant to long-term, fixed-rate, time charters to the world's largest container shipping liners. As of September 30, 2020, Seaspan's fleet consists of 127 containerships, representing total capacity of approximately 1,073,000 TEU. Seaspan's operating fleet of vessels has an average age of approximately seven years and an average remaining lease period of approximately four years, on a TEU-weighted basis. For more information visit seaspancorp.com Cautionary Note Regarding Forward-Looking Statements This release contains certain forward-looking statements (as such term is defined in Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events, including forward-looking statements regarding the expected benefits of the newbuild orders to Atlas's financial condition and results from operations. Statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "expects", "anticipates", "intends", "plans", "believes", "estimates", "projects", "forecasts", "will", "may", "potential", "should", and similar expressions are forward-looking statements. These forward-looking statements reflect management's current expectations only as of the date of this release. As a result, you are cautioned not to rely on any forward-looking statements. Although these statements are based upon assumptions we believe to be reasonable based upon available information, they are subject to risks and uncertainties. These risks and uncertainties include but are not limited to: the potential for early termination of the charters and Seaspan's inability to replace them; the possibility that we will not be able to continue to execute on our growth strategy; and other factors detailed from time to time in our periodic reports and filings with the Securities and Exchange Commission, including Atlas's Annual Report on Form 20-F for the year ended December 31, 2019. We expressly disclaim any obligation to update or revise any of these forward-looking statements, whether because of future events, new information, a change in our views or expectations, or otherwise. We make no prediction or statement about the performance of any of our securities. SOURCE Atlas Corp. Related Links http://www.seaspancorp.com/
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.